View
5
Download
0
Category
Preview:
Citation preview
MOH/P/IKN/01.16 (AR)
MALAYSIAN NATIONALCANCER REGISTRY REPORT
2007-2011
MOH/P/IKN/01.16 (AR)
Azizah Ab M *, Nor Saleha I.T**, Noor Hashimah A***, Asmah Z.A****, Mastulu W*****
*Penang State Health Department, ** Disease Control Division, MOH, ***Kelantan State Health Department, ****Perak State Health Department, *****Sarawak State Health Department
Non Communicable Disease Sector Disease Control Division
Ministry Of Health MALAYSIA
National Cancer Institute Ministry Of Health
PutrajayaMALAYSIA
Published by the National Cancer Institute,Ministry of Health, No 4, Jalan P7, Presint 7,62250 Putrajaya, MALAYSIATel: (603) 88925555Fax: (603) 88925625© National Cancer Registry, June 2015
http://nci.moh.gov.my
Year of Publication: 2016Copyright © Ministry of Health MalaysiaAll rights reserved. This report may not be reproduced,in whole or in part, in any form or means, electronic or mechanical, including photocopying, without written permission from publisher
EDITORIAL BOARD:
CHIEF EDITOR: Dr. Azizah Ab Manan, MBBS, MPH
Public Health Physician & State Epidemiologist (NCDC), Penang State Health Department
EDITORS: Dr. Nor Saleha Ibrahim Tamin, MD, MPH
Public Health Physician & Senior Principal Assistant Director (Head of Cancer Unit)Non-Communicable Disease Sector, Ministry Of Health
Dr. Noor Hashimah Abdullah, MD, MPHPublic Health Physician & State Epidemiologist (NCDC), Kelantan State Health Department
Dr. Asmah Zainal Abidin, MD, MPHPublic Health Physician & State Epidemiologist (NCDC), Perak State Health Department
Mastulu WahabMedical Record Assistant, Sarawak State Health Department
SUPPORTING EDITORS:Dr. Misliza Ahmad, MBBS, MPH
Public Health Physician & State Epidemiologist (NCDC) Wilayah Persekutuan Kuala Lumpur & Putrajaya State Health Department
Dr. Renuga K. RamanMedical Officer & Coordinator of Cancer Registry Unit, National Cancer Institute, Putrajaya
Dr. Nabihah AliMedical Officer, Cancer Registry Unit, National Cancer Institute, Putrajaya
Dr. Puteri Nureylia AmirMedical Officer, Cancer Registry Unit, National Cancer Institute, Putrajaya
Wan Roslida OthmanStatistician, Health Informatic Centre, Ministry Of Health, Putrajaya
SUPPORTING STAFF:Dr. Ruzawati Zahri
Medical Officer (NCDC), Pahang State Health Department
Salina Asha’ariStaff Nurse, Cancer Registry Unit, National Cancer Institute, Putrajaya
Nik Zanariah Nik ManAdministrator Assistant, Kelantan State Health Department
Muhammad Izzat Mat IsaAssistant Medical Officer, Kuala Lumpur & Putrajaya State Health Department
Mohd Hafiz IshakAssistant Environmental Health Officer, Selangor State Health Department
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
CONTENTSPREFACEFOREWORDMESSAGEACKNOWLEDGEMENT SECRETARIATLIST OF TABLES LIST OF FIGURESLIST OF APPENDICES 1.0 OVERVIEW 2.0 INTRODUCTION 3.0 BACKGROUND 3.1. Geography 3.2. Population 3.3. Health status, socioeconomic and health facilities 3.4. Cancer Death Certification 4.0 METHODS 4.1. Sources of data 4.2. Data collection 4.3. Registration procedure 4.4. Quality control 4.5. Description of statistical methods 5.0 RESULTS 5.1. Overall cancer incidence 5.2. Cancer trends 5.3. Incidence of ten most common cancers 5.4. Age variations 5.5. Age groups and cancers 5.6. Ethnic variations 5.7. Staging 5.8. Data Quality 6.0 INCIDENCE SUMMARY TABLES: All Sites, 2007-2011 7.0 COMMENTARY ON 15 SELECTED CANCER SITES 7.1. Female Breast C50 7.2. Colorectal C18-C21 7.3. Trachea, Bronchus, Lung C33-C34 7.4. Lymphoma C81-C85, C96 7.5. Nasopharynx C11 7.6. Leukaemia C91-C95 7.7. Cervix Uteri C53 7.8. Liver C22 7.9. Ovary C56 7.10. Stomach C16 7.11. Prostate C61 7.12. Other skin C44 7.13. Thyroid C73 7.14. Brain, nervous system C70-C72 7.15. Corpus Uteri C54 REFERENCESAPPENDICES
iiiiivvixxi
xiiixv
1
2
2357
888
1111
1315161821232829
31
333639424447505356596265676971
7374
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
ii
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
PREFACE
This is the first 5-year report of the Malaysian National Cancer Registry (MNCR) since it was established in all states in 2007 under the Public Health Division, Ministry of Health. The report is based on new cancers diagnosed for the period of 1st January 2007 through to 31st December 2011 and registered by state registries. The data reported in this report were as they stood on 1st June 2015.
The cancer registry database is dynamic, and the data are continually updated in the light of the most recent available information. Accordingly, the numbers in this report for the earlier years may vary slightly from those in previous publications.
The value of cancer registries will be enhanced when they are linked with other well established international databases as these will help to profile the different types of cancers and how such cancers are linked with the specific environmental, socio-cultural, ethnic and other related characteristic inherent in a specific population or defined geographical area. In this report we made the international comparisons with Singapore (Singapore Cancer Registry, Interim Report: Trends in Cancer Incidence in Singapore 2009 – 2013) and with other countries (Cancer Incidence in Five Continents Volume X, 2014).
The registry collects and disseminates reliable population-based cancer data to assist in the planning of services and in the prevention and treatment of cancer. In addition, timely, accurate, reliable and validated information on cancers occurring in the country is crucial in the planning of effective preventive and management strategies for cancer. There will also be research opportunities for those who are keen to study more about the aetiology of common cancers in our population or to look for more innovative ways of diagnosing or treat patients with specific cancers.
Much time and effort has been put into accuracy, completeness and data quality, in the process of collecting the data and in preparing this report. We sincerely hope that the data in this report would be used as a referencematerial.
We wish to record our thanks to all participating hospitals, clinics, institutions, and laboratories for their corporation and regular notifications to the respective state cancer registries. We also wish to extend our appreciation to Health Informatics Centre (HIC), Ministry of Health for their assistance in active searching of cancer data. Lastly, our deep appreciation to National Cancer Institute staff especially Dr Gerard Lim Chin Chye and Cancer Registry Unit for giving us the full support during the preparation of this report.
FOREWORD
Staff from both central and state agencies have worked hard, in ensuring the validity of the data which has been gathered. Appreciation is mentioned particularly to Dr. Azizah Abd Manan, Dr. Nor Saleha, Dr. Noor Hashimah, and Dr. Asmah Zainal Abidin and other state epidemiology officers and staff, staff of Cancer Registry Unit of National Cancer Institute (NCI), Health Informatic Centre (PIK) and all who have been contributing in one way or another towards the production of this report. Special mention is made to Dr. Noor Hashimah for allowing the use of her template in the analysis of the data.
Much time and effort has been put into the process of collecting data and ensuring its accuracy, completeness and quality by the National Cancer Registry. It is hoped that this report can provide an insight on cancer incidence in Malaysia which can be used by the health authorities, service providers and researchers. Cancer Registries are crucial in any Cancer Control Programme as the data in the Cancer Registries are needed in developing strategies in primary, secondary and tertiary prevention, as well as health care planning and planning for patient care and research.
The following actions can be taken to improve the future reports: establishing closer rapport with all the Source Data Providers (SDP’s), providing feedback regularly to respective SDP’s including their performance, regular road shows and strengthening human resource. To strengthen and sustain population based cancer registries according to international standards requires meticulous planning, cooperation of medical institutions, dedicated andcommitted personnel, and adequate resources.
We look forward to further developments of the National Cancer Registry.
Thank you.
DR. GERARD LIM CHIN CHYEHead of Department, Department of Radiotherapy and Oncology National Cancer Institute, Putrajaya
In 2002, the National Cancer Registry (NCR) was operating under the ClinicalResearch Centre (CRC). In 2007, the NCR and the Regional Cancer Registries were merged and managed by the Non-Communicable Disease Sector, Disease Control Division of the Ministry of Health.
This will be the first Report of the National Cancer Registry that is published after the National Cancer Institute took over as the secretariat on 1st January 2015. The National Cancer Registry will be reporting on Cancer Incidence of Malaysia. Much work has already been carried out by the Disease Control Division of the Ministry of Health, together with the State Epidemiology officers and staff of the State Health Departments.
iii
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
iv
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
FOREWORD
risk factors and advances in cancer care.
The Government will intensify its efforts to increase quality of health care by targeting the areas that has lack of access to health services by uplifting the capacity of healthcare facilities, and trained health personnel.
Regional Cancer Registries such as Penang, Johor, Kelantan, Pahang, Melaka, Sabah and Sarawak have each published a 5-year report. The Penang Cancer Registry has published its third 5-year report since it wasestablished in 1994; its report has also been included in the Cancer Incidence in Five Continents Volume IX, 2007 and Volume X, 2014.
We thank all the physicians, epidemiologists, pathologists, statisticians and data managers in hospitals, State Cancer Registries and Ministry of Health who have effortlessly collaborated and cooperated in supporting the Malaysia Cancer Registry. Our special thanks for this publication go to all our data managers who have worked so meticulously to compile the present information. We are also grateful to all of our close collaborators and look forward to continue this effort.
I would also like to acknowledge and place on record the excellent teamwork by members of the Cancer Unit of Disease Control Division, Health Informatics Centre (Pusat Informatik Kesihatan), the State Epidemiology Officers (NCDC) and staff, and Cancer Registry Unit of National Cancer Institute who have been involved in producing, gathering and processing the data for the Malaysia Cancer Registry. The close rapport between the source data providers, experts and staff of the NCR is one of the main reasons for the success of the NCR. We look forward to continuation of these efforts in providing reliable national data on cancer.
Thank you.
This 5-year Malaysian National Cancer Registry (MNCR) report, which covers the years 2007 to 2011, is another milestone in the development of healthcare services in this country, whereby it will enable us to appreciate the overallcancer incidence and burden in Malaysia.
The report from this registry will facilitates the planning and institutionalisation of appropriate measures and the distribution of cancer care. The overall benefits derived from this result will be reflected in our ability to provideeffective healthcare services which is in line with the 11th Malaysia Plan(RMK-11). Cancer trends represent a subtle interplay between incidence,mortality and survival. These patterns are altering due to many interacting causes such as early detection, screening programmes, changing exposure to
v
MESSAGE
In 2013, World Health Organization (WHO) had launched the global action plan for the prevention and control of non-communicable disease 2013-2020 that aims to reduce premature mortality from cancer and other NCDCs by 25%. The World Health Organization Members State agreed that among the indicators of progress in the fight against NCDCs is the need to record “cancer incidence, by type of cancer, per 100,000 populations”, thus placing an onus on countries to establish population- based cancer registries and to report on the progress.
The National Cancer Registry provides important epidemiological data of cancers, cancer burdens, trending and high risk group identification. The National Cancer Registry is one of the key priorities in the National CancerControl Blueprint 2008-2015. Previously the National Cancer Registry was run by the Disease Control Division at the Ministry of Health until 2014. Since January 2015, the NCR is now within the jurisdiction of the National Cancer Institute, Putrajaya. Data for the year 2015 and onwards will be handled and managed by the NCI, Cancer Registry Unit.
Cancer registration should never be a goal in itself. The global objective is to improve the quality of life for cancer survivors and outcome of cancer treatments. Registration takes into account prognostic variables and allowsindividual feedback to all cancer centres on process and outcome indicators. Joint venture researches and the use of cancer registry data by researchers show that the effort invested by all authorities involved in public health has been successful. Let us continue this path to be at par with international examples on population- based cancer researches.
Thank you.
DATUK SERI DR. S. SUBRAMANIAMMinister of Health, MALAYSIA
Cancer constitutes an enormous burden on societies globally. The occurrence of cancer is increasing because of growth and aging of the population, as well as anincreasing prevalence of established risk factors such as smoking, overweight, physical inactivity and changing reproductive patterns associated with urbanization and economic development. According to WHO, cancer is among the leadingcauses of morbidity and mortality worldwide with approximately 14 million newcases and 8.2 million cancer related deaths in 2012. More than 60% of the world’s total new annual cases occur in Africa, Asia and Central and South America. These regions account of 70% of the world’s cancer deaths. It is expected that annual cancer cases will escalate from 14 million in 2012 to 22 million within the next 2 decades.
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
vi
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
ACKNOWLEDGEMENT
We would like to express gratitude to all individuals and organisations that have directly or indirectly contributed to the Malaysian National Cancer Registry Report, 2007-2011.
We would like to thank especially the following:
The Honourable Minister of Health Malaysia, Y.B. Datuk Seri Dr. S. Subramaniam. Director General of Health Malaysia, YBhg. Datuk Dr. Noor Hisham Bin Abdullah. Deputy Director General of Health Malaysia (Public Health), YBhg. Datuk Dr. Lokman Hakim b. Sulaiman. Deputy Director General of Health Malaysia (Medical), YBhg. Datuk Dr. Jeyaindran Tan Sri Sinnadurai. Deputy Director General of Health Malaysia (Research & Technical Support), YBhg. Datuk Dr. Shahnaz Bt. Murad. Head of Department, Department of Radiotherapy and Oncology, National Cancer Institute, Putrajaya, Dr. Gerard Lim Chin Chye. Deputy Director Health Informatics Centre, Planning Division, Ministry of Health, Malaysia, Dr. Md. Khadzir b Sheikh Haji Ahmad State Health Directors. Deputy State Directors. Oncologists, pathologists, other disciplines specialists, palliative care professionals, and all other members of the medical profession from various government, universities, non-government and private centres. Director of National Registration Department. Medical record departments of all hospitals. All hospitals, institutions, public and private clinics.
We also would like to express our gratitude to all states Epidemiology Officers (NCDCC), Medical Officers,Statisticians, Paramedics, Assistant Record Officers and Clerical Staff at all State Cancer Registries, forcontinuously collecting and contributing data to the National Cancer Registry.
Epidemiologist and Medical Officer of State Cancer Registries:
Dr. Zulhizzam Hj. Abdullah Public Health Physician & State Epidemiologist (NCDC), Perlis State Health Department
Dr. Husna Hakimah Tajau Rahim Medical Officer (NCDC), Perlis State Health Department
Dr. Shahrul Bariyah Ahmad Public Health Physician & State Epidemiologist (NCDC), Kedah State Health Department
Dr. Muhamad Fadhil Mohamad Marzuki Medical Officer (NCDC), Kedah State Health Department
Dr. Azizah Ab Manan Public Health Physician & State Epidemiologist (NCDC), Penang State Health Department
Dr. Muhammad Ihsan Suhaidi Medical Officer (NCDC), Penang State Health Department
1.2.3.4.5.
6.
7.
8.9.10.
11.12.13.
1.
2.
3.
vii
Dr. Asmah Zainal Abidin Public Health Physician & State Epidemiologist (NCDC), Perak State Health Department
Dr. Norli Abd Jabbar Public Health Physician & State Epidemiologist (NCDC), Selangor State Health Department
Dr. Ozrinalifah Omar Medical Officer (NCDC), Selangor State Health Department
Dr. Misliza Ahmad Public Health Physician & State Epidemiologist (NCDC), WP. Kuala Lumpur (WPKL) & Putrajaya State Health Department
Dr. Khalijah Mohd Yusof Public Health Physician & State Epidemiologist (NCDC), Negeri Sembilan State Health Department
Dr. Murni Hayati Baharom Medical Officer (NCDC), Negeri Sembilan State Health Department
Dr. Suhaila Osman Public Health Physician & State Epidemiologist (NCDC), Melaka State Health Department
Dr. Yusmah Muhamad Public Health Physician & State Epidemiologist (NCDC), Johor State Health Department
Dr. Rahayu Othman Medical Officer (NCDC), Johor State Health Department
Dr. Fatimah A. Majid Public Health Physician & State Epidemiologist (NCDC), Pahang State Health Department
Dr. Ruzawati Zahri Medical Officer (NCDC), Pahang State Health Department
Dr. Fatimah Muda Public Health Physician & State Epidemiologist (NCDC), Terengganu State Health Department
Dr. Noor Hashimah Abdullah Public Health Physician & State Epidemiologist (NCDC), Kelantan State Health Department
Dr. Hashimah Basri Public Health Physician & State Epidemiologist (NCDC), Sarawak State Health Department
Dr. Nirmal Kaur A/P Sadhu Singh Public Health Physician & State Epidemiologist (NCDC), Sabah State Health Department
Dr. Nafisah Ahmad Medical Officer (NCDC), Sabah State Health Department
Dr. Wan Mohd Harith Wan Mustapa Medical Officer (NCDC), W.P. Labuan State Health Department
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
viii
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Special gratitude to all stakeholders for their support and valuable comments on the report:
Dato’ Dr. Abd Jamil Abdullah National Advisor for Surgery, Sultanah Nur Zahirah Hospital
Dr. Arni Talib National Advisor for Pathology, Kuala Lumpur Hospital
Dr. Azura Daniel Head of Department, Department of Radiotherapy & Oncology, Kuala Lumpur Hospital
Dato’ Dr. Chang Kian Meng National Advisor for Hematology, Ampang Hospital
Prof. Dr. Cheong Soon Keng Dean of Medical & Health Science Faculty, Tunku Abdul Rahman University
Dato’ Dr. Fitjerald Henry National Advisor for Colorectal Surgery, Selayang Hospital
Assc. Prof. Dato’ Dr. Fuad Ismail Head of Department, Department of Radiotherapy & Oncology, Universiti Kebangsaan Malaysia Medical Centre
Dato’ Dr. Ghazali Ismail National Advisor for Gynaecology Oncology, Sultan Ismail Hospital
Dr. Goh Pik Pin Director of National Clinical Research Centre
Dr. Hishamshah Mohd Ibrahim National Advisor for Paediatric Oncology, Kuala Lumpur Hospital
Dr. Jamaiyah Haniff Head of Unit, Malaysia Health Care Performance
Dr. Jamalul Azizi Abdul Rahaman National Advisor for Respiratory Medicine, Serdang Hospital
Dr. Krishnan Raman National Advisor for Hepatobiliary Surgery, Selayang Hospital
Dr. Lim Teck Onn Senior Consultant, ClinResearch Sdn. Bhd.
Dr. Matin Mellor Abdullah President of Malaysian Oncology Society, Subang Jaya Medical Centre
Dr. Mohd Roslan Haron National Advisor for Radiotherapy & Oncology, Sultan Ismail Hospital
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
ix
Dato’ Dr. Muhammad Radzi Abu Hassan National Advisor for Gastroenterology, Sultanah Bahiyah Hospital
Dato’ Sri Dr. N. Premchandran National Advisor for Orthopaedic Surgery, Tengku Ampuan Hafzan Hospital
Dr. Nor Aina Emran National Advisor for Breast and Endocrine Surgery, Kuala Lumpur Hospital
Prof. Dr. Nur Aishah Mohd Taib Breast Surgeon, Department of Surgery, University Malaya Medical Centre
Dr. Richard Lim Boon Leong National Advisor for Palliative Medicine, Selayang Hospital
Dato’ Dr. Rohan Malek Dato’ Dr. Johan Thambu National Advisor for Urology, Selayang Hospital
Dr. Saunthari Somasundram President of National Cancer Society of Malaysia
Datin Dr. Siti Sabzah Mohd Hashim National Advisor for Otolaryngology, Sultanah Bahiyah Hospital
Prof. Dr. Teo Soo Hwang Cancer Research Initiatives Foundation (CARIF), Subang Jaya Medical Centre
Gratitude also to the international reviewers:
Mr. Les Mery (International Agency for Research on Cancer, Lyon, France) Global Programme Manager, Global Initiative for Cancer Registry Development.
Dr. Suleeporn Sangrajrang (NCI Bangkok, Thailand) Medical Scientist, Expert Level Deputy Director, Health System Development, National Cancer Institute, Thailand.
To all others who had contributed directly and indirectly towards this report.
17.
18.
19.
20.
21.
22.
23.
24.
25.
1.
2.
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
x
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
SECRETARIAT
The National Cancer Registry (NCR) previously was under the Non-Communicable Disease Sector, DiseaseControl Division, at the Ministry of Health. Since January 2015, its secretariat had been transferred to the National Cancer Institute in Putrajaya.
Secretariat of the National Cancer Registry (2007 - 2014)
Dr. Chong Chee Kheong Director of Non-Communicable Disease Sector, Disease Control Division, Ministry of Health
Dr. Zainal Ariffin Omar Deputy Director of Non-Communicable Disease Sector, Disease Control Division, Ministry of Health
Dr. Nor Saleha Ibrahim Tamin Head of Cancer Unit, Non-Communicable Disease Sector, Disease Control Division, Ministry of Health
Dr. Renuga K. Raman (2013-2014) Senior Assistant Director
Puan Raja Rohanira Raja Taib Administrative Assistant
Puan Dayang Pujiah Awang Shamsudin Administrative Assistant
Secretariat of the National Cancer Registry (Starting from 1st January 2015 until present)
Dr. Asmayani Khalib Director of National Cancer Institute Dr. Gerard Lim Chin Chye Head of Radiotherapy and Oncology Department, National Cancer Institute
Dr. Renuga K. Raman Medical Officer & Coordinator of Cancer Registry Unit, National Cancer Institute
Dr. Nabihah Ali Medical Officer of Cancer Registry Unit, National Cancer Institute
Dr. Puteri Nureylia Amir Medical Officer of Cancer Registry Unit, National Cancer Institute
Salina Asha’ari Staff Nurse of Cancer Registry Unit, National Cancer Institute
1.
2.
3.
4.
5.
6.
.
1.
2.
3.
4.
5.
6.
xi
LIST OF TABLES
Malaysian population, 2011Malaysian citizens by sex, 2011Malaysian citizens by ethnic groups, 2011Malaysian population by state and area of land coverage, 2011Gross domestic product (GDP) per capita, Malaysia, 2007-2011Health facilities and number of Doctors in Malaysia, 2007-2011Number of new cancer cases, Crude Rate (CR), Age-standardised rate (ASR), Cumulative Risk (CumR) and Lifetime Risk by sex, Malaysia, 2007-2011Incidence summary by major ethnic groups and sex, Malaysia, 2007-2011Incidence summary by state and sex, Malaysia, 2007-2011ASR by sex comparing Malaysia, Penang, Sarawak Cancer Registry 2007-2011 and Globocan 2012Ten most common cancers, all residents, Malaysia, 2007-2011Ten most common cancers in Malaysia by sex, all residents, 2007-2011Age-standardised rates for ten most common cancer in males by ethnicity, Malaysia, 2007-2011Age-standardised rates for ten most common cancer in females by ethnicity, Malaysia, 2007-2011Ten most common cancers in Malaysia, Malay residents by sex, 2007-2011Ten most common cancers in Malaysia, Chinese residents by sex, 2007-2011Ten most common cancers in Malaysia, Indian residents by sex, 2007-2011Ten most common cancers in Malaysia, other ethnic groups by sex, 2007-2011Staging for all cancer types, Malaysia, 2007-2011Quality IndicatorSummary of all cancer sites 2007-2011 by sex, year and ethnicSummary of all cancer sites 2007-2011 by statesFemale Breast: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011Female Breast: Incidence summary by ethnicity, Malaysia, 2007-2011Female Breast: Incidence summary by year, Malaysia, 2007-2011Colorectal: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Colorectal: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Colorectal: Incidence summary by year and sex, Malaysia, 2007-2011Trachea, Bronchus, Lung: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74),Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Trachea, Bronchus, Lung: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Trachea, Bronchus, Lung: Incidence summary by year and sex, Malaysia, 2007-2011Lymphoma: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Lymphoma: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Lymphoma: Incidence summary by year and sex, Malaysia, 2007-2011Nasopharynx: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Nasopharynx: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Nasopharynx: Incidence summary by year and sex, Malaysia, 2007-2011Leukaemia: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Leukaemia: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Leukaemia: Incidence summary by year and sex, Malaysia, 2007-2011
Table 1Table 2Table 3Table 4Table 5Table 6Table 7
Table 8Table 9Table 10Table 11Table 12Table 13Table 14Table 15Table 16Table 17Table 18Table 19Table 20Table 21Table 22Table 23
Table 24Table 25Table 26
Table 27Table 28Table 29
Table 30Table 31Table 32
Table 33Table 34Table 35
Table 36Table 37Table 38
Table 39Table 40
Page44445613
13131416172323242526272830313133
333336
363639
393942
424244
444447
4747
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
xii
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Cervix Uteri: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) andCumulative Risk (CumR), Malaysia, 2007-2011Cervix Uteri: Incidence summary by ethnicity, Malaysia, 2007-2011Cervix Uteri: Incidence summary by year, Malaysia, 2007-2011Liver: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Liver: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Liver: Incidence summary by year and sex, Malaysia, 2007-2011Ovary: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011Ovary: Incidence summary by ethnicity, Malaysia, 2007-2011 Ovary: Incidence summary by year, Malaysia, 2007-2011Stomach: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Stomach: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Stomach: Incidence summary by year and sex, Malaysia, 2007-2011Prostate: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) andCumulative Risk (CumR), Malaysia, 2007-2011Prostate: Incidence summary by ethnicity, Malaysia, 2007-2011Prostate: Incidence summary by year, Malaysia, 2007-2011Other skin: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Other skin: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Other skin: Incidence summary by year and sex, Malaysia, 2007-2011Thyroid: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Thyroid: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Thyroid: Incidence summary by year and sex, Malaysia, 2007-2011Brain, Nervous system: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011Brain, Nervous system: Incidence summary by ethnicity and sex, Malaysia, 2007-2011Brain, Nervous system: Incidence summary by year and sex, Malaysia, 2007-2011Corpus Uteri: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) andCumulative Risk (CumR), Malaysia, 2007-2011Corpus Uteri: Incidence summary by ethnicity, Malaysia, 2007-2011Corpus Uteri: Incidence summary by year, Malaysia, 2007-2011
Table 41
Table 42Table 43Table 44
Table 45Table 46Table 47
Table 48Table 49Table 50
Table 51Table 52Table 53
Table 54Table 55Table 56
Table 57Table 58Table 59
Table 60Table 61Table 62
Table 63Table 64Table 65
Table 66Table 67
Page50
505053
535356
565659
595962
626265
656567
676769
696971
7171
xiii
LIST OF FIGURES
Map of MalaysiaPopulation pyramid, Malaysia, all residents, 2011Perinatal, Neonatal, Infant and Maternal mortality rates in MOH Hospitals, Malaysia, 2007-2011Number of medically certified and non-medically certified cancer death, Malaysia, 2007-2011Certified and uncertified cancer death, Malaysia, 2007-2011Outline of registration proceduresAge-standardised rate (ASR) by state and sex, Malaysia, 2007-2011Annual Age-standardised rate (ASR) by sex, Malaysia, 2007-2011Percentage of ten most common cancers, all residents, Malaysia, 2007-2011Age-standardised rate (ASR) for ten common cancer by sex, Malaysia, 2007-2011Age-specific incidence rate by sex, all sites, Malaysia, 2007-2011Age-specific incidence rate for ten common sites, males, Malaysia 2007-2011Age-specific incidence rate for ten common sites, females, Malaysia, 2007-2011 Common cancers among 0-14 years age group by sex, Malaysia, 2007-2011Common cancers among 15-24 years age group by sex, Malaysia, 2007-2011Common cancers among 25-59 years age group by sex, Malaysia, 2007-2011Common cancers among 60-74 years age group by sex, Malaysia, 2007-2011Common cancers in 75 years and above age group by sex, Malaysia, 2007-2011 Age-standardised rate (ASR) for ten common cancers in Malays by sex, Malaysia, 2007-2011 Age-standardised rate (ASR) for ten common cancers in Chinese by sex, Malaysia, 2007-2011Age-standardised rate (ASR) for ten common cancers in Indians by sex, Malaysia, 2007-2011Age-standardised rate (ASR) for ten common cancers in other ethnic groups by sex, Malaysia, 2007-2011All sites: International comparisons- Age standardised ratesFemale Breast: Age-specific incidence rate, Malaysia, 2007-2011Female Breast: Stage Female Breast: Age-standardised rate (ASR) by state, Malaysia, 2007-2011Female Breast: International comparisons- Age standardised ratesColorectal: Age-specific incidence rate by sex, Malaysia, 2007-2011Colorectal: Stage by sexColorectal: Age -standardised rate (ASR) by state and sex, Malaysia, 2007-2011Colorectal: International comparisons- Age standardised ratesTrachea, Bronchus, Lung: Age -specific incidence rate by sex, Malaysia, 2007-2011Trachea, Bronchus ,Lung: Stage by sexTrachea, Bronchus, Lung: Age -standardised rate (ASR) by state and sex, Malaysia, 2007-2011Trachea, Bronchus, Lung: International comparisons- Age standardised rates Lymphoma: Age-specific incidence rate by sex, Malaysia, 2007-2011Lymphoma: Stage by sexLymphoma: Age -standardised rate (ASR) by state and sex, Malaysia, 2007-2011Nasopharynx: Age-specific incidence rate by sex, Malaysia, 2007-2011Nasopharynx: Stage by sexNasopharynx: Age -standardised rate (ASR) by state and sex, Malaysia, 2007-2011Nasopharynx: International comparisons- Age-standardised ratesLeukaemia: Age-specific incidence rate by sex, Malaysia, 2007-2011Leukaemia types: Age-specific incidence rate, males, Malaysia, 2007-2011Leukaemia types: Age-specific incidence rate, females, Malaysia, 2007-2011Leukaemia: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011Leukaemia: International comparisons- Age-standardised rates Cervix Uteri: Age-specific incidence rate ,Malaysia, 2007-2011
Figure 1Figure 2Figure 3Figure 4Figure 5Figure 6Figure 7Figure 8Figure 9Figure 10Figure 11Figure 12Figure 13Figure 14Figure 15Figure 16Figure 17Figure 18Figure 19Figure 20Figure 21Figure 22Figure 23Figure 24Figure 25Figure 26Figure 27Figure 28Figure 29Figure 30Figure 31Figure 32Figure 33Figure 34Figure 35Figure 36Figure 37Figure 38Figure 39Figure 40Figure 41Figure 42Figure 43Figure 44Figure 45Figure 46Figure 47Figure 48
Page3357710141516181819202121212222242526273234343435373737384040404143434345454546474848484951
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
xiv
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Cervix Uteri: Stage Cervix Uteri: Age-standardised rate (ASR) by state, Malaysia 2007-2011Cervix Uteri: International comparisons- Age-standardised ratesLiver: Age-specific incidence rate by sex, Malaysia, 2007-2011Liver: Stage by sexLiver: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011Liver: International comparisons- Age-standardised ratesOvary: Age-specific incidence rate, Malaysia, 2007-2011Ovary: Stage Ovary: Age-standardised rate (ASR) by state, Malaysia, 2007-2011 Ovary: International comparisons- Age-standardised ratesStomach: Age-specific incidence rate by sex, Malaysia, 2007-2011Stomach: Stage by sexStomach: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011Stomach: International comparisons- Age-standardised rates Prostate: Age-specific incidence rate, Malaysia, 2007-2011Prostate: StageProstate: Age-standardised rate (ASR) by state, Malaysia, 2007-2011Prostate: International comparisons- Age-standardised rates Other Skin: Age-specific incidence rate by sex, Malaysia, 2007-2011Other Skin: Stage by sexOther Skin Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011Thyroid: Age-specific incidence rate by sex, Malaysia, 2007-2011Thyroid: Stage by sexThyroid: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011Brain, Nervous system: Age-specific incidence rate by sex, Malaysia, 2007-2011Brain, Nervous system: Stage by sexBrain, Nervous system: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011Corpus Uteri: Age-specific incidence rate, Malaysia, 2007-2011Corpus Uteri: StageCorpus Uteri: Age-standardised rate (ASR) by state, Malaysia, 2007-2011
Figure 49Figure 50Figure 51Figure 52Figure 53Figure 54Figure 55Figure 56Figure 57Figure 58Figure 59Figure 60Figure 61Figure 62Figure 63Figure 64Figure 65Figure 66Figure 67Figure 68Figure 69Figure 70Figure 71Figure 72Figure 73Figure 74Figure 75Figure 76Figure 77Figure 78Figure 79
Page51515254545455575757586060606163636364666666686868707070727272
xv
LIST OF APPENDICES
Person-years at risk by sex, ethnic and age group, Malaysian residents, 2007-2011Person-years at risk by sex, state and age group, Malaysian residents, 2007-2011Person-years at risk, all Malaysian, 2007-2011Person-years at risk, Malay residents, Malaysia, 2007-2011Person-years at risk, Chinese residents, Malaysia, 2007-2011Person-years at risk, Indian residents, Malaysia, 2007-2011Person-years at risk, Others residents, Malaysia, 2007-2011Incidence summary table, all residents, males, Malaysia, 2007-2011Incidence summary table, all residents, females, Malaysia, 2007-2011Incidence summary table, Malay males, Malaysia, 2007-2011Incidence summary table, Malay females, Malaysia, 2007-2011Incidence summary table, Chinese males, Malaysia, 2007-2011Incidence summary table, Chinese females, Malaysia, 2007-2011Incidence summary table, Indian males, Malaysia, 2007-2011Incidence summary table, Indian females, Malaysia, 2007-2011Incidence summary table, Others males, Malaysia, 2007-2011Incidence summary table, Others females, Malaysia, 2007-2011Incidence summary table of 15 selected cancer sites by state and sex, Malaysia, 2007-2011Number of new cancer cases by sites and age group, all residents, males, Malaysia, 2007-2011Number of new cancer cases by sites and age group, all residents, females, Malaysia, 2007-2011Cancer incidence by sites and age group, all residents, males, Malaysia, 2007-2011Cancer incidence by sites and age group, all residents, females, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Malay males, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Malay females, Malaysia, 2007-2011Cancer incidence by sites and age group, Malay males, Malaysia, 2007-2011Cancer incidence by sites and age group, Malay females, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Chinese males, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Chinese females, Malaysia, 2007-2011Cancer incidence by sites and age group, Chinese males, Malaysia, 2007-2011Cancer incidence by sites and age group, Chinese females, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Indian males, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Indian females, Malaysia, 2007-2011Cancer incidence by sites and age group, Indian males, Malaysia, 2007-2011Cancer incidence by sites and age group, Indian females, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Others males, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Others females, Malaysia, 2007-2011Cancer incidence by sites and age group, Others males, Malaysia, 2007-2011Cancer incidence by sites and age group, Other females, Malaysia, 2007-2011Number of new cancer cases by sites and age group, Selangor, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Selangor, all residents, females, 2007-2011Cancer incidence by sites and age group, Selangor, all residents, males, 2007-2011Cancer incidence by sites and age group, Selangor, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Johor, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Johor, all residents, females, 2007-2011Cancer incidence by sites and age group, Johor, all residents, males, 2007-2011Cancer incidence by sites and age group, Johor, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Sabah, all residents, males, 2007-2011
Appendix 1Appendix 2Appendix 3Appendix 4Appendix 5Appendix 6Appendix 7Appendix 8Appendix 9Appendix 10Appendix 11Appendix 12Appendix 13Appendix 14Appendix 15Appendix 16Appendix 17Appendix 18Appendix 19Appendix 20Appendix 21Appendix 22Appendix 23Appendix 24Appendix 25Appendix 26Appendix 27Appendix 28Appendix 29Appendix 30Appendix 31Appendix 32Appendix 33Appendix 34Appendix 35Appendix 36Appendix 37Appendix 38Appendix 39Appendix 40Appendix 41Appendix 42Appendix 43Appendix 44Appendix 45Appendix 46Appendix 47
Page7475787980818283848586878889909192939899100101102103104105106107108109110111112113114115116117118119120121122123124125126
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
xvi
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Number of new cancer cases by sites and age group, Sabah, all residents, females, 2007-2011Cancer incidence by sites and age group, Sabah, all residents, males, 2007-2011Cancer incidence by sites and age group, Sabah, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Sarawak, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Sarawak, all residents, females, 2007-2011Cancer incidence by sites and age group, Sarawak, all residents, males, 2007-2011Cancer incidence by sites and age group, Sarawak, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Perak, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Perak, all residents, females, 2007-2011Cancer incidence by sites and age group, Perak, all residents, males, 2007-2011Cancer incidence by sites and age group, Perak, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Kedah, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Kedah, all residents, females, 2007-2011Cancer incidence by sites and age group, Kedah, all residents, males, 2007-2011Cancer incidence by sites and age group, Kedah, all residents, females, 2007-2011Number of new cancer cases by sites and age group, WPKL & Putrajaya, all residents, males, 2007-2011Number of new cancer cases by sites and age group, WPKL & Putrajaya, all residents, females, 2007-2011Cancer incidence by sites and age group, WPKL & Putrajaya, all residents, males, 2007-2011Cancer incidence by sites and age group, WPKL & Putrajaya, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Kelantan, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Kelantan, all residents, females, 2007-2011Cancer incidence by sites and age group, Kelantan, all residents, males, 2007-2011Cancer incidence by sites and age group, Kelantan, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Penang, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Penang, all residents, females, 2007-2011Cancer incidence by sites and age group, Penang, all residents, males, 2007-2011Cancer incidence by sites and age group, Penang, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Pahang, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Pahang, all residents, females, 2007-2011Cancer incidence by sites and age group, Pahang, all residents, males, 2007-2011Cancer incidence by sites and age group, Pahang, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Terengganu, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Terengganu, all residents, females, 2007-2011Cancer incidence by sites and age group, Terengganu, all residents, males, 2007-2011Cancer incidence by sites and age group, Terengganu, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Negeri Sembilan, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Negeri Sembilan, all residents, females, 2007-2011Cancer incidence by sites and age group, Negeri Sembilan, all residents, males, 2007-2011Cancer incidence by sites and age group, Negeri Sembilan, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Melaka, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Melaka, all residents, females, 2007-2011Cancer incidence by sites and age group, Melaka, all residents, males, 2007-2011Cancer incidence by sites and age group, Melaka, all residents, females, 2007-2011Number of new cancer cases by sites and age group, Perlis, all residents, males, 2007-2011Number of new cancer cases by sites and age group, Perlis, all residents, females, 2007-2011Cancer incidence by sites and age group, Perlis, all residents, males, 2007-2011
Appendix 48Appendix 49Appendix 50Appendix 51Appendix 52Appendix 53Appendix 54Appendix 55Appendix 56Appendix 57Appendix 58Appendix 59Appendix 60Appendix 61Appendix 62Appendix 63
Appendix 64
Appendix 65Appendix 66Appendix 67Appendix 68Appendix 69Appendix 70Appendix 71Appendix 72Appendix 73Appendix 74Appendix 75Appendix 76Appendix 77Appendix 78Appendix 79Appendix 80Appendix 81Appendix 82Appendix 83
Appendix 84
Appendix 85Appendix 86Appendix 87Appendix 88Appendix 89Appendix 90Appendix 91Appendix 92Appendix 93
Page127128129130131132133134135136137138139140141142
143
144145146147148149150151152153154155156157158159160161162
163
164165166167168169170171172
xvi
Cancer incidence by sites and age group, Perlis, all residents, females, 2007-2011Number of new cancer cases by sites and age group, W.P. Labuan, all residents, males, 2007-2011Number of new cancer cases by sites and age group, W.P. Labuan, all residents, females, 2007-2011Cancer incidence by sites and age group, W.P. Labuan, all residents, males, 2007-2011Cancer incidence by sites and age group, W.P. Labuan, all residents, females, 2007-2011Morphologically verified cases by histology types, all sites, Malaysia, 2007-2011Cancer Notification FormExplanatory notes for completing Cancer Notification Form
Appendix 94Appendix 95Appendix 96
Appendix 97Appendix 98Appendix 99Appendix 100Appendix 101
Page173174175
176177178201202
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
1
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
The first five year report of the Malaysian National Cancer Registry attempts to provide information on cancerincidence from 2007 to 2011 on cases which were reported and recorded in thirteen states and two federalterritories. This report will serve as a baseline by which future reports will be compared with. It is recommended that in this report, caution is advised in the interpretation of the incidence of cancer rather than focusing on the absolute numbers and rates of the burden of cancer. The profile of cancer should be looked at in terms of distribution by age, ethnicity, sex and geography. The incidence varies between states partialy due to the difference of population structure, for example the incidence rates in Penang are among the highest and this could be due to higherproportion of Chinese in Penang compared to other states.
A total number of 103,507 new cancer cases were diagnosed in Malaysia during the period of 2007 to 2011. Of these 46,794 (45.2%) were reported in males and 56,713 (54.8%) in females. The age standardised incidence rates (ASR) for males and females were 86.9 and 89.0 per 100,000 population in males and females respectively. The ASR in Chinese males were 112.9 per 100,000 population while in females were 126.2 per 100,000population, Malay males were 70.7 per 100,000 population and females were 81.9 per 100,000 population, Indian males were 70.4 per 100,000 population and females were 110.1 per 100,000 population. The five most common cancers among males were cancers of the colorectal, lung, nasopharynx, lymphoma and prostate. Among females, the five most common were cancers of the breast, colorectal, cervix uteri, ovary and lung.
Further analysis was done based on six regional registries which were established before 2007 (Penang, Kelantan, Pahang, Johor, Sabah, Sarawak). The ASR were higher compared to the incidence based on all state registries which were 100.0 per 100,000 population in males and 109.0 per 100,000 population in females. As the period of coverage of the report begins in 2007, and since registries generally require several years of operation before they attain adequate levels of data quality (defined as completeness of case ascertainment, accuracy and timeliness of reporting), the main concern is underreporting in the nine new registries, for this more time would be required for other registries to mature.
The stage of cancer at the time of diagnosis was reported based on information provided by the notifying clinician. The staging system was based on the TNM Classification System for most tumour sites. In total 51.0% of recorded cases had reports on staging, of those cases whose staging was recorded, 17.1% in stage I, 23.6% in stage II, 23.0% in stage III and 35.8% in stage IV.
1.0 OVERVIEW
1.1 Cancer Incidence
1.2 Staging
2
Ministry of Health has started its population-based cancer registry in 1993. It was started with regionalpopulation-based cancer registries to ensure long term sustainability. Penang was chosen as a pilot location in 1994 to cover northern region. Following this, other regional registries were established in Sarawak, Kelantan,Pahang, Johor and Sabah. Since 2007 all states in Malaysia had set up their own population-based registries which were headed by National Cancer Registry in the Ministry of Heatlh under the Non-Communicable Disease Sector, Disease Control Division. The secretariat for the NCR has been transferred to the National Cancer Institute (NCI) since 1st January 2015.
Cancer is one of the leading causes of death in Malaysia today. This report aims to provide an epidemiological profile of cancer, which is important in the National Cancer Control Programme. Cancer represents a tremendous burden on patients, families and the society they live in. Besides financial cost, cancer has an importantpsychosocial effect on patients and their families. Specification of cancer incidence with varying degrees of confidence is fundamental for cancer control. These data do not only establish the burden of disease as it may impinge upon public health and clinical services planning, they also indicate in many instances, causative relationships, the impact of socioeconomic differences and priorities that maybe accorded to particular cancer control options.
This is the first five year national report which covers the period of 2007-2011. This MNCR report follows reports for 2003-2005, 2006, 2007 and 2008. The initial reports only covered cancer incidence among all residents inPeninsular Malaysia. Meanwhile the subsequent reports in 2007 and 2008 covered residents in all states inMalaysia. This 2007-2011 report applied to Malaysian citizens living in Malaysia at the time of diagnosis. Thepopulation denominator used was the 2009 intercensal population. The Segi World Standard Population (1960) was applied as a reference in calculating the ASR.
Malaysia covers an area of about 330,289 sq. km, consisting of Peninsular Malaysia and East Malaysia (Sabah, Sarawak and Federal Territory of Labuan). It is separated by the South China Sea and has its frontier with Thailand, Singapore, Indonesia and Brunei.
Peninsular Malaysia is located south of Thailand, north of Singapore and east of the Indonesian Island ofSumatera. East Malaysia comprises most of the northern part of Borneo and shares borders with Brunei andIndonesia. Located near the equator, Malaysia’s climate is categorised as equatorial, being hot and humidthroughout the year.
Malaysia is divided into thirteen states and three Federal Territories. Eleven states and two Federal Territories are found in Peninsular Malaysia meanwhile, two states and one Federal Territory are found in East Malaysia.
The Peninsular Malaysia consists of the following states (from north to south): Perlis, Kedah, Pulau Pinang(Penang), Perak, Selangor, Federal Territory of Kuala Lumpur and Putrajaya (WPKL & Putrajaya), Negeri Sembilan, Melaka, Johor, Pahang, Terengganu and Kelantan. The East Malaysia consists of Sabah, Sarawak and Federal Territory Labuan (W.P. Labuan).
2.0 INTRODUCTION
3.0 BACKGROUND
3.1 Geography
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
3
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 2: Population pyramid, Malaysia, all residents, 2011Source: Dept. of Statistics Malaysia
Figure 1: Map of Malaysia
The estimated Malaysian population in 2011 was 29.1 million including the non-citizens. The population pyramid and its distribution of ethnic, sex and age group is shown in Figure 2, Table 2 and Table 3 respectively. Overall, there were 50.7% males and 49.3% females (Table 2). The ethnic distribution was as follows: Malay 54.7%,Chinese 24.3%, Indian 7.3%, other Bumiputera 12.8% and others 0.9%. In addition, there were almost 2.5 million non-citizens (8.4%) in Malaysia (Table 1). Intercensal Population Estimates are data that will be reviewed every ten years after Population and Housing Census is conducted using the final data on births and deaths. The projection is calculated yearly and used the cohort-component method which contained births, deaths, internal andinternational migration of the reference year. These estimates provide an overview of the growth and potential changes in population in terms of structure and compositions.
3.2 Population
SOUTH CHINA SEA
BORNEO
SARAWAK
Eastern RegionPetunjuk:
Northern RegionCentral RegionSouthern Region
East Malaysia
4
Table 1: Malaysian population, 2011
Table 2: Malaysian citizens by sex, 2011
Table 3: Malaysian citizens by ethnic groups, 2011
CitizenshipCitizenNon-citizenTotal
SexMaleFemaleTotal
EthnicMalayChineseIndian*OthersTotal
Numbers26,617,1002,445,000
29,062,100
Numbers13,489,10013,127,800
26,616,100
Numbers14,551,3006,471,1001,939,7003,654,800
26,616,900
%91.68.4
100.0
%50.749.3
100.0
%54.724.37.3
13.7100.0
Source: Dept. of Statistics Malaysia
Source: Dept. of Statistics Malaysia
* Other Bumiputera and Others Source: Dept. of Statistics Malaysia
Table 4: Malaysian population by state and area of land coverage, 2011
State
Selangor
Johor
Sabah
Sarawak
Perak
Kedah
Kelantan
W.P. Kuala Lumpur
Penang
Pahang
Terengganu
Negeri Sembilan
Melaka
Perlis
W.P. Labuan
W.P. Putrajaya
TOTAL
5,126,200
3,131,700
2,446,700
2,399,000
2,326,800
1,898,700
1,578,200
1,544,800
1,493,700
1,446,300
1,055,100
985,300
797,600
230,300
81,200
75,500
26,616,900
2,869,200
1,792,300
232,300
578,400
1,264,500
1,481,200
1,492,400
692,300
648,700
1,067,800
1,019,500
584,500
521,300
202,700
31,100
73,000
14,551,300
1,460,900
1,049,900
298,300
589,300
701,500
256,900
52,800
659,800
674,900
232,900
26,900
226,900
210,700
18,900
10,100
500
6,471,100
685,900
220,200
10,400
7,200
285,700
137,300
4,600
159,200
159,000
64,000
2,800
151,000
47,700
3,100
700
900
1,939,700
73,800
54,900
1,801,500
1,217,100
66,300
4,700
17,700
18,700
6,400
75,300
3,800
19,500
13,600
1,100
37,700
1,000
3,413,100
36,400
14,400
104,300
7,000
8,800
18,700
10,600
14,600
4,600
6,300
2,100
3,600
4,200
4,600
1,600
0
3,413,100
7,930
18,987
73,620
124,450
21,005
9,425
15,105
243
1,031
35,965
12,955
6,657
1652
795
92
49
329,961
56.0
57.2
9.5
24.1
54.3
78.0
94.6
44.8
43.4
73.8
96.6
59.3
65.4
88.0
38.3
96.7
28.5
33.5
12.2
24.6
30.1
13.5
3.3
42.7
45.2
16.1
2.5
23.0
26.4
8.2
12.4
0.7
13.4
7.0
0.4
0.3
12.3
7.2
0.3
10.3
10.6
4.4
0.3
15.3
6.0
1.3
0.9
1.2
1.4
1.8
73.6
50.7
2.8
0.2
1.1
1.2
0.4
5.2
0.4
2.0
1.7
0.5
46.4
1.3
0.7
0.5
4.3
0.3
0.4
1.0
0.7
0.9
0.3
0.4
0.2
0.4
0.5
2.0
2.0
0.0
Total
EthnicsArea (Km²)Malay
Numbers Numbers Numbers Numbers Numbers% % % % %Chinese Indian OthersOther Bumiputera
Note: The added total may differ due to rounding Source: Dept. of Statistics Malaysia
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
5
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 3: Perinatal, Neonatal, Infant and Maternal mortality rates in MOH Hospitals, Malaysia, 2007-2011
The health status of Malaysia has also been enhanced by improvement in health infrastructure and health services. Since Independence in 1957, changes in disease pattern in relation to lifestyle related conditions are occurring. Life expectancy in Malaysia at birth for both sexes has increased over the years, rising from 56 years for males and 58 for females in 1957 to 72.2 years for males and 76.8 years for females in 2011. Over the same period, the crude death rate fell from 12.4 per 1,000 population to 4.7. The average crude birth rate from 2007 to 2011 was 17.66 per 1,000 population and the crude of natural increase in average from 2007 to 2011 was 13.04 per 1,000 population (Department of Statistics Malaysia, Time Series Data). A decrease in perinatal, infant and maternal mortality rates from 2007 to 2011 are viewed in Figure 3. The gross domestic product (GDP) per capita 2007-2011 in Malaysia is depicted in Table 5.
3.3 Health Status, Socioeconomic and Health Facilities.
* Health Facts source Health Informatics Centre, MOH
Table 5: Gross domestic product (GDP) per capita, Malaysia, 2007-2011
YearGDP per capita, Malaysia (USD
20077,241
20088,487
20097,312
20109,069
201110,427
* World Development Indicators, World Bank
6
Table 6: Health facilities and number of Doctors in Malaysia, 2007-2011
No. of Medical OfficerGovernment (MOH)Government (non-MOH)PrivateTotalDoctor: Population ratioHospitalsGovernment (MOH)Government (non-MOH)PrivateTotalHospitals BedsGovernment (MOH)Government (non-MOH)PrivateTotalHealth Clinics1Malaysia ClinicsGovernment (MOH)Private (GP)Total
2007
12,2732,0259,440
23,7381:1,145
1366
229371
37,2932,908
11,72251,923
NA2,8302,9925,822
2008
13,0962,000
10,00625,102
1:1,105
1367
246389
37,9343,245
12,16553,344
NA2,8246,3719,195
2009
17,3022,890
10,34430,5361:927
1368
245389
38,0573,523
12,61954,199
NA2,8186,3079,125
2011
22,4373,408
10,76236,6071:791
1388
263409
38,3943,322
14,07355,789
1092,8496,5899,547
2010
19,4293,000
10,55032,9791:859
1378
254399
37,7933,690
13,57655,059
532,8336,4429,328
Private Hospitals: Private Hospitals, Private Maternity Home, Private Nursing Home And HospiceGovernment (MOH) Health Clinics: Health Clinic, Community Clinic, Maternal and Child Health ClinicGovernment (non-MOH) Hospitals: Army Hospitals, University Hospitals1Malaysia Clinic: initiated in 2010Source: Health Indicators Ministry of Health Malaysia, Health Facts Ministry of Health Malaysia
The following table provides an overview of the health delivery system in Malaysia. An overall number of health facilities and doctors treating all types of diseases are seen in Table 6. From 2007 to 2011 the number of doctorsto the population ratio had increased from 1:791 to 1:1,145. Gradual increases in a total number of hospitals were from 371 in 2007 to 409 in 2011. Whereas, there was also increase in hospital beds (Government MOH,Government Non-MOH, and Private) from 51,923 in 2007 to 55,789 in 2011. Other public health facilities include 1Malaysia Clinics, Government (MOH) and Private (GP), form a total of 5,822 in 2007 and have increased to 9,547 by the year 2011.
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
7
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 4: Number of medically certified and non-medically certified cancer death, Malaysia, 2007-2011
Figure 5: Certified and uncertified cancer death, Malaysia, 2007-2011
A total of 64,275 medically certified and non-medically certified cancer deaths were reported by the NationalRegistration Department of the period 2007 to 2011. Over the years, the numbers of medically certified cancer deaths have gradually increased. However, the number of non-medically certified cancer death remained relatively unchanged (Figure 4). Medically Certified Death was certified by medical practitioners with Malaysian Medical Council, which involves medical officers, district health officers and coroners. Non-medically Certified Deathcertified by persons such as policemen, medical assistants and other informants. The proportion of medicallycertified cancer death is 64.3% and non-medically certified cancer death is 35.7% (Figure 5).
3.4 Cancer Death Certification
Source: Department of Statistic, Malaysia
Source: Department of Statistic, Malaysia
8
The registry sought to obtain basic epidemiological and clinical data on all cases of cancer diagnosed in Malaysia since 1st January 2007, regardless of citizenship, place of stay and basis of diagnosis. The registry receivednotifications from all data source providers in government and private health facilities (hospitals, clinics,laboratories, Hospice, National Registration Department and Health Informatics, MOH) in Malaysia. The National Cancer Registry team consolidated information from all state registries.
Case registration is based primarily on voluntary notifications. All identified data providers were asked to provide information concerning cancer on the standardised forms as attached in Appendix 100 and were sent to therespective registries. Patient confidentiality was maintained at all times. Both passive and active case findingmethods were used by the registries.
Passive notification – registry relies on other healthcare workers to complete notification forms and forward them to the registry.
Active search – collecting at source, whereby registry staff would visit the sources of data to extract the required information and record it onto forms, or to obtain copies of the relevant information.
To ensure completeness of the data, active case finding and routine checks were done using government andprivate hospital discharge records, as well as pathology records from the public and private laboratories. These were supplemented by case detection from death records supplied by the National Registration Department. Any cancer case detected from pathology and death records were then checked with previously registered cases. If they were not yet notified, reminders were sent to the person in-charge for more information. Additional missing data for these cases were also sought by registry staff by searching the relevant hospital records.
Every item relating to the patient were collated and updated. The registry registered all new cases of cancerdiagnosed in Malaysia. Multiple sources of data had assisted in optimising completeness of collection; however, this could create problem of multiple notification of a patient. This issue was addressed by cross checking names, age, date of birth and National Registration Identity Card numbers (NRIC) using CanReg4 software prior to the case registration. Identification card number is a unique number given to each Malaysian citizen and permanent resident. Children below 12 years of age are registered under their mother’s identification card number. In this report, the population is divided into 5 ethnic groups which are ‘Malay’, ‘Chinese’, ‘Indian’, ‘Other Bumiputera’ and ‘Others’. ‘Other Bumiputera’ refers to indigenous peoples, natives of Sarawak and Sabah meanwhile, ‘Others’ refers to ethnic groups which are not mentioned in other ethnic groups. The CanReg program accommodates comparison of essential variables across cases. 80% conformity is the standard used to trigger a further check of duplication. If the patient has been registered before, a check will be done along with the previous notifications to ascertain if it was a new primary. If the cancer is a new primary, the case is registered with a new registration number and if it is not, the records are updated.
Data from hospital discharges and reports from laboratories and death list from National Registration Department (NRD) were also sent to the registry and the same procedures were followed as described above.
4.0 METHODS
4.1 Sources of data
4.2. Data Collection
4.3. Registration Procedure
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
9
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Every effort was made to ensure that all the variables were completed. In the event if there was incompleteinformation, the notification forms with incomplete information were sent back to the respective data providers for further clarification and returned back to the registry upon completion. If there were no clarification, or incomplete forms returned, registries staff would visit the source providers to obtain the required information and to decide whether the case can be registered or not. For most cases the staging used was TNM Classification System. However, for cases with other staging classifications the registry staff assisted in converting it to TNM Classification System too.
Death certificate list were obtained from the National Registration Department, government and private hospitals in the same procedures as explained earlier. Those with mention of cancer on death certificate were identified, and transcripts of associated reports or certificates were used by the registry. If no information was available, then the case would be registered as Death Certificate Only (DCO). All updated information collected on hardcopies, either passively or actively, were entered into the computer database. Electronic data maintained in the cancer registry databases were subjected to on-going quality control.
10
Figure 6: Outline of registration procedure NRIC: National Ragistration Identification Card, RN: Registration Number, ICD-O: International Classification of Disease for Oncology
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
11
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
The number of new cancer cases (incidence cases) observed in the population during a defined period, divided by the number of population at risk in the same period. It is usually expressed per 100,000.
CR = N / P x 100,000 N – Total number of new cancer cases P – Person-years at risk
4.5 Description of statistical methods
4.5.1 Crude incidence rate (CR)
In order to achieve a high validity and accuracy of data the Malaysian National Cancer Registry (MNCR) has used the same five common indices as indicated in the Cancer Incidence in Five Continents (CI5), Vol X, which are (a) Internal consistency; (b) Histological verification; (c) Death certificate only (DCO); (d) Other and unspecified cases (ill-defined cases ) and (e) Age unknown.
All data supplied for this report were coded to ICD-O-3 and then were converted to ICD-10 for analysis and report writing. To ensure data comparability, all cases notified to the registry must follow the IARC rules.
4.4 Quality control
Incidence rate in a specified five-year age group; calculated by dividing the number of cancer cases in the five-year age group by the Malaysian population in the particular age group and multiply by 100,000.
AR = N / P x 100,000 N - Number of new cancer occurring in the i age group P – Person-years at risk in the i age group
4.5.2 Age-specific rate (AR)
i ththi
i i
Since the incidence of cancer depends heavily on the age structure of the population, there is a need for age adjustment for comparative analysis. The age-standardised incidence rate is a summary measure, indicating the rate that a population would have if it had a standard age structure.
It is calculated by summing the age-specific rates weighting to the world standard population; the calculated incidence rate is then called the World Standardised incidence rate. It is also expressed per 100,000.
ASR = ∑ (AR x P ) / total world standard population AR - Age specific rate in the i age class P - The number in the i age class of world standard population
4.5.3 Age-standardised rate (ASR)
thth
ii.std
i.stdi
As with any measurement of a population, incidence rates have a certain amount of chance variation. The index measure of this variability is known as the standard error and is computed as follows:
SE = √ ∑ d (w /y ) d - Number of cases of the cancer of interest in the age class i w - Standard world population for age class i y - Person-years at risk for age class i
4.5.4 Standard error (SE)
ii
i
i i i i 2
12
ASRs are subject to random variation around the true underlying rate. 95% confidence limits are endpoints of a range in which the true rate would be expected to fall 95% of the time. 95%CLs are computed from the standard error (SE) of the ASR using the following formula: 95% CL = ASR ± (1.96 x SE)
4.5.5 95% Confidence Limit of ASR (95% CL)
Cumulative risk is defined as a probability that an individual would develop cancer during a certain age period, in the absence of any competing cause of death. The age period over which the risk is accumulated in this report is 0-74 years. The precise mathematical relationship between the cumulative rate and the cumulative risk is:
CumR = 100 x [1 – exp (- CR74/100)] exp - exponential
4.5.7 Cumulative risk (CumR)
Lifetime risk is defined as the likelihood that a person who is free of a certain type of cancer will develop or die from that type of cancer during his or her lifetime. Lifetime risk estimates are usually expressed as the odds of developing cancer (‘1 in x’) or as a percentage.
4.5.8 Lifetime risk
Cumulative rate is the weighted sum of age-specific incidence rates until completion of 74 years of age. The weighting used in this calculation is based simply on the widths of the age groups, i.e. multiplying the five-year age-sex specific rates per person by 5 and summing over age groups from 0-4 to 70-74. CR74 is necessary in order to ascertain the cumulative risk and is expressed in percentages.
CR74 = 5 x ∑ (d /y ) x 100 i - 5-year age groups d – Number of cases in age class i y – Person-years at risk of age class i
4.5.6 Cumulative rate (CR74)
ii
i i i
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
13
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
A total of 103,507 new cancer cases were diagnosed in Malaysia for the period of 2007- 2011.
The age-standardised rates (ASR) were 86.9 per 100,000 males and 99.3 per 100,000 females. The cumulative risk (CumR) was 9.8 for males and 10.6 for females, representing the risks of males and females in Malaysia developing cancer before the age of 75, in the absence of other causes of death. The lifetime risk for males was 1 in 10 and 1 in 9 for females (Table 7). The incidence was highest among Chinese for both sexes (ASR: 112.9 per 100,000 population in male and 126.2 per 100,000 populations in female).
A comparison of age-standardised rates in Table 9 ranging from 51 to 151 per 100,000 in males and 42 to 158 per 100,000 in females are due to the difference in population structure and size. The small population in Labuan could also contribute to the limitation of the report and the rates could fluctuate in such instances.
5.0 RESULTS
5.1 Overall cancer incidence
SexMalesFemalesBoth
Number46,79456,713
103,507
%45.254.8
100.0
CR71.489.0
ASR86.999.3
CR7410.311.2
CumR9.8
10.6
Lifetime Risk109
Table 7: Number of new cancer cases, Crude Rate (CR), Age-standardised rate (ASR), Cumulative Risk (CumR) and Lifetime Risk by sex, Malaysia, 2007-2011
Ethnicity
MalayChineseIndianOthers*
18,75720,424
2,6794,934
24,18822,1144,7985,613
70.7112.970.480.5
81.9126.2110.189.6
53.1124.4
56.055.0
69.5143.2101.264.4
8.012.58.19.2
8.713.212.29.7
Number NumberMale Female
ASR ASRCumR CumRCR CR
* Other Bumiputera and Others: ‘Other Bumiputera’ includes indigenous peoples, natives of Sarawak and natives of Sabah while ‘Others’ other than mentioned before not including missing ethnicity.
Table 8: Incidence summary by major ethnic groups and sex, Malaysia, 2007-2011
State
SelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan
6,2617,2023,5224,5494,4652,7742,2772,1055,2452,1931,6681,9171,811
40553
8,4848,1104,0455,1855,5043,5653,3072,2816,0852,4991,9772,5282,214
49551
49.391.858.976.477.959.659.554.8
144.160.963.779.094.246.226.5
69.2109.469.890.396.676.788.359.6
166.673.679.1
106.9110.286.426.8
71.3109.093.685.774.766.573.168.0
150.575.183.189.1
104.772.850.9
89.7118.7105.3100.288.477.0
101.265.8
157.882.693.8
108.9108.184.941.7
Number NumberMale Male
ASR ASRCR CR
Table 9: Incidence summary by state and sex, Malaysia, 2007-2011
14
The cancer incidence reported in this publication is different from the estimates of WHO publication in Globocan 2012. The incidence rate reported by Globocan was higher compared to MNCR. The WHO Globocan data was an estimate with the purpose of comparing the distribution of cancer cases in the world. This comparison was done among countries using best available data for the respective countries. The estimation of ASR for Malaysia was based on Penang and Sarawak Registries where the ethnic distributions were not similar to the national distribution.
State
Malaysian National Cancer Registry (total of 15 states)Globocan 2012Penang Cancer RegistrySarawak Cancer Registry
86.9144.9150.585.7
99.3143.4157.8100.2
ASRFemaleMale
*Globocan 2012: Simple mean of the incidence rates recorded in Peninsular Malaysia, Penang (2006), Penang (2004-2008) and Sarawak (1998-2002)
Table 10: ASR by sex comparing Malaysia, Penang, Sarawak Cancer Registry 2007-2011 and Globocan 2012
Figure 7: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Selang
orJo
hor
Sabah
Sarawak
Perak
Kedah
Kelanta
n
Penan
g
Pahan
g
Tereng
ganu
Negeri
Sem
bilan
Melaka
Perlis
W.P.
Labu
an
WPKL &
Putr
ajaya
200Males Females
180
160
140
120
100
80
60
40
20
0
Inci
denc
e pe
r 100
,000
State
15
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
The annual cancer incidence in Malaysia varied over the 5 years (2007-2011) in males between 80.9 and 90.2, and in females between 93.8 and 102.6.
5.2 Cancer trends
Figure 8: Annual age-standardised rate (ASR) by sex, Malaysia, 2007-2011
2007 2008 2009 2010 20110
40
20
60
80 89.7 90.2 87.9
98.4 98.8 93.8
85.4 80.9
102.6
Male Female
102.3100
120
140
160
180
200
Year
Inci
denc
e pe
r 100
,000
16
The three most common cancers among Malaysian residents were breast followed by colorectal and lung (Table 11 and Figure 9). The most common cancer among male and female residents was colorectal and breast respectively (Table 12 and Figure 10).
5.3 Incidence of ten most common cancers
Figure 9: Percentage of ten most common cancers, all residents, Malaysia, 2007-2011
Table 11: Ten most common cancers, all residents, Malaysia, 2007-2011
ICD-10C50C18-C21C33-C34C81-C85,C96C11C91-C95C53C22C56C16
SitesBreastColorectalTrachea, Bronchus, LungLymphomaNasopharynxLeukaemiaCervix UteriLiverOvaryStomachOthersTotal
Number18,34313,69310,6085,3745,0904,5734,3524,1283,4723,461
30,413103,507
%17.713.210.25.24.94.44.24.03.43.3
29.4100.0
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
17
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Table 12: Ten most common cancers in Malaysia by sex, all residents, 2007-2011
C18-C21C33-C34C11C81-C85,C96C61C22C91-C95C16C67C44
C50C18-C21C53C56C33-C34C81-C85,C96C54C91-C95C73C16
ColorectalTrachea, Bronchus, LungNasopharynxLymphomaProstateLiverLeukaemiaStomachBladderOther SkinOthersTotal
BreastColorectalCervix UteriOvaryTrachea, Bronchus, LungLymphomaCorpus UteriLeukaemiaThyroidStomachOthersTotal
7,6467,4153,7853,1713,1323,0542,5492,0141,4771,384
11,16746,794
18,2066,0474,3523,4723,1932,2032,1812,0241,7231,447
11,86556,713
16.315.88.16.86.76.55.44.33.23.0
23.9100.0
32.110.77.76.15.63.93.83.63.02.6
20.9100.0
11.711.35.84.84.84.73.93.12.32.1
71.4
28.69.56.85.45.03.53.43.22.72.3
89.0
14.614.46.45.56.65.64.23.92.92.7
86.9
31.111.17.65.96.03.83.83.42.92.6
99.3
ICD-10
Male
Female
Sites Number % CR ASR
18
Figure 10: Age-standardised rate (ASR) for ten common cancers by sex, Malaysia 2007-2011
Male Female
The incidence of cancer increased for both males and females after the age of 30 years (Figure 11). The incidence rate in males exceeded the incidence rate in females after the age of 60 years.
5.4 Age variations
Figure 11: Age-specific incidence rate by sex, all sites, Malaysia, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site
s
Incidence per 100,000
Colorectal
Lymphoma
Nasopharynx
Leukaemia
Liver
Prostate
Stomach
Bladder
Other Skin
Trachea,Bronchus,Lung
10 15 20
14.6
14.4
6.6
6.4
5.6
5.5
4.2
3.9
2.9
2.7
0 5
.0
19
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 12: Age-specific incidence rate for ten common sites, males, Malaysia, 2007-2011
20
Figure 13: Age-specific incidence rate for ten common sites, females, Malaysia, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
21
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
The five most common cancers by sex in each of the five broad age groups are shown in Figures 14-18.
In children below age of 14 years, main cancers in both sexes were leukaemia (47.1% in males, 45.5% in females) followed by brain, nervous system (13.8% in males, 16.0% in females) and lymphoma (11.3% in males, 8.4% in females). Childhood cancer age 0 to 18 years old comprised of 3,829 cases, 2,131 (55.7%) cases were males and 1,698 (44.3%) cases were females.
In the 15-24 year age group, the most common cancers in males were leukaemia (23.0%) followed by lymphoma (20.9%) and bone cancer (9.4%). While in females, the most common cancers were lymphoma (17.7%) wasfollowed by leukaemia (15.3%) and ovarian cancer (14.5%).
In the group aged 25-59 years, colorectal cancer was the most common cancer in males (16.0%), followed bynasopharyngeal cancer (13.7%), and lung cancer (13.4%). The most common cancers seen in females were breast (40.7%), cervix uteri (8.9%) and colorectal cancers (7.6%).
5.5 Age groups and cancers
Figure 14: Common cancers among 0-14 years age group by sex, Malaysia, 2007-2011
Figure 16: Common cancers among 25-59 years age group by sex, Malaysia, 2007-2011
Male
Male Female
Female
Male Female
Figure 15: Common cancers among 15-24 years age group by sex, Malaysia, 2007-2011
22
In the 60-74 year age group, the most common cancers in males were lung (19.8%), colorectal (18.3%) and prostate cancers (10.4%). In females the most common cancers were breast (24.4%), colorectal (15.4%) and lung cancers (8.8%).
In the group aged 75 years and above, cancer of the lung remained the most common cancer among males (19.1%) followed by colorectal (19.1%) and prostate cancers (14.5%). In females, colorectal cancer (21.3%) was followed by cancer of the breast (14.5%) and lung (10.3%).
Figure 17: Common cancers among 60-74 years age group by sex, Malaysia, 2007-2011
Figure 18: Common cancers in 75 years and above age group by sex, Malaysia, 2007-2011
Male
Male
Female
Female
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Other skin
23
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
ColorectalTrachea, Bronchus, LungNasopharynxLymphomaProstateLiverLeukaemiaStomachBladderOther Skin
BreastColorectalCervix UteriOvaryTrachea, Bronchus, LungLymphomaCorpus UteriLeukaemiaThyroidStomach
Sites
Sites
Ethnic Groups
Ethnic Groups
11.312.6
3.35.65.34.54.41.73.32.0
Malay
27.28.15.15.84.43.73.33.53.31.1
Malay
21.118.811.05.09.07.74.05.62.83.8
Chinese
41.517.19.86.38.53.74.93.42.14.1
Chinese
The incidences of cancer among the ethnic groups for ten common cancers are shown in Table 13 and Table 14. In males, the incidence of colorectal, lung, nasopharynx, prostate, and liver cancers were more common inChinese whereas leukaemia and bladder cancers were more common in Malays. In females, the incidence of breast, colorectal, ovarian and lung cancers were more common in Chinese whereas leukaemia and thyroid cancer were more common in Malays.
5.6 Ethnic variations
Table 13: Age-standardised rates for ten most common cancers in males by ethnicity, Malaysia, 2007-2011
Table 14: Age-standardised rates for ten most common cancers in females by ethnicity, Malaysia, 2007-2011
Indian
10.37.61.14.26.13.13.85.22.51.3
Indian
37.18.77.66.13.13.04.83.02.53.2
Others*
9.411.99.96.73.85.83.87.11.82.6
Others*
14.37.4
12.04.97.44.52.53.23.24.9
* Other Bumiputera and Others
* Other Bumiputera and Others
24
Among Malay males, the most common cancers were lung, colorectal, lymphoma, prostate and liver cancers, whereas among Malay females, breast, colorectal, ovarian, cervix uteri and lung cancers were the most common.
Table 15: Ten most common cancers in Malaysia, Malay residents by sex, 2007-2011
C33-C34C18-C21C81-C85,C96C91-C95C22C61C11C67C70-C72C44
C50C18-C21C56C53C33-C34C81-C85,C96C91-C95C73C54C70-C72
Trachea, Bronchus, LungColorectalLymphomaLeukaemiaLiverProstateNasopharynxBladderBrain, Nervous systemOther SkinOthersTotal
BreastColorectalOvaryCervix UteriTrachea, Bronchus, LungLymphomaLeukaemiaThyroidCorpus UteriBrain, Nervous systemOthersTotal
3,0942,8721,6391,4191,1951,163
959781612504
4,51918,757
8,2252,2311,7541,5021,1871,1421,1191,023
964566
4,47524,188
16.515.38.77.66.46.25.14.23.32.7
24.1100.0
34.09.27.36.24.94.74.64.24.02.3
18.5100.0
8.88.14.64.03.43.32.72.21.71.4
53.1
23.66.45.04.33.43.33.22.92.81.6
69.5
12.611.35.64.44.55.33.33.31.92.0
70.7
27.28.15.85.14.43.73.53.33.31.8
81.9
ICD-10
Male
Female
Sites Number % CR ASR
Figure 19: Age-standardised rate (ASR) for ten common cancers in Malays by sex, Malaysia, 2007-2011
Male Female
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
25
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Among Chinese males, the most common cancers were colorectal, lung, nasopharynx, prostate and liver cancers, whereas among Chinese females, breast, colorectal, cervix uteri, lung and ovarian cancers were the most common.Table 16: Ten most common cancers in Malaysia, Chinese residents by sex, 2007-2011
C18-C21C33-C34C11C61C22C16C81-C85,C96C44C91-C95C25
C50C18-C21C53C33-C34C56C54C16C81-C85,C96C11C91-C95
ColorectalTrachea, Bronchus, LungNasopharynxProstateLiverStomachLymphomaOther SkinLeukaemiaPancreasOthersTotal
BreastColorectalCervix UteriTrachea, Bronchus, LungOvaryCorpus UteriStomachLymphomaNasopharynxLeukaemiaOthersTotal
3,8253,3902,1041,5891,4161,001
908687657516
4,33120,424
7,3333,0231,7321,4861,107
853725639611527
4,07822,114
18.716.610.37.86.94.94.43.43.22.5
21.2100.0
33.213.77.86.75.03.93.32.92.82.4
18.4100.0
23.320.612.89.78.66.15.54.24.03.1
124.4
47.519.611.29.67.25.54.74.14.03.4
143.2
21.118.811.09.07.75.65.03.84.02.8
112.9
41.517.19.88.56.34.94.13.73.53.4
126.2
ICD-10
Male
Female
Sites Number % CR ASR
Figure 20: Age-standardised rate (ASR) for ten common cancers in Chinese by sex, Malaysia, 2007-2011
Male Female
26
Among Indian males, the most common cancers were colorectal, lung, prostate, stomach and lymphoma, whereas among Indian females, breast, colorectal, cervix uteri, mouth and ovarian cancers were the most common.Table 17: Ten most common cancers in Malaysia, Indian residents by sex, 2007-2011
C18-C21C33-C34C61C16C81-C85,C96C91-C95C22C03-C06C15C32
C50C18-C21C53C03-C06C56C54C15C16C91-C95C81-C85,C96
ColorectalTrachea, Bronchus, LungProstateStomach LymphomaLeukaemiaLiverMouthOesophagusLarynxOthersTotal
BreastColorectalCervix UteriMouthOvaryCorpus UteriOesophagusStomachLeukaemiaLymphomaOthersTotal
3892701881871871711141079890
8782,679
1,705364327287277204145137137130
1,0854,798
14.510.17.07.07.06.44.34.03.73.4
32.8100.0
35.57.66.86.05.84.33.02.92.92.7
22.6100.0
8.15.63.93.93.93.62.42.22.01.9
56.0
36.07.76.96.15.84.33.12.92.92.7
101.2
10.37.66.15.24.23.83.12.92.72.3
70.4
37.18.77.67.56.14.83.63.23.03.0
110.1
ICD-10
Male
Female
Sites Number % CR ASR
FemaleMale
Figure 21: Age-standardised rate (ASR) for ten common cancers in Indians by sex, Malaysia, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
27
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
In other ethnic groups, the most common cancers among males were nasopharynx, lung, colorectal, lymphoma and stomach, whereas among females, breast, cervix uteri, colorectal, lung and ovarian cancers were the most common.Table 18: Ten most common cancers in Malaysia, other ethnic groups by sex, 2007-2011
C11C33-C34C18-C21C81-C85,C96C16C22C91-C95C61C44C70-C72
C50C53C18-C21C33-C34C56C81-C85,C96C16C11C91-C95C73
NasopharynxTrachea, Bronchus, LungColorectalLymphomaStomachLiverLeukaemiaProstateOther SkinBrain, Nervous systemOthersTotal
BreastCervix UteriColorectalTrachea, Bronchus, LungOvaryLymphomaStomachNasopharynxLeukaemiaThyroidOthersTotal
678661560437397329302192148113
1,1174,934
943791429393334292273268241210
1,4395,613
13.713.411.38.98.06.76.13.93.02.3
22.6100.0
16.814.17.67.06.05.24.94.84.33.7
25.6100.0
7.67.46.24.94.43.73.42.11.61.3
55.0
10.89.14.94.53.83.33.13.12.82.4
64.4
9.911.99.46.77.15.83.83.82.61.5
80.5
14.312.07.47.44.94.54.94.03.23.2
89.6
ICD-10
Male
Female
Sites Number % CR ASR
Figure 22: Age-standardised rate (ASR) for ten common cancers in other ethnic groups by sex, Malaysia, 2007-2011
Male Female
28
Table 19: Staging for all cancer types, Malaysia, 2007-2011 5.7 Staging
C00
C01-C02
C03-C06
C07-C08
C09
C10
C11
C12-C13
C14
C15
C16
C17
C18-C21
C22
C23-C24
C25
C30-C31
C32
C33-C34
C37-C38
C40-C41
C43
C44
C45
C46
C47;C49
C50
C51C52C53C54C55C56C57C58C60C61C62C63C64
C65
C66
C67
C68
C69
C70-C72
C73
C74
C75
C81-C85;C96
C90
C91-C95
LIP
TONGUE
MOUTH
SALIVARY GLAND
TONSIL
OTHER OROPHARYNX
NASOPHARYNX
HYPOPHARYNX
PHARYNX UNSPEC
OESOPHAGUS
STOMACH
SMALL INTESTINE
COLORECTAL
LIVER
GALLBLADDER
PANCREAS
NOSE,SINUSES ETC.
LARYNX
TRACHEA,BRONCHUS,LUNG
OTHER THORACIC ORGANS
BONE
MELANOMA OF SKIN
OTHER SKIN
MESOTHELIOMA
KAPOSI SARCOMA
CONNECTIVE TISSUE
BREAST
VULVAVAGINA
CERVIX UTERICORPUS UTERI
UTERUS UNSPECOVARY
OTHER FEMALE GENITALPLACENTA
PENISPROSTATE
TESTISOTHER MALE GENITAL
KIDNEY
RENAL PELVIS
URETER
BLADDER
OTHER URINARY ORGANS
EYE
BRAIN,NERVOUS SYSTEM
THYROID
ADRENAL GLAND
OTHER ENDOCRINE
LYMPHOMA
MULTIPLE MYELOMA
LEUKAEMIA
OTHER & UNSPEC
ICD-10 SITES SEX TOTALSTAGENUMBER
WITH RECORDED
STAGE
%I II III IV% % % %
MFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFMFFFFFFFFFMMMMMFMFMFMFMFMFMFMFMFMFMFMFMFMF
Grand Total
3055461401391525273226127688130
3,7851,305172863720737429
2,0131,44715489
7,6466,0473,0541,074413409
1,041788270138825113
7,4153,193167123493365167155
1,3841,045
2219172
434378137
18,206123124
4,3522,181580
3,4724265115
3,132496319014341381911
1,477400171010467
1,1761,060549
1,723474510951
3,1712,203396348
2,5492,024746654
103,507
1534
2722212103041179474335514
2,07265286461810
3652038236496537
4,2633,3721,22141214719353540713265
50962
4,1891,769
6238
1841376058
43631913820
1368973
11,9386461
2,7941,442272
2,358251440
1,59223514
50424287
127
68817556
2414
43336121367116172712
1,3239315638
168132253242
52,794
50.061.859.055.153.757.942.941.658.348.567.946.754.750.050.053.548.650.049.547.340.944.942.241.655.855.840.038.435.647.251.451.648.947.161.754.956.555.437.130.937.337.535.937.431.530.559.142.111.80.0
31.323.553.365.652.049.264.266.146.967.959.521.534.850.847.445.255.955.861.587.563.263.646.643.829.460.023.120.936.834.138.838.934.037.824.823.541.742.314.110.96.66.5
33.937.051.0
71039362647242111382
2437010312
2214735948
44832812437152235292319
12416
1495575
242697
2191701000
402116
2,373911
66866411672985
102491056
78484434
205480084
9311147
24513
106
219152911--
3219
9,029
27
62574453282813474
513193261042
6552
130107116
1,006845134392028654334109916
290125108
411475
90642100
241925
4,4131515
1,00028647
309406
388462
98592031
182373241
787455
1550180
328250118--
2636
12,445
28
6452495330171516115
602195221363
99552111491411
1,2941,0751696929266870201011715
967344168
1822131341372300
229
202,753
2112
61228851
760614
297243
65260232
121320011
637533761243
314199125--
3430
12,135
49
1077691
15135283510293
714194282073
17982
4093343612
1,5151,124794267831173672655526
16915
2,7831,245
2917
10175313386488420
504012
2,3991923
51420458
56078
20658603
2631092130
1805824118
19910178
195141153
4623302414--
161157
18,885
46.729.414.316.312.415.520.522.314.99.1
14.514.311.710.711.66.55.6
20.06.06.98.99.16.2
21.610.59.7
10.29.0
10.211.46.57.1
17.429.224.425.83.63.111.313.213.019.015.012.150.253.37.70.00.00.0
29.423.621.919.914.118.023.946.042.630.932.035.725.015.644.742.915.519.850.057.125.057.129.827.40.00.0
33.328.621.530.722.136.56.3
17.637.050.016.616.316.128.9
--
12.67.9
17.1
13.320.622.825.821.017.423.929.817.612.112.728.624.829.630.221.722.220.017.825.615.816.516.916.223.625.111.09.5
13.614.512.110.625.815.419.425.86.97.1
16.121.122.310.211.78.6
20.620.115.412.50.00.0
17.621.334.237.023.424.635.819.817.313.116.00.0
15.024.419.614.319.424.425.00.0
25.014.326.521.160.033.316.77.1
18.020.525.823.10.05.9
29.60.0
24.826.919.621.1
--
10.314.923.6
13.323.523.523.523.317.425.618.120.348.520.035.729.129.925.628.333.330.027.127.125.623.021.529.730.431.913.816.719.713.512.717.215.215.423.024.223.119.425.821.19.8
16.121.722.49.411.615.437.50.00.0
16.210.127.423.132.819.721.920.018.832.224.07.1
10.018.710.221.412.910.70.0
28.625.028.617.618.30.00.04.27.1
14.520.815.511.36.311.814.825.023.721.421.413.2
--
13.412.422.9
26.726.539.334.443.349.729.929.847.330.352.721.434.529.832.643.538.930.049.040.449.751.555.432.435.533.365.064.856.560.668.665.141.740.033.224.266.470.446.844.754.954.751.756.919.715.061.550.0
100.00.0
36.844.916.420.129.737.718.414.121.323.728.057.150.041.325.521.452.245.025.014.325.00.0
26.233.140.066.745.857.146.028.036.629.187.564.718.525.034.935.442.936.8
--
63.664.935.8
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
29
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Summary table for all cancer sites is shown in Table 19. A total of 103,507 new cancer cases were reported, of whom 52,794 (51.0%) had reports on staging. Of the patients whose stages were reported, 9,029 (17.1%) were in stage I, 12,445 (23.6%) in stage II, 12,135 (23.0%) in stage III and 18,885 (35.8%) in stage IV. Thus at the time of diagnosis, 31,020 (58.8%) had advanced cancers (classified as either stage III or IV).
The Data Quality in this report were measured through data completeness, comparability and validity. Validity can be defined as the proportion of cases in a data-set which truly have the reported attribute. The Malaysian National Cancer Registry (MNCR) has used the same five common indices as indicated in the Cancer Incidence in Five Continents (CI5), Vol X, which are (a) internal consistency; (b) histological verification; (c) death certificate only (DCO); (d) other and unspecified cases (ill-defined cases ) and (e) age unknown.
Internal consistency: The MNCR uses the IARC/IACR CHECK program to perform consistency checks on the cancer notifications. All cases queried are checked by the registry staff, using the software program, before incorporating relevant items into the database.
Histological verification: The accuracy of the stated diagnosis is likely to be higher if there is histological confirmation by a pathologist or cytology/haematology confirmation. As the MNCR does not distinguish between histology and cytology/haematology verification, morphologically verified (MV) is used rather than histological verification. For cancers with specified sites, the morphologically verified proportion was 96.6% of all cases for both sexes.
Death Certificate Only (DCO): All the death notified by the public, private health facilities to the registry was traced and checked with the National Registry Departments. For cancer with specified sites, the DCO percentage was 0.3% of total cases for both sexes. Other and unspecified cases (ill-defined cases): For this category, the percentage was 2.7% (1.6% for males and 1.1% for females) A low proportion of cases that are assigned to this category generally imply a better diagnostic precision in determining the site of primary cancer.
Age unknown: If there are a large number of cases with age unknown, several of the figures and graphs from the data-set would not be accurate. In this report, all the ages were known.
5.8 Data Quality
(a)
(b)
(c)
(d)
(e)
30
Table 20: Quality indicator
C00C01-C02C03-C06C07-C08C09C10C11C12-C13C14C15C16C17C18-C21C22C23-C24C25C30-C31C32C33-C34C37-C38C40-C41C43C44C45C46C47;C49C50C51C52C53C54C55C56C57C58C60C61C62C63C64C65C66C67C68C69C70-C72C73C74C75C81-C85,C96C88C90C91-C95
LipTongueMouthSalivary glandsTonsilOther OropharynxNasopharynxHypopharynxPharynx unspec.OesophagusStomachSmall intestineColorectalLiverGallbladder etc.PancreasNose, sinuses etc.LarynxTrachea,Bronchus,LungOther Thoracic organsBoneMelanoma of SkinOther SkinMesotheliomaKaposi sarcomaConnective,Soft tissueBreastVulvaVaginaCervix UteriCorpus UteriUterus unspec.OvaryOther Female GenitalPlacentaPenisProstateTestisOther male genitalKidneyRenal PelvisUreterBladderOther Urinary organsEyeBrain, Nervous systemThyroidAdrenal glandOther EndocrineLymphomaImmunoproliferative dis.Multiple MyelomaLeukaemiaOther & unspecifiedAll Sites Total
85862916499195111
5,09025857
1,1663,461242
13,6934,128822
1,829408938
10,608290858322
2,4294119812
18,343123124
4,3522,181580
3,4724265115
3,13249631
1,3352130
1,87727171
2,2362,272
92160
5,37412744
4,5731,388
103,507
85854913487192110
5,02425254
1,1463,377240
13,4903,260779
1,573400924
9,826284802320
2,4234118781
18,258123123
4,3242,171575
3,4083962114
3,08948831
1,3022029
1,84226155
1,9252,249
87153
5,34811
7254,5701,08299,984
100.099.199.797.698.599.198.797.794.798.397.699.298.579.094.886.098.098.592.697.993.599.499.8100.094.796.299.5100.099.299.499.599.198.292.995.499.198.698.4100.097.595.296.798.196.390.686.199.094.695.699.591.797.499.978.096.6
0100100111803537141031060000017002100000200200100101001001
116282
0.00.10.00.00.50.00.00.41.80.10.20.00.30.90.10.20.20.00.30.00.70.00.00.00.00.00.10.00.00.00.00.00.00.00.00.00.10.00.00.10.00.00.10.00.00.40.00.00.00.00.00.00.08.40.3
ICD-10 SITE TOTAL QUALITY INDICATORMV % DCO %
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
31
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
The table below explains the incidence by year, sex, ethnic group and states.
Table 21: Summary of all cancer sites 2007-2011 by sex, year and ethnic
Table 22: Summary of all cancer sites 2007-2011 by states
6.0 INCIDENCE SUMMARY TABLES : All sites, 2007-2011
Year20072008200920102011EthnicAll ResidentsMalayChineseIndianOther
8,9699,3839,4959,5719,376
46,79418,75720,4242,6794,934
11,03511,34411,21611,67211,446
56,71324,18822,1144,7985,613
70.872.572.571.968.6
71.453.1
124.456.055.0
89.589.788.090.187.2
89.069.5
143.2101.264.4
89.790.287.985.480.9
86.970.7
112.970.480.5
102.6102.398.498.893.8
99.381.9
126.2110.189.6
10.110.19.99.79.3
9.88.0
12.58.19.2
10.810.910.610.610.0
10.68.7
13.212.29.7
(87.8 , 91.6)(88.3 , 92.0)(86.1 , 89.7)(83.7 , 87.2)(79.2 , 82.5)
(86.1 , 87.7)(69.7 , 71.8)
(111.4 , 114.5)(67.6 , 73.2)(78.2 , 82.8)
(100.6 , 104.5)(100.4 , 104.2)(96.5 , 100.2)(97.0 , 100.6)(92.0 , 95.5)
(98.4 , 100.1)(80.8 , 82.9)
(124.5 , 127.9)(106.9 , 113.3)(87.2 , 92.0)
FemaleNo. CR ASR (ASR 95% CL) CumR
MaleNo. CR ASR (ASR 95% CL) CumR
SelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuN.SembilanMelakaPerlisW.P. Labuan
6,2617,2023,5224,5494,4652,7742,2772,1055,2452,1931,6681,9171,811
40553
8,4848,1104,0455,1855,5043,5653,3072,2816,0852,4991,9772,5282,214
49551
49.391.858.976.477.959.659.554.8
144.160.963.779.094.246.226.5
69.2109.469.890.396.676.788.359.6
166.673.679.1
106.9110.286.426.8
71.3109.093.685.774.766.573.168.0
150.575.183.189.1
104.772.850.9
89.7118.7105.3100.288.477.0
101.265.8
157.882.693.8
108.9108.184.941.7
8.512.210.89.58.37.48.67.5
15.98.69.59.9
11.38.46.1
10.012.411.310.59.28.2
11.17.1
16.18.79.8
11.611.38.74.9
(69.4 , 73.2)(106.5 , 111.6)(90.3 , 96.8)(83.2 , 88.3)(72.5 , 76.9)(64.0 , 69.1)(70.0 , 76.2)(65.0 , 70.9)
(146.4 , 154.6)(71.9 , 78.2)(79.0 , 87.2)(85.1 , 93.2)(99.8 , 109.6)(65.7 , 80.0)(36.0 , 65.8)
(87.7 , 91.7)(116.1 , 121.3)(101.9 , 108.8)(97.5 , 103.0)(86.1 , 90.8)(74.4 , 79.5)(97.6 , 104.7)(63.1 , 68.6)
(153.8 , 161.8)(79.4 , 85.9)(89.6 , 98.0)
(104.6 , 113.2)(103.6 , 112.7)(77.4 , 92.5)(28.7 , 54.7)
FemaleNo. CR ASR (ASR 95% CL) CumR
MaleNo. CR ASR (ASR 95% CL) CumR
32
**The highest incidence from CI5 Volume X *The lowest incidence from CI5 Volume X NB: Singapore (2009-2013 report)Note: International comparisons of age standardised rates of selected countries according to ethnicities and sex.
Figure 23: All Sites: International comparisons – Age standardised rates
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
33
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Female breast cancer was accounted for 32.1% of all cancer among females in Malaysia. The incidence of breast cancer was highest among Chinese followed by Indian and Malay.
The cumulative risk (CumR) was highest among Chinese and lowest among Malay. The lifetime risk was 1 in 30, while for Chinese was 1 in 22, Indian 1 in 24 and Malay 1 in 35. The percentage of breast cancer detected at stage I and II was 56.9%.
In this section, cancers are reviewed focussing on ethnic variations, staging, Age-specific incidence rate as well as annual and state distributions. International comparisons were made with Singapore (Singapore Cancer Registry, Interim Report: Trends in Cancer Incidence in Singapore 2009-2013) and other countries (Cancer Incidence in Five Continents Volume X, 2014). Fifteen most common cancers (male and female combined) were selected.
7.0 COMMENTARY ON 15 SELECTED CANCER SITES
7.1 Female Breast (ICD-10: C50)
SexFemale
No.18,206
CR28.6
ASR31.1
CR743.4
CumR3.4
(ASR 95%CL)(30.7, 31.6)
EthnicMalayChineseIndian
No.8,2257,3331,705
CR23.647.536.0
ASR27.241.537.1
CR742.94.64.2
CumR2.94.54.2
Year20072008200920102011
No.3,5793,6433,5013,7173,766
CR29.028.827.528.728.7
ASR32.332.029.930.830.4
CR743.53.53.33.43.4
CumR3.43.53.33.33.3
Table 23: Female Breast: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011
Table 24: Female Breast: Incidence summary by ethnicity, Malaysia, 2007-2011
Table 25: Female Breast: Incidence summary by year, Malaysia, 2007-2011
34
Figure 24: Female Breast: Age-specific incidence rate, Malaysia, 2007-2011
Figure 25: Female Breast: Stage
Figure 26: Female Breast: Age-standardised rate (ASR) by state, Malaysia, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
35
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 27: Female Breast: International comparisons – Age-standardised rates
** The highest incidence from CI5, Volume X *The lowest incidence from CI5, Volume X NB: Singapore (2009-2013 report)
36
Colorectal cancer was the most common cancer in male and second in female. The incidence of colorectal cancer increases with age and highest among Chinese for males and females. The lifetime risk for males was 1 in 56. It was 1 in 39 for Chinese, 1 in 72 for Malay and 1 in 82 for Indian. The lifetime risk for females was 1 in 74; forChinese 1 in 49, Indian 1 in 91 and Malay 1 in 100. The male to female ASR ratio was 1.3:1.
The percentage of colorectal cancer detected at stage I and II was only 34.1% and 34.8% respectively for both male and female.
7.2 Colorectal (ICD10: C18-C21)
SexMaleFemaleBoth
No.7,6466,047
13,693
CR11.79.5
ASR14.611.1
CR741.81.4
CumR1.81.3
(ASR 95%CL)(14.2, 14.9)(10.8, 11.4)
EthnicMalayChineseIndian
Year20072008200920102011
Male
Male
Female
Female
No.2,8723,825
389
No.1,3711,4831,5661,6331,593
No.2,2313,023
364
No.1,1241,1941,2531,2511,225
CR8.1
23.38.1
CR10.811.512.012.311.7
CR6.4
19.67.7
CR9.19.49.89.79.3
ASR11.321.110.3
ASR14.114.615.014.914.0
ASR8.1
17.18.7
ASR11.111.311.611.010.4
CR741.42.61.2
CR741.71.81.91.91.7
CR741.02.11.1
CR741.41.41.41.31.3
CumR1.42.51.2
CumR1.71.81.81.91.7
CumR1.02.01.1
CumR1.31.31.41.31.3
Table 26: Colorectal: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011
Table 27: Colorectal: Incidence summary by ethnicity and sex, Malaysia, 2007-2011
Table 28: Colorectal: Incidence summary by year and sex, Malaysia, 2007-2011
%55.844.2
100.0
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
37
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 28: Colorectal: Age-specific incidence rate by sex, Malaysia, 2007-2011
Figure 29: Colorectal: Stage by sex
Figure 30: Colorectal: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011
38
Figure 31: Colorectal: International comparisons by sex – Age-standardised rates
** The highest incidence from CI5, Volume X *The lowest incidence from CI5, Volume X NB: Singapore (2009-2013 report)
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
39
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Lung cancer is the second most common cancer among males and fifth among females in Malaysia. The incidence increased with age and the peak of age-specific incidence rate was at the age of 70 and above.
The lifetime risk for males was 1 in 55. For Indian, Malay and Chinese, it was 1 in 103, 1 in 62 and 1 in 43,respectively. The lifetime risk for females was 1 in 135. For Indian it was 1 in 255, 1 in 185 for Malay and 1 in 97 for Chinese. The male to female ASR ratio was 2.4:1.
Most of lung cancer cases were detected at late stage (stage III and stage IV) for both sexes.
7.3 Trachea, Bronchus, Lung (ICD-10: C33-C34)
SexMaleFemaleBoth
No.7,4153,193
10,608
CR11.35.0
ASR14.46.0
CR741.80.7
CumR1.80.7
(ASR 95%CL)(14.1, 14.8)(5.8, 6.2)
EthnicMalayChineseIndian
Year20072008200920102011
Male
Male
Female
Female
No.3,0943,390
270
No.1,4741,5041,4991,4931,445
No.1,1871,486
127
No.596658649658632
CR8.8
20.65.6
CR11.611.611.411.210.6
CR3.49.62.7
CR4.85.25.15.14.8
ASR12.618.87.6
ASR15.515.414.513.913.0
ASR4.48.53.1
ASR6.16.36.06.05.4
CR741.62.41.0
CR742.02.01.91.81.7
CR740.51.00.4
CR740.80.80.80.80.6
CumR1.62.31.0
CumR2.02.01.81.71.7
CumR0.51.00.4
CumR0.80.80.80.80.6
Table 29: Trachea, Bronchus, Lung: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011
Table 30: Trachea, Bronchus, Lung: Incidence summary by ethnicity and sex, Malaysia, 2007-2011
Table 31: Trachea, Bronchus, Lung: Incidence summary by year and sex, Malaysia, 2007-2011
%69.930.1
100.0
40
Figure 32: Trachea, Bronchus, Lung: Age-specific incidence rate by sex, Malaysia, 2007-2011
Figure 33: Trachea, Bronchus, Lung: Stage by sex
Figure 34: Trachea, Bronchus, Lung: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
41
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 35: Trachea, Bronchus, Lung: International comparisons – Age-standardised rates
** The highest incidence from CI5, Volume X *The lowest incidence from CI5, Volume X NB: Singapore (2009-2013 report)
42
Lymphoma ranked fourth in males and sixth in females. Malay males had the higher rate compared to Chinese and Indian.
The lifetime risk for males was 1 in 167; 1 in 229 for Indian, 1 in 177 for Chinese and 1 in 165 for Malay. The lifetime risk for females was 1 in 247; 1 in 285 for Indian, 1 in 253 for Malay and 1 in 248 for Chinese.
7.4 Lymphoma (ICD10: C81-C85; C96)
SexMaleFemaleBoth
No.3,1712,2035,374
CR4.83.5
ASR5.53.8
CR740.60.4
CumR0.60.4
(ASR 95%CL)(5.3, 5.7)(3.6, 3.9)
EthnicMalayChineseIndian
Year20072008200920102011
Male
Male
Female
Female
No.1,639
908187
No.532659664641675
No.1,142
639130
No.358480431477457
CR4.65.53.9
CR4.25.15.14.84.9
CR3.34.12.7
CR2.93.83.43.73.5
ASR5.65.04.2
ASR4.95.95.75.35.5
ASR3.73.73.0
ASR3.34.23.73.93.6
CR740.60.60.4
CR740.50.70.60.60.6
CR740.40.40.4
CR740.30.50.40.40.4
CumR0.60.60.4
CumR0.50.70.60.60.6
CumR0.40.40.4
CumR0.30.50.40.40.4
Table 32: Lymphoma: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011
Table 33: Lymphoma: Incidence summary by ethnicity and sex, Malaysia, 2007-2011
Table 34: Lymphoma: Incidence summary by year and sex, Malaysia, 2007-2011
%59.041.0
100.0
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
43
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 38: Lymphoma: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011
Figure 36: Lymphoma: Age-specific incidence rate by sex, Malaysia, 2007-2011
Figure 37: Lymphoma: Stage by sex
Stage 1 16%
Stage 2 25% Stage 3
24%
Stage 4 35%
Male (n = 1,323)
Stage 1 16%
Stage 2 27%
Stage 3 22%
Stage 4 35%
Female (n = 931)
44
Nasopharynx was the fifth most common cancer in Malaysian population and third most common in males. The lifetime risk for males was 1 in 143 and for females was 1 in 417. The incidence in males increased at the age of 25 years old and peaked at the age of 65 years old.
Most of nasopharynx cancer cases in males were detected at stage III and IV (63.6%).
7.5 Nasopharynx (ICD10:C11)
SexMaleFemaleBoth
No.3,7851,3055,090
CR5.82.0
ASR6.42.2
CR740.70.2
CumR0.70.2
(ASR 95%CL)(6.1, 6.6)(2.1, 2.3)
EthnicMalayChineseIndian
Year20072008200920102011
Male
Male
Female
Female
No.959
2,10444
No.762857791689686
No.40161125
No.281264244268248
CR2.7
12.80.9
CR6.06.66.05.25.0
CR1.24.00.5
CR2.32.11.92.11.9
ASR3.3
11.01.1
ASR6.97.46.65.65.4
ASR1.33.50.6
ASR2.52.32.02.22.0
CR740.41.20.1
CR740.80.80.70.60.6
CR740.10.40.1
CR740.30.30.20.20.2
CumR0.41.20.1
CumR0.80.80.70.60.6
CumR0.10.40.1
CumR0.30.30.20.20.2
Table 35: Nasopharynx: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011
Table 36: Nasopharynx: Incidence summary by ethnicity and sex, Malaysia, 2007-2011
Table 37: Nasopharynx: Incidence summary by year and sex, Malaysia, 2007-2011
%74.425.6
100.0
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
45
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 41: Nasopharynx: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011
Figure 39: Nasopharynx: Age-specific incidence rate by sex, Malaysia, 2007-2011
Figure 40: Nasopharynx: Stage by sex
0
5
10
15
20
25
0- 5-
Inci
denc
e per
100
,000
Age group (years)
Male Female
10- 15- 20- 25- 30- 35- 40- 45- 50- 55- 60- 65- 70- 75+
46
Figure 42: Nasopharynx: International comparisons – Age-standardised rates
** The highest incidence from CI5, Volume X * The lowest incidence from CI5, Volume X
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
47
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Leukaemia is the sixth most common cancer in Malaysian population and seventh most common in males and eighth most common in females. It is the most common cancer among 0-14 years old. Malay had the highest rate followed by Chinese and Indian in both sexes. The lifetime risk for males was 1 in 275 and for females was 1 in 348.
7.6 Leukaemia (ICD-10: C91-C95)
SexMaleFemaleBoth
No.2,5492,0244,573
CR3.93.2
ASR4.23.4
CR740.40.3
CumR0.4 0.3
(ASR 95%CL)(4.0, 4.4)(3.2, 3.5)
EthnicMalayChineseIndian
Year20072008200920102011
Male
Male
Female
Female
No.1,419
657171
No.484525554517469
No.1,119
527137
No.374421431428370
CR4.04.03.6
CR3.84.14.23.93.4
CR3.23.42.9
CR3.03.33.43.32.8
ASR4.44.03.8
ASR4.14.44.54.23.7
ASR3.53.43.0
ASR3.23.63.63.53.0
CR740.40.40.3
CR740.40.40.40.40.3
CR740.30.30.3
CR740.30.30.30.30.3
CumR0.40.30.3
CumR0.40.40.40.40.3
CumR0.30.30.3
CumR0.30.30.30.30.3
Table 38: Leukaemia: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011
Table 39: Leukaemia: Incidence summary by ethnicity and sex, Malaysia, 2007-2011
Table 40: Leukaemia: Incidence summary by year and sex, Malaysia, 2007-2011
%55.744.3
100.0
Figure 43: Leukaemia: Age-specific incidence rate by sex, Malaysia, 2007-2011
48
Figure 44: Leukaemia types: Age-specific incidence rate, males, Malaysia, 2007-2011
Figure 45: Leukaemia types: Age-specific incidence rate, females, Malaysia, 2007-2011
Figure 46: Leukaemia: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
49
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 47: Leukaemia: International comparisons – Age-standardised rates
** The highest incidence from CI5, Volume X * The lowest incidence from CI5, Volume X
50
Cancer of the cervix uteri was the third most common cancer in females. The lifetime risk was 1 in 116. Chinese had higher incidence rate followed by Indian and Malay. The cumulative risk (CumR) for Chinese was 1.2, Indian 0.9 and Malay 0.6. The incidence rate over the five years was found to have decreased from 8.4 to 6.5.
Almost 60% of cervix uteri cancer cases were detected at stage I and II.
7.7 Cervix Uteri (ICD-10:C53)
SexFemale
No.4,352
CR6.8
ASR7.6
CR740.9
CumR0.9
(ASR 95%CL)(7.3, 7.8)
Table 41: Cervix Uteri: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011
Table 42: Cervix Uteri: Incidence summary by ethnicity, Malaysia, 2007-2011
Table 43: Cervix Uteri: Incidence summary by year, Malaysia, 2007-2011
EthnicMalayChineseIndian
No.1,5021,732
327
CR4.3
11.26.9
ASR5.19.87.6
CR740.61.20.9
CumR0.61.20.9
Year20072008200920102011
No.895937884841795
CR7.37.46.96.56.1
ASR8.38.47.67.16.5
CR740.91.00.90.80.7
CumR0.90.90.90.80.7
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
51
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 48: Cervix Uteri: Age-specific incidence rate, Malaysia, 2007-2011
Figure 49: Cervix Uteri: Stage
Figure 50: Cervix Uteri: Age-standardised rate (ASR) by state, Malaysia, 2007-2011
52
Figure 51: Cervix Uteri: International comparisons – Age-standardised rates
** The highest incidence from CI5, Volume X *The lowest incidence from CI5, Volume X NB: Singapore (2009-2013 report)
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
53
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Liver cancer is the eighth most common cancer among Malaysian population and sixth most common cancer among males. The incidence of liver cancer increased with age and higher in males compared to females. Chinese were found to have higher incidence rate compared to Malay and Indian. The lifetime risk was 1 in 144 for males and 1 in 418 for females.
Most of liver cancer cases were detected at late stage (stage III and stage IV) for both sexes.
7.8 Liver (ICD-10:C22)
EthnicMalayChineseIndian
Male FemaleNo.
1,1951,416
114
No.47741158
CR3.48.62.4
CR1.42.71.2
ASR4.57.73.1
ASR1.72.31.5
CR740.50.90.4
CR740.20.30.2
CumR0.50.90.4
CumR0.20.30.2
Table 45: Liver: Incidence summary by ethnicity and sex, Malaysia, 2007-2011
Year20072008200920102011
Male FemaleNo.544570658692590
No.201218219207229
CR4.34.45.05.24.3
CR1.61.71.71.61.7
ASR5.55.56.16.15.1
ASR2.02.12.11.82.0
CR740.70.70.70.70.6
CR740.20.30.30.20.2
CumR0.70.70.70.70.6
CumR0.20.30.30.20.2
Table 46: Liver: Incidence summary by year and sex, Malaysia, 2007-2011
SexMaleFemaleBoth
No.3,0541,0744,128
CR4.71.7
ASR5.62.0
CR740.70.2
CumR0.70.2
(ASR 95%CL)(5.4, 5.8)(1.9, 2.1)
Table 44: Liver: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011
%74.026.0
100.0
54 Figure 54: Liver: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011
Figure 52: Liver: Age-specific incidence rate by sex, Malaysia, 2007-2011
Figure 53: Liver: Stage by sex
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
55
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 55: Liver: International comparisons – Age-standardised rates
** The highest incidence from CI5, Volume X * The lowest incidence from CI5, Volume X
56
Ovary cancer was ninth most common cancer in all residents and fourth in female. The incidence was highest among Chinese followed by Indian and Malay. The lifetime risk was 1 in 158. For Chinese 1 in 147, Indian 1 in 153 and Malay 1 in 159. Forty four per cent of ovary cancer cases were detected at stage I and II.
7.9 Ovary (ICD10: C56)
SexFemale
No.3,472
CR5.4
ASR5.9
CR740.6
CumR0.6
(ASR 95%CL)(5.7, 6.1)
Table 47: Ovary: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) andCumulative Risk (CumR), Malaysia, 2007-2011
Table 48: Ovary: Incidence summary by ethnicity, Malaysia, 2007-2011
Table 49: Ovary: Incidence summary by year, Malaysia, 2007-2011
EthnicMalayChineseIndian
No.1,7541,107
277
CR5.07.25.8
ASR5.86.36.1
CR740.60.70.7
CumR0.60.70.7
Year20072008200920102011
No.709615739695714
CR5.74.95.85.45.4
ASR6.45.46.35.75.7
CR740.70.60.70.60.6
CumR0.70.60.70.60.6
5.1
6.4 6.1 6.1 5.9
5.0
3.5
5.3
8.6
5.0
8.1
7.1 7.8
3.9
1.7
0
2
4
6
8
10
Inci
denc
e pe
r 100
,000
State
57
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 56: Ovary: Age-specific incidence rate, Malaysia, 2007-2011
Figure 57: Ovary: Stage
Figure 58: Ovary: Age-standardised rate (ASR) by state, Malaysia, 2007-2011
58
Figure 59: Ovary: International comparisons – Age-standardised rates
** The highest incidence from CI5, Volume X *The lowest incidence from CI5, Volume NB: Singapore (2009-2013 report)
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
59
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Cancer of the stomach was eighth most common cancer in males and tenth in females. The incidence of stomach cancer increased with age. The incidence was highest among Chinese followed by Indian and Malay for both sexes.
The lifetime risk for males was 1 in 215 and for females was 1 in 326. For males, it was 1 in 156 for Chinese and Indian, and 1 in 489 for Malay. For females, it was 1 in 223 for Chinese, 1 in 268 for Indian and 1 in 733 for Malay.
Most of stomach cancer cases were detected at late stage (stage III and stage IV) for both sexes.
7.10 Stomach (ICD10: C16)
EthnicMalayChineseIndian
Male FemaleNo.429
1,001187
No.312725137
CR1.26.13.9
CR0.94.72.9
ASR1.75.65.2
ASR1.14.13.2
CR740.20.60.6
CR740.10.40.4
CumR0.20.60.6
CumR0.10.40.4
Table 51: Stomach: Incidence summary by ethnicity and sex, Malaysia, 2007-2011
Year20072008200920102011
Male FemaleNo.373388418411424
No.306291278319253
CR2.93.03.23.13.1
CR2.52.32.22.51.9
ASR3.93.94.03.83.7
ASR3.02.72.52.82.1
CR740.50.50.50.50.4
CR740.40.30.30.30.2
CumR0.50.50.50.50.4
CumR0.40.30.30.30.2
Table 52: Stomach: Incidence summary by year and sex, Malaysia, 2007-2011
SexMaleFemaleBoth
No.2,0141,4473,461
CR3.12.3
ASR3.92.6
CR740.50.3
CumR0.50.3
(ASR 95%CL)(3.7, 4.1)(2.5, 2.8)
Table 50: Stomach: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011
%58.241.8
100.0
60 Figure 62: Stomach: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011
Figure 61: Stomach: Stage by sex
Figure 60: Stomach: Age-specific incidence rate by sex, Malaysia, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
61
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 63: Stomach: International comparisons – Age-standardised rates
** The highest incidence from CI5, Volume X * The lowest incidence from CI5, Volume X
62
Prostate cancer was fifth in male and eleventh most common cancer in all residents. The incidence of prostate cancer increased with age. The incidence was highest among Chinese followed by Indian and Malay. The lifetime risk was 1 in 117. It was 1 in 86 for Chinese, 1 in 124 for Indian and 1 in 146 for Malay. The percentage of prostate cancer detected at stage I and II was 40%.
7.11 Prostate (ICD10: C61)
SexMale
No.3,132
CR4.8
ASR6.6
CR740.9
CumR0.9
(ASR 95%CL)(6.3, 6.8)
Table 53: Prostate: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) andCumulative Risk (CumR), Malaysia, 2007-2011
Table 54: Prostate: Incidence summary by ethnicity, Malaysia, 2007-2011
Table 55: Prostate: Incidence summary by year, Malaysia, 2007-2011
EthnicMalayChineseIndian
No.1,1631,589
188
CR3.39.73.9
ASR5.39.06.1
CR740.71.20.8
CumR0.71.20.8
Year20072008200920102011
No.575621608651677
CR4.54.84.64.95.0
ASR6.66.86.46.56.5
CR740.90.80.80.90.9
CumR0.90.80.80.90.9
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
63
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Figure 66: Prostate: Age-standardised rate (ASR) by state, Malaysia, 2007-2011
Figure 64: Prostate: Age-specific incidence rate, Malaysia, 2007-2011
Figure 65: Prostate: Stage
64
Figure 67: Prostate: International comparisons – Age-standardised rates
** The highest incidence from CI5, Volume X *The lowest incidence from CI5, Volume X NB: Singapore (2009-2013 report)
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
65
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Skin cancer other than melanoma ranked twelve among all residents, ten most common cancer in males andfourteenth in females. The cumulative risk (CumR) for males was 0.3 and females 0.2. The incidence rate was highest among Chinese in both sexes.
The lifetime risk for males was 1 in 317. Among Chinese male, it was 1 in 237, Malay 1 in 402 and Indian 1 in 642. The lifetime risk for females was 1 in 466. For Chinese female, it was 1 in 388, Indian 1 in 627 and Malay was 1 in 633.
Staging was reported for 436 cases in males and 319 cases in females. Of these 71% were diagnosed at stage I and II in males and 73% in females.
7.12 Other Skin (ICD10: C44)
EthnicMalayChineseIndian
Male FemaleNo.504687
45
No.36344659
CR1.44.20.9
CR1.02.91.2
ASR2.03.81.3
ASR1.32.51.5
CR740.20.40.2
CR740.20.30.2
CumR0.20.40.2
CumR0.20.30.2
Table 57: Other skin: Incidence summary by ethnicity and sex, Malaysia, 2007-2011
Year20072008200920102011
Male FemaleNo.288259276283278
No.189200178255223
CR2.32.02.12.12.0
CR1.51.61.42.01.7
ASR3.02.62.72.62.5
ASR1.81.91.62.21.9
CR740.40.30.30.30.3
CR740.20.20.20.20.2
CumR0.40.30.30.30.3
CumR0.20.20.20.20.2
Table 58: Other skin: Incidence summary by year and sex, Malaysia, 2007-2011
SexMaleFemaleBoth
No.1,3841,0452,429
CR2.11.6
ASR2.71.9
CR740.30.2
CumR0.30.2
(ASR 95%CL)(2.5, 2.8)(1.8, 2.0)
Table 56: Other skin: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011
%57.043.0
100.0
66 Figure 70: Other Skin: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011
Figure 69: Other Skin: Stage by sex
Figure 68: Other skin: Age-specific incidence rate by sex, Malaysia, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
67
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Thyroid cancer was ranked seventeenth among males and ninth among females. The incidence rate was thehighest among Malays in both sexes.
The lifetime risk was 1 in 884 for males and 1 in 336 for females, whereas among Malay males 1 in 734 and females 1 in 284.
Staging was reported for 213 cases in males and 671 cases in females, 48% were diagnosed at stage I and II in males and 60% in females.
7.13 Thyroid (ICD10: C73)
EthnicMalayChineseIndian
Male FemaleNo.312142
30
No.1,023
371119
CR0.90.90.6
CR2.92.42.5
ASR1.10.80.7
ASR3.32.12.5
CR740.10.10.1
CR740.40.20.3
CumR0.10.10.1
CumR0.40.20.3
Table 60: Thyroid: Incidence summary by ethnicity and sex, Malaysia, 2007-2011
Year20072008200920102011
Male FemaleNo.137108100108
96
No.345352327352347
CR1.10.80.80.80.7
CR2.82.82.62.72.6
ASR1.31.00.90.90.8
ASR3.03.02.72.82.7
CR740.10.10.10.10.1
CR740.30.30.30.30.3
CumR0.10.10.10.10.1
CumR0.30.30.30.30.3
Table 61: Thyroid: Incidence summary by year and sex, Malaysia, 2007-2011
SexMaleFemaleBoth
No.549
1,7232,272
CR0.82.7
ASR1.02.9
CR740.10.3
CumR0.10.3
(ASR 95%CL)(0.9, 1.0)(2.7, 3.0)
Table 59: Thyroid: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011
%24.275.8
100.0
68 Figure 73: Thyroid: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011
Figure 72: Thyroid: Stage by sex
Figure 71: Thyroid: Age-specific incidence rate by sex, Malaysia, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
69
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Cancer of the brain and nervous system were ranked as eleventh most common cancer in males and thirteenth in females. Chinese have the highest incidence rate followed by Malay and Indian in both sexes.
The lifetime risk for males was 1 in 533, of these Chinese was 1 in 480, 1 in 550 in Malay and 1 in 587 in Indian. Whereas, for females was 1 in 563, Chinese 1 in 530, Malay 1 in 560 and Indian 1 in 636. 39% was detected at stage I and II in males and 51% in females.
7.14 Brain, Nervous system (ICD10: C70-C72)
EthnicMalayChineseIndian
Male FemaleNo.612368
83
No.56630578
CR1.72.21.7
CR1.62.01.6
ASR1.92.11.8
ASR1.81.91.7
CR740.20.20.2
CR740.20.20.2
CumR0.20.20.2
CumR0.20.20.2
Table 63: Brain, Nervous system: Incidence summary by ethnicity and sex, Malaysia, 2007-2011
Year20072008200920102011
Male FemaleNo.271248214223220
No.227226169202236
CR2.11.91.61.71.6
CR1.81.81.31.61.8
ASR2.42.11.81.71.7
ASR2.02.01.41.71.9
CR740.20.20.20.20.2
CR740.20.20.10.20.2
CumR0.20.20.20.20.2
CumR0.20.20.10.20.2
Table 64: Brain, Nervous system: Incidence summary by year and sex, Malaysia, 2007-2011
SexMaleFemaleBoth
No.1,1761,0602,236
CR1.81.7
ASR1.91.8
CR740.20.2
CumR0.20.2
(ASR 95%CL)(1.8, 2.1)(1.7, 1.9)
Table 62: Brain, Nervous system: Number, Percentage, Crude Rate (CR), Cumulative Rate (CR74),Age-Standardised Rate (ASR) and Cumulative Risk (CumR) by sex, Malaysia, 2007-2011
%52.647.4
100.0
70Figure 76: Brain, Nervous system: Age-standardised rate (ASR) by state and sex, Malaysia, 2007-2011
Figure 75: Brain, Nervous system: Stage by sex
Figure 74: Brain, Nervous system: Age-specific incidence rate by sex, Malaysia, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
71
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Corpus uteri cancer was the seventh most common cancer in females. The incidence was highest among Chinese followed by Indian and Malay. The lifetime risk was 1 in 224, 1 in 170 for Indian, 1 in 175 for Chinese and 1 in 263 for Malay.
Staging was reported for 1,442 cases, of which 66% were diagnosed at stage I and II
7.15 Corpus Uteri (ICD10: C54)
SexFemale
No.2,181
CR3.4
ASR3.8
CR740.4
CumR0.4
(ASR 95%CL)(3.7, 4.0)
Table 65: Corpus Uteri: Number, Crude Rate (CR), Cumulative Rate (CR74), Age-Standardised Rate (ASR) and Cumulative Risk (CumR), Malaysia, 2007-2011
Table 66: Corpus Uteri: Incidence summary by ethnicity, Malaysia, 2007-2011
Table 67: Corpus Uteri: Incidence summary by year, Malaysia, 2007-2011
EthnicMalayChineseIndian
No.964853204
CR2.85.54.3
ASR3.34.94.8
CR740.40.60.6
CumR0.40.60.6
Year20072008200920102011
No.446393414466462
CR3.63.13.23.63.5
ASR4.13.63.74.03.8
CR740.50.40.50.50.4
CumR0.50.40.50.50.4
72Figure 79: Corpus Uteri: Age-standardised rate (ASR) by state, Malaysia, 2007-2011
Figure 78: Corpus Uteri: Stage
Figure 77: Corpus Uteri: Age-specific incidence rate, Malaysia, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
73
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Ahmad Zudfadli et al, Pahang Cancer Registry Report, 1999-2003, Pahang State Health Department,Malaysia.
Azizah Ab M, Devaraj T, Bina Rai S, Norbaiyah Y, Nooraihan M, Noorshila S (2010, August), Penang Cancer Registry Report 2004-2008, Penang State Health Department, Malaysia.
Curado M.P., Edwards B., Shin H.R., Storm H., Ferlay J., Heanue M. and Boyle P., eds (2007), CancerIncidence in Five Continents, Vol. X, IARC Scientific Publications No 160, Lyon, France.
D. Forman, F. Bray, D.H. Brewster, C. Gombe Mbalawa, B. Kohler, M. Pineros, E. Steliarova-Foucher, R. Swaminathan and J. Ferlay (2014), Cancer Incidence in Five Continents, Vol. X, IARC Scientific Publications No.164, Lyon, France.
Department of Statistics, Malaysia (2007-2011), Population Distribution and Basic DemographicCharacteristics, Population and Housing Census of Malaysia 2010, Malaysia.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F, GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: Population Fact Sheets, Malaysia [Internet].
Fritz A., et al., 2000, International Classification of Diseases for Oncology, 3rd Edition, World HealthOrganization.
Health Facts 2009-2013, Health Informatics Center, Planning and Development Division, Ministry of Health Malaysia.
National Cancer Institute (NIH), www.cancer.gov/publication/dictionaries/cancer-terms.
Noor Hashimah A., Fauziah M.N., Norazmi A., Rohaida I., Anees A.H and Wan Mansor H (2011), Kelantan Cancer Registry Report 2004-2008, Kelantan State Health Department, Malaysia.
O.M. Jensen, D.M. Parkin, R. MacLennan, C.S. Muir and R.G. Skeet (1991), Cancer Registration: Principles and Methods, IARC Scientific Publications No. 95, Lyon, France.
Parkin, D.M., Chen, V.W., Ferlay, J., Galceran, J., Storm, H.H. & Whelan, S.L. (1994), Comparability and Quality Control in Cancer Registration, IARC Technical Report No. 19, Lyon, France.
Percy, C., Van Holten, V., Muir, C. (1990), International Classification of Diseases for Oncology, 2nd Edition, World Health Organization.
Segi, M. (1960), Cancer Mortality for Selected Sites in 24 Countries (1950-1957), Sendai, Japan, Tohoku University School of Medicine, Department of Public Health.
Singapore Cancer Registry, Annual Registry Report; Trends in Cancer Incidence in Singapore 2009-2013, National Registry of Disease Office, Singapore.
Sobin LH, Gospodarowicz MK & Wittekind C (eds.). (2009). TNM Classification of Malignant Tumours. (7th Edition). Wiley Blackwell.
Zainal Ariffin Omar, Nor Saleha Ibrahim Tamin (2011, Feb), National Cancer Registry Report 2007, Ministry of Health, Putrajaya, Malaysia.
References
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
74
APPENDIX 1: PERSON-YEARS AT RISK BY SEX, ETHNIC AND AGE GROUP, MALAYSIAN RESIDENTS, 2007-2011
ETHNIC GROUPSAGE GROUPMale 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total
Total 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+TOTAL
Female 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total
Source: Dept. of Statistics Malaysia, 2007-2011Note: The added total may differ due to rounding
3,727,4003,897,4003,878,0003,770,0003,459,0003,026,9002,403,2002,160,4002,021,7001,872,9001,572,4001,231,200
889,200577,900415,100458,000
35,361,000
7,263,5007,596,1007,569,1007,437,0006,879,5005,993,8004,750,8004,347,7004,090,7003,723,4003,154,0002,463,5001,794,3001,195,600
891,0001,048,900
70,198,600
3,536,1003,698,8003,691,0003,667,1003,420,5002,966,9002,347,4002,187,2002,069,1001,850,5001,581,4001,232,300
905,000617,800476,000590,400
34,837,700
1,137,2001,295,4001,359,6001,396,3001,348,6001,325,2001,244,3001,202,7001,173,7001,148,8001,023,800
855,200690,100490,800357,700352,800
16,401,800
2,202,4002,517,7002,643,9002,719,1002,667,9002,596,0002,389,3002,333,8002,299,1002,174,1001,943,8001,631,8001,317,500
933,900696,300776,000
31,842,400
1,065,2001,222,3001,284,4001,322,8001,319,4001,270,8001,145,0001,131,2001,125,4001,025,300
920,100776,600627,600442,900338,400423,400
15,440,400
387,900437,900450,200459,400466,700434,900374,200335,500320,000314,300266,100199,100136,40077,30055,50060,700
4,776,600
760,100858,800888,800903,300913,600857,800733,900672,500651,800624,800536,300404,200283,300164,200123,000140,200
9,516,700
372,300421,000438,700443,900446,800423,000359,500337,300331,800310,400270,200205,000146,80086,80067,60078,500
4,740,100
1,039,0001,045,6001,020,500
980,200857,800752,300585,000543,300506,900450,900362,900255,200179,400135,70091,400
116,2008,922,800
2,028,8002,042,7002,009,3001,954,1001,738,5001,503,2001,167,7001,085,200
995,800865,000681,600480,100353,000268,200184,900239,700
17,597,600
989,700997,100988,600973,800880,900750,700582,900541,900488,800414,400318,500224,700173,500132,80093,500
123,5008,674,900
6,291,3006,676,3006,708,3006,606,0006,131,7005,539,5004,606,7004,241,7004,022,5003,786,8003,225,2002,540,9001,895,2001,281,500
919,700989,000
65,462,200
12,254,90013,015,70013,111,10013,013,40012,199,50010,950,8009,041,6008,439,1008,037,6007,387,4006,315,4004,979,5003,748,0002,561,9001,895,2002,204,900
129,155,300
5,963,5006,339,3006,402,5006,407,4006,067,8005,411,3004,434,9004,197,5004,015,0003,600,4003,090,3002,438,7001,852,9001,280,300
975,7001,215,700
63,693,100
MALAY CHINESE INDIAN OTHERS TOTAL
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
75
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
APPENDIX 2: PERSON-YEARS AT RISK BY SEX, STATE AND AGE GROUP, MALAYSIANRESIDENTS, 2007-2011
Source: Dept. of Statistics Malaysia, 2007-2011Note: The added total may differ due to rounding
STATEAGE GROUPMale 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total
Female 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total
Total 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+TOTAL
1,186,6001,170,1001,102,6001,128,8001,348,2001,330,6001,098,300
962,000830,000723,200577,700428,200301,600183,600124,800128,900
12,624,400
1,126,6001,114,7001,057,4001,127,3001,389,8001,311,9001,026,200
894,400769,200648,900520,900400,300304,600177,500130,100160,800
12,160,900
2,313,2002,284,5002,159,9002,256,3002,738,0002,642,6002,124,4001,856,4001,599,0001,371,9001,098,400
828,500606,200361,000255,000290,100
24,785,500
728,400786,400783,600734,700720,100680,800581,200538,600500,800463,000387,500307,900232,000158,700115,600124,700
7,844,200
682,100739,300732,000687,800678,400641,200533,700509,500479,600423,100370,200291,500215,900149,500116,000147,000
7,396,500
1,410,4001,525,4001,515,4001,422,3001,398,4001,322,0001,114,9001,047,900
980,400886,400757,600599,600448,100308,200231,900271,500
15,240,600
690,600702,500692,900673,000581,900524,700387,400350,100332,900306,100250,100169,500109,20083,90056,80065,200
5,976,300
654,500667,700669,200664,300600,500536,000394,900354,900319,200274,100214,900144,200100,10077,80056,70063,500
5,790,700
1,345,3001,370,1001,362,0001,337,4001,182,0001,060,700
782,400704,900652,100580,200465,100313,600209,400161,900113,600128,700
11,769,100
574,400631,400619,400593,600499,200436,900384,500397,200391,200359,600303,400237,900177,300127,50082,900
107,2005,924,100
559,100613,000601,800580,700516,300433,000380,300386,400361,000321,200266,700215,700164,200122,60085,400
125,6005,732,400
1,133,5001,244,5001,221,3001,174,3001,015,500
870,100764,800783,500752,300680,700569,900453,500341,400250,200168,300232,900
11,660,600
482,500573,200597,800587,500500,800376,100333,200330,100349,300353,000330,700281,500224,800160,000122,000129,000
5,730,600
465,000562,500593,100579,400472,300357,500325,300332,000360,700349,800324,800282,400229,300162,800138,200160,600
5,695,400
947,5001,135,6001,190,9001,166,700
973,000733,900658,300662,000710,000702,700655,500563,900454,100322,700260,100288,900
11,426,100
SELANGOR JOHOR SABAH SARAWAK PERAK
76
APPENDIX 2: PERSON-YEARS AT RISK BY SEX, STATE AND AGE GROUP, MALAYSIAN RESIDENTS, 2007-2011 (CONTINUE)
Source: Dept. of Statistics Malaysia, 2007-2011Note: The added total may differ due to rounding
STATEAGE GROUPMale 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total
Female 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total
Total 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+TOTAL
440,200493,500539,000480,300390,000326,600285,700283,200286,200275,300241,600198,000146,200100,300
80,40083,400
4,650,300
419,400467,600504,200462,200381,900324,000291,000298,900299,700280,100252,400203,300149,400109,300
92,500111,400
4,647,200
859,600961,300
1,043,100942,400772,100650,700576,300582,300585,400555,100493,900401,200295,500209,500173,200195,300
9,297,200
327,200333,600303,100348,500392,100407,500352,500284,200247,300250,000202,400156,000112,50071,80051,80049,400
3,889,300
307,600315,300294,600346,100413,200421,200328,900279,000278,500223,100187,700144,100105,00070,80047,30055,900
3,818,200
634,800649,200597,600694,500805,100828,600681,200563,400525,600473,200390,200300,100217,400142,50099,000
105,2007,707,500
435,400472,000503,600469,500317,600252,200198,700185,400197,100194,600171,700140,600114,20073,60052,00064,000
3,841,200
409,700446,400471,700438,300292,300229,500203,000215,900225,100216,200189,100146,700116,00084,90060,20085,800
3,830,200
845,200918,200975,500907,700609,600481,900401,900401,300422,000410,900360,900287,100230,000158,100112,100148,600
7,671,500
289,900312,400324,600328,400302,700309,600285,800271,300252,900234,000203,200168,500133,80088,80064,80065,800
3,636,200
277,100302,600315,400319,200314,200314,300283,500272,900257,100229,800204,900170,900134,80094,70070,50090,000
3,652,300
567,200615,000640,100647,900616,800623,900569,400544,000510,100463,600408,200339,700268,400183,700135,200155,200
7,288,700
373,500386,500402,600402,300345,200307,300227,600202,000199,100194,400173,200142,300113,50075,00052,20048,500
3,644,700
342,900350,500370,800360,800303,900281,300204,800201,400197,900194,800171,200134,700104,60066,40051,60056,100
3,393,000
716,200736,900773,400763,000649,000588,500432,200403,200397,000389,100344,300277,000218,100141,400103,600104,600
7,037,900
KEDAH WPKL & P KELANTAN PENANG PAHANG
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
77
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
APPENDIX 2: PERSON-YEARS AT RISK BY SEX, STATE AND AGE GROUP, MALAYSIANRESIDENTS, 2007-2011 (CONTINUE)
Source: Dept. of Statistics Malaysia, 2007-2011Note: The added total may differ due to rounding
STATEAGE GROUPMale 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total
Female 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+Total
Total 0-4 5-9 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+TOTAL
290,300302,800307,000304,900253,400192,100150,200137,800137,200133,700115,30089,10066,90045,80031,60035,200
2,593,700
273,500285,200292,600289,800236,500173,000145,400143,700144,200135,600113,40084,30063,30048,90035,40044,800
2,509,700
563,900588,200599,400595,000490,000365,200295,500281,600281,500269,500228,800173,500130,000
94,60067,50079,600
5,103,300
225,200249,100249,900253,400228,000184,200157,900144,200140,800141,200132,500110,00077,30051,90039,30040,400
2,426,300
208,500226,200231,700241,600218,100176,400154,200147,000149,200147,400136,200106,60075,50053,10043,40050,700
2,366,400
433,800475,400481,800494,900446,100360,900311,900291,200290,100288,600268,900216,700152,900105,00082,90091,400
4,792,500
173,900189,200203,500211,300176,600147,500120,700114,800114,200115,60098,20080,40062,70044,50032,60034,700
1,920,900
168,600178,100190,000214,700177,900151,700121,000119,900128,900113,500100,30082,80067,30045,60035,20044,900
1,940,100
342,700367,500393,500426,200354,700299,200241,500234,700243,100229,100198,500163,300130,20089,80067,80080,300
3,861,200
50,10052,70059,80070,80054,60038,40028,20027,80031,90032,20029,50025,40020,40015,10011,10012,300
560,100
48,10050,70059,10076,00051,50037,30029,40029,70033,90033,80031,40026,40020,40015,20012,40017,100
571,300
98,600103,200119,100146,800106,10075,70057,50057,40065,70066,00060,90052,00040,40030,10023,40029,300
1,131,500
22,80021,00018,70018,60022,00024,90015,30012,60011,70011,2008,2005,3003,0002,1001,3001,700
200,000
20,50019,80019,30019,50021,10022,50014,00012,60011,0008,8006,5004,2002,6002,0001,1002,000
186,700
43,40040,80037,80038,30043,10047,20029,00025,10022,70019,80014,6009,6005,8003,6002,4003,100
386,800
TERENGGANU N. SEMBILAN MELAKA PERLIS W. P. LABUAN
78
AGE GROUPMALAYSIA POPULATION
MALE FEMALEWORLD STANDARD
POPULATION
0-4 5-9
10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
TOTAL
6,291,3006,676,3006,708,3006,606,0006,131,7005,539,5004,606,7004,241,7004,022,5003,786,8003,225,2002,540,9001,895,2001,281,500919,700989,000
65,462,200
5,963,5006,339,3006,402,5006,407,4006,067,8005,411,3004,434,9004,197,5004,015,0003,600,4003,090,3002,438,7001,852,9001,280,300975,700
1,215,70063,693,100
12,00010,0009,0009,0008,0008,0006,0006,0006,0006,0005,0004,0004,0003,0002,0002,000
100,000
APPENDIX 3: PERSON-YEARS AT RISK, ALL MALAYSIAN, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
79
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
AGE GROUP MALE FEMALE
0-4 5-9
10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
TOTAL
3,727,4003,897,4003,878,0003,770,0003,459,0003,026,9002,403,2002,160,4002,021,7001,872,9001,572,4001,231,200889,200577,900415,100458,000
35,361,000
3,536,1003,698,8003,691,0003,667,1003,420,5002,966,9002,347,4002,187,2002,069,1001,850,5001,581,4001,232,300905,000617,800476,000590,400
34,837,700
APPENDIX 4: PERSON-YEARS AT RISK, MALAY RESIDENTS, MALAYSIA, 2007-2011
80
AGE GROUP MALE FEMALE
0-4 5-9
10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
TOTAL
1,137,2001,295,4001,359,6001,396,3001,348,6001,325,2001,244,3001,202,7001,173,7001,148,8001,023,800855,200690,100490,800357,700352,800
16,401,800
1,065,2001,222,3001,284,4001,322,8001,319,4001,270,8001,145,0001,131,2001,125,4001,025,300920,100776,600627,600442,900338,400423,400
15,440,400
APPENDIX 5: PERSON-YEARS AT RISK, CHINESE RESIDENTS, MALAYSIA, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
81
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
AGE GROUP MALE FEMALE
0-4 5-9
10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
TOTAL
387,900437,900450,200459,400466,700434,900374,200335,500320,000314,300266,100199,100136,40077,30055,50060,700
4,776,600
372,300421,000438,700443,900446,800423,000359,500337,300331,800310,400270,200205,000146,80086,80067,60078,500
4,740,100
APPENDIX 6: PERSON-YEARS AT RISK, INDIAN RESIDENTS, MALAYSIA, 2007-2011
82
AGE GROUP MALE FEMALE
0-4 5-9
10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75+
TOTAL
1,039,0001,045,6001,020,500980,200857,800752,300585,000543,300506,900450,900362,900255,200179,400135,70091,400116,200
8,922,800
989,700997,100988,600973,800880,900750,700582,900541,900488,800414,400318,500224,700173,500132,80093,500123,500
8,674,900
APPENDIX 7: PERSON-YEARS AT RISK, OTHER RESIDENTS, MALAYSIA, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
83
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
APPENDIX 8: INCIDENCE SUMMARY TABLE, ALL RESIDENTS, MALES, MALAYSIA, 2007-2011
ICD 10C18-C21C33-C34C11C81-C85,C96C61C22C91-C95C16C67C44C70-C72C25C64C32OtherC15C73C62C40-C41C01-C02C47;C49C23-C24C90C03-C06C07-C08C30-C31C12-C13C43C37-C38C17C50C09C60C75C69C10C74C14C63C00C45C66C46C68C65C88All
ColorectalTrachea,Bronchus,LungNasopharynxLymphomaProstateLiverLeukaemiaStomachBladderOther SkinBrain, Nervous systemPancreasKidneyLarynxOther & unspecifiedOesophagusThyroidTestisBoneTongueConnective,Soft tissueGallbladder etc.Multiple MyelomaMouthSalivary glandsNose, sinuses etc.HypopharynxMelanoma of SkinOther Thoracic organsSmall intestineBreastTonsilPenisOther EndocrineEyeOther OropharynxAdrenal glandPharynx unspec.Other male genitalLipMesotheliomaUreterKaposi sarcomaOther Urinary organsRenal PelvisImmunoproliferative dis.All sites Total
(14.2 , 14.9)(14.1 , 14.8)(6.1 , 6.6)(5.3 , 5.7)(6.3 , 6.8)(5.4 , 5.8)(4.0 , 4.4)(3.7 , 4.1)(2.8 , 3.1)(2.5 , 2.8)(1.8 , 2.1)(1.9 , 2.1)(1.6 , 1.8)(1.5 , 1.7)(1.3 , 1.5)(1.3 , 1.5)(0.9 , 1.0)(0.7 , 0.8)(0.7 , 0.8)(0.8 , 0.9)(0.7 , 0.8)(0.7 , 0.9)(0.7 , 0.8)(0.7 , 0.8)(0.4 , 0.5)(0.4 , 0.5)(0.3 , 0.4)(0.3 , 0.4)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.2)(0.1 , 0.2)(0.2 , 0.2)(0.1 , 0.2)(0.1 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)
(86.1 , 87.7)
7,6467,4153,7853,1713,1323,0542,5492,0141,4771,3841,1761,041
901825741737549496493461434413396391273270172167167153137127115109104
814737313022191717135
46,794
16.415.88.16.86.76.55.44.33.23.02.52.21.91.81.61.61.21.11.11.00.90.90.80.80.60.60.40.40.40.30.30.30.20.20.20.20.10.10.10.10.00.00.00.00.00.0
100.0
1.81.80.70.60.90.70.40.50.40.30.20.30.20.20.20.20.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
10.3
11.711.35.84.84.84.73.93.12.32.11.81.61.41.31.11.10.80.80.80.70.70.60.60.60.40.40.30.30.30.20.20.20.20.20.20.10.10.10.00.00.00.00.00.00.00.0
71.4
14.614.46.45.56.65.64.23.92.92.71.92.01.71.61.41.41.00.70.80.80.70.80.70.70.50.50.30.30.30.30.30.20.20.20.20.20.10.10.10.10.00.00.00.00.00.0
86.9
1.81.80.70.60.90.70.40.50.40.30.20.30.20.20.20.20.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.09.8
SITE NO. % CR CR74 ASR (ASR 95%CL) CumR
84
ICD 10C50C18-C21C53C56C33-C34C81-C85,C96C54C91-C95C73C16C11C22C70-C72C44C25OtherC55C03-C06C64C15C23-C24C01-C02C67C47;C49C40-C41C90C07-C08C43C30-C31C52C37-C38C51C32C17C12-C13C09C69C58C00C75C74C57C10C14C45C66C68C65C88C46All
BreastColorectalCervix UteriOvaryTrachea,Bronchus,LungLymphomaCorpus UteriLeukaemiaThyroidStomachNasopharynxLiverBrain, Nervous systemOther SkinPancreasOther & unspecifiedUterus unspec.MouthKidneyOesophagusGallbladder etc.TongueBladderConnective,Soft tissueBoneMultiple MyelomaSalivary glandsMelanoma of SkinNose, sinuses etc.VaginaOther Thoracic organsVulvaLarynxSmall intestineHypopharynxTonsilEyePlacentaLipOther EndocrineAdrenal glandOther Female GenitalOther OropharynxPharynx unspec.MesotheliomaUreterOther Urinary organsRenal PelvisImmunoproliferative dis.Kaposi sarcomaAll sites Total
(30.7 , 31.6)(10.8 , 11.4)(7.3 , 7.8)(5.7 , 6.1)(5.8 , 6.2)(3.6 , 3.9)(3.7 , 4.0)(3.2 , 3.5)(2.7 , 3.0)(2.5 , 2.8)(2.1 , 2.3)(1.9 , 2.1)(1.7 , 1.9)(1.8 , 2.0)(1.4 , 1.6)(1.1 , 1.2)(0.9 , 1.1)(0.9 , 1.1)(0.7 , 0.9)(0.7 , 0.9)(0.7 , 0.8)(0.6 , 0.8)(0.7 , 0.8)(0.6 , 0.7)(0.5 , 0.7)(0.6 , 0.7)(0.3 , 0.4)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.3)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.1)(0.1 , 0.1)(0.1 , 0.1)(0.1 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)
(98.4 , 100.1)
18,2066,0474,3523,4723,1932,2032,1812,0241,7231,4471,3051,0741,0601,045
7886475805254344294094014003783653482261551381241231231138986686765555145423020191110872
56,713
32.110.77.76.15.63.93.83.53.02.62.31.91.91.81.41.11.00.90.80.80.70.70.70.70.60.60.40.30.20.20.20.20.20.20.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.0
100.0
3.41.40.90.60.70.40.40.30.30.30.20.20.20.20.20.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
11.2
28.69.56.85.45.03.53.43.22.72.32.01.71.71.61.21.00.90.80.70.70.60.60.60.60.60.50.40.20.20.20.20.20.20.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.0
89.0
31.111.17.65.96.03.83.83.42.92.62.22.01.81.91.51.11.01.00.80.80.80.70.70.60.60.70.40.30.20.20.20.20.20.20.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.0
99.3
3.41.30.90.60.70.40.40.30.30.30.20.20.20.20.20.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
10.6
SITE NO. % CR CR74 ASR (ASR 95%CL) CumR
APPENDIX 9: INCIDENCE SUMMARY TABLE, ALL RESIDENTS, FEMALES, MALAYSIA, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
85
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
APPENDIX 10: INCIDENCE SUMMARY TABLE, MALAY MALES, MALAYSIA, 2007-2011
ICD 10C33-C34C18-C21C81-C85,C96C91-C95C22C61C11C67C70-C72C44C16C25C64C73C40-C41C62OtherC15C32C47;C49C90C01-C02C23-C24C03-C06C30-C31C07-C08C17C43C69C37-C38C75C50C09C12-C13C60C74C10C63C14C45C00C46C66C65C68C88All
Trachea,Bronchus,LungColorectalLymphomaLeukaemiaLiverProstateNasopharynxBladderBrain, Nervous systemOther SkinStomachPancreasKidneyThyroidBoneTestisOther & unspecifiedOesophagusLarynxConnective,Soft tissueMultiple MyelomaTongueGallbladder etc.MouthNose, sinuses etc.Salivary glandsSmall intestineMelanoma of SkinEyeOther Thoracic organsOther EndocrineBreastTonsilHypopharynxPenisAdrenal glandOther OropharynxOther male genitalPharynx unspec.MesotheliomaLipKaposi sarcomaUreterRenal PelvisOther Urinary organsImmunoproliferative dis.All sites Total
(12.1 , 13.0)(10.8 , 11.7)(5.3 , 5.9)(4.2 , 4.7)(4.2 , 4.7)(5.0 , 5.6)(3.1 , 3.5)(3.1 , 3.6)(1.8 , 2.1)(1.8 , 2.2)(1.5 , 1.8)(1.3 , 1.7)(1.1 , 1.3)(1.0 , 1.3)(0.7 , 1.0)(0.7 , 0.8)(0.9 , 1.1)(0.9 , 1.2)(0.9 , 1.2)(0.7 , 0.9)(0.7 , 1.0)(0.5 , 0.7)(0.6 , 0.8)(0.4 , 0.6)(0.4 , 0.5)(0.3 , 0.5)(0.2 , 0.3)(0.2 , 0.3)(0.2 , 0.3)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)
(69.7 , 71.8)
3,0942,8721,6391,4191,1951,163
9597816125044293793163122822732732582522402201651651301281226962616161504235262222141411844333
18,757
16.515.38.77.66.46.25.14.23.32.72.32.01.71.71.51.51.51.41.31.31.20.90.90.70.70.70.40.30.30.30.30.30.20.20.10.10.10.10.10.10.00.00.00.00.00.0
100.0
1.61.40.60.40.50.70.40.40.20.20.20.20.10.10.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.08.3
8.88.14.64.03.43.32.72.21.71.41.21.10.90.90.80.80.80.70.70.70.60.50.50.40.40.30.20.20.20.20.20.10.10.10.10.10.10.00.00.00.00.00.00.00.00.0
53.1
12.611.35.64.44.55.33.33.31.92.01.71.51.21.10.90.81.01.11.00.80.80.60.70.50.50.40.30.20.20.20.20.20.20.20.10.10.10.00.10.00.00.00.00.00.00.0
70.7
1.61.40.60.40.50.70.40.40.20.20.20.20.10.10.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.08.0
SITE NO. % CR CR74 ASR (ASR 95%CL) CumR
86
ICD 10C50C18-C21C56C53C33-C34C81-C85,C96C91-C95C73C54C70-C72C22C11C44C16C25C55OtherC47;C49C40-C41C90C64C01-C02C23-C24C67C15C03-C06C07-C08C43C30-C31C51C58C37-C38C32C52C17C69C12-C13C09C75C57C74C00C14C10C45C88C65C66C68C46All
BreastColorectalOvaryCervix UteriTrachea,Bronchus,LungLymphomaLeukaemiaThyroidCorpus UteriBrain, Nervous systemLiverNasopharynxOther SkinStomachPancreasUterus unspec.Other & unspecifiedConnective,Soft tissueBoneMultiple MyelomaKidneyTongueGallbladder etc.BladderOesophagusMouthSalivary glandsMelanoma of SkinNose, sinuses etc.VulvaPlacentaOther Thoracic organsLarynxVaginaSmall intestineEyeHypopharynxTonsilOther EndocrineOther Female GenitalAdrenal glandLipPharynx unspec.Other OropharynxMesotheliomaImmunoproliferative dis.Renal PelvisUreterOther Urinary organsKaposi sarcomaAll sites Total
(26.6 , 27.8)(7.8 , 8.4)(5.5 , 6.1)(4.8 , 5.4)(4.1 , 4.6)(3.5 , 4.0)(3.3 , 3.7)(3.1 , 3.5)(3.1 , 3.5)(1.7 , 2.0)(1.6 , 1.9)(1.2 , 1.4)(1.2 , 1.5)(1.0 , 1.3)(0.9 , 1.1)(0.8 , 1.0)(0.7 , 0.9)(0.6 , 0.7)(0.5 , 0.6)(0.6 , 0.8)(0.5 , 0.7)(0.5 , 0.6)(0.5 , 0.7)(0.5 , 0.6)(0.5 , 0.7)(0.3 , 0.5)(0.3 , 0.4)(0.2 , 0.3)(0.2 , 0.3)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.1)(0.1 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)
(80.8 , 82.9)
8,2252,2311,7541,5021,1871,1421,1191,023
964566477401363312273264236207190178167163155151149112101
69644642403838373128242421211710
8652221
24,188
34.09.37.36.24.94.74.74.24.02.32.01.71.51.31.11.11.00.90.80.70.70.70.60.60.60.50.40.30.30.20.20.20.20.20.20.10.10.10.10.10.10.10.00.00.00.00.00.00.00.0
100.0
2.91.00.60.60.50.40.30.40.40.20.20.10.20.10.10.10.10.10.00.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.09.1
23.66.45.04.33.43.33.22.92.81.61.41.21.00.90.80.80.70.60.50.50.50.50.40.40.40.30.30.20.20.10.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.0
69.5
27.28.15.85.14.43.73.53.33.31.81.71.31.31.11.00.90.80.60.50.70.60.60.60.60.60.40.30.20.20.20.10.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.0
81.9
2.91.00.60.60.50.40.30.40.40.20.20.10.20.10.10.10.10.10.00.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.08.7
SITE NO. % CR CR74 ASR (ASR 95%CL) CumR
APPENDIX 11: INCIDENCE SUMMARY TABLE, MALAY FEMALES, MALAYSIA, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
87
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
APPENDIX 12: INCIDENCE SUMMARY TABLE,CHINESE MALES, MALAYSIA, 2007-2011
ICD 10C18-C21C33-C34C11C61C22C16C81-C85,C96C44C91-C95C25C67C64C32C70-C72OtherC15C23-C24C01-C02C73C40-C41C62C47;C49C30-C31C03-C06C90C07-C08C12-C13C37-C38C50C17C43C09C60C75C10C69C63C66C68C74C14C00C65C45C46C88All
ColorectalTrachea,Bronchus,LungNasopharynxProstateLiverStomachLymphomaOther SkinLeukaemiaPancreasBladderKidneyLarynxBrain, Nervous systemOther & unspecifiedOesophagusGallbladder etc.TongueThyroidBoneTestisConnective,Soft tissueNose, sinuses etc.MouthMultiple MyelomaSalivary glandsHypopharynxOther Thoracic organsBreastSmall intestineMelanoma of SkinTonsilPenisOther EndocrineOther OropharynxEyeOther male genitalUreterOther Urinary organsAdrenal glandPharynx unspec.LipRenal PelvisMesotheliomaKaposi sarcomaImmunoproliferative dis.All sites Total
(20.4 , 21.7)(18.2 , 19.4)(10.5 , 11.5)(8.6 , 9.5)(7.3 , 8.1)(5.2 , 5.9)(4.7 , 5.3)(3.5 , 4.1)(3.7 , 4.4)(2.6 , 3.1)(2.6 , 3.1)(2.5 , 3.0)(2.2 , 2.6)(1.9 , 2.3)(1.6 , 2.0)(1.5 , 1.9)(0.8 , 1.1)(0.8 , 1.1)(0.6 , 0.9)(0.6 , 0.9)(0.6 , 0.9)(0.6 , 0.8)(0.5 , 0.7)(0.5 , 0.7)(0.4 , 0.7)(0.4 , 0.6)(0.3 , 0.5)(0.3 , 0.5)(0.3 , 0.4)(0.3 , 0.4)(0.2 , 0.4)(0.2 , 0.3)(0.1 , 0.3)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.0)
(111.4 , 114.5)
3,8253,3902,1041,5891,4161,001
908687657516510498431368327305177171142128126126116110102
987473646253463931302315141412111010762
20,424
18.716.610.37.86.94.94.53.43.22.52.52.42.11.81.61.50.90.80.70.60.60.60.60.50.50.50.40.40.30.30.30.20.20.20.10.10.10.10.10.10.10.00.00.00.00.0
100.0
2.62.41.21.20.90.60.60.40.40.40.30.30.30.20.20.20.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
13.4
23.320.612.89.78.66.15.54.24.03.13.13.02.62.22.01.91.11.00.90.80.80.80.70.70.60.60.50.40.40.40.30.30.20.20.20.10.10.10.10.10.10.10.10.00.00.0
124.4
21.118.811.09.07.75.65.03.84.02.82.82.72.42.11.81.71.00.90.80.70.70.70.60.60.60.50.40.40.40.30.30.20.20.20.20.20.10.10.10.10.10.10.10.00.00.0
112.9
2.52.31.21.20.90.60.60.40.30.40.30.30.30.20.20.20.10.10.10.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
12.5
SITE NO. % CR CR74 ASR (ASR 95%CL) CumR
88
ICD 10C50C18-C21C53C33-C34C56C54C16C81-C85,C96C11C91-C95C44C22C25C73C70-C72OtherC64C55C67C23-C24C40-C41C47;C49C01-C02C90C15C07-C08C03-C06C43C30-C31C51C52C37-C38C32C17C09C75C69C74C57C12-C13C66C10C45C00C58C65C68C14C46C88All
BreastColorectalCervix UteriTrachea,Bronchus,LungOvaryCorpus UteriStomachLymphomaNasopharynxLeukaemiaOther SkinLiverPancreasThyroidBrain, Nervous systemOther & unspecifiedKidneyUterus unspec.BladderGallbladder etc.BoneConnective,Soft tissueTongueMultiple MyelomaOesophagusSalivary glandsMouthMelanoma of SkinNose, sinuses etc.VulvaVaginaOther Thoracic organsLarynxSmall intestineTonsilOther EndocrineEyeAdrenal glandOther Female GenitalHypopharynxUreterOther OropharynxMesotheliomaLipPlacentaRenal PelvisOther Urinary organsPharynx unspec.Kaposi sarcomaImmunoproliferative dis.All sites Total
(40.6 , 42.5)(16.5 , 17.7)(9.4 , 10.3)(8.1 , 8.9)(6.0 , 6.7)(4.5 , 5.2)(3.8 , 4.4)(3.4 , 4.0)(3.2 , 3.7)(3.1 , 3.7)(2.2 , 2.7)(2.1 , 2.6)(2.1 , 2.5)(1.9 , 2.3)(1.7 , 2.2)(1.4 , 1.7)(1.1 , 1.4)(1.0 , 1.3)(0.9 , 1.2)(0.8 , 1.1)(0.5 , 0.7)(0.5 , 0.7)(0.4 , 0.7)(0.4 , 0.7)(0.4 , 0.6)(0.3 , 0.5)(0.3 , 0.5)(0.2 , 0.4)(0.2 , 0.4)(0.2 , 0.4)(0.2 , 0.4)(0.2 , 0.4)(0.2 , 0.3)(0.1 , 0.2)(0.1 , 0.2)(0.1 , 0.2)(0.0 , 0.1)(0.0 , 0.2)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)(0.0 , 0.0)
(124.5 , 127.9)
7,3333,0231,7321,4861,107
8537256396115274464114003713052732141991851711051049998827166555252524941322418161412109887554311
22,114
33.213.77.86.75.03.93.32.92.82.42.01.91.81.71.41.21.00.90.80.80.50.50.40.40.40.30.30.20.20.20.20.20.20.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.0
100.0
4.62.11.21.00.70.60.40.40.40.30.30.30.30.20.20.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
14.2
47.519.611.29.67.25.54.74.14.03.42.92.72.62.42.01.81.41.31.21.10.70.70.60.60.50.50.40.40.30.30.30.30.30.20.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.0
143.2
41.517.19.88.56.34.94.13.73.53.42.52.32.32.11.91.51.21.11.01.00.60.60.60.60.50.40.40.30.30.30.30.30.20.20.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.0
126.2
4.52.01.21.00.70.60.40.40.40.30.30.30.30.20.20.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
13.2
SITE NO. % CR CR74 ASR (ASR 95%CL) CumR
APPENDIX 13: INCIDENCE SUMMARY TABLE,CHINESE FEMALES, MALAYSIA, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
89
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
APPENDIX 14: INCIDENCE SUMMARY TABLE, INDIAN MALES, MALAYSIA, 2007-2011
ICD 10C18-C21C33-C34C61C16C81-C85,C96C91-C95C22C03-C06C15C32C67C70-C72C01-C02C25OtherC64C44C11C62C12-C13C73C09C40-C41C23-C24C10C90C07-C08C60C47;C49C50C75C00C17C14C43C30-C31C37-C38C69C74C45C46C63C66All
ColorectalTrachea,Bronchus,LungProstateStomachLymphomaLeukaemiaLiverMouthOesophagusLarynxBladderBrain, Nervous systemTonguePancreasOther & unspecifiedKidneyOther SkinNasopharynxTestisHypopharynxThyroidTonsilBoneGallbladder etc.Other OropharynxMultiple MyelomaSalivary glandsPenisConnective,Soft tissueBreastOther EndocrineLipSmall intestinePharynx unspec.Melanoma of SkinNose, sinuses etc.Other Thoracic organsEyeAdrenal glandMesotheliomaKaposi sarcomaOther male genitalUreterAll sites Total
(9.2 , 11.4)(6.6 , 8.5)(5.2 , 7.0)(4.4 , 5.9)(3.6 , 4.8)(3.2 , 4.3)(2.5 , 3.7)(2.3 , 3.4)(2.1 , 3.2)(1.8 , 2.8)(2.0 , 3.1)(1.4 , 2.2)(1.4 , 2.3)(1.3 , 2.2)(1.0 , 1.8)(0.9 , 1.6)(0.9 , 1.6)(0.8 , 1.4)(0.6 , 1.1)(0.7 , 1.4)(0.4 , 1.0)(0.5 , 1.0)(0.4 , 0.8)(0.4 , 1.0)(0.4 , 1.0)(0.5 , 1.1)(0.4 , 0.9)(0.2 , 0.6)(0.1 , 0.5)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.3)(0.0 , 0.3)(0.0 , 0.1)(0.0 , 0.2)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)
(67.6 , 73.2)
3892701881871871711141079890868374705547454443383029282726252416141010998864421111
2,679
14.510.17.07.07.06.44.34.03.73.43.23.12.82.62.11.81.71.61.61.41.11.11.01.01.00.90.90.60.50.40.40.30.30.30.30.20.10.10.10.00.00.00.0
100.0
1.21.00.80.60.40.30.40.30.40.30.30.20.20.20.20.20.20.10.10.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.08.4
8.15.63.93.93.93.62.42.22.01.91.81.71.51.51.21.00.90.90.90.80.60.60.60.60.50.50.50.30.30.20.20.20.20.20.20.10.10.10.00.00.00.00.0
56.0
10.37.66.15.24.23.83.12.92.72.32.51.81.91.81.41.31.31.10.81.00.70.70.60.70.70.80.60.40.30.20.20.20.20.20.20.20.10.10.10.00.00.00.0
70.4
1.21.00.80.60.40.30.40.30.40.30.30.20.20.20.20.20.20.10.10.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.08.1
SITE NO. % CR CR74 ASR (ASR 95%CL) CumR
90
ICD 10C50C18-C21C53C03-C06C56C54C15C16C91-C95C81-C85,C96C33-C34C73C01-C02C70-C72C55C44C22OtherC25C23-C24C12-C13C64C40-C41C11C67C90C32C07-C08C47;C49C00C52C10C09C30-C31C37-C38C51C75C17C14C43C57C69C45C58C65C74C88All
BreastColorectalCervix UteriMouthOvaryCorpus UteriOesophagusStomachLeukaemiaLymphomaTrachea,Bronchus,LungThyroidTongueBrain, Nervous systemUterus unspec.Other SkinLiverOther & unspecifiedPancreasGallbladder etc.HypopharynxKidneyBoneNasopharynxBladderMultiple MyelomaLarynxSalivary glandsConnective,Soft tissueLipVaginaOther OropharynxTonsilNose, sinuses etc.Other Thoracic organsVulvaOther EndocrineSmall intestinePharynx unspec.Melanoma of SkinOther Female GenitalEyeMesotheliomaPlacentaRenal PelvisAdrenal glandImmunoproliferative dis.All sites Total
(35.3 , 38.9)(7.8 , 9.7)(6.7 , 8.4)(6.6 , 8.4)(5.3 , 6.8)(4.1 , 5.4)(3.0 , 4.2)(2.7 , 3.8)(2.5 , 3.5)(2.5 , 3.5)(2.5 , 3.7)(2.0 , 3.0)(2.0 , 2.9)(1.3 , 2.1)(1.1 , 1.8)(1.1 , 1.8)(1.1 , 1.9)(1.1 , 1.8)(1.0 , 1.7)(0.6 , 1.3)(0.6 , 1.1)(0.4 , 0.8)(0.4 , 0.9)(0.3 , 0.8)(0.4 , 0.9)(0.4 , 0.9)(0.3 , 0.7)(0.2 , 0.5)(0.2 , 0.6)(0.2 , 0.5)(0.1 , 0.5)(0.1 , 0.5)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.3)(0.1 , 0.4)(0.0 , 0.3)(0.0 , 0.2)(0.0 , 0.2)(0.0 , 0.2)(0.0 , 0.2)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)
(106.9 , 113.3)
1,705364327287277204145137137130127119100
786059585857373527262524242018161514111010101086554321111
4,798
35.57.66.86.05.84.33.02.92.92.72.62.52.11.61.31.21.21.21.20.80.70.60.50.50.50.50.40.40.30.30.30.20.20.20.20.20.20.10.10.10.10.10.00.00.00.00.0
100.0
4.21.10.91.00.70.60.50.40.30.40.40.30.30.20.20.20.20.20.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
13.0
36.07.76.96.15.84.33.12.92.92.72.72.52.11.61.31.21.21.21.20.80.70.60.50.50.50.50.40.40.30.30.30.20.20.20.20.20.20.10.10.10.10.10.00.00.00.00.0
101.2
37.18.77.67.56.14.83.63.23.03.03.12.52.51.71.41.51.51.41.30.90.90.60.60.60.60.60.50.40.40.40.30.30.20.20.20.20.20.10.10.10.10.10.00.00.00.00.0
110.1
4.21.10.91.00.70.60.50.40.30.40.40.30.30.20.20.20.20.20.20.10.10.10.10.10.10.10.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
12.2
SITE NO. % CR CR74 ASR (ASR 95%CL) CumR
APPENDIX 15: INCIDENCE SUMMARY TABLE, INDIAN FEMALES, MALAYSIA, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
91
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
APPENDIX 16: INCIDENCE SUMMARY TABLE, OTHERS MALES, MALAYSIA, 2007-2011
ICD 10C11C33-C34C18-C21C81-C85,C96C16C22C91-C95C61C44C70-C72C67OtherC25C15C73C40-C41C62C47;C49C32C01-C02C90C23-C24C43C03-C06C64C60C07-C08C37-C38C12-C13C30-C31C69C17C50C74C09C75C46C14C00C10C45C63All
NasopharynxTrachea,Bronchus,LungColorectalLymphomaStomachLiverLeukaemiaProstateOther SkinBrain, Nervous systemBladderOther & unspecifiedPancreasOesophagusThyroidBoneTestisConnective,Soft tissueLarynxTongueMultiple MyelomaGallbladder etc.Melanoma of SkinMouthKidneyPenisSalivary glandsOther Thoracic organsHypopharynxNose, sinuses etc.EyeSmall intestineBreastAdrenal glandTonsilOther EndocrineKaposi sarcomaPharynx unspec.LipOther OropharynxMesotheliomaOther male genitalAll sites Total
(9.1 , 10.6)(11.0 , 12.8)(8.6 , 10.2)(6.0 , 7.3)(6.4 , 7.8)(5.1 , 6.4)(3.3 , 4.2)(3.2 , 4.3)(2.2 , 3.1)(1.2 , 1.7)(1.4 , 2.2)(1.1 , 1.8)(1.0 , 1.7)(1.1 , 1.7)(0.8 , 1.3)(0.4 , 0.8)(0.4 , 0.8)(0.5 , 1.0)(0.7 , 1.3)(0.6 , 1.1)(0.6 , 1.1)(0.6 , 1.0)(0.5 , 1.0)(0.5 , 1.0)(0.4 , 0.9)(0.3 , 0.7)(0.2 , 0.6)(0.3 , 0.7)(0.3 , 0.7)(0.2 , 0.4)(0.1 , 0.3)(0.1 , 0.3)(0.1 , 0.3)(0.1 , 0.3)(0.1 , 0.3)(0.0 , 0.1)(0.0 , 0.2)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.0)
(78.2 , 82.8)
6786615604373973293021921481131008676766555545452514944444440342929252016131311107643331
4,934
13.713.411.38.98.06.76.13.93.02.32.01.71.51.51.31.11.11.11.11.01.00.90.90.90.80.70.60.60.50.40.30.30.30.20.20.10.10.10.10.10.10.0
100.0
1.11.51.10.80.90.70.30.50.30.10.30.20.20.20.10.10.10.10.10.10.10.10.10.10.10.10.00.10.10.00.00.00.00.00.00.00.00.00.00.00.00.09.7
7.67.46.24.94.43.73.42.11.61.31.11.00.80.80.70.60.60.60.60.60.50.50.50.50.40.40.30.30.30.20.20.10.10.10.10.10.10.00.00.00.00.0
55.0
9.911.99.46.77.15.83.83.82.61.51.81.51.41.41.10.60.60.71.00.90.80.80.80.80.60.50.40.50.50.30.20.20.20.20.20.10.10.10.00.10.00.0
80.5
1.11.51.10.80.90.70.30.50.30.10.30.20.20.20.10.10.10.10.10.10.10.10.10.10.10.10.00.10.10.00.00.00.00.00.00.00.00.00.00.00.00.09.2
SITE NO. % CR CR74 ASR (ASR 95%CL) CumR
92
ICD 10C50C53C18-C21C33-C34C56C81-C85,C96C16C11C91-C95C73C44C54C22C70-C72OtherC03-C06C25C55C15C47;C49C90C23-C24C40-C41C67C01-C02C07-C08C43C64C37-C38C52C58C69C00C51C17C32C12-C13C30-C31C09C74C57C68C10C45C14C75All
BreastCervix UteriColorectalTrachea,Bronchus,LungOvaryLymphomaStomachNasopharynxLeukaemiaThyroidOther SkinCorpus UteriLiverBrain, Nervous systemOther & unspecifiedMouthPancreasUterus unspec.OesophagusConnective,Soft tissueMultiple MyelomaGallbladder etc.BoneBladderTongueSalivary glandsMelanoma of SkinKidneyOther Thoracic organsVaginaPlacentaEyeLipVulvaSmall intestineLarynxHypopharynxNose, sinuses etc.TonsilAdrenal glandOther Female GenitalOther Urinary organsOther OropharynxMesotheliomaPharynx unspec.Other EndocrineAll sites Total
(13.3 , 15.2)(11.2 , 12.9)(6.6 , 8.1)(6.7 , 8.2)(4.3 , 5.4)(4.0 , 5.1)(4.3 , 5.5)(3.5 , 4.5)(2.8 , 3.6)(2.7 , 3.6)(2.7 , 3.7)(2.1 , 2.9)(1.9 , 2.7)(1.2 , 1.8)(1.0 , 1.6)(0.8 , 1.4)(0.7 , 1.3)(0.6 , 1.1)(0.7 , 1.3)(0.5 , 0.9)(0.6 , 1.1)(0.6 , 1.1)(0.4 , 0.7)(0.5 , 1.0)(0.4 , 0.8)(0.3 , 0.7)(0.3 , 0.6)(0.2 , 0.5)(0.2 , 0.6)(0.2 , 0.5)(0.1 , 0.3)(0.1 , 0.3)(0.2 , 0.5)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.4)(0.1 , 0.3)(0.1 , 0.3)(0.0 , 0.2)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)(0.0 , 0.1)
(87.2 , 92.0)
943791429393334292273268241210177160128111806058575351484644403936262624201717161514141312109543321
5,613
16.814.17.67.06.05.24.94.84.33.73.22.92.32.01.41.11.01.00.90.90.90.80.80.70.70.60.50.50.40.40.30.30.30.30.20.20.20.20.20.20.10.10.10.10.00.0
100.0
1.51.30.91.00.50.50.60.40.30.40.40.30.30.20.10.20.10.10.10.10.10.10.00.10.10.10.10.00.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
10.2
10.89.14.94.53.83.33.13.12.82.42.01.81.51.30.90.70.70.70.60.60.60.50.50.50.40.40.30.30.30.20.20.20.20.20.20.20.10.10.10.10.10.00.00.00.00.0
64.4
14.312.07.47.44.94.54.94.03.23.23.22.52.31.51.31.11.00.91.00.70.90.90.50.70.60.50.50.40.40.30.20.20.30.30.20.30.30.20.20.10.10.10.10.10.00.0
89.6
1.51.30.91.00.50.50.60.40.30.40.40.30.30.20.10.20.10.10.10.10.10.10.00.10.10.10.10.00.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.09.7
SITE NO. % CR CR74 ASR (ASR 95%CL) CumR
APPENDIX 17: INCIDENCE SUMMARY TABLE, OTHERS FEMALES, MALAYSIA, 2007-2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
93
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
APPENDIX 18: INCIDENCE SUMMARY TABLE OF 15 SELECTED CANCER SITES BY STATE AND SEX, MALAYSIA, 2007-2011
STATE
1. Female BreastSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan2. ColorectalSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan3. Trachea, Bronchus, LungSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan
3,1592,792
8051,1981,8091,2201,453
5941,958
79053488373115117
889920367509532422348266720239175322251473
35348729434729919317514134116411312292271
1,1081,173
519638657545428357810355227400298
6910
7591,289
482619788400383333861444313270343
695
1.82.31.71.51.31.61.91.42.71.51.62.52.11.51.3
1.22.71.81.61.61.21.61.43.22.02.21.62.51.60.7
8.715.0
8.710.711.511.711.29.3
22.39.98.7
16.515.5
7.95.0
6.016.4
8.110.413.7
8.610.0
8.723.712.311.911.117.8
7.92.5
13.518.214.312.310.913.214.511.923.312.312.019.217.412.411.4
9.420.314.012.213.19.8
12.911.225.115.916.712.920.412.46.3
1.82.21.71.51.31.61.91.42.61.51.62.42.11.51.3
1.22.61.81.51.61.21.61.43.12.02.21.62.51.60.7
25.837.713.920.931.826.238.815.553.623.321.437.436.426.48.9
7.3
12.46.38.99.39.19.37.0
19.77.07.0
13.612.58.21.6
2.96.65.16.05.24.24.73.79.34.84.55.24.64.70.5
3.64.32.22.53.22.74.81.85.52.82.64.04.02.91.5
1.41.71.31.21.01.21.51.02.21.01.11.71.50.90.3
0.50.91.21.00.60.50.70.51.00.70.70.70.60.50.3
31.739.819.722.729.325.942.217.050.025.724.837.035.726.412.6
10.614.110.610.28.39.3
11.87.8
18.78.18.9
14.412.27.72.8
4.37.69.27.34.74.26.04.28.95.95.75.44.54.51.5
3.54.22.12.43.12.74.71.85.42.72.63.93.92.91.5
1.41.71.31.21.01.21.51.02.11.01.11.71.50.90.3
0.50.91.21.00.60.50.70.51.00.70.70.70.60.50.2
FEMALENO. CR CR74 ASR CumR
MALENO. CR CR74 ASR CumR
94
STATE
4. LymphomaSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan5. NasopharynxSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan6. LeukaemiaSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan
1332019525517385
10682
191106609197136
130172152258141487128
1274035385331
35028815319615112875
11618396967683114
24456261359219153135132272160107139145
245
382524369665459182210
77394135
7014311223
9
439392212248147152
91145217116131
8611832
0
2.34.33.44.43.01.82.82.15.23.12.43.84.82.33.1
1.12.32.64.52.51.01.90.73.51.21.41.62.60.50.5
2.93.92.63.42.72.82.03.05.02.83.83.24.11.92.1
2.75.84.46.03.83.33.53.47.54.44.15.77.52.72.5
3.06.76.2
11.28.03.95.52.0
10.83.72.75.95.82.64.5
3.55.03.54.22.63.32.43.86.03.25.03.56.13.70.0
0.20.50.50.50.30.20.40.20.60.40.30.40.50.20.3
0.10.20.40.50.20.10.20.10.40.20.20.10.30.10.1
0.30.30.20.30.20.20.20.30.40.30.40.30.40.10.4
0.60.70.70.70.40.40.50.40.80.60.60.60.90.60.5
0.40.81.01.30.90.50.60.31.10.50.30.70.60.51.0
0.40.40.30.40.20.30.30.30.60.30.40.40.50.50.0
2.14.64.84.92.81.83.22.45.03.52.84.04.62.13.5
1.22.43.74.82.31.02.00.83.31.31.71.52.60.60.7
3.24.13.03.72.62.92.13.25.33.04.23.34.42.13.1
4.36.46.36.63.73.53.93.97.65.34.96.07.94.34.0
3.57.28.5
11.67.74.15.92.4
10.24.43.16.26.14.08.1
4.05.33.94.52.73.42.64.06.43.55.23.86.66.00.0
0.20.50.50.50.30.20.40.20.60.40.30.40.50.20.3
0.10.20.40.50.20.10.20.10.40.20.20.10.30.10.1
0.30.30.20.30.20.20.20.30.40.30.40.30.40.10.4
0.60.70.70.70.40.40.50.40.80.60.60.60.90.60.5
0.40.81.01.20.90.50.60.31.10.50.30.70.60.51.0
0.40.40.30.40.20.30.30.30.60.30.40.40.50.50.0
FEMALENO. CR CR74 ASR CumR
MALENO. CR CR74 ASR CumR
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
95
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
STATE
7. Cervix UteriSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan8. LiverSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan9. OvarySelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan
537518471640380295222132399193120190162557
185144848873662469
13557494935110
508446259325359233118184332158173168161232
550413236289226128
79166361150157127126
202
0.80.70.80.70.50.40.30.61.20.60.90.70.90.40.0
4.35.33.94.93.92.72.14.39.94.26.05.26.62.31.0
6.46.16.65.53.73.12.55.4
10.25.07.65.87.23.61.9
0.80.70.80.70.50.40.30.61.20.60.90.70.90.40.0
4.47.08.1
11.26.76.35.93.5
10.95.74.88.08.19.63.7
1.51.91.41.51.31.40.61.83.71.72.02.11.71.90.0
4.16.04.55.76.35.03.14.89.14.76.97.18.04.01.0
0.70.91.31.30.70.70.80.41.20.70.71.00.91.00.6
0.30.30.40.20.10.20.10.20.40.20.30.30.20.20.0
0.60.70.60.60.60.50.40.60.90.50.90.80.80.40.2
5.77.6
11.512.16.16.36.83.8
10.16.35.88.27.99.66.3
2.22.22.71.81.11.40.72.03.61.92.52.31.71.80.0
5.16.46.16.15.95.03.55.38.65.08.17.17.83.91.7
0.70.91.31.30.70.70.80.41.20.70.71.00.91.00.6
0.30.30.40.20.10.20.10.20.40.20.30.30.20.20.0
0.20.40.60.50.20.20.30.10.50.20.20.40.30.20.1
FEMALENO. CR CR74 ASR CumR
MALENO. CR CR74 ASR CumR
96
STATE
10. StomachSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan11. ProstateSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan12. Other SkinSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan
162208183195121776523
1844533755862
7715714890
163483354
1254035343340
237310253337155
808035
2386535986512
3
383548199206325216187170447106
96100101
242
120206125110208
884264
18460585252
51
1.32.83.23.42.11.71.70.65.01.31.33.22.91.01.0
0.62.12.61.62.91.00.91.43.41.21.41.41.60.70.0
1.94.04.25.72.71.72.10.96.51.81.34.03.41.41.5
3.07.03.33.55.74.64.94.4
12.32.93.74.15.32.71.0
0.92.62.11.83.61.91.11.75.11.72.22.12.70.60.5
0.20.40.60.50.20.20.30.10.50.20.20.40.30.20.1
0.10.30.50.20.30.10.10.20.40.20.20.20.20.00.0
0.40.61.00.80.30.20.30.10.80.30.30.60.50.20.6
0.81.20.80.50.70.71.00.81.70.50.80.70.70.60.6
0.10.40.50.20.40.30.20.30.60.30.30.20.30.10.3
1.93.25.44.01.91.72.20.64.71.61.63.42.80.90.9
0.92.44.61.82.51.01.21.63.31.51.71.51.60.50.0
2.84.97.46.62.61.92.71.16.92.31.94.73.82.13.5
5.59.36.44.35.45.57.15.9
13.84.05.65.16.44.22.8
1.53.23.72.13.52.11.62.15.42.22.92.43.10.91.3
0.20.40.60.50.20.20.30.10.50.20.20.40.30.20.1
0.10.30.50.20.30.10.10.20.40.20.20.20.20.00.0
0.40.60.90.80.30.20.30.10.80.30.30.60.40.20.6
0.81.20.80.50.70.71.00.81.70.50.80.70.70.60.6
0.10.40.50.20.40.30.20.30.60.30.30.20.30.10.3
FEMALENO. CR CR74 ASR CumR
MALENO. CR CR74 ASR CumR
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
97
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
STATE
13. ThyroidSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan14. BrainSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan15. Corpus UteriSelangorJohorSabahSarawakPerakKedahWPKL & PutrajayaKelantanPenangPahangTerengganuNegeri SembilanMelakaPerlisW.P. Labuan
21026513516114910170
17012496
1114362200
1311246889
2047451498363413327141
33632611919019012711288
273789796
109202
53795541423823465041261925
70
168172
8096
1925974569051394734
93
0.10.10.20.10.10.10.10.20.10.10.10.10.10.20.0
0.20.20.20.10.30.10.20.10.20.10.10.20.20.10.2
0.41.00.90.70.70.80.61.21.41.11.00.81.30.80.0
1.32.21.31.63.31.31.91.52.51.41.51.91.81.01.5
0.61.11.40.80.70.90.71.51.41.41.20.81.41.30.0
1.62.41.71.63.21.32.01.52.51.61.62.01.91.61.8
0.10.10.20.10.10.10.10.20.10.10.10.10.10.20.0
0.20.20.20.10.30.10.20.10.20.10.10.20.20.10.2
1.73.62.32.82.62.21.94.43.42.84.41.83.13.50.0
1.11.71.21.63.61.61.41.32.31.91.61.41.32.40.5
2.74.42.13.33.32.73.02.37.52.33.94.15.43.51.0
0.20.40.30.30.30.20.20.50.30.30.50.20.30.40.0
0.10.20.20.10.30.10.20.10.20.20.20.20.10.20.1
0.40.60.30.40.40.30.40.30.80.30.50.50.60.40.5
1.93.63.23.02.52.22.04.93.13.05.21.83.03.70.0
1.31.81.61.63.41.61.61.42.31.91.91.51.42.50.7
3.74.83.13.73.12.83.52.57.02.54.64.15.23.42.5
0.20.40.30.30.30.20.20.50.30.30.50.20.30.40.0
0.10.20.20.10.30.10.20.10.20.20.20.20.10.20.1
0.40.60.30.40.40.30.40.30.80.30.50.50.60.40.5
FEMALENO. CR CR74 ASR CumR
MALENO. CR CR74 ASR CumR
98
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages 30 46
139
127
312
7 8137
85 172 37 737
2014 15
338
2637
31 8930
54 413
1041 27
082
574
15 167
493
167
1384 22 17 43
413
711
531
32 496 31 901 13 19
1477 17 10
411
76 549 47 109
379
2792 5
396
779
1328 44
274
1---
--46
794
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 20 0 0 1 0 0 0 6 1 1 0 0 17 0 2 0 40 1 26 1 0 2 0 52 87 0 14 4 3 32 0 019
9 74 90 6---
--68
2
5-
-
9 0 0 0 2 0 0 4 0 1 0 0 0 1 0 0 3 0 0 2 2 0 0 16 0 4 0 0 8 0 1 0 7 0 4 0 0 1 0 5 61 2 3 1 9 60 0 012
1 42 58 6---
--42
4
10-
-
14 0 0 3 0 0 0 28 0 0 0 1 0 4 0 0 8 0 0 4 2 0 3 62 0 5 0 0 11 0 0 0 13 0 3 0 0 0 0 1 72 6 2 10 16 61 0 0 74 57 37 6---
--48
9
15-
-
19 0 2 3 3 1 1 57 1 0 0 2 0 5 2 0 3 0 0 3 0 3 6 82 4 12 0 0 25 0 0 3 38 3 2 0 0 3 0 0 65 10 1 11 47 90 0 0 54 78 35 10 -----
665
20-
-
24 0 6 3 13 1 1 58 1 0 3 4 3 20 13 1 11 1 1 4 1 30 16 54 5 10 0 2 18 0 2 3 80 0 3 0 0 2 0 0 46 15 0 5 52 113 0 1 44 98 23 10 -----
777
25-
-
29 0 10 11 12 2 1 91 0 0 3 21 3 44 24 0 24 3 6 2 1 38 13 34 3 15 0 1 23 1 0 2 93 2 5 0 0 5 0 0 42 29 2 3 40 95 0 4 39 83 24 13 -----
867
30-
-
34 1 17 4 16 1 018
2 1 0 5 29 6 62 61 2 52 1 13 3 7 67 7 18 3 27 0 1 20 4 4 2 60 1 13 0 0 9 0 4 68 15 0 3 25 110 0 3 26 67 9 9
-----
1038
35-
-
39 0 18 14 21 4 031
3 0 1 7 56 210
9 89 3 82 10 19 17 813
5 14 19 6 27 0 2 23 5 7 1 55 0 22 0 1 21 0 3 72 30 1 8 24 135 0 8 21 85 17 25 -----
1540
40-
-
44 4 32 18 19 7 244
0 3 0 27 79 919
115
0 916
8 17 44 26 16 253 12 29 10 49 1 4 34 11 11 14 25 1 55 0 0 46 1 1 82 46 2 10 27 191 0 19 26 97 13 39 -----
2370
45-
-
49 2 57 34 30 15 857
4 8 2 54 132 20 281
282 5
255 30 92 32 45 483 11 21 10 85 2 1 41 13 9 26 23 2 90 3 0 74 1 4 94 58 1 14 22 229 0 43 20 103 11 56 -----
3508
50-
-
54 5 53 42 25 13 858
5 17 6 71 188 14 400
384 10 438 46 116 43 94 754 18 23 22 92 4 1 42 18 10 100 20 3
116 0 1
116 0 7
117 58 3 12 31 304 1 48 29 115 29 75 -----
4727
55-
-
59 3 64 48 31 16 650
2 18 610
421
9 27 526
499 10 511 69 148 25 114
911 16 29 26 148 2 1 47 18 17 231 9 4
130 2 0
153 3 3
112 74 4 11 25 325 0 75 41 117 18 101
-----
5599
60-
-
64 2 60 59 34 27 15 376 24 8
121
271 22 535
619 15 506 65 186 44 166
1219 15 34 19 181 2 0 37 21 17 474 10 4
143 0 4
215 5 2 86 62 4 7 12 335 0 71 25 93 19 99 -----
6370
65-
-
69 4 49 46 23 11 829
8 31 411
131
0 21 522
620 11 368 60 169 23 148
1267 18 28 28 214 5 2 43 16 16 671 8 4
124 3 8
251 3 4 69 63 4 7 15 314 1 55 24 89 19 99 -----
6309
70-
-
74 4 47 39 25 15 14 170 38 2
103
301 21 515
476 13 322 60 123 16 107
1120 8 16 14 210 3 0 18 13 8
745 7 3
103 2 3
257 1 7 56 46 4 1 17 201 0 34 21 67 18 80 -----
5494
75+
5 46 67 19 14 16 106 29 7
128
401 5
611
512 10 283 51 124 25 114
1135 10 22 16 304 3 2 27 17 11 860 8 3 62 2 2
322 3 11 47 35 2 2 14 197 3 35 15 63 22 107
-----
5935
% of
Total
0.10%
1.00%
0.80%
0.60%
0.30%
0.20%
8.10%
0.40%
0.10%
1.60%
4.30%
0.30%
8.20%
8.00%
0.20%
6.50%
0.90%
2.20%
0.60%
1.80%
15.80
%0.4
0%1.1
0%0.4
0%3.0
0%0.0
0%0.0
0%0.9
0%0.3
0%0.2
0%6.7
0%1.1
0%0.1
0%1.9
0%0.0
0%0.0
0%3.2
0%0.0
0%0.2
0%2.5
0%1.2
0%0.1
0%0.2
0%0.8
0%6.0
0%0.0
0%0.8
0%1.7
0%2.8
0%0.9
0%1.6
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
19:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
AL
L R
ESI
DE
NT
S, M
AL
ES,
MA
LA
YSI
A, 2
007-
2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
99
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages 55 40
152
522
6 68 3013
05 86 20 429
1447 89
3350
2611 86
1074 40
978
813
811
331
93 123
365
155
1045 19 2
378
1820
612
312
443
5221
81 580
3472 42 65 43
4 8 11 400 10 67
1060
1723 45 51 27
919
24 734
852
411
49 351
647
-----
5671
3
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 2 0 1 0 0 0 0 0 0 16 0 1 3 1 1 0 7 1 2 0 0 17 0 0 1 0 0 0 11 0 0 21 0 0 1 0 28 60 0 11 0 0 23 0 014
8 67 75 10 -----
508
5-
-
9 0 0 1 2 0 0 2 0 0 0 0 0 0 1 0 1 0 0 0 0 0 2 14 0 4 0 0 12 0 0 0 0 0 0 11 0 0 3 0 0 0 0 3 74 2 4 0 1 22 0 0 83 32 33 6---
--31
3
10-
-
14 1 2 3 6 0 1 4 0 1 0 1 0 3 1 0 1 0 0 3 0 0 3 49 0 3 0 0 14 2 0 1 0 0 0 43 0 0 5 0 0 1 0 2 64 15 0 1 4 54 0 0 56 39 28 2---
--41
3
15-
-
19 0 1 4 9 1 0 24 0 0 0 10 0 7 0 0 6 0 0 2 0 1 1 49 1 12 0 0 30 3 0 0 0 0 0 94 0 2 6 0 0 1 0 3 40 55 1 3 40 63 0 0 38 59 22 7---
--59
5
20-
-
24 0 3 2 10 0 1 48 2 0 0 10 3 30 13 1 5 1 6 3 0 10 5 21 4 8 0 0 15 71 0 0 16 2 411
7 0 9 7 1 0 3 0 0 46 101 1 2 59 96 1 0 22 71 12 23 -----
865
25-
-
29 0 12 5 15 0 1 42 2 0 0 23 1 47 24 1 11 1 8 3 0 27 3 16 4 14 0 0 24 251 0 2 64 30 10 127 1 10 6 1 0 1 0 3 44 132 1 1 49 88 0 1 16 62 13 13 -----
1210
30-
-
34 1 17 3 7 2 1 59 1 2 0 29 7 64 46 0 22 10 14 3 3 36 6 21 5 21 0 0 19 714 3 0
136 59 19 133 2 11 10 0 0 6 0 1 41 123 1 1 29 72 0 0 13 71 8 18 -----
1870
35-
-
39 1 13 10 16 1 110
1 0 0 5 41 2 97 72 1 35 9 20 13 4 79 5 12 10 20 1 0 2713
29 3 733
710
5 33 196 4 16 20 0 0 7 0 1 62 166 4 5 10 92 0 9 20 93 18 28 -----
3161
40-
-
44 1 39 19 23 4 015
4 4 1 19 71 514
612
8 6 47 8 38 10 314
7 7 30 16 44 0 0 2823
65 6 749
119
0 60 330 5 6 16 1 0 12 0 2 82 175 4 5 14 108 0 22 18 82 15 37 -----
5051
45-
-
49 2 35 18 24 6 219
3 9 1 22 109 6
248
196 4 73 22 44 5 8
261 8 21 9 53 0 1 43
3286 11 13 683
278 96 527 12 8 45 0 0 26 0 4
108
194 2 6 18 166 0 22 17 108 19 55 -----
7127
50-
-
54 7 59 49 22 8 119
2 7 3 48 145 17 329
285 11 99 30 83 14 10 335 11 18 12 68 2 0 26
3030 16 11 67
638
3 98 557 6 1 55 1 2 32 3 4
112
194 5 11 15 217 1 46 25 112 21 61 -----
7586
55-
-
59 5 40 56 20 13 316
9 13 4 60 172 12 464
363 12 144 70 116 23 14 411 17 24 15 89 5 0 28
2647 18 24 58
841
0 92 449 3 1 50 0 1 50 1 3 89 157 2 8 10 224 1 62 19 116 19 83 -----
7489
60-
-
64 3 52 78 24 7 512
6 13 3 62 180 6
445
339 12 148 54 130 8 17 455 14 24 17 95 3 0 22
1790 12 9
455
309 67 319 1 1 60 1 0 51 4 4 76 125 3 4 10 209 2 66 13 87 16 77 -----
6113
65-
-
69 4 28 79 15 6 4 80 9 1 57 190 9
392
347 10 139 59 99 13 18 500 14 19 23 145 2 0 29
1174 12 15 330
186 36 256 5 0 39 1 5 56 0 3 82 143 2 3 5
178 0 47 14 44 17 56 -----
5000
70-
-
74 11 51 95 21 8 4 66 16 1 63 174 7
455
376 8
144 64 103 14 15 416 13 18 15 160 4 1 20 820 17 16 320
119 42 159 1 0 40 1 1 58 0 2 48 70 2 1 6
156 0 46 8 53 13 72 -----
4414
75+ 19 49 10
3 12 12 6 43 10 2 93 292 14 623
420 20 183 81 126 21 20 514 14 22 23 307 2 0 24 724 25 18 256
110 23 143 2 0 51 1 2 95 2 4 32 71 2 0 9
156 2 27 14 53 22 99 -----
4998
% of
Total
0.10%
0.70%
0.90%
0.40%
0.10%
0.10%
2.30%
0.20%
0.00%
0.80%
2.60%
0.20%
5.90%
4.60%
0.20%
1.90%
0.70%
1.40%
0.20%
0.20%
5.60%
0.20%
0.60%
0.30%
1.80%
0.00%
0.00%
0.70%
32.10
%0.2
0%0.2
0%7.7
0%3.8
0%1.0
0%6.1
0%0.1
0%0.1
0%0.8
0%0.0
0%0.0
0%0.7
0%0.0
0%0.1
0%1.9
0%3.0
0%0.1
0%0.1
0%0.5
0%3.4
0%0.0
0%0.6
0%0.9
0%2.0
0%0.6
0%1.1
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
20:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
MA
LA
YSI
A, 2
007-
2011
100
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages 30 46
139
127
312
7 8137
85 172 37 737
2014 15
338
2637
31 8930
54 413
1041 27
082
574
15 167
493
167
1384 22 17 43
413
711
531
32 496 31 901 13 19
1477 17 10
411
76 549 47 109
379
2792 5
396
779
1328 44
274
1---
--46
794
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.1 0 0 0 0 0.3 0 0 0 0.6 0 0.4 0 0 0 0 0.8 1.4 0 0.2 0.1 0 0.5 0 0 3.2 1.2 1.4 0.1 ----- 11
5-
-
9 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0.1 0 0 0.1 0 0 0 0.1 0 0.1 0 0 0 0 0.1 0.9 0 0 0 0.1 0.9 0 0 1.8 0.6 0.9 0.1 ----- 6
10-
-
14 0 0 0 0 0 0 0.4 0 0 0 0 0 0.1 0 0 0.1 0 0 0.1 0 0 0 0.9 0 0.1 0 0 0.2 0 0 0 0.2 0 0 0 0 0 0 0 1.1 0.1 0 0.1 0.2 0.9 0 0 1.1 0.8 0.6 0.1 ----- 7
15-
-
19 0 0 0 0 0 0 0.9 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.1 1.2 0.1 0.2 0 0 0.4 0 0 0 0.6 0 0 0 0 0 0 0 1 0.2 0 0.2 0.7 1.4 0 0 0.8 1.2 0.5 0.2 ----- 10
20-
-
24 0 0.1 0 0.2 0 0 0.9 0 0 0 0.1 0 0.3 0.2 0 0.2 0 0 0.1 0 0.5 0.3 0.9 0.1 0.2 0 0 0.3 0 0 0 1.3 0 0 0 0 0 0 0 0.8 0.2 0 0.1 0.8 1.8 0 0 0.7 1.6 0.4 0.2 ----- 13
25-
-
29 0 0.2 0.2 0.2 0 0 1.6 0 0 0.1 0.4 0.1 0.8 0.4 0 0.4 0.1 0.1 0 0 0.7 0.2 0.6 0.1 0.3 0 0 0.4 0 0 0 1.7 0 0.1 0 0 0.1 0 0 0.8 0.5 0 0.1 0.7 1.7 0 0.1 0.7 1.5 0.4 0.2 ----- 16
30-
-
34 0 0.4 0.1 0.3 0 0 4 0 0 0.1 0.6 0.1 1.4 1.3 0 1.1 0 0.3 0.1 0.2 1.5 0.2 0.4 0.1 0.6 0 0 0.4 0.1 0.1 0 1.3 0 0.3 0 0 0.2 0 0.1 1.5 0.3 0 0.1 0.5 2.4 0 0.1 0.6 1.5 0.2 0.2 ----- 23
35-
-
39 0 0.4 0.3 0.5 0.1 0 7.4 0 0 0.2 1.3 0 2.6 2.1 0.1 1.9 0.2 0.4 0.4 0.2 3.2 0.3 0.4 0.1 0.6 0 0 0.5 0.1 0.2 0 1.3 0 0.5 0 0 0.5 0 0.1 1.7 0.7 0 0.2 0.6 3.2 0 0.2 0.5 2 0.4 0.6 ----- 36
40-
-
44 0.1 0.8 0.4 0.5 0.2 010
.9 0.1 0 0.7 2 0.2 4.7 3.7 0.2 4.2 0.4 1.1 0.6 0.4 6.3 0.3 0.7 0.2 1.2 0 0.1 0.8 0.3 0.3 0.3 0.6 0 1.4 0 0 1.1 0 0 2 1.1 0 0.2 0.7 4.7 0 0.5 0.6 2.4 0.3 1---
-- 59
45-
-
49 0.1 1.5 0.9 0.8 0.4 0.2 15.1 0.2 0.1 1.4 3.5 0.5 7.4 7.4 0.1 6.7 0.8 2.4 0.8 1.2 12.7 0.3 0.6 0.3 2.2 0.1 0 1.1 0.3 0.2 0.7 0.6 0.1 2.4 0.1 0 1.9 0 0.1 2.5 1.5 0 0.4 0.6 6 0 1.1 0.5 2.7 0.3 1.5 ----- 92
50-
-
54 0.2 1.6 1.3 0.8 0.4 0.2 18.2 0.5 0.2 2.2 5.8 0.4 12.4
11.9 0.3 13.6 1.4 3.6 1.3 2.9 23.4 0.6 0.7 0.7 2.9 0.1 0 1.3 0.6 0.3 3.1 0.6 0.1 3.6 0 0 3.6 0 0.2 3.6 1.8 0.1 0.4 1 9.4 0 1.5 0.9 3.6 0.9 2.3 -----
147
55-
-
59 0.1 2.5 1.9 1.2 0.6 0.2 19.8 0.7 0.2 4.1 8.6 1.1 20.7
19.7 0.4 20.1 2.7 5.8 1 4.5 35.9 0.6 1.1 1 5.8 0.1 0 1.9 0.7 0.7 9.1 0.4 0.2 5.1 0.1 0 6 0.1 0.1 4.4 2.9 0.2 0.4 1
12.8 0 3 1.6 4.6 0.7 4
-----
221
60-
-
64 0.1 3.2 3.1 1.8 1.4 0.8 19.8 1.3 0.4 6.4 14.3 1.2 28.1
32.6 0.8 26.6 3.4 9.8 2.3 8.7 64.1 0.8 1.8 1 9.5 0.1 0 1.9 1.1 0.9 24.9 0.5 0.2 7.5 0 0.2 11.3 0.3 0.1 4.5 3.3 0.2 0.4 0.6 17.6 0 3.7 1.3 4.9 1 5.2 -----
335
65-
-
69 0.3 3.9 3.6 1.8 0.9 0.6 23.6 2.5 0.3 8.8 24.6 1.7 41.4
49.1 0.9 29.2 4.8 13.4 1.8 11.7
100.4 1.4 2.2 2.2 17 0.4 0.2 3.4 1.3 1.3 53.2 0.6 0.3 9.8 0.2 0.6 19.9 0.2 0.3 5.5 5 0.3 0.6 1.2 24.9 0.1 4.4 1.9 7.1 1.5 7.8 -----
500
70-
-
74 0.4 5 4.2 2.7 1.6 1.5 18.2 4.1 0.2 11
32.2 2.2 55.2 51 1.4 34.5 6.4 13.2 1.7 11.5 120 0.9 1.7 1.5 22
.5 0.3 0 1.9 1.4 0.9 79.8 0.7 0.3 11 0.2 0.3 27.5 0.1 0.7 6 4.9 0.4 0.1 1.8 21.5 0 3.6 2.2 7.2 1.9 8.6 -----
589
75+ 0.5 4.7 6.9 2 1.4 1.6 10
.9 3 0.7 13.2
41.2 0.5 62.8
52.7 1
29.1 5.2 12.8 2.6 11.7
116.7 1 2.3 1.6 31.3 0.3 0.2 2.8 1.7 1.1 88.4 0.8 0.3 6.4 0.2 0.2 33.1 0.3 1.1 4.8 3.6 0.2 0.2 1.4 20.3 0.3 3.6 1.5 6.5 2.3 11 -----
610
Crud
e Ra
te 0 0.7 0.6 0.4 0.2 0.1 5.8 0.3 0.1 1.1 3.1 0.2 5.8 5.7 0.1 4.7 0.6 1.6 0.4 1.3 11.3 0.3 0.8 0.3 2.1 0 0 0.7 0.2 0.2 4.8 0.8 0 1.4 0 0 2.3 0 0.2 1.8 0.8 0.1 0.2 0.6 4.3 0 0.6 1.2 2 0.7 1.1 -----
71.4
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
21:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, A
LL
RE
SID
EN
TS,
MA
LE
S, M
AL
AY
SIA
, 200
7-20
11
ASR
Wor
ld 0.1 0.8 0.7 0.5 0.2 0.2 6.4 0.3 0.1 1.4 3.9 0.3 7.2 7.2 0.2 5.6 0.8 2 0.5 1.6 14.4 0.3 0.8 0.3 2.7 0 0 0.7 0.3 0.2 6.6 0.7 0.1 1.7 0 0 2.9 0 0.2 1.9 1 0.1 0.2 0.6 4.9 0 0.7 1.3 2.2 0.7 1.4 -----
86.9
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
101
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages 55 40
152
522
6 68 3013
05 86 20 429
1447 89
3350
2611 86
1074 40
978
813
811
331
93 123
365
155
1045 19 2
378
1820
612
312
443
5221
81 580
3472 42 65 43
4 8 11 400 10 67
1060
1723 45 51 27
919
24 734
852
411
49 351
647
-----
5671
3
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.1 0 0 0 0.1 0 0 0 0 0.3 0 0 0 0 0 0 0.2 0 0 0.4 0 0 0 0 0.5 1 0 0.2 0 0 0.4 0 0 2.5 1.1 1.3 0.2 ----- 8
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0.1 0 0 0.2 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 1.2 0 0.1 0 0 0.3 0 0 1.3 0.5 0.5 0.1 ----- 5
10-
-
14 0 0 0 0.1 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0.2 0 0 0 0 0 0 0.7 0 0 0.1 0 0 0 0 0 1 0.2 0 0 0.1 0.8 0 0 0.9 0.6 0.4 0---
-- 6
15-
-
19 0 0 0.1 0.1 0 0 0.4 0 0 0 0.2 0 0.1 0 0 0.1 0 0 0 0 0 0 0.8 0 0.2 0 0 0.5 0 0 0 0 0 0 1.5 0 0 0.1 0 0 0 0 0 0.6 0.9 0 0 0.6 1 0 0 0.6 0.9 0.3 0.1 ----- 9
20-
-
24 0 0 0 0.2 0 0 0.8 0 0 0 0.2 0 0.5 0.2 0 0.1 0 0.1 0 0 0.2 0.1 0.3 0.1 0.1 0 0 0.2 1.2 0 0 0.3 0 0.1 1.9 0 0.1 0.1 0 0 0 0 0 0.8 1.7 0 0 1 1.6 0 0 0.4 1.2 0.2 0.4 ----- 14
25-
-
29 0 0.2 0.1 0.3 0 0 0.8 0 0 0 0.4 0 0.9 0.4 0 0.2 0 0.1 0.1 0 0.5 0.1 0.3 0.1 0.3 0 0 0.4 4.6 0 0 1.2 0.6 0.2 2.3 0 0.2 0.1 0 0 0 0 0.1 0.8 2.4 0 0 0.9 1.6 0 0 0.3 1.1 0.2 0.2 ----- 22
30-
-
34 0 0.4 0.1 0.2 0 0 1.3 0 0 0 0.7 0.2 1.5 1 0 0.5 0.2 0.3 0.1 0.1 0.8 0.1 0.5 0.1 0.5 0 0 0.4 16.3 0.1 0 3.1 1.3 0.4 3 0 0.3 0.2 0 0 0.1 0 0 0.9 2.8 0 0 0.7 1.6 0 0 0.3 1.6 0.2 0.4 ----- 43
35-
-
39 0 0.3 0.2 0.4 0 0 2.4 0 0 0.1 1 0 2.3 1.7 0 0.8 0.2 0.5 0.3 0.1 1.9 0.1 0.3 0.2 0.5 0 0 0.6 31.7 0.1 0.2 8 2.5 0.8 4.7 0.1 0.4 0.5 0 0 0.2 0 0 1.5 4 0.1 0.1 0.2 2.2 0 0.2 0.5 2.2 0.4 0.7 ----- 75
40-
-
44 0 1 0.5 0.6 0.1 0 3.8 0.1 0 0.5 1.8 0.1 3.6 3.2 0.1 1.2 0.2 0.9 0.2 0.1 3.6 0.2 0.7 0.4 1.1 0 0 0.7 58.7 0.1 0.2 12.2 4.7 1.5 8.2 0.1 0.1 0.4 0 0 0.3 0 0 2 4.3 0.1 0.1 0.3 2.7 0 0.5 0.4 2 0.4 0.9 -----
125
45-
-
49 0.1 1 0.5 0.7 0.2 0.1 5.4 0.3 0 0.6 3 0.2 6.9 5.4 0.1 2 0.6 1.2 0.1 0.2 7.3 0.2 0.6 0.3 1.5 0 0 1.2 91.3 0.3 0.4 19 7.7 2.7 14.6 0.3 0.2 1.3 0 0 0.7 0 0.1 3 5.4 0.1 0.2 0.5 4.6 0 0.6 0.5 3 0.5 1.5 -----
198
50-
-
54 0.2 1.9 1.6 0.7 0.3 0 6.2 0.2 0.1 1.6 4.7 0.5 10.6 9.2 0.4 3.2 1 2.7 0.5 0.3 10.8 0.4 0.6 0.4 2.2 0.1 0 0.8 97.9 0.5 0.4 21.8
12.4 3.2 18 0.2 0 1.8 0 0.1 1 0.1 0.1 3.6 6.3 0.2 0.4 0.5 7 0 1.5 0.8 3.6 0.7 2
-----
245
55-
-
59 0.2 1.6 2.3 0.8 0.5 0.1 6.9 0.5 0.2 2.5 7.1 0.5 19.1
14.9 0.5 5.9 2.9 4.8 0.9 0.6 16.9 0.7 1 0.6 3.7 0.2 0 1.2
108.7 0.7 1
24.2
16.8 3.8 18.4 0.1 0 2.1 0 0 2.1 0 0.1 3.7 6.4 0.1 0.3 0.4 9.2 0 2.5 0.8 4.8 0.8 3.4 -----
308
60-
-
64 0.2 2.8 4.2 1.3 0.4 0.3 6.8 0.7 0.2 3.3 9.7 0.3 23.9
18.2 0.6 8 2.9 7 0.4 0.9 24.4 0.8 1.3 0.9 5.1 0.2 0 1.2 96.2 0.6 0.5 24.4
16.6 3.6 17.1 0.1 0.1 3.2 0.1 0 2.7 0.2 0.2 4.1 6.7 0.2 0.2 0.5 11.2 0.1 3.5 0.7 4.7 0.9 4.1 -----
328
65-
-
69 0.3 2.2 6.3 1.2 0.5 0.3 6.4 0.7 0.1 4.5 15.2 0.7 31.3
27.7 0.8 11.1 4.7 7.9 1 1.4 39.9 1.1 1.5 1.8 11.6 0.2 0 2.3 93.6 1 1.2 26.3
14.8 2.9 20.4 0.4 0 3.1 0.1 0.4 4.5 0 0.2 6.5 11.4 0.2 0.2 0.4 14.2 0 3.7 1.1 3.5 1.4 4.5 -----
399
70-
-
74 1.1 5.2 9.6 2.1 0.8 0.4 6.7 1.6 0.1 6.4 17.6 0.7 46.1
38.1 0.8 14.6 6.5 10.4 1.4 1.5 42.2 1.3 1.8 1.5 16.2 0.4 0.1 2
83.1 1.7 1.6 32.4
12.1 4.3 16.1 0.1 0 4.1 0.1 0.1 5.9 0 0.2 4.9 7.1 0.2 0.1 0.6 15.8 0 4.7 0.8 5.4 1.3 7.3 -----
447
75+ 1.6 4.1 8.6 1 1 0.5 3.6 0.8 0.2 7.8 24
.4 1.2 52 35 1.7 15.3 6.8 10.5 1.8 1.7 42.9 1.2 1.8 1.9 25.6 0.2 0 2
60.4 2.1 1.5 21.4 9.2 1.9 11.9 0.2 0 4.3 0.1 0.2 7.9 0.2 0.3 2.7 5.9 0.2 0 0.8 13 0.2 2.3 1.2 4.4 1.8 8.3 -----
417
Crud
eRa
te 0.1 0.6 0.8 0.4 0.1 0 2 0.1 0 0.7 2.3 0.1 5.3 4.1 0.1 1.7 0.6 1.2 0.2 0.2 5 0.2 0.6 0.2 1.6 0 0 0.6 28.6 0.2 0.2 6.8 3.4 0.9 5.4 0.1 0.1 0.7 0 0 0.6 0 0.1 1.7 2.7 0.1 0.1 0.4 3 0 0.5 0.8 1.8 0.6 1
----- 89
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
22:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, M
AL
AY
SIA
, 200
7-20
11
ASR
Wor
ld 0.1 0.7 1 0.4 0.1 0.1 2.2 0.2 0 0.8 2.6 0.2 6.1 4.8 0.2 2 0.8 1.5 0.2 0.2 6 0.2 0.6 0.3 1.9 0 0 0.6 31
.1 0.2 0.2 7.6 3.9 1 5.9 0.1 0.1 0.8 0 0 0.7 0 0.1 1.8 2.9 0.1 0.1 0.4 3.3 0 0.7 0.9 1.9 0.6 1.1 -----
99.3
102
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
816
513
012
2 42 22 959 35 14 258
429 69
1291
1536 45
1195 16
537
912
825
230
94 61 282 62 504 11 4
240 50 26
1163 27
3 14 316 3 4
781 3 61 612
312 22 61 226
1413 3
220
381
704
334
273
-----
1875
7
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 10 0 0 1 0 0 0 5 1 1 0 0 12 0 1 0 19 1 14 1 0 2 0 33 62 0 7 1 2 18 0 010
7 55 69 2---
--42
5
5-
-
9 0 0 0 1 0 0 2 0 1 0 0 0 1 0 0 0 0 0 1 1 0 0 12 0 3 0 0 5 0 1 0 4 0 3 0 0 0 0 5 33 1 1 1 4 31 0 0 59 25 53 3---
--25
1
10-
-
14 0 0 3 0 0 0 18 0 0 0 1 0 2 0 0 4 0 0 1 1 0 3 32 0 4 0 0 6 0 0 0 11 0 3 0 0 0 0 0 40 2 1 6 14 40 0 0 41 29 30 4---
--29
6
15-
-
19 0 1 0 1 0 1 25 0 0 0 2 0 5 0 0 2 0 0 2 0 1 4 56 2 9 0 0 16 0 0 2 23 2 2 0 0 1 0 0 34 9 0 8 30 44 0 0 26 48 25 7---
--38
8
20-
-
24 0 2 3 6 1 1 28 0 0 1 1 2 10 6 1 8 0 0 3 0 20 11 25 5 7 0 0 11 0 1 3 52 0 2 0 0 1 0 0 31 10 0 3 37 73 0 1 24 52 18 5---
--46
5
25-
-
29 0 6 5 8 1 1 43 0 0 2 5 1 20 14 0 14 1 5 1 0 21 7 27 1 10 0 0 18 1 0 2 62 1 3 0 0 3 0 0 18 21 1 2 24 55 0 1 20 46 18 8---
--49
7
30-
-
34 1 7 2 11 1 0 38 0 0 0 9 4 31 43 0 30 0 7 2 2 37 4 11 1 12 0 1 12 3 1 1 28 1 5 0 0 4 0 3 42 10 0 2 18 57 0 1 8 32 8 5---
--49
5
35-
-
39 0 4 8 14 1 0 66 0 1 4 21 0 49 51 2 43 5 6 8 2 76 6 12 3 13 0 1 7 1 1 1 25 0 9 0 1 8 0 1 36 17 0 6 19 70 0 7 9 42 12 9---
--67
7
40-
-
44 1 18 10 5 4 1 92 0 0 13 24 3 86 75 7 80 9 28 13 313
7 4 10 5 24 0 1 17 6 2 4 9 1 15 0 0 25 1 1 40 23 1 7 17 109 0 14 13 53 10 20 -----
1041
45-
-
49 1 25 10 12 4 513
6 3 0 21 48 911
412
8 311
5 11 43 17 19 239 3 11 4 43 1 0 28 4 0 10 13 1 34 1 0 49 0 1 50 32 1 8 13 129 0 29 10 55 7 35 -----
1535
50-
-
54 1 23 15 10 3 214
8 1 3 24 54 717
117
6 622
8 27 45 18 30 361 5 13 8 36 1 0 23 5 1 44 6 3 48 0 0 65 0 4 65 29 1 7 20 167 1 32 12 68 22 32 -----
2071
55-
-
59 1 18 13 12 4 011
5 6 2 33 48 15 206
205 3
198 27 51 13 45 397 1 13 10 56 2 0 27 10 5 80 5 1 51 0 0 77 2 2 60 43 2 3 8
163 0 43 13 54 13 32 -----
2188
60-
-
64 0 18 17 15 8 2 96 1 2 54 50 10 181
267 9
168 24 73 22 39 517 5 22 2 70 1 0 18 6 6
171 6 0 42 0 1
124 0 1 36 36 1 5 4
151 0 37 12 46 14 35 -----
2425
65-
-
69 1 12 16 6 2 2 71 6 2 31 64 713
523
0 511
8 22 53 9 35 460 3 14 9 75 1 1 17 3 3
229 5 1 40 0 1
131 0 2 29 31 3 2 6
139 1 27 12 39 10 18 -----
2139
70-
-
74 0 16 11 11 5 1 47 6 0 37 48 813
218
4 5 93 24 35 7 31 435 3 9 6 69 3 0 8 5 1
287 2 1 30 1 0
127 0 3 18 30 2 0 5 85 0 15 10 29 12 26 -----
1923
75+
2 15 17 10 8 5 34 12 3 38 54 314
815
7 4 84 15 33 10 44 393 2 10 5 72 2 0 15 6 3
329 3 1 15 0 1
164 0 5 18 18 1 0 5 82 1 13 5 31 13 32 -----
1941
% of
Total
0.00%
0.90%
0.70%
0.70%
0.20%
0.10%
5.10%
0.20%
0.10%
1.40%
2.30%
0.40%
6.90%
8.20%
0.20%
6.40%
0.90%
2.00%
0.70%
1.30%
16.50
%0.3
0%1.5
0%0.3
0%2.7
0%0.1
0%0.0
0%1.3
0%0.3
0%0.1
0%6.2
0%1.5
0%0.1
0%1.7
0%0.0
0%0.0
0%4.2
0%0.0
0%0.3
0%3.3
0%1.7
0%0.1
0%0.3
0%1.2
0%7.5
0%0.0
0%1.2
0%2.0
0%3.8
0%1.8
0%1.5
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
23:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
MA
LA
Y M
AL
ES,
MA
LA
YSI
A, 2
007-
2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
103
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages 17 16
311
210
1 24 840
1 28 10 149
312 37
1101
1104 26 47
715
527
3 64 3811
87 40 190 69 363 6 1
207
8225 46 38
1502 96
426
417
54 21 42 167 2 2
151 2 31 566
1023 21 24 16
497
8 517
825
962
623
423
6---
--24
188
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 9 0 1 3 0 1 0 7 0 2 0 0 11 0 0 0 0 0 0 5 0 0 17 0 0 1 0 14 30 0 5 0 0 17 0 0 83 46 58 4---
--31
6
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 2 11 0 2 0 0 9 0 0 0 0 0 0 8 0 0 0 0 0 0 0 3 46 0 3 0 0 10 0 0 33 18 24 4---
--17
4
10-
-
14 1 1 2 1 0 1 2 0 1 0 1 0 2 1 0 1 0 0 2 0 0 2 29 0 2 0 0 8 1 0 1 0 0 0 28 0 0 3 0 0 0 0 2 39 7 0 1 3 28 0 0 29 24 20 1---
--24
4
15-
-
19 0 0 3 6 1 0 12 0 0 0 4 0 5 0 0 6 0 0 1 0 0 1 31 0 9 0 0 20 3 0 0 0 0 0 61 0 1 4 0 0 1 0 1 22 34 1 2 24 29 0 0 24 38 12 2---
--35
8
20-
-
24 0 3 0 4 0 1 19 1 0 0 1 1 17 6 0 3 1 4 2 0 7 2 12 2 4 0 0 9 46 0 0 5 2 0 63 0 5 3 1 0 2 0 0 28 71 1 2 42 68 1 0 18 49 10 14 -----
530
25-
-
29 0 4 3 6 0 1 18 0 0 0 9 1 26 10 0 7 0 2 2 0 12 3 12 2 10 0 0 16 146 0 1 23 18 8 80 0 5 3 1 0 1 0 3 27 82 1 1 24 57 0 1 5 29 11 7
-----
678
30-
-
34 1 10 2 2 2 1 20 1 2 0 8 4 33 29 0 12 6 8 1 1 18 1 11 2 9 0 0 11 415 2 0 45 38 10 74 2 9 3 0 0 1 0 0 19 67 0 1 20 39 0 0 4 44 4 6
-----
998
35-
-
39 0 5 2 7 0 0 30 0 0 1 10 0 38 37 1 16 7 13 7 1 44 1 7 3 5 1 0 14 723 1 3
108 52 21 111 2 9 11 0 0 3 0 0 36 108 2 3 4 38 0 2 9 48 13 16 -----
1573
40-
-
44 0 20 6 7 0 0 34 3 0 6 23 4 65 73 3 24 1 17 2 2 62 2 18 8 23 0 0 2311
78 4 320
110
3 22 163 4 4 8 0 0 8 0 0 41 104 2 4 8 54 0 13 10 42 9 13 -----
2424
45-
-
49 0 22 5 11 2 0 61 2 0 6 29 211
4 99 2 40 11 17 1 211
5 2 11 6 25 0 0 1815
96 4 425
813
0 45 256 6 7 19 0 0 10 0 1 64 112 0 3 14 102 0 11 6 60 14 27 -----
3352
50-
-
54 2 21 10 11 2 1 54 1 1 21 41 714
113
4 2 59 14 26 3 315
3 3 8 5 23 1 0 1613
85 8 725
617
4 46 286 1 1 25 0 0 10 0 2 55 107 2 3 9
110 0 30 12 50 11 20 -----
3373
55-
-
59 2 18 7 7 4 0 59 4 1 20 36 515
616
4 3 72 31 48 14 416
1 4 11 7 30 3 0 1511
23 7 623
317
6 49 226 3 0 18 0 1 27 1 1 47 82 1 4 7
103 1 35 7 66 14 30 -----
3154
60-
-
64 0 13 17 13 1 1 41 5 1 18 41 114
814
2 5 65 23 45 4 615
9 7 6 8 37 0 0 10 708 3 1
163
127 27 135 0 1 22 0 0 17 1 1 40 79 2 0 2
113 2 28 6 43 10 29 -----
2377
65-
-
69 1 11 14 7 0 0 17 3 0 20 38 410
413
9 3 58 17 27 7 716
2 5 3 11 48 0 0 11 411 4 5 87 76 20 124 2 0 16 0 1 20 0 1 36 90 0 0 1 73 0 27 3 27 7 13 -----
1761
70-
-
74 5 13 19 11 5 0 24 4 1 26 34 413
014
8 0 54 18 38 6 613
8 3 8 5 57 0 1 728
5 8 3 72 37 13 84 0 0 10 0 0 20 0 1 23 42 0 0 2 71 0 22 5 19 6 26 -----
1514
75+
5 22 22 8 7 2 9 4 2 31 37 412
212
2 7 50 26 27 9 615
5 2 5 10 77 1 0 920
5 5 4 51 31 3 50 1 0 5 0 0 30 0 1 13 38 1 0 4 66 1 9 5 23 11 24 -----
1362
% of
Total
0.10%
0.70%
0.50%
0.40%
0.10%
0.00%
1.70%
0.10%
0.00%
0.60%
1.30%
0.20%
4.60%
4.60%
0.10%
2.00%
0.60%
1.10%
0.30%
0.20%
4.90%
0.20%
0.80%
0.30%
1.50%
0.00%
0.00%
0.90%
34.00
%0.2
0%0.2
0%6.2
0%4.0
0%1.1
0%7.3
0%0.1
0%0.2
0%0.7
0%0.0
0%0.0
0%0.6
0%0.0
0%0.1
0%2.3
0%4.2
0%0.1
0%0.1
0%0.7
0%4.0
0%0.0
0%0.7
0%1.1
0%2.6
0%1.0
0%1.0
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
24:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
MA
LA
Y F
EM
AL
ES,
MA
LA
YSI
A, 2
007-
2011
104
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
816
513
012
2 42 22 959 35 14 258
429 69
1291
1536 45
1195 16
537
912
825
230
94 61 282 62 504 11 4
240 50 26
1163 27
3 14 316 3 4
781 3 61 612
312 22 61 226
1413 3
220
381
704
334
273
-----
1875
7
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.1 0 0 0 0 0.3 0 0 0 0.5 0 0.4 0 0 0.1 0 0.9 1.7 0 0.2 0 0.1 0.5 0 0 2.9 1.5 1.9 0.1 ----- 11
5-
-
9 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0.1 0 0 0.1 0 0 0 0.1 0 0.1 0 0 0 0 0.1 0.8 0 0 0 0.1 0.8 0 0 1.5 0.6 1.4 0.1 ----- 6
10-
-
14 0 0 0.1 0 0 0 0.5 0 0 0 0 0 0.1 0 0 0.1 0 0 0 0 0 0.1 0.8 0 0.1 0 0 0.2 0 0 0 0.3 0 0.1 0 0 0 0 0 1 0.1 0 0.2 0.4 1 0 0 1.1 0.7 0.8 0.1 ----- 8
15-
-
19 0 0 0 0 0 0 0.7 0 0 0 0.1 0 0.1 0 0 0.1 0 0 0.1 0 0 0.1 1.5 0.1 0.2 0 0 0.4 0 0 0.1 0.6 0.1 0.1 0 0 0 0 0 0.9 0.2 0 0.2 0.8 1.2 0 0 0.7 1.3 0.7 0.2 ----- 10
20-
-
24 0 0.1 0.1 0.2 0 0 0.8 0 0 0 0 0.1 0.3 0.2 0 0.2 0 0 0.1 0 0.6 0.3 0.7 0.1 0.2 0 0 0.3 0 0 0.1 1.5 0 0.1 0 0 0 0 0 0.9 0.3 0 0.1 1.1 2.1 0 0 0.7 1.5 0.5 0.1 ----- 13
25-
-
29 0 0.2 0.2 0.3 0 0 1.4 0 0 0.1 0.2 0 0.7 0.5 0 0.5 0 0.2 0 0 0.7 0.2 0.9 0 0.3 0 0 0.6 0 0 0.1 2 0 0.1 0 0 0.1 0 0 0.6 0.7 0 0.1 0.8 1.8 0 0 0.7 1.5 0.6 0.3 ----- 16
30-
-
34 0 0.3 0.1 0.5 0 0 1.6 0 0 0 0.4 0.2 1.3 1.8 0 1.3 0 0.3 0.1 0.1 1.6 0.2 0.5 0 0.5 0 0 0.5 0.1 0 0 1.2 0 0.2 0 0 0.2 0 0.1 1.8 0.4 0 0.1 0.8 2.4 0 0 0.3 1.3 0.3 0.2 ----- 21
35-
-
39 0 0.2 0.4 0.6 0 0 3.1 0 0 0.2 1 0 2.3 2.4 0.1 2 0.2 0.3 0.4 0.1 3.5 0.3 0.6 0.1 0.6 0 0 0.3 0 0 0 1.2 0 0.4 0 0 0.4 0 0 1.7 0.8 0 0.3 0.9 3.2 0 0.3 0.4 1.9 0.6 0.4 ----- 31
40-
-
44 0 0.9 0.5 0.2 0.2 0 4.5 0 0 0.6 1.2 0.1 4.3 3.7 0.3 4 0.4 1.4 0.6 0.1 6.8 0.2 0.5 0.2 1.2 0 0 0.8 0.3 0.1 0.2 0.4 0 0.7 0 0 1.2 0 0 2 1.1 0 0.3 0.8 5.4 0 0.7 0.6 2.6 0.5 1---
-- 51
45-
-
49 0.1 1.3 0.5 0.6 0.2 0.3 7.2 0.2 0 1.1 2.6 0.5 6.1 6.8 0.2 6.1 0.6 2.3 0.9 112
.7 0.2 0.6 0.2 2.3 0.1 0 1.5 0.2 0 0.5 0.7 0.1 1.8 0.1 0 2.6 0 0.1 2.7 1.7 0.1 0.4 0.7 6.9 0 1.5 0.5 2.9 0.4 1.9 ----- 82
50-
-
54 0.1 1.5 1 0.6 0.2 0.1 9.4 0.1 0.2 1.5 3.4 0.4 10.9
11.2 0.4 14.5 1.7 2.9 1.1 1.9 23 0.3 0.8 0.5 2.3 0.1 0 1.5 0.3 0.1 2.8 0.4 0.2 3.1 0 0 4.1 0 0.3 4.1 1.8 0.1 0.4 1.3 10.6 0.1 2 0.8 4.3 1.4 2
-----
132
55-
-
59 0.1 1.5 1.1 1 0.3 0 9.3 0.5 0.2 2.7 3.9 1.2 16.7
16.6 0.2 16.1 2.2 4.1 1.1 3.7 32.2 0.1 1.1 0.8 4.5 0.2 0 2.2 0.8 0.4 6.5 0.4 0.1 4.1 0 0 6.2 0.2 0.2 4.9 3.5 0.2 0.2 0.6 13.2 0 3.5 1.1 4.4 1.1 2.6 -----
178
60-
-
64 0 2 1.9 1.7 0.9 0.2 10.8 0.1 0.2 6.1 5.6 1.1 20.3 30 1
18.9 2.7 8.2 2.5 4.4 58 0.6 2.5 0.2 7.9 0.1 0 2 0.7 0.7 19.2 0.7 0 4.7 0 0.1 13.9 0 0.1 4 4 0.1 0.6 0.4 16.9 0 4.2 1.3 5.2 1.6 3.9 -----
272
65-
-
69 0.2 2.1 2.8 1.1 0.4 0.4 12.5 1.1 0.4 5.5 11.3 1.2 23.8
40.6 0.9 20.8 3.9 9.3 1.6 6.2 81.1 0.5 2.5 1.6 13.2 0.2 0.2 3 0.5 0.5 40.4 0.9 0.2 7.1 0 0.2 23.1 0 0.4 5.1 5.5 0.5 0.4 1.1 24.5 0.2 4.8 2.1 6.9 1.8 3.2 -----
377
70-
-
74 0 3.8 2.6 2.6 1.2 0.2 11.1 1.4 0 8.7 11.3 1.9 31.2
43.5 1.2 22 5.7 8.3 1.7 7.3
102.7 0.7 2.1 1.4 16.3 0.7 0 1.9 1.2 0.2 67.8 0.5 0.2 7.1 0.2 0 30 0 0.7 4.3 7.1 0.5 0 1.2 20.1 0 3.5 2.4 6.8 2.8 6.1 -----
454
75+ 0.4 3.3 3.8 2.2 1.8 1.1 7.6 2.7 0.7 8.5 12 0.7 33 35 0.9 18
.7 3.3 7.4 2.2 9.8 87.5 0.4 2.2 1.1 16 0.4 0 3.3 1.3 0.7 73.3 0.7 0.2 3.3 0 0.2 36.5 0 1.1 4 4 0.2 0 1.1 18.3 0.2 2.9 1.1 6.9 2.9 7.1 -----
432
Crud
eRa
te 0 0.5 0.4 0.3 0.1 0.1 2.7 0.1 0 0.7 1.2 0.2 3.7 4.3 0.1 3.4 0.5 1.1 0.4 0.7 8.8 0.2 0.8 0.2 1.4 0 0 0.7 0.1 0.1 3.3 0.8 0 0.9 0 0 2.2 0 0.2 1.7 0.9 0.1 0.2 0.6 4 0 0.6 1.1 2 0.9 0.8 -----
53.1
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
25:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, M
AL
AY
MA
LE
S, M
AL
AY
SIA
, 200
7-20
11
ASR
Wor
ld 0 0.6 0.5 0.4 0.2 0.1 3.3 0.2 0.1 1.1 1.7 0.3 5 6.1 0.2 4.5 0.7 1.5 0.5 112
.6 0.2 0.9 0.2 2 0 0 0.8 0.2 0.1 5.3 0.8 0 1.2 0 0 3.3 0 0.2 1.9 1.1 0.1 0.2 0.6 5 0 0.8 1.1 2.3 1 1---
--70
.8
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
105
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages 17 16
311
210
1 24 840
1 28 10 149
312 37
1101
1104 26 47
715
527
3 64 3811
87 40 190 69 363 6 1
207
8225 46 38
1502 96
426
417
54 21 42 167 2 2
151 2 31 566
1023 21 24 16
497
8 517
825
962
623
423
6---
--24
188
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.1 0 0 0 0.2 0 0.1 0 0 0.3 0 0 0 0 0 0 0.1 0 0 0.5 0 0 0 0 0.4 0.9 0 0.1 0 0 0.5 0 0 2.4 1.3 1.6 0.1 ----- 9
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.3 0 0.1 0 0 0.2 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0.1 1.2 0 0.1 0 0 0.3 0 0 0.9 0.5 0.6 0.1 ----- 5
10-
-
14 0 0 0.1 0 0 0 0.1 0 0 0 0 0 0.1 0 0 0 0 0 0.1 0 0 0.1 0.8 0 0.1 0 0 0.2 0 0 0 0 0 0 0.8 0 0 0.1 0 0 0 0 0.1 1.1 0.2 0 0 0.1 0.8 0 0 0.8 0.7 0.5 0---
-- 7
15-
-
19 0 0 0.1 0.2 0 0 0.3 0 0 0 0.1 0 0.1 0 0 0.2 0 0 0 0 0 0 0.8 0 0.2 0 0 0.5 0.1 0 0 0 0 0 1.7 0 0 0.1 0 0 0 0 0 0.6 0.9 0 0.1 0.7 0.8 0 0 0.7 1 0.3 0.1 ----- 10
20-
-
24 0 0.1 0 0.1 0 0 0.6 0 0 0 0 0 0.5 0.2 0 0.1 0 0.1 0.1 0 0.2 0.1 0.4 0.1 0.1 0 0 0.3 1.3 0 0 0.1 0.1 0 1.8 0 0.1 0.1 0 0 0.1 0 0 0.8 2.1 0 0.1 1.2 2 0 0 0.5 1.4 0.3 0.4 ----- 16
25-
-
29 0 0.1 0.1 0.2 0 0 0.6 0 0 0 0.3 0 0.9 0.3 0 0.2 0 0.1 0.1 0 0.4 0.1 0.4 0.1 0.3 0 0 0.5 4.9 0 0 0.8 0.6 0.3 2.7 0 0.2 0.1 0 0 0 0 0.1 0.9 2.7 0 0 0.8 1.9 0 0 0.2 1 0.4 0.2 ----- 23
30-
-
34 0 0.4 0.1 0.1 0.1 0 0.9 0 0.1 0 0.3 0.2 1.4 1.3 0 0.5 0.3 0.3 0 0 0.8 0 0.5 0.1 0.4 0 0 0.5 17.9 0.1 0 1.9 1.6 0.4 3.2 0.1 0.4 0.1 0 0 0 0 0 0.8 2.9 0 0 0.9 1.7 0 0 0.2 1.9 0.2 0.3 ----- 43
35-
-
39 0 0.2 0.1 0.3 0 0 1.4 0 0 0 0.5 0 1.7 1.7 0 0.7 0.3 0.6 0.3 0 2 0 0.3 0.1 0.2 0 0 0.6 33.1 0 0.1 4.9 2.4 1 5.1 0.1 0.4 0.5 0 0 0.1 0 0 1.6 4.9 0.1 0.1 0.2 1.7 0 0.1 0.4 2.2 0.6 0.7 ----- 72
40-
-
44 0 1 0.3 0.3 0 0 1.6 0.1 0 0.3 1.1 0.2 3.1 3.5 0.1 1.2 0 0.8 0.1 0.1 3 0.1 0.9 0.4 1.1 0 0 1.1 56.8 0.2 0.1 9.7 5 1.1 7.9 0.2 0.2 0.4 0 0 0.4 0 0 2 5 0.1 0.2 0.4 2.6 0 0.6 0.5 2 0.4 0.6 -----
117
45-
-
49 0 1.2 0.3 0.6 0.1 0 3.3 0.1 0 0.3 1.6 0.1 6.2 5.3 0.1 2.2 0.6 0.9 0.1 0.1 6.2 0.1 0.6 0.3 1.4 0 0 186
.2 0.2 0.2 13.9 7 2.4 13.8 0.3 0.4 1 0 0 0.5 0 0.1 3.5 6.1 0 0.2 0.8 5.5 0 0.6 0.3 3.2 0.8 1.5 -----
181
50-
-
54 0.1 1.3 0.6 0.7 0.1 0.1 3.4 0.1 0.1 1.3 2.6 0.4 8.9 8.5 0.1 3.7 0.9 1.6 0.2 0.2 9.7 0.2 0.5 0.3 1.5 0.1 0 187
.4 0.5 0.4 16.1 11 2.9 18 0.1 0.1 1.6 0 0 0.6 0 0.1 3.5 6.7 0.1 0.2 0.6 6.9 0 1.9 0.8 3.2 0.7 1.3 -----
213
55-
-
59 0.2 1.5 0.6 0.6 0.3 0 4.8 0.3 0.1 1.6 2.9 0.4 12.7
13.3 0.2 5.8 2.5 3.9 1.1 0.3 13.1 0.3 0.9 0.6 2.4 0.2 0 1.2 91.1 0.6 0.5 18.9
14.3 4
18.3 0.2 0 1.5 0 0.1 2.2 0.1 0.1 3.8 6.7 0.1 0.3 0.6 8.4 0.1 2.8 0.6 5.4 1.1 2.4 -----
256
60-
-
64 0 1.4 1.9 1.4 0.1 0.1 4.5 0.6 0.1 2 4.5 0.1 16.3
15.6 0.6 7.2 2.5 5 0.4 0.7 17.5 0.8 0.7 0.9 4.1 0 0 1.1 78 0.3 0.1 18 14 3
14.9 0 0.1 2.4 0 0 1.9 0.1 0.1 4.4 8.7 0.2 0 0.2 12.5 0.2 3.1 0.7 4.7 1.1 3.2 -----
262
65-
-
69 0.2 1.8 2.3 1.2 0 0 2.8 0.5 0 3.3 6.3 0.7 17.2 23 0.5 9.6 2.8 4.5 1.2 1.2 26.8 0.8 0.5 1.8 7.9 0 0 1.8 68.1 0.7 0.8 14.4
12.6 3.3 20.5 0.3 0 2.6 0 0.2 3.3 0 0.2 6
14.9 0 0 0.2 12.1 0 4.5 0.5 4.5 1.2 2.2 -----
292
70-
-
74 1 2.7 3.9 2.3 1 0 5 0.8 0.2 5.4 7 0.8 26.9
30.6 0
11.2 3.7 7.9 1.2 1.2 28.5 0.6 1.7 1
11.8 0 0.2 1.4 58.9 1.7 0.6 14.9 7.6 2.7 17.4 0 0 2.1 0 0 4.1 0 0.2 4.8 8.7 0 0 0.4 14.7 0 4.5 1 3.9 1.2 5.4 -----
313
75+ 0.9 3.8 3.8 1.4 1.2 0.3 1.5 0.7 0.3 5.3 6.4 0.7 21 21 1.2 8.6 4.5 4.6 1.5 1
26.7 0.3 0.9 1.7 13.2 0.2 0 1.5 35.3 0.9 0.7 8.8 5.3 0.5 8.6 0.2 0 0.9 0 0 5.2 0 0.2 2.2 6.5 0.2 0 0.7 11.4 0.2 1.5 0.9 4 1.9 4.1 -----
234
Crud
eRa
te
0 0.5 0.3 0.3 0.1 0 1.2 0.1 0 0.4 0.9 0.1 3.2 3.2 0.1 1.4 0.4 0.8 0.2 0.1 3.4 0.1 0.5 0.2 1 0 0 0.6 23.6 0.1 0.1 4.3 2.8 0.8 5 0.1 0.1 0.5 0 0 0.4 0 0.1 1.6 2.9 0.1 0.1 0.5 2.8 0 0.5 0.7 1.8 0.7 0.7 -----
69.5
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
26:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, M
AL
AY
FE
MA
LE
S, M
AL
AY
SIA
, 200
7-20
11
ASR
Wor
ld 0.1 0.6 0.4 0.3 0.1 0 1.3 0.1 0 0.6 1.1 0.1 4 4.1 0.1 1.7 0.6 1 0.2 0.1 4.4 0.1 0.5 0.2 1.3 0 0 0.6 27.2 0.2 0.1 5.1 3.3 0.9 5.8 0.1 0.1 0.6 0 0 0.6 0 0.1 1.8 3.3 0.1 0.1 0.4 3.3 0 0.7 0.8 2 0.7 0.8 -----
81.9
106
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages 10 17
111
0 98 46 3021
04 74 11 305
1001 62
2033
1764 28
1416 17
751
611
643
133
90 73 128 53 687 7 6
126 64 39
1589 12
6 15 498 10 14 510 14 23 368
142 12 31 78 830 2
102
204
383 70 327
-----
2042
4
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 6 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 8 0 6 0 0 0 0 8 12 0 2 0 0 4 0 0 42 8 15 1---
--11
6
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 1 1 0 0 2 0 1 0 0 2 0 0 0 3 0 1 0 0 0 0 0 12 1 1 0 1 2 0 0 20 8 4 1---
-- 64
10-
-
14 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 3 0 0 2 0 0 0 17 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 18 0 0 0 0 9 0 0 19 13 4 1---
-- 90
15-
-
19 0 0 1 0 1 0 13 0 0 0 0 0 0 1 0 1 0 0 0 0 1 2 13 1 1 0 0 4 0 0 0 8 1 0 0 0 2 0 0 18 0 1 1 8 13 0 0 13 15 5 3---
--12
7
20-
-
24 0 2 0 7 0 0 9 0 0 2 0 0 6 2 0 2 0 0 1 1 6 4 11 0 2 0 1 2 0 1 0 11 0 0 0 0 1 0 0 9 5 0 2 8 24 0 0 11 25 2 3---
--16
0
25-
-
29 0 2 1 1 1 0 25 0 0 0 10 2 6 5 0 3 1 0 0 1 11 5 5 0 5 0 1 3 0 0 0 14 1 2 0 0 1 0 0 14 4 0 0 8 17 0 3 11 22 3 4---
--19
2
30-
-
34 0 7 1 2 0 011
1 0 0 3 9 1 13 12 1 13 1 2 0 2 22 2 4 0 9 0 0 5 1 0 0 18 0 8 0 0 5 0 0 19 3 0 1 3 23 0 0 11 20 1 2---
--33
5
35-
-
39 0 8 3 4 3 018
5 0 0 1 15 1 44 20 0 25 3 11 6 4 33 2 7 0 7 0 1 10 2 3 0 21 0 12 0 0 8 0 2 22 9 0 1 3 44 0 1 4 25 1 14 -----
565
40-
-
44 1 10 5 7 3 026
4 2 0 7 27 2 68 48 1 67 5 12 10 10 81 5 11 3 19 1 2 12 3 1 8 11 0 33 0 0 15 0 0 21 13 0 2 5 46 0 2 8 32 3 10 -----
896
45-
-
49 1 16 8 12 3 232
5 2 1 20 43 911
211
2 110
9 11 33 12 21 161 6 5 4 29 0 1 9 6 0 11 7 0 46 2 0 12 1 0 25 19 0 3 6 65 0 8 6 28 2 14 -----
1329
50-
-
54 1 18 11 10 4 233
9 6 1 22 73 417
515
8 215
6 14 51 23 42 280 8 7 6 38 2 0 12 9 3 38 11 0 51 0 0 28 0 1 33 15 2 5 6 67 0 5 8 28 3 25 -----
1803
55-
-
59 1 29 12 11 7 129
9 8 2 43 98 11 260
241 5
238 29 75 10 47 403 14 12 10 70 0 0 14 3 6
118 2 3 69 2 0 50 1 1 37 18 2 8 8
108 0 21 19 40 2 42 -----
2510
60-
-
64 0 23 20 12 8 521
5 15 4 45 141 9
293
300 5
259 30 92 20 92 537 7 8 9 95 1 0 14 13 7
240 3 3 89 0 3 73 5 0 41 15 1 1 3
121 0 20 11 30 3 46 -----
2987
65-
-
69 2 20 15 13 4 317
6 15 0 51 153 11 327
330 4
195 29 99 8 97 645 9 9 13 113 2 0 17 10 7
368 3 3 75 3 7 84 3 2 32 19 1 4 6
130 0 14 9 39 9 65 -----
3253
70-
-
74 2 19 11 12 9 9 95 17 1 44 178 10 334
248 5
177 25 68 8 57 583 3 6 2
107 0 0 10 7 4
376 1 2 65 1 3 99 1 4 29 9 1 1 9 76 0 15 7 26 5 40 -----
2821
75+
2 17 22 7 3 8 46 9 2 67 254 2
394
287 4
159 29 73 15 56 627 6 10 5
191 1 0 9 10 7
430 4 2 41 2 1
132 3 5 26 12 1 2 4 81 2 13 5 24 8 56 -----
3176
% of
Total 0.0
0%0.8
0%0.5
0%0.5
0%0.2
0%0.1
0%10
.30%
0.40%
0.10%
1.50%
4.90%
0.30%
10.00
%8.6
0%0.1
0%6.9
0%0.9
0%2.5
0%0.6
0%2.1
0%16
.60%
0.40%
0.60%
0.30%
3.40%
0.00%
0.00%
0.60%
0.30%
0.20%
7.80%
0.60%
0.10%
2.40%
0.00%
0.10%
2.50%
0.10%
0.10%
1.80%
0.70%
0.10%
0.20%
0.40%
4.10%
0.00%
0.50%
1.00%
1.90%
0.30%
1.60% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
27:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
CH
INE
SE M
AL
ES,
MA
LA
YSI
A, 2
007-
2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
107
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
7 99 66 71 24 861
1 10 3 82 725 32
1837
1151 35 41
117
140
0 52 4114
86 49 105 55 446 8 1
104
7333 52 52
1732 85
319
911
07 12 521
4 5 918
5 4 16 305
371 14 18 70 569 1 98 133
314 80 273
-----
2211
4
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 4 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 2 0 0 2 0 0 0 0 1 21 0 3 0 0 3 0 0 25 9 10 2---
-- 85
5-
-
9 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 2 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 14 1 1 0 1 6 0 0 23 4 5 1---
-- 63
10-
-
14 0 0 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 8 0 1 0 0 3 0 0 0 0 0 0 5 0 0 1 0 0 1 0 0 11 5 0 0 1 11 0 0 12 11 7 0---
-- 82
15-
-
19 0 0 1 3 0 0 5 0 0 0 2 0 0 0 0 0 0 0 1 0 0 0 5 1 1 0 0 6 0 0 0 0 0 0 17 0 0 0 0 0 0 0 0 10 12 0 1 11 19 0 0 8 12 6 1---
--12
2
20-
-
24 0 0 1 2 0 0 14 0 0 0 4 0 6 3 0 1 0 1 0 0 1 2 4 2 2 0 0 6 13 0 0 5 0 2 23 0 1 2 0 0 0 0 0 10 12 0 0 7 15 0 0 4 9 1 4---
--15
7
25-
-
29 0 4 0 5 0 0 13 0 0 0 6 0 10 6 0 3 1 4 1 0 8 0 1 1 1 0 0 4 61 0 0 18 7 0 28 0 1 0 0 0 0 0 0 5 29 0 0 13 20 0 0 3 25 2 3---
--28
3
30-
-
34 0 5 0 2 0 0 21 0 0 0 12 2 17 9 0 2 2 4 2 1 11 3 7 3 9 0 0 420
0 0 0 45 9 7 37 0 0 3 0 0 2 0 0 12 30 0 0 7 18 0 0 6 14 2 8---
--51
6
35-
-
39 0 6 2 5 1 1 42 0 0 0 16 0 47 19 0 11 1 5 4 3 23 2 3 6 10 0 0 842
5 0 011
1 27 9 52 0 2 7 0 0 4 0 1 19 26 0 2 3 37 0 3 5 30 3 4---
--98
5
40-
-
44 0 7 2 10 3 0 87 0 0 1 29 1 57 33 2 14 4 13 5 0 62 1 7 5 12 0 0 282
6 2 113
5 53 17 99 0 1 7 0 0 2 0 2 25 40 2 0 4 32 0 6 6 20 3 13 -----
1653
45-
-
49 1 5 2 7 2 1 90 0 0 5 47 2 93 68 0 19 8 16 4 310
3 5 6 2 12 0 1 1612
24 3 524
310
0 33 170 5 0 17 0 0 11 0 2 27 42 0 2 3 31 0 4 8 34 3 16 -----
2501
50-
-
54 1 15 5 4 3 0 92 2 2 2 52 713
710
4 5 26 11 38 9 312
7 4 7 4 25 1 0 811
83 7 223
814
7 42 171 2 0 23 1 2 13 2 2 31 46 3 4 4 58 1 6 6 36 6 27 -----
2757
55-
-
59 0 10 5 9 4 1 88 0 0 8 80 525
314
2 2 47 27 48 5 417
7 5 10 4 34 0 0 911
38 6 823
417
6 25 162 0 0 26 0 0 17 0 0 26 42 1 2 2 76 0 17 8 23 3 35 -----
3004
60-
-
64 0 15 11 4 3 1 63 1 1 9 93 324
215
4 5 55 20 70 4 621
5 6 15 5 40 2 0 884
2 6 719
512
9 23 128 0 0 33 1 0 26 2 3 24 25 0 3 4 48 0 19 6 27 6 34 -----
2642
65-
-
69 0 8 10 5 3 0 42 0 0 14 97 224
717
2 5 59 22 63 5 824
5 7 11 7 61 2 0 12 608 5 7
169 84 11 88 3 0 19 1 4 26 0 2 37 24 2 3 3 68 0 9 6 11 8 27 -----
2332
70-
-
74 1 9 10 8 2 2 26 2 0 9 90 127
418
8 6 63 36 52 2 420
6 5 7 7 67 2 0 840
5 7 11 188 61 18 59 1 0 29 1 1 29 0 1 18 13 1 1 3 62 0 21 2 26 6 32 -----
2083
75+
4 15 15 4 3 2 27 5 0 34 197 9
454
252 10 107 39 86 10 8
308 8 13 8
169 1 0 10 408 16 10 151 60 12 65 1 0 44 1 2 54 0 2 15 24 1 0 4 65 0 13 5 23 9 66 -----
2849
% of
Total
0.00%
0.40%
0.30%
0.30%
0.10%
0.00%
2.80%
0.00%
0.00%
0.40%
3.30%
0.10%
8.30%
5.20%
0.20%
1.90%
0.80%
1.80%
0.20%
0.20%
6.70%
0.20%
0.50%
0.20%
2.00%
0.00%
0.00%
0.50%
33.20
%0.2
0%0.2
0%7.8
0%3.9
0%0.9
0%5.0
0%0.1
0%0.0
0%1.0
0%0.0
0%0.0
0%0.8
0%0.0
0%0.1
0%1.4
0%1.7
0%0.1
0%0.1
0%0.3
0%2.6
0%0.0
0%0.4
0%0.6
0%1.4
0%0.4
0%1.2
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
28:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
CH
INE
SE F
EM
AL
ES,
MA
LA
YSI
A, 2
007-
2011
108
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages 10 17
111
0 98 46 3021
04 74 11 305
1001 62
2033
1764 28
1416 17
751
611
643
133
90 73 128 53 687 7 6
126 64 39
1589 12
6 15 498 10 14 510 14 23 368
142 12 31 78 830 2
102
204
383 70 327
-----
2042
4
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0.1 0 0 0 0 0.2 0 0 0 0.7 0 0.5 0 0 0 0 0.7 1.1 0 0.2 0 0 0.4 0 0 3.7 0.7 1.3 0.1 ----- 10
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.1 0.1 0 0 0.2 0 0.1 0 0 0.2 0 0 0 0.2 0 0.1 0 0 0 0 0 0.9 0.1 0.1 0 0.1 0.2 0 0 1.5 0.6 0.3 0.1 ----- 5
10-
-
14 0 0 0 0 0 0 0.1 0 0 0 0 0 0.1 0 0 0.2 0 0 0.1 0 0 0 1.2 0 0 0 0 0.1 0 0 0 0.1 0 0 0 0 0 0 0 1.3 0 0 0 0 0.7 0 0 1.4 1 0.3 0.1 ----- 7
15-
-
19 0 0 0.1 0 0.1 0 0.9 0 0 0 0 0 0 0.1 0 0.1 0 0 0 0 0.1 0.1 0.9 0.1 0.1 0 0 0.3 0 0 0 0.6 0.1 0 0 0 0.1 0 0 1.3 0 0.1 0.1 0.6 0.9 0 0 0.9 1.1 0.4 0.2 ----- 9
20-
-
24 0 0.1 0 0.5 0 0 0.7 0 0 0.1 0 0 0.4 0.1 0 0.1 0 0 0.1 0.1 0.4 0.3 0.8 0 0.1 0 0.1 0.1 0 0.1 0 0.8 0 0 0 0 0.1 0 0 0.7 0.4 0 0.1 0.6 1.8 0 0 0.8 1.9 0.1 0.2 ----- 12
25-
-
29 0 0.2 0.1 0.1 0.1 0 1.9 0 0 0 0.8 0.2 0.5 0.4 0 0.2 0.1 0 0 0.1 0.8 0.4 0.4 0 0.4 0 0.1 0.2 0 0 0 1.1 0.1 0.2 0 0 0.1 0 0 1.1 0.3 0 0 0.6 1.3 0 0.2 0.8 1.7 0.2 0.3 ----- 14
30-
-
34 0 0.6 0.1 0.2 0 0 8.9 0 0 0.2 0.7 0.1 1 1 0.1 1 0.1 0.2 0 0.2 1.8 0.2 0.3 0 0.7 0 0 0.4 0.1 0 0 1.4 0 0.6 0 0 0.4 0 0 1.5 0.2 0 0.1 0.2 1.9 0 0 0.9 1.6 0.1 0.2 ----- 27
35-
-
39 0 0.7 0.2 0.3 0.2 015
.4 0 0 0.1 1.2 0.1 3.7 1.7 0 2.1 0.2 0.9 0.5 0.3 2.7 0.2 0.6 0 0.6 0 0.1 0.8 0.2 0.2 0 1.7 0 1 0 0 0.7 0 0.2 1.8 0.7 0 0.1 0.2 3.7 0 0.1 0.3 2.1 0.1 1.2 ----- 47
40-
-
44 0.1 0.9 0.4 0.6 0.3 022
.5 0.2 0 0.6 2.3 0.2 5.8 4.1 0.1 5.7 0.4 1 0.9 0.9 6.9 0.4 0.9 0.3 1.6 0.1 0.2 1 0.3 0.1 0.7 0.9 0 2.8 0 0 1.3 0 0 1.8 1.1 0 0.2 0.4 3.9 0 0.2 0.7 2.7 0.3 0.9 ----- 76
45-
-
49 0.1 1.4 0.7 1 0.3 0.2 28.2 0.2 0.1 1.7 3.7 0.8 9.7 9.7 0.1 9.5 1 2.9 1 1.8 14 0.5 0.4 0.3 2.5 0 0.1 0.8 0.5 0 1 0.6 0 4 0.2 0 1 0.1 0 2.2 1.6 0 0.3 0.5 5.6 0 0.7 0.5 2.4 0.2 1.2 -----
115
50-
-
54 0.1 1.8 1.1 1 0.4 0.2 33.1 0.6 0.1 2.2 7.1 0.4 17.1
15.4 0.2 15.3 1.4 5 2.2 4.1 27.4 0.8 0.7 0.6 3.7 0.2 0 1.2 0.9 0.3 3.7 1.1 0 5 0 0 2.7 0 0.1 3.2 1.5 0.2 0.5 0.6 6.6 0 0.5 0.8 2.7 0.3 2.4 -----
176
55-
-
59 0.1 3.4 1.4 1.3 0.8 0.1 35 0.9 0.2 511
.5 1.3 30.4
28.2 0.6 27.9 3.4 8.8 1.2 5.5 47.2 1.6 1.4 1.2 8.2 0 0 1.6 0.4 0.7 13.8 0.2 0.4 8.1 0.2 0 5.9 0.1 0.1 4.3 2.1 0.2 0.9 0.9 12.6 0 2.5 2.2 4.7 0.2 4.9 -----
294
60-
-
64 0 3.3 2.9 1.7 1.2 0.7 31 2.2 0.6 6.5 20.3 1.3 42.2
43.2 0.7 37.3 4.3 13.3 2.9 13.3
77.4 1 1.2 1.3 13.7 0.1 0 2 1.9 1
34.6 0.4 0.4 12.8 0 0.4 10.5 0.7 0 5.9 2.2 0.1 0.1 0.4 17.4 0 2.9 1.6 4.3 0.4 6.6 -----
430
65-
-
69 0.4 4.1 3.1 2.7 0.8 0.6 36.3 3.1 0
10.5
31.6 2.3 67.5
68.1 0.8 40.3 6
20.4 1.7 20
133.1 1.9 1.9 2.7 23.3 0.4 0 3.5 2.1 1.4 76 0.6 0.6 15.5 0.6 1.4 17.3 0.6 0.4 6.6 3.9 0.2 0.8 1.2 26.8 0 2.9 1.9 8.1 1.9 13.4 -----
672
70-
-
74 0.6 5.2 3 3.3 2.5 2.5 26.2 4.7 0.3 12.1 49 2.8 92 68.3 1.4 48.8 6.9 18.7 2.2 15.7
160.6 0.8 1.7 0.6 29.5 0 0 2.8 1.9 1.1
103.6 0.3 0.6 17.9 0.3 0.8 27.3 0.3 1.1 8 2.5 0.3 0.3 2.5 20.9 0 4.1 1.9 7.2 1.4 11 -----
777
75+ 0.6 4.9 6.3 2 0.9 2.3 13
.3 2.6 0.6 19.3
73.2 0.6
113.6 82.7 1.2 45.8 8.4 21 4.3 16.1
180.7 1.7 2.9 1.4 55.1 0.3 0 2.6 2.9 2
123.9 1.2 0.6 11
.8 0.6 0.3 38 0.9 1.4 7.5 3.5 0.3 0.6 1.2 23.3 0.6 3.7 1.4 6.9 2.3 16.1 -----
915
Crud
eRa
te 0.1 1 0.7 0.6 0.3 0.2 12.8 0.5 0.1 1.9 6.1 0.4 12.4
10.7 0.2 8.6 1.1 3.1 0.7 2.6 20.7 0.4 0.8 0.3 4.2 0 0 0.8 0.4 0.2 9.7 0.8 0.1 3 0.1 0.1 3.1 0.1 0.1 2.2 0.9 0.1 0.2 0.5 5.1 0 0.6 1.2 2.3 0.4 2
-----
124.4
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
29:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, C
HIN
ESE
MA
LE
S, M
AL
AY
SIA
, 200
7-20
11
ASR
Wor
ld 0.1 0.9 0.6 0.5 0.2 0.2 11 0.4 0.1 1.7 5.6 0.3 11.2 9.7 0.2 7.7 1 2.8 0.6 2.4 18.8 0.4 0.7 0.3 3.8 0 0 0.7 0.4 0.2 9 0.7 0.1 2.7 0.1 0.1 2.8 0.1 0.2 2.1 0.8 0.1 0.2 0.4 4.6 0 0.6 1.4 2.2 0.5 1.8 -----
113
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
109
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
7 99 66 71 24 861
1 10 3 82 725 32
1837
1151 35 41
117
140
0 52 4114
86 49 105 55 446 8 1
104
7333 52 52
1732 85
319
911
07 12 521
4 5 918
5 4 16 305
371 14 18 70 569 1 98 133
314 80 273
-----
2211
4
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.4 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0.2 0 0 0.2 0 0 0 0 0.1 2 0 0.3 0 0 0.3 0 0 2.3 0.8 0.9 0.2 ----- 8
5-
-
9 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.1 0 0.2 0 0 0 0 0 0 0 0 0 0.1 0 0 0.1 0 0 0 0 0 1.1 0.1 0.1 0 0.1 0.5 0 0 1.9 0.3 0.4 0.1 ----- 5
10-
-
14 0 0 0.1 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0.6 0 0.1 0 0 0.2 0 0 0 0 0 0 0.4 0 0 0.1 0 0 0.1 0 0 0.9 0.4 0 0 0.1 0.9 0 0 0.9 0.9 0.5 0---
-- 6
15-
-
19 0 0 0.1 0.2 0 0 0.4 0 0 0 0.2 0 0 0 0 0 0 0 0.1 0 0 0 0.4 0.1 0.1 0 0 0.5 0 0 0 0 0 0 1.3 0 0 0 0 0 0 0 0 0.8 0.9 0 0.1 0.8 1.4 0 0 0.6 0.9 0.5 0.1 ----- 9
20-
-
24 0 0 0.1 0.2 0 0 1.1 0 0 0 0.3 0 0.5 0.2 0 0.1 0 0.1 0 0 0.1 0.2 0.3 0.2 0.2 0 0 0.5 1 0 0 0.4 0 0.2 1.7 0 0.1 0.2 0 0 0 0 0 0.8 0.9 0 0 0.5 1.1 0 0 0.3 0.7 0.1 0.3 ----- 12
25-
-
29 0 0.3 0 0.4 0 0 1 0 0 0 0.5 0 0.8 0.5 0 0.2 0.1 0.3 0.1 0 0.6 0 0.1 0.1 0.1 0 0 0.3 4.8 0 0 1.4 0.5 0 2.2 0 0.1 0 0 0 0 0 0 0.4 2.3 0 0 1 1.6 0 0 0.2 2 0.2 0.2 ----- 22
30-
-
34 0 0.4 0 0.2 0 0 1.8 0 0 0 1.1 0.2 1.5 0.8 0 0.2 0.2 0.4 0.2 0.1 1 0.3 0.6 0.3 0.8 0 0 0.4 17.6 0 0 4 0.8 0.6 3.3 0 0 0.3 0 0 0.2 0 0 1.1 2.6 0 0 0.6 1.6 0 0 0.5 1.2 0.2 0.7 ----- 45
35-
-
39 0 0.5 0.2 0.4 0.1 0.1 3.7 0 0 0 1.4 0 4.2 1.7 0 1 0.1 0.4 0.4 0.3 2 0.2 0.3 0.5 0.9 0 0 0.7 37.6 0 0 9.8 2.4 0.8 4.6 0 0.2 0.6 0 0 0.4 0 0.1 1.7 2.3 0 0.2 0.3 3.3 0 0.3 0.4 2.7 0.3 0.4 ----- 87
40-
-
44 0 0.6 0.2 0.9 0.3 0 7.7 0 0 0.1 2.6 0.1 5 2.9 0.2 1.2 0.4 1.2 0.4 0 5.5 0.1 0.6 0.4 1.1 0 0 0.2 73.1 0.2 0.1 11.9 4.7 1.5 8.8 0 0.1 0.6 0 0 0.2 0 0.2 2.2 3.5 0.2 0 0.4 2.8 0 0.5 0.5 1.8 0.3 1.2 -----
146
45-
-
49 0.1 0.5 0.2 0.7 0.2 0.1 8.8 0 0 0.5 4.6 0.2 9.1 6.7 0 1.9 0.8 1.6 0.4 0.3 10.1 0.5 0.6 0.2 1.2 0 0.1 1.6 120 0.3 0.5 23.8 9.8 3.2 16.7 0.5 0 1.7 0 0 1.1 0 0.2 2.6 4.1 0 0.2 0.3 3 0 0.4 0.8 3.3 0.3 1.6 -----
245
50-
-
54 0.1 1.6 0.5 0.4 0.3 0 10 0.2 0.2 0.2 5.7 0.8 14.9
11.3 0.5 2.8 1.2 4.1 1 0.3 13.8 0.4 0.8 0.4 2.7 0.1 0 0.9
128.6 0.8 0.2 25
.9 16 4.6 18.6 0.2 0 2.5 0.1 0.2 1.4 0.2 0.2 3.4 5 0.3 0.4 0.4 6.3 0.1 0.7 0.7 3.9 0.7 2.9 -----
300
55-
-
59 0 1.3 0.6 1.2 0.5 0.1 11.3 0 0 1
10.3 0.6 32.6
18.3 0.3 6.1 3.5 6.2 0.6 0.5 22.8 0.6 1.3 0.5 4.4 0 0 1.2
146.7 0.8 1
30.2
22.7 3.2 20.9 0 0 3.4 0 0 2.2 0 0 3.4 5.4 0.1 0.3 0.3 9.8 0 2.2 1 3 0.4 4.5 -----
387
60-
-
64 0 2.4 1.7 0.6 0.5 0.2 10 0.2 0.2 1.4 14.7 0.5 38.3
24.4 0.8 8.7 3.2 11.1 0.6 1
34.1 1 2.4 0.8 6.3 0.3 0 1.3
133.4 1 1.1 30.9
20.4 3.6 20.3 0 0 5.2 0.2 0 4.1 0.3 0.5 3.8 4 0 0.5 0.6 7.6 0 3 1 4.3 1 5.4 -----
418
65-
-
69 0 1.8 2.3 1.2 0.7 0 9.7 0 0 3.2 22.4 0.5 56.9
39.6 1.2 13.6 5.1 14.5 1.2 1.8 56.5 1.6 2.5 1.6 14.1 0.5 0 2.8
140.1 1.2 1.6 38.9
19.4 2.5 20.3 0.7 0 4.4 0.2 0.9 6 0 0.5 8.5 5.5 0.5 0.7 0.7 15.7 0 2.1 1.4 2.5 1.8 6.2 -----
537
70-
-
74 0.3 2.6 2.9 2.3 0.6 0.6 7.6 0.6 0 2.6 26.4 0.3 80.2
55.1 1.8 18.5
10.5
15.2 0.6 1.2 60.3 1.5 2.1 2.1 19.6 0.6 0 2.3
118.6 2.1 3.2 55.1
17.9 5.3 17.3 0.3 0 8.5 0.3 0.3 8.5 0 0.3 5.3 3.8 0.3 0.3 0.9 18.2 0 6.2 0.6 7.6 1.8 9.4 -----
610
75+
1 3.6 3.6 1 0.7 0.5 6.5 1.2 0 8.1 47.2 2.2
108.8 60
.4 2.4 25.6 9.3 20.6 2.4 1.9 73.8 1.9 3.1 1.9 40.5 0.2 0 2.4 97.7 3.8 2.4 36.2
14.4 2.9 15.6 0.2 0
10.5 0.2 0.5 12.9 0 0.5 3.6 5.7 0.2 0 1
15.6 0 3.1 1.2 5.5 2.2 15.8 -----
682
Crud
eRa
te
0 0.6 0.4 0.5 0.2 0.1 4 0.1 0 0.5 4.7 0.2 11.9 7.5 0.2 2.7 1.1 2.6 0.3 0.3 9.6 0.3 0.7 0.4 2.9 0.1 0 0.7 47.5 0.3 0.3 11.2 5.5 1.3 7.2 0.1 0 1.4 0 0.1 1.2 0 0.1 2 2.4 0.1 0.1 0.5 3.7 0 0.6 0.9 2 0.5 1.8 -----
143.2
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
30:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, C
HIN
ESE
FE
MA
LE
S, M
AL
AY
SIA
, 200
7-20
11
ASR
Wor
ld 0 0.6 0.4 0.4 0.1 0 3.5 0.1 0 0.5 4.1 0.2 10.4 6.6 0.2 2.3 1 2.3 0.3 0.2 8.5 0.3 0.6 0.3 2.5 0 0 0.6 41.5 0.3 0.3 9.8 4.9 1.1 6.3 0.1 0 1.2 0 0.1 1 0 0.1 1.9 2.1 0.1 0.1 0.4 3.3 0 0.6 1 1.9 0.5 1.5 -----
126.2
110
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
9 74 107 24 29 26 44 38 8 98 187 9
197
183 9
114 27 70 6 90 270 4 28 8 45 1 1 14 10 16 188 43 1 47 0 1 86 0 4 83 30 2 10 31 156 0 25 67 89 15 55 -----
2679
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 2 3 0 1 0 0 0 0 0 10 1 3 0---
-- 24
5-
-
9 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 9 0 0 14 1 0 0---
-- 30
10-
-
14 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 6 1 1 1 1 4 0 0 3 7 2 0---
-- 31
15-
-
19 0 0 2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 2 0 0 1 0 0 0 3 0 0 0 0 0 0 0 5 0 0 1 6 12 0 0 6 5 3 0---
-- 50
20-
-
24 0 1 0 0 0 0 1 1 0 0 2 1 1 1 0 1 0 0 0 0 2 0 8 0 0 0 0 2 0 0 0 9 0 1 0 0 0 0 0 2 0 0 0 3 7 0 0 6 3 1 0---
-- 53
25-
-
29 0 0 2 0 0 0 1 0 0 1 3 0 3 2 0 3 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 10 0 0 0 0 1 0 0 3 3 0 1 5 7 0 0 3 8 1 0---
-- 60
30-
-
34 0 2 0 0 0 0 3 1 0 0 8 0 5 1 0 1 0 2 0 3 1 1 0 1 1 0 0 0 0 0 1 7 0 0 0 0 0 0 0 3 2 0 0 0 11 0 0 5 7 0 1---
-- 67
35-
-
39 0 3 0 1 0 0 3 0 0 2 4 1 6 5 1 0 0 1 1 1 4 0 0 1 0 0 0 0 1 1 0 4 0 0 0 0 2 0 0 9 0 0 1 1 5 0 0 3 4 0 0---
-- 65
40-
-
44 0 0 2 4 0 1 2 0 0 4 7 1 10 8 1 2 2 4 1 2 9 1 4 0 2 0 0 1 1 0 2 3 0 5 0 0 2 0 0 7 3 0 1 2 13 0 1 4 4 0 4---
--12
0
45-
-
49 0 12 14 2 6 1 2 2 0 7 11 1 27 20 0 12 4 7 0 4 26 0 2 0 3 0 0 3 0 3 4 2 0 5 0 0 5 0 0 10 3 0 3 0 6 0 1 3 11 2 2---
--22
6
50-
-
54 3 8 13 1 4 4 6 10 2 19 22 0 20 29 1 13 2 14 0 17 37 1 2 1 5 0 0 0 3 3 8 1 0 8 0 1 11 0 0 10 5 0 0 3 25 0 2 3 10 1 9---
--33
7
55-
-
59 1 13 18 5 4 5 6 3 1 16 28 0 27 27 2 19 5 10 2 15 30 0 2 1 6 0 0 2 2 3 14 1 0 5 0 0 12 0 0 8 5 0 0 5 19 0 1 4 10 0 13 -----
350
60-
-
64 2 17 15 5 9 7 8 5 1 11 22 1 28 23 1 17 6 14 0 23 50 0 2 1 1 0 0 1 1 1 30 1 1 6 0 0 9 0 1 5 2 0 1 1 14 0 9 0 7 2 7---
--36
8
65-
-
69 1 5 10 3 2 3 5 3 2 19 31 1 22 24 1 11 1 4 1 5 40 0 2 0 4 1 0 2 1 3 40 0 0 8 0 0 20 0 0 1 3 0 1 1 10 0 6 1 4 0 6---
--30
8
70-
-
74 2 5 11 1 1 3 2 9 1 10 22 3 21 18 1 19 3 10 1 10 36 0 0 2 10 0 0 0 0 1 42 1 0 4 0 0 11 0 0 4 2 0 0 2 7 0 1 0 4 0 4---
--28
4
75+
0 8 20 1 3 2 4 3 1 9 27 0 27 25 1 14 4 3 0 9 35 0 2 0 10 0 1 1 1 1 47 1 0 3 0 0 13 0 1 2 1 0 0 1 7 0 4 2 3 0 9---
--30
6
% of
Total 0.3
0%2.8
0%4.0
0%0.9
0%1.1
0%1.0
0%1.6
0%1.4
0%0.3
0%3.7
0%7.0
0%0.3
0%7.4
0%6.8
0%0.3
0%4.3
0%1.0
0%2.6
0%0.2
0%3.4
0%10
.10%
0.10%
1.00%
0.30%
1.70%
0.00%
0.00%
0.50%
0.40%
0.60%
7.00%
1.60%
0.00%
1.80%
0.00%
0.00%
3.20%
0.00%
0.10%
3.10%
1.10%
0.10%
0.40%
1.20%
5.80%
0.00%
0.90%
2.50%
3.30%
0.60%
2.10% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
31:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
IN
DIA
N M
AL
ES,
MA
LA
YSI
A, 2
007-
2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
111
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages 15 10
028
7 18 10 11 25 35 514
513
7 618
217
0 12 58 37 57 10 20 127 10 26 5 59 2 0 16
1705 10 14 32
720
4 60 277 4 1 27 1 0 24 0 3 78 119 1 8 25 105 1 24 45 72 20 58 -----
4798
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 1 0 0 7 1 6 1---
-- 20
5-
-
9 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 5 0 0 0 0 0 0 0 9 2 3 0---
-- 25
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 4 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0 0 0 0 0 4 1 0 0 0 5 0 0 4 1 0 0---
-- 24
15-
-
19 0 0 0 0 0 0 1 0 0 0 2 0 1 0 0 0 0 0 0 0 0 0 3 0 1 0 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 2 2 0 0 2 3 0 0 1 2 2 1---
-- 28
20-
-
24 0 0 0 0 0 0 1 0 0 0 2 0 2 2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 3 0 0 3 0 0 9 0 0 0 0 0 0 0 0 2 9 0 0 4 3 0 0 0 0 0 1---
-- 42
25-
-
29 0 1 0 2 0 0 0 2 0 0 4 0 3 0 1 0 0 1 0 0 0 0 1 0 0 0 0 1 20 0 0 4 1 0 4 0 0 1 0 0 0 0 0 7 9 0 0 8 2 0 0 6 4 0 1---
-- 83
30-
-
34 0 1 0 0 0 0 0 0 0 0 3 1 5 5 0 2 0 1 0 1 2 1 1 0 1 0 0 1 57 0 0 6 3 1 4 0 0 2 0 0 0 0 0 4 8 0 0 1 3 0 0 3 6 1 3---
--12
7
35-
-
39 1 1 3 1 0 0 0 0 0 3 6 0 3 8 0 1 1 2 2 0 2 1 0 0 2 0 0 1 87 1 2 15 12 0 11 1 0 0 0 0 0 0 0 3 15 0 0 2 5 0 0 4 6 2 2---
--20
6
40-
-
44 0 7 7 3 1 0 2 1 0 9 8 0 12 11 0 4 2 1 0 1 8 2 2 0 4 0 0 119
2 0 0 21 14 7 29 0 0 1 1 0 1 0 0 7 9 0 1 2 4 0 0 0 4 2 6---
--38
7
45-
-
49 1 6 10 3 1 0 1 6 1 8 13 2 12 9 1 3 1 4 0 1 11 0 1 1 2 0 0 226
4 1 2 40 22 5 49 1 0 5 0 0 1 0 0 6 14 1 1 0 7 0 3 1 7 1 1---
--53
2
50-
-
54 2 16 31 4 2 0 5 3 0 21 19 2 18 26 0 4 2 13 0 3 18 0 2 0 5 0 0 031
4 1 2 58 32 4 52 1 0 6 0 0 3 0 0 13 17 0 4 2 12 0 2 4 13 2 5---
--74
3
55-
-
59 1 9 37 1 2 2 6 7 2 21 19 0 25 25 4 7 9 10 2 5 21 4 2 1 9 1 0 028
1 3 4 45 33 11 33 0 1 3 0 0 2 0 2 8 10 0 1 1 14 0 5 4 10 0 8---
--71
1
60-
-
64 0 22 46 3 2 1 2 5 1 26 15 0 31 24 2 8 5 8 0 2 16 0 0 1 6 0 0 217
6 1 0 44 38 14 33 1 0 3 0 0 3 0 0 7 10 0 1 3 16 0 6 1 8 0 6---
--59
9
65-
-
69 0 6 41 0 2 4 2 5 1 17 14 1 16 13 1 9 6 4 1 0 17 0 4 1 7 0 0 311
5 1 2 30 21 4 25 0 0 2 0 0 1 0 0 4 8 0 0 0 15 0 5 1 1 0 10 -----
420
70-
-
74 2 22 55 0 0 2 3 5 0 20 14 0 30 25 1 8 5 6 3 5 16 1 3 0 7 1 0 210
2 1 0 31 16 7 7 0 0 0 0 0 6 0 0 1 6 0 0 0 9 0 0 0 5 0 9---
--43
6
75+
8 9 57 0 0 2 1 1 0 20 18 0 23 22 2 12 6 7 0 2 16 1 2 1 15 0 0 2 93 1 2 30 12 7 14 0 0 2 0 0 7 0 1 1 1 0 0 0 6 1 3 0 2 1 4---
--41
5
% of
Total
0.30%
2.10%
6.00%
0.40%
0.20%
0.20%
0.50%
0.70%
0.10%
3.00%
2.90%
0.10%
3.80%
3.50%
0.30%
1.20%
0.80%
1.20%
0.20%
0.40%
2.60%
0.20%
0.50%
0.10%
1.20%
0.00%
0.00%
0.30%
35.50
%0.2
0%0.3
0%6.8
0%4.3
0%1.3
0%5.8
0%0.1
0%0.0
0%0.6
0%0.0
0%0.0
0%0.5
0%0.0
0%0.1
0%1.6
0%2.5
0%0.0
0%0.2
0%0.5
0%2.2
0%0.0
0%0.5
0%0.9
0%1.5
0%0.4
0%1.2
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
32:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
IN
DIA
N F
EM
AL
ES,
MA
LA
YSI
A, 2
007-
2011
112
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
9 74 107 24 29 26 44 38 8 98 187 9
197
183 9
114 27 70 6 90 270 4 28 8 45 1 1 14 10 16 188 43 1 47 0 1 86 0 4 83 30 2 10 31 156 0 25 67 89 15 55 -----
2679
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0.5 0.8 0 0.3 0 0 0 0 0 2.6 0.3 0.8 0---
-- 6
5-
-
9 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.1 0 0 0 0 2.1 0 0 3.2 0.2 0 0---
-- 7
10-
-
14 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.2 0 0.2 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 1.3 0.2 0.2 0.2 0.2 0.9 0 0 0.7 1.6 0.4 0---
-- 7
15-
-
19 0 0 0.4 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0.4 0 0 0.2 0 0 0 0.7 0 0 0 0 0 0 0 1.1 0 0 0.2 1.3 2.6 0 0 1.3 1.1 0.7 0---
-- 11
20-
-
24 0 0.2 0 0 0 0 0.2 0.2 0 0 0.4 0.2 0.2 0.2 0 0.2 0 0 0 0 0.4 0 1.7 0 0 0 0 0.4 0 0 0 1.9 0 0.2 0 0 0 0 0 0.4 0 0 0 0.6 1.5 0 0 1.3 0.6 0.2 0---
-- 11
25-
-
29 0 0 0.5 0 0 0 0.2 0 0 0.2 0.7 0 0.7 0.5 0 0.7 0 0.2 0 0 0 0.2 0 0.2 0 0 0 0 0 0 0 2.3 0 0 0 0 0.2 0 0 0.7 0.7 0 0.2 1.1 1.6 0 0 0.7 1.8 0.2 0---
-- 14
30-
-
34 0 0.5 0 0 0 0 0.8 0.3 0 0 2.2 0 1.3 0.3 0 0.3 0 0.5 0 0.8 0.3 0.3 0 0.3 0.3 0 0 0 0 0 0.3 1.9 0 0 0 0 0 0 0 0.8 0.5 0 0 0 3 0 0 1.3 1.9 0 0.3 ----- 18
35-
-
39 0 0.9 0 0.3 0 0 0.9 0 0 0.6 1.2 0.3 1.8 1.5 0.3 0 0 0.3 0.3 0.3 1.2 0 0 0.3 0 0 0 0 0.3 0.3 0 1.2 0 0 0 0 0.6 0 0 2.7 0 0 0.3 0.3 1.5 0 0 0.9 1.2 0 0---
-- 19
40-
-
44 0 0 0.6 1.3 0 0.3 0.6 0 0 1.3 2.2 0.3 3.1 2.5 0.3 0.6 0.6 1.3 0.3 0.6 2.8 0.3 1.3 0 0.6 0 0 0.3 0.3 0 0.6 0.9 0 1.6 0 0 0.6 0 0 2.2 0.9 0 0.3 0.6 4.1 0 0.3 1.3 1.3 0 1.3 ----- 38
45-
-
49 0 3.8 4.4 0.6 1.9 0.3 0.6 0.6 0 2.2 3.5 0.3 8.5 6.3 0 3.8 1.3 2.2 0 1.3 8.2 0 0.6 0 0.9 0 0 0.9 0 0.9 1.3 0.6 0 1.6 0 0 1.6 0 0 3.2 0.9 0 0.9 0 1.9 0 0.3 0.9 3.5 0.6 0.6 ----- 71
50-
-
54 1.1 3 4.9 0.4 1.5 1.5 2.3 3.8 0.8 7.1 8.3 0 7.5 10.9 0.4 4.9 0.8 5.3 0 6.4 13.9 0.4 0.8 0.4 1.9 0 0 0 1.1 1.1 3 0.4 0 3 0 0.4 4.1 0 0 3.8 1.9 0 0 1.1 9.4 0 0.8 1.1 3.8 0.4 3.4 -----
127
55-
-
59 0.5 6.5 9 2.5 2 2.5 3 1.5 0.5 814
.1 013
.613
.6 1 9.5 2.5 5 1 7.5 15.1 0 1 0.5 3 0 0 1 1 1.5 7 0.5 0 2.5 0 0 6 0 0 4 2.5 0 0 2.5 9.5 0 0.5 2 5 0 6.5 -----
176
60-
-
64 1.5 12.4
10.9 3.6 6.5 5.1 5.8 3.6 0.7 8 16 0.7 20.4
16.7 0.7 12.4 4.4 10.2 0
16.7
36.4 0 1.5 0.7 0.7 0 0 0.7 0.7 0.7 21.8 0.7 0.7 4.4 0 0 6.5 0 0.7 3.6 1.5 0 0.7 0.7 10.2 0 6.5 0 5.1 1.5 5.1 -----
268
65-
-
69 1.3 6.7 13.4 4 2.7 4 6.7 4 2.7 25.5
41.6 1.3 29.5
32.2 1.3 14.8 1.3 5.4 1.3 6.7 53.7 0 2.7 0 5.4 1.3 0 2.7 1.3 4
53.7 0 0
10.7 0 0
26.8 0 0 1.3 4 0 1.3 1.3 13.4 0 8.1 1.3 5.4 0 8.1 -----
413
70-
-
74 3.5 8.9 19.5 1.8 1.8 5.3 3.5 15.9 1.8 17.7
38.9 5.3 37.2
31.9 1.8 33.6 5.3 17.7 1.8 17.7
63.7 0 0 3.5 17.7 0 0 0 0 1.8 74.3 1.8 0 7.1 0 0
19.5 0 0 7.1 3.5 0 0 3.5 12.4 0 1.8 0 7.1 0 7.1 -----
503
75+
013
.132
.8 1.6 4.9 3.3 6.6 4.9 1.6 14.8
44.3 0
44.3 41 1.6 23 6.6 4.9 0
14.8
57.4 0 3.3 0
16.4 0 1.6 1.6 1.6 1.6 77.1 1.6 0 4.9 0 0
21.3 0 1.6 3.3 1.6 0 0 1.6 11.5 0 6.6 3.3 4.9 0
14.8 -----
502
Crud
eRa
te 0.2 1.5 2.2 0.5 0.6 0.5 0.9 0.8 0.2 2 3.9 0.2 4.1 3.8 0.2 2.4 0.6 1.5 0.1 1.9 5.6 0.1 0.6 0.2 0.9 0 0 0.3 0.2 0.3 3.9 0.9 0 1 0 0 1.8 0 0.1 1.7 0.6 0 0.2 0.6 3.3 0 0.5 1.4 1.9 0.3 1.2 ----- 56
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
33:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, I
ND
IAN
MA
LE
S, M
AL
AY
SIA
, 200
7-20
11
ASR
Wor
ld 0.2 1.9 2.9 0.6 0.7 0.7 1.1 1 0.2 2.7 5.2 0.2 5.2 4.9 0.2 3.1 0.7 1.8 0.2 2.3 7.6 0.1 0.6 0.2 1.3 0 0 0.3 0.2 0.4 6.1 0.8 0 1.3 0 0 2.5 0 0.1 1.8 0.7 0.1 0.2 0.7 3.5 0 0.8 1.5 2 0.3 1.4 -----
70.4
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
113
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages 15 10
028
7 18 10 11 25 35 514
513
7 618
217
0 12 58 37 57 10 20 127 10 26 5 59 2 0 16
1705 10 14 32
720
4 60 277 4 1 27 1 0 24 0 3 78 119 1 8 25 105 1 24 45 72 20 58 -----
4798
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.1 0 0 0 0 0.3 0 0 1.9 0.3 1.6 0.3 ----- 5
5-
-
9 0 0 0 0.2 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 1.2 0 0 0 0 0 0 0 2.1 0.5 0.7 0---
-- 6
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0.2 0 0 0 0.9 0 0 0 0 0 0.2 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0 0.9 0.2 0 0 0 1.1 0 0 0.9 0.2 0 0---
-- 5
15-
-
19 0 0 0 0 0 0 0.2 0 0 0 0.5 0 0.2 0 0 0 0 0 0 0 0 0 0.7 0 0.2 0 0 0 0 0 0 0 0 0 1.1 0 0 0 0 0 0 0 0 0.5 0.5 0 0 0.5 0.7 0 0 0.2 0.5 0.5 0.2 ----- 6
20-
-
24 0 0 0 0 0 0 0.2 0 0 0 0.4 0 0.4 0.4 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.7 0 0 0.7 0 0 2 0 0 0 0 0 0 0 0 0.4 2 0 0 0.9 0.7 0 0 0 0 0 0.2 ----- 9
25-
-
29 0 0.2 0 0.5 0 0 0 0.5 0 0 0.9 0 0.7 0 0.2 0 0 0.2 0 0 0 0 0.2 0 0 0 0 0.2 4.7 0 0 0.9 0.2 0 0.9 0 0 0.2 0 0 0 0 0 1.6 2.1 0 0 1.9 0.5 0 0 1.4 0.9 0 0.2 ----- 20
30-
-
34 0 0.3 0 0 0 0 0 0 0 0 0.8 0.3 1.4 1.4 0 0.6 0 0.3 0 0.3 0.6 0.3 0.3 0 0.3 0 0 0.3 16 0 0 1.7 0.8 0.3 1.1 0 0 0.6 0 0 0 0 0 1.1 2.3 0 0 0.3 0.8 0 0 0.8 1.7 0.3 0.8 ----- 36
35-
-
39 0.3 0.3 0.9 0.3 0 0 0 0 0 0.9 1.8 0 0.9 2.4 0 0.3 0.3 0.6 0.6 0 0.6 0.3 0 0 0.6 0 0 0.3 25.9 0.3 0.6 4.5 3.6 0 3.3 0.3 0 0 0 0 0 0 0 0.9 4.5 0 0 0.6 1.5 0 0 1.2 1.8 0.6 0.6 ----- 61
40-
-
44 0 2.1 2.1 0.9 0.3 0 0.6 0.3 0 2.7 2.4 0 3.6 3.3 0 1.2 0.6 0.3 0 0.3 2.4 0.6 0.6 0 1.2 0 0 0.3 57.7 0 0 6.3 4.2 2.1 8.7 0 0 0.3 0.3 0 0.3 0 0 2.1 2.7 0 0.3 0.6 1.2 0 0 0 1.2 0.6 1.8 -----
116
45-
-
49 0.3 1.9 3.2 1 0.3 0 0.3 1.9 0.3 2.6 4.2 0.6 3.9 2.9 0.3 1 0.3 1.3 0 0.3 3.5 0 0.3 0.3 0.6 0 0 0.6 85 0.3 0.6 12.9 7.1 1.6 15.8 0.3 0 1.6 0 0 0.3 0 0 1.9 4.5 0.3 0.3 0 2.3 0 1 0.3 2.3 0.3 0.3 -----
171
50-
-
54 0.7 5.9 11.4 1.5 0.7 0 1.8 1.1 0 7.8 7 0.7 6.6 9.6 0 1.5 0.7 4.8 0 1.1 6.6 0 0.7 0 1.8 0 0 0
115.9 0.4 0.7 21
.411
.8 1.5 19.2 0.4 0 2.2 0 0 1.1 0 0 4.8 6.3 0 1.5 0.7 4.4 0 0.7 1.5 4.8 0.7 1.8 -----
274
55-
-
59 0.5 4.4 18.1 0.5 1 1 2.9 3.4 1
10.3 9.3 0
12.2
12.2 2 3.4 4.4 4.9 1 2.4 10.3 2 1 0.5 4.4 0.5 0 0
137.4 1.5 2 22 16
.1 5.4 16.1 0 0.5 1.5 0 0 1 0 1 3.9 4.9 0 0.5 0.5 6.8 0 2.4 2 4.9 0 3.9 -----
348
60-
-
64 014
.931
.1 2 1.4 0.7 1.4 3.4 0.7 17.6
10.1 0
20.9
16.2 1.4 5.4 3.4 5.4 0 1.4 10.8 0 0 0.7 4.1 0 0 1.4
118.9 0.7 0
29.7
25.7 9.5 22.3 0.7 0 2 0 0 2 0 0 4.7 6.8 0 0.7 2
10.8 0 4.1 0.7 5.4 0 4.1 -----
405
65-
-
69 0 7.2 49.4 0 2.4 4.8 2.4 6 1.2 20.5
16.9 1.2 19.3
15.7 1.2 10.8 7.2 4.8 1.2 0
20.5 0 4.8 1.2 8.4 0 0 3.6
138.6 1.2 2.4 36.1
25.3 4.8 30.1 0 0 2.4 0 0 1.2 0 0 4.8 9.6 0 0 0
18.1 0 6 1.2 1.2 0 12 -----
506
70-
-
74 2.9 32.1
80.3 0 0 2.9 4.4 7.3 0
29.2
20.4 0
43.8
36.5 1.5 11.7 7.3 8.8 4.4 7.3 23.4 1.5 4.4 0
10.2 1.5 0 2.9
148.9 1.5 0
45.3
23.4
10.2
10.2 0 0 0 0 0 8.8 0 0 1.5 8.8 0 0 0
13.1 0 0 0 7.3 0
13.1 -----
637
75+ 10
.311
.673
.6 0 0 2.6 1.3 1.3 025
.823
.2 029
.728
.4 2.6 15.5 7.7 9 0 2.6 20.6 1.3 2.6 1.3 19.4 0 0 2.6 120 1.3 2.6 38
.715
.5 918
.1 0 0 2.6 0 0 9 0 1.3 1.3 1.3 0 0 0 7.7 1.3 3.9 0 2.6 1.3 5.2 -----
536
Crud
eRa
te 0.3 2.1 6.1 0.4 0.2 0.2 0.5 0.7 0.1 3.1 2.9 0.1 3.8 3.6 0.3 1.2 0.8 1.2 0.2 0.4 2.7 0.2 0.5 0.1 1.2 0 0 0.3 36 0.2 0.3 6.9 4.3 1.3 5.8 0.1 0 0.6 0 0 0.5 0 0.1 1.6 2.5 0 0.2 0.5 2.2 0 0.5 0.9 1.5 0.4 1.2 -----
101.2
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
34:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, I
ND
IAN
FE
MA
LE
S, M
AL
AY
SIA
, 200
7-20
11
ASR
Wor
ld 0.4 2.5 7.5 0.4 0.2 0.3 0.6 0.9 0.1 3.6 3.2 0.1 4.4 4 0.3 1.5 0.9 1.3 0.2 0.5 3.1 0.2 0.6 0.1 1.5 0 0 0.4 37.1 0.2 0.3 7.6 4.8 1.4 6.1 0.1 0 0.6 0 0 0.6 0 0.1 1.7 2.5 0 0.2 0.5 2.5 0 0.6 1 1.5 0.5 1.4 -----
110.1
114
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
3 51 44 29 10 367
8 25 4 76 397 13 305
248 7
329 44 76 20 52 661 29 55 44 148 3 6 54 13 34 192 54 1 40 0 0
100 0 16 113 65 11 7 44 393 0 49 127
152 23 86 -----
4934
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 3 0 1 0 13 0 4 0 0 0 0 9 10 0 4 3 1 10 0 0 40 10 3 3---
--11
7
5-
-
9 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 11 0 1 0 4 18 0 0 28 8 1 2---
-- 79
10-
-
14 0 0 0 0 0 0 8 0 0 0 0 0 1 0 0 1 0 0 1 0 0 0 12 0 0 0 0 3 0 0 0 1 0 0 0 0 0 0 1 8 3 0 3 1 8 0 0 11 8 1 1---
-- 72
15-
-
19 0 1 0 2 0 0 19 0 0 0 0 0 0 1 0 0 0 0 1 0 1 0 10 1 0 0 0 4 0 0 1 4 0 0 0 0 0 0 0 8 1 0 1 3 21 0 0 9 10 2 0---
--10
0
20-
-
24 0 1 0 0 0 0 20 0 0 0 1 0 3 4 0 0 1 1 0 0 2 1 10 0 1 0 1 3 0 0 0 8 0 0 0 0 0 0 0 4 0 0 0 4 9 0 0 3 18 2 2---
-- 99
25-
-
29 0 2 3 3 0 0 22 0 0 0 3 0 15 3 0 4 1 0 1 0 6 0 2 1 0 0 0 2 0 0 0 7 0 0 0 0 0 0 0 7 1 1 0 3 16 0 0 5 7 2 1---
--11
8
30-
-
34 0 1 1 3 0 0 30 0 0 2 3 1 13 5 1 8 0 2 1 0 7 0 3 1 5 0 0 3 0 3 0 7 0 0 0 0 0 0 1 4 0 0 0 4 19 0 2 2 8 0 1---
--14
1
35-
-
39 0 3 3 2 0 0 59 0 0 0 16 0 10 13 0 14 2 1 2 1 22 6 0 2 7 0 0 6 1 2 0 5 0 1 0 0 3 0 0 5 4 1 0 1 16 0 0 5 14 4 2---
--23
3
40-
-
44 2 4 1 3 0 0 82 1 0 3 21 3 27 19 0 19 1 0 2 1 26 2 4 2 4 0 1 4 1 8 0 2 0 2 0 0 4 0 0 14 7 1 0 3 23 0 2 1 8 0 5---
--31
3
45-
-
49 0 4 2 4 2 011
1 1 1 6 30 1 28 22 1 19 4 9 3 1 57 2 3 2 10 1 0 1 3 6 1 1 1 5 0 0 8 0 3 9 4 0 0 3 29 0 5 1 9 0 5---
--41
8
50-
-
54 0 4 3 4 2 0 92 0 0 6 39 3 34 21 1 41 3 6 2 5 76 4 1 7 13 1 1 7 1 3 10 2 0 9 0 0 12 0 2 9 9 0 0 2 45 0 9 6 9 3 9---
--51
6
55-
-
59 0 4 5 3 1 0 82 1 1 12 45 1 33 26 0 56 8 12 0 7 81 1 2 5 16 0 1 4 3 3 19 1 0 5 0 0 14 0 0 7 8 0 0 4 35 0 10 5 13 3 14 -----
551
60-
-
64 0 2 7 2 2 1 57 3 1 11 58 2 33 29 0 62 5 7 2 12 115 3 2 7 15 0 0 4 1 3 33 0 0 6 0 0 9 0 0 4 9 2 0 4 49 0 5 2 10 0 11 -----
590
65-
-
69 0 12 5 1 3 0 46 7 0 10 62 2 38 36 1 44 8 13 5 11 122 6 3 6 22 1 1 7 2 3 34 0 0 1 0 0 16 0 0 7 10 0 0 2 35 0 8 2 7 0 10 -----
609
70-
-
74 0 7 6 1 0 1 26 6 0 12 53 0 28 26 2 33 8 10 0 9 66 2 1 4 24 0 0 0 1 2 40 3 0 4 0 0 20 0 0 5 5 1 0 1 33 0 3 4 8 1 10 -----
466
75+
1 6 8 1 0 1 22 5 1 14 66 0 42 43 1 26 3 15 0 5 80 2 0 6 31 0 1 2 0 0 54 0 0 3 0 0 13 0 0 1 4 0 0 4 27 0 5 3 5 1 10 -----
512
% of
Total 0.1
0%1.0
0%0.9
0%0.6
0%0.2
0%0.1
0%13
.70%
0.50%
0.10%
1.50%
8.00%
0.30%
6.20%
5.00%
0.10%
6.70%
0.90%
1.50%
0.40%
1.10%
13.40
%0.6
0%1.1
0%0.9
0%3.0
0%0.1
0%0.1
0%1.1
0%0.3
0%0.7
0%3.9
0%1.1
0%0.0
0%0.8
0%0.0
0%0.0
0%2.0
0%0.0
0%0.3
0%2.3
0%1.3
0%0.2
0%0.1
0%0.9
0%8.0
0%0.0
0%1.0
0%2.6
0%3.1
0%0.5
0%1.7
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
35:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
OT
HE
RS
MA
LE
S, M
AL
AY
SIA
, 200
7-20
11
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
115
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages 16 39 60 36 10 326
8 13 2 53 273 14 230
186 13 128 46 58 12 14 393 24 44 26 177 3 0 51 943 15 20 791
160 57 334 5 17 26 0 0 40 4 17 111
210 9 1 20 272 0 48 87 137 17 80 -----
5613
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 1 0 0 0 6 0 0 0 0 0 0 4 0 0 2 0 0 0 0 13 5 0 3 0 0 2 0 0 33 11 1 3---
-- 87
5-
-
9 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 9 1 0 0 0 6 0 0 18 8 1 1---
-- 51
10-
-
14 0 1 0 2 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 0 3 0 0 0 0 0 0 8 0 0 1 0 0 0 0 0 10 2 0 0 0 10 0 0 11 3 1 1---
-- 63
15-
-
19 0 1 0 0 0 0 6 0 0 0 2 0 1 0 0 0 0 0 0 0 1 0 10 0 1 0 0 4 0 0 0 0 0 0 11 0 1 2 0 0 0 0 2 6 7 0 0 3 12 0 0 5 7 2 3---
-- 87
20-
-
24 0 0 1 4 0 0 14 1 0 0 3 2 5 2 1 1 0 1 0 0 2 1 5 0 2 0 0 0 9 0 0 3 0 2 22 0 3 2 0 0 1 0 0 6 9 0 0 6 10 0 0 0 13 1 4---
--13
6
25-
-
29 0 3 2 2 0 0 11 0 0 0 4 0 8 8 0 1 0 1 0 0 7 0 2 1 3 0 0 3 24 0 1 19 4 2 15 1 4 2 0 0 0 0 0 5 12 0 0 4 9 0 0 2 4 0 2---
--16
6
30-
-
34 0 1 1 3 0 0 18 0 0 0 6 0 9 3 0 6 2 1 0 0 5 1 2 0 2 0 0 3 42 1 0 40 9 1 18 0 2 2 0 0 3 0 1 6 18 1 0 1 12 0 0 0 7 1 1---
--22
9
35-
-
39 0 1 3 3 0 0 29 0 0 1 9 2 9 8 0 7 0 0 0 0 10 1 2 1 3 0 0 4 94 1 210
3 14 3 22 1 5 2 0 0 0 0 0 4 17 2 0 1 12 0 4 2 9 0 6---
--39
7
40-
-
44 1 5 4 3 0 0 31 0 1 3 11 0 12 11 1 5 1 7 3 0 15 2 3 3 5 0 0 216
9 0 313
4 20 14 39 1 1 0 0 0 1 0 0 9 22 0 0 0 18 0 3 2 16 1 5---
--58
7
45-
-
49 0 2 1 3 1 1 41 1 0 3 20 0 29 20 1 11 2 7 0 2 32 1 3 0 14 0 0 720
2 3 214
2 26 13 52 0 1 4 0 0 4 0 1 11 26 1 0 1 26 0 4 2 7 1 11 -----
742
50-
-
54 2 7 3 3 1 0 41 1 0 4 33 1 33 21 4 10 3 6 2 1 37 4 1 3 15 0 0 214
8 0 012
4 30 6 48 2 0 1 0 0 6 1 0 13 24 0 0 0 37 0 8 3 13 2 9---
--71
3
55-
-
59 2 3 7 3 3 0 16 2 1 11 37 2 30 32 3 18 3 10 2 1 52 4 1 3 16 1 0 410
5 2 6 76 25 7 28 0 0 3 0 0 4 0 0 8 23 0 1 0 31 0 5 0 17 2 10 -----
620
60-
-
64 3 2 4 4 1 2 20 2 0 9 31 2 24 19 0 20 6 7 0 3 65 1 3 3 12 1 0 2 64 2 1 53 15 3 23 0 0 2 0 0 5 1 0 5 11 1 0 1 32 0 13 0 9 0 8---
--49
5
65-
-
69 3 3 14 3 1 0 19 1 0 6 41 2 25 23 1 13 14 5 0 3 76 2 1 4 29 0 0 3 40 2 1 44 5 1 19 0 0 2 0 0 9 0 0 5 21 0 0 1 22 0 6 4 5 2 6---
--48
7
70-
-
74 3 7 11 2 1 0 13 5 0 8 36 2 21 15 1 19 5 7 3 0 56 4 0 3 29 1 0 3 28 1 2 29 5 4 9 0 0 1 0 0 3 0 0 6 9 1 0 1 14 0 3 1 3 1 5---
--38
1
75+
2 3 9 0 2 0 6 0 0 8 40 1 24 24 1 14 10 6 2 4 35 3 2 4 46 0 0 3 18 3 2 24 7 1 14 0 0 0 0 0 4 2 0 3 8 0 0 1 19 0 2 4 5 1 5---
--37
2
% of
Total
0.30%
0.70%
1.10%
0.60%
0.20%
0.10%
4.80%
0.20%
0.00%
0.90%
4.90%
0.20%
4.10%
3.30%
0.20%
2.30%
0.80%
1.00%
0.20%
0.20%
7.00%
0.40%
0.80%
0.50%
3.20%
0.10%
0.00%
0.90%
16.80
%0.3
0%0.4
0%14
.10%
2.90%
1.00%
6.00%
0.10%
0.30%
0.50%
0.00%
0.00%
0.70%
0.10%
0.30%
2.00%
3.70%
0.20%
0.00%
0.40%
4.80%
0.00%
0.90%
1.50%
2.40%
0.30%
1.40% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
36:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
OT
HE
RS
FE
MA
LE
S, M
AL
AY
SIA
, 200
7-20
11
116
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
3 51 44 29 10 367
8 25 4 76 397 13 305
248 7
329 44 76 20 52 661 29 55 44 148 3 6 54 13 34 192 54 1 40 0 0
100 0 16 113 65 11 7 44 393 0 49 127
152 23 86 -----
4934
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0.1 0 1.2 0 0.4 0 0 0 0 0.8 0.9 0 0.4 0.3 0.1 0.9 0 0 3.8 0.9 0.3 0.3 ----- 11
5-
-
9 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.1 0 0 1 0 0.1 0 0.4 1.7 0 0 2.7 0.8 0.1 0.2 ----- 8
10-
-
14 0 0 0 0 0 0 0.8 0 0 0 0 0 0.1 0 0 0.1 0 0 0.1 0 0 0 1.2 0 0 0 0 0.3 0 0 0 0.1 0 0 0 0 0 0 0.1 0.8 0.3 0 0.3 0.1 0.8 0 0 1.1 0.8 0.1 0.1 ----- 7
15-
-
19 0 0.1 0 0.2 0 0 1.9 0 0 0 0 0 0 0.1 0 0 0 0 0.1 0 0.1 0 1 0.1 0 0 0 0.4 0 0 0.1 0.4 0 0 0 0 0 0 0 0.8 0.1 0 0.1 0.3 2.1 0 0 0.9 1 0.2 0---
-- 10
20-
-
24 0 0.1 0 0 0 0 2.3 0 0 0 0.1 0 0.3 0.5 0 0 0.1 0.1 0 0 0.2 0.1 1.2 0 0.1 0 0.1 0.3 0 0 0 0.9 0 0 0 0 0 0 0 0.5 0 0 0 0.5 1 0 0 0.3 2.1 0.2 0.2 ----- 12
25-
-
29 0 0.3 0.4 0.4 0 0 2.9 0 0 0 0.4 0 2 0.4 0 0.5 0.1 0 0.1 0 0.8 0 0.3 0.1 0 0 0 0.3 0 0 0 0.9 0 0 0 0 0 0 0 0.9 0.1 0.1 0 0.4 2.1 0 0 0.7 0.9 0.3 0.1 ----- 15
30-
-
34 0 0.2 0.2 0.5 0 0 5.2 0 0 0.3 0.5 0.2 2.2 0.9 0.2 1.4 0 0.3 0.2 0 1.2 0 0.5 0.2 0.9 0 0 0.5 0 0.5 0 1.2 0 0 0 0 0 0 0.2 0.7 0 0 0 0.7 3.3 0 0.3 0.3 1.4 0 0.2 ----- 24
35-
-
39 0 0.5 0.5 0.4 0 010
.8 0 0 0 2.9 0 1.8 2.4 0 2.6 0.4 0.2 0.4 0.2 4 1.1 0 0.4 1.3 0 0 1.1 0.2 0.4 0 0.9 0 0.2 0 0 0.5 0 0 0.9 0.7 0.2 0 0.2 2.9 0 0 0.9 2.6 0.7 0.4 ----- 43
40-
-
44 0.4 0.8 0.2 0.6 0 016
.1 0.2 0 0.6 4.1 0.6 5.3 3.7 0 3.7 0.2 0 0.4 0.2 5.1 0.4 0.8 0.4 0.8 0 0.2 0.8 0.2 1.6 0 0.4 0 0.4 0 0 0.8 0 0 2.8 1.4 0.2 0 0.6 4.5 0 0.4 0.2 1.6 0 1---
-- 62
45-
-
49 0 0.9 0.4 0.9 0.4 024
.4 0.2 0.2 1.3 6.6 0.2 6.2 4.8 0.2 4.2 0.9 2 0.7 0.2 12.5 0.4 0.7 0.4 2.2 0.2 0 0.2 0.7 1.3 0.2 0.2 0.2 1.1 0 0 1.8 0 0.7 2 0.9 0 0 0.7 6.4 0 1.1 0.2 2 0 1.1 ----- 92
50-
-
54 0 1.1 0.8 1.1 0.5 025
.2 0 0 1.6 10.7 0.8 9.3 5.8 0.3 11.2 0.8 1.6 0.5 1.4 20.8 1.1 0.3 1.9 3.6 0.3 0.3 1.9 0.3 0.8 2.7 0.5 0 2.5 0 0 3.3 0 0.5 2.5 2.5 0 0 0.5 12.3 0 2.5 1.6 2.5 0.8 2.5 -----
141
55-
-
59 0 1.6 2 1.2 0.4 032
.4 0.4 0.4 4.7 17.8 0.4 13 10.3 0
22.1 3.2 4.7 0 2.8 32 0.4 0.8 2 6.3 0 0.4 1.6 1.2 1.2 7.5 0.4 0 2 0 0 5.5 0 0 2.8 3.2 0 0 1.6 13.8 0 3.9 2 5.1 1.2 5.5 -----
217
60-
-
64 0 1.1 3.9 1.1 1.1 0.6 31.9 1.7 0.6 6.2 32.5 1.1 18.5
16.2 0
34.7 2.8 3.9 1.1 6.7 64.4 1.7 1.1 3.9 8.4 0 0 2.2 0.6 1.7 18.5 0 0 3.4 0 0 5 0 0 2.2 5 1.1 0 2.2 27.5 0 2.8 1.1 5.6 0 6.2 -----
331
65-
-
69 0 8.8 3.7 0.7 2.2 033
.7 5.1 0 7.3 45.4 1.5 27.8
26.4 0.7 32.2 5.9 9.5 3.7 8.1 89.4 4.4 2.2 4.4 16.1 0.7 0.7 5.1 1.5 2.2 24.9 0 0 0.7 0 0
11.7 0 0 5.1 7.3 0 0 1.5 25.6 0 5.9 1.5 5.1 0 7.3 -----
446
70-
-
74 0 7.7 6.6 1.1 0 1.1 28.7 6.6 0
13.3
58.6 0
30.9
28.7 2.2 36.5 8.8 11.1 0 9.9 72.9 2.2 1.1 4.4 26.5 0 0 0 1.1 2.2 44.2 3.3 0 4.4 0 0
22.1 0 0 5.5 5.5 1.1 0 1.1 36.5 0 3.3 4.4 8.8 1.1 11.1 -----
515
75+ 0.9 5.2 6.9 0.9 0 0.9 19 4.3 0.9 12
.156
.9 036
.237
.1 0.9 22.4 2.6 12.9 0 4.3 69 1.7 0 5.2 26.7 0 0.9 1.7 0 0
46.6 0 0 2.6 0 0
11.2 0 0 0.9 3.4 0 0 3.4 23.3 0 4.3 2.6 4.3 0.9 8.6 -----
441
Crud
eRa
te 0 0.6 0.5 0.3 0.1 0 7.6 0.3 0 0.8 4.4 0.1 3.4 2.8 0.1 3.7 0.5 0.8 0.2 0.6 7.4 0.3 0.6 0.5 1.6 0 0.1 0.6 0.1 0.4 2.1 0.6 0 0.4 0 0 1.1 0 0.2 1.3 0.7 0.1 0.1 0.5 4.4 0 0.5 1.4 1.7 0.3 1---
-- 55
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
37:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, O
TH
ER
S M
AL
ES,
MA
LA
YSI
A, 2
007-
2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
ASR
Wor
ld 0 0.9 0.8 0.4 0.2 0.1 9.9 0.5 0.1 1.4 7.1 0.2 5 4.2 0.1 5.8 0.8 1.4 0.3 111
.9 0.5 0.6 0.8 2.6 0 0.1 0.7 0.2 0.5 3.8 0.6 0 0.6 0 0 1.8 0 0.2 1.5 1.1 0.2 0.1 0.6 6.1 0 0.8 1.5 2 0.3 1.5 -----
80.5
117
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages 16 39 60 36 10 326
8 13 2 53 273 14 230
186 13 128 46 58 12 14 393 24 44 26 177 3 0 51 943 15 20 791
160 57 334 5 17 26 0 0 40 4 17 111
210 9 1 20 272 0 48 87 137 17 80 -----
5613
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0.1 0 0 0 0.6 0 0 0 0 0 0 0.4 0 0 0.2 0 0 0 0 1.3 0.5 0 0.3 0 0 0.2 0 0 3.3 1.1 0.1 0.3 ----- 9
5-
-
9 0 0 0 0.1 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0.2 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0.9 0.1 0 0 0 0.6 0 0 1.8 0.8 0.1 0.1 ----- 5
10-
-
14 0 0.1 0 0.2 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0.3 0 0 0 0 0 0 0.8 0 0 0.1 0 0 0 0 0 1 0.2 0 0 0 1 0 0 1.1 0.3 0.1 0.1 ----- 6
15-
-
19 0 0.1 0 0 0 0 0.6 0 0 0 0.2 0 0.1 0 0 0 0 0 0 0 0.1 0 1 0 0.1 0 0 0.4 0 0 0 0 0 0 1.1 0 0.1 0.2 0 0 0 0 0.2 0.6 0.7 0 0 0.3 1.2 0 0 0.5 0.7 0.2 0.3 ----- 9
20-
-
24 0 0 0.1 0.5 0 0 1.6 0.1 0 0 0.3 0.2 0.6 0.2 0.1 0.1 0 0.1 0 0 0.2 0.1 0.6 0 0.2 0 0 0 1 0 0 0.3 0 0.2 2.5 0 0.3 0.2 0 0 0.1 0 0 0.7 1 0 0 0.7 1.1 0 0 0 1.5 0.1 0.5 ----- 15
25-
-
29 0 0.4 0.3 0.3 0 0 1.5 0 0 0 0.5 0 1.1 1.1 0 0.1 0 0.1 0 0 0.9 0 0.3 0.1 0.4 0 0 0.4 3.2 0 0.1 2.5 0.5 0.3 2 0.1 0.5 0.3 0 0 0 0 0 0.7 1.6 0 0 0.5 1.2 0 0 0.3 0.5 0 0.3 ----- 22
30-
-
34 0 0.2 0.2 0.5 0 0 3.1 0 0 0 1 0 1.6 0.5 0 1 0.3 0.2 0 0 0.9 0.2 0.3 0 0.3 0 0 0.5 7.3 0.2 0 6.9 1.6 0.2 3.1 0 0.3 0.3 0 0 0.5 0 0.2 1 3.1 0.2 0 0.2 2.1 0 0 0 1.2 0.2 0.2 ----- 40
35-
-
39 0 0.2 0.6 0.6 0 0 5.3 0 0 0.2 1.7 0.4 1.7 1.5 0 1.3 0 0 0 0 1.8 0.2 0.4 0.2 0.6 0 0 0.7 17.3 0.2 0.4 18.9 2.6 0.6 4 0.2 0.9 0.4 0 0 0 0 0 0.7 3.1 0.4 0 0.2 2.2 0 0.7 0.4 1.7 0 1.1 ----- 73
40-
-
44 0.2 1 0.8 0.6 0 0 6.3 0 0.2 0.6 2.2 0 2.4 2.2 0.2 1 0.2 1.4 0.6 0 3.1 0.4 0.6 0.6 1 0 0 0.4 34.4 0 0.6 27.3 4.1 2.9 7.9 0.2 0.2 0 0 0 0.2 0 0 1.8 4.5 0 0 0 3.7 0 0.6 0.4 3.3 0.2 1
-----
120
45-
-
49 0 0.5 0.2 0.7 0.2 0.2 9.8 0.2 0 0.7 4.8 0 7 4.8 0.2 2.6 0.5 1.7 0 0.5 7.7 0.2 0.7 0 3.4 0 0 1.7 48.4 0.7 0.5 34.1 6.2 3.1 12.5 0 0.2 1 0 0 1 0 0.2 2.6 6.2 0.2 0 0.2 6.2 0 1 0.5 1.7 0.2 2.6 -----
178
50-
-
54 0.6 2.2 0.9 0.9 0.3 0 13 0.3 0 1.3 10.4 0.3 10.4 6.6 1.3 3.2 0.9 1.9 0.6 0.3 11.7 1.3 0.3 0.9 4.7 0 0 0.6 46.8 0 0
39.2 9.5 1.9 15.2 0.6 0 0.3 0 0 1.9 0.3 0 4.1 7.6 0 0 0
11.7 0 2.5 0.9 4.1 0.6 2.8 -----
226
55-
-
59 0.9 1.4 3.2 1.4 1.4 0 7.2 0.9 0.5 516
.7 0.9 13.5
14.4 1.4 8.1 1.4 4.5 0.9 0.5 23.5 1.8 0.5 1.4 7.2 0.5 0 1.8 47.4 0.9 2.7 34.3
11.3 3.2 12.6 0 0 1.4 0 0 1.8 0 0 3.6 10.4 0 0.5 0 14 0 2.3 0 7.7 0.9 4.5 -----
280
60-
-
64 1.7 1.1 2.3 2.3 0.6 1.1 11.5 1.1 0 5.2 17.8 1.1 13.8
10.9 0
11.5 3.4 4 0 1.7 37.3 0.6 1.7 1.7 6.9 0.6 0 1.1 36.7 1.1 0.6 30.4 8.6 1.7 13.2 0 0 1.1 0 0 2.9 0.6 0 2.9 6.3 0.6 0 0.6 18.3 0 7.5 0 5.2 0 4.6 -----
284
65-
-
69 2.2 2.2 10.5 2.2 0.7 0
14.2 0.7 0 4.5 30.7 1.5 18.7
17.2 0.7 9.7 10.5 3.7 0 2.2 56.9 1.5 0.7 3
21.7 0 0 2.2 30 1.5 0.7 33 3.7 0.7 14.2 0 0 1.5 0 0 6.7 0 0 3.7 15.7 0 0 0.7 16.5 0 4.5 3 3.7 1.5 4.5 -----
365
70-
-
74 3.2 7.6 11.9 2.2 1.1 0
14.1 5.4 0 8.6 38.9 2.2 22.7
16.2 1.1 20.5 5.4 7.6 3.2 0
60.5 4.3 0 3.2 31.4 1.1 0 3.2 30.3 1.1 2.2 31.4 5.4 4.3 9.7 0 0 1.1 0 0 3.2 0 0 6.5 9.7 1.1 0 1.1 15.1 0 3.2 1.1 3.2 1.1 5.4 -----
412
75+ 1.6 2.4 7.3 0 1.6 0 4.9 0 0 6.5 32
.7 0.8 19.6
19.6 0.8 11.4 8.2 4.9 1.6 3.3 28.6 2.4 1.6 3.3 37.6 0 0 2.4 14.7 2.4 1.6 19.6 5.7 0.8 11.4 0 0 0 0 0 3.3 1.6 0 2.4 6.5 0 0 0.8 15.5 0 1.6 3.3 4.1 0.8 4.1 -----
304
Crud
eRa
te 0.2 0.4 0.7 0.4 0.1 0 3.1 0.1 0 0.6 3.1 0.2 2.6 2.1 0.1 1.5 0.5 0.7 0.1 0.2 4.5 0.3 0.5 0.3 2 0 0 0.6 10.8 0.2 0.2 9.1 1.8 0.7 3.8 0.1 0.2 0.3 0 0 0.5 0 0.2 1.3 2.4 0.1 0 0.2 3.1 0 0.6 1 1.6 0.2 0.9 -----
64.4
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
38:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, O
TH
ER
S F
EM
AL
ES,
MA
LA
YSI
A, 2
007-
2011
ASR
Wor
ld 0.3 0.6 1.1 0.5 0.2 0.1 4 0.3 0 1 4.9 0.2 3.9 3.2 0.2 2.3 0.9 1 0.2 0.3 7.4 0.4 0.5 0.5 3.2 0.1 0 0.7 14.3 0.3 0.3 12 2.5 0.9 4.9 0.1 0.2 0.4 0 0 0.7 0.1 0.2 1.5 3.2 0.1 0 0.2 4.3 0 0.9 1 1.9 0.2 1.3 -----
89.6
118
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
7 55 71 33 22 24 382 15 4
106
237 24 487
605 16 550 90 159 30 134
759 14 44 16 120 5 3 40 16 14 383 71 5
118 3 2
183 2 10 168 53 2 17 83 492 0 68 138
286 15 80 -----
6261
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 4 8 0 0 0 1 1 0 0 21 4 2 0---
-- 43
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 1 2 0 0 12 4 1 0---
-- 30
10-
-
14 0 0 1 0 0 0 2 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9 0 0 2 2 6 0 0 9 9 1 0---
-- 46
15-
-
19 0 1 0 0 0 1 3 0 0 0 0 0 0 0 0 1 0 0 0 0 0 2 7 0 1 0 0 2 0 0 0 7 0 0 0 0 1 0 0 4 1 0 3 10 15 0 0 9 23 2 1---
-- 94
20-
-
24 0 1 0 2 0 0 6 0 0 1 1 1 5 1 0 2 0 0 1 0 2 3 8 2 0 0 1 1 0 0 1 14 0 1 0 0 0 0 0 8 2 0 0 17 20 0 0 15 22 2 1---
--14
1
25-
-
29 0 2 1 1 0 0 11 0 0 0 6 1 6 5 0 5 1 1 0 0 4 1 3 1 1 0 0 1 1 0 0 19 2 0 0 0 0 0 0 6 4 0 0 9 25 0 0 8 19 1 2---
--14
7
30-
-
34 0 3 0 3 0 0 27 0 0 0 7 1 5 16 0 9 0 2 0 0 11 1 0 0 4 0 0 5 1 0 1 12 0 1 0 0 0 0 1 10 1 0 1 6 24 0 2 8 16 0 3---
--18
1
35-
-
39 0 1 0 2 2 0 32 0 0 0 7 1 13 17 1 14 1 3 3 3 24 1 4 0 1 0 1 1 0 3 0 8 0 6 0 0 2 0 2 19 2 0 2 6 20 0 3 8 21 0 5---
--23
9
40-
-
44 0 2 2 1 0 2 54 0 0 5 12 0 30 25 2 31 7 7 3 3 38 0 5 1 6 1 0 2 0 1 2 2 0 8 0 0 8 0 0 11 4 0 2 8 29 0 2 9 32 1 4---
--36
2
45-
-
49 0 9 12 9 3 1 64 0 0 10 16 1 35 50 1 49 8 12 2 7 50 1 1 1 14 0 0 3 2 0 5 1 0 12 1 0 4 0 0 13 7 0 2 6 50 0 7 6 27 0 7---
--50
9
50-
-
54 3 5 13 3 3 3 55 5 0 11 36 0 52 67 1 85 12 22 4 23 83 1 2 2 6 1 0 4 4 2 9 3 0 14 0 0 15 0 1 19 7 0 0 4 56 0 9 5 17 0 14 -----
681
55-
-
59 1 9 11 3 2 2 55 3 1 17 24 7 81 73 4 89 14 31 6 16 102 0 2 2 18 0 0 9 3 1 38 0 0 25 0 0 24 0 0 15 5 0 1 5 67 0 17 12 25 1 12 -----
833
60-
-
64 1 10 6 3 6 4 32 2 2 24 28 4 73 91 1 87 15 30 4 30 129 1 5 1 19 0 0 4 3 2 63 3 1 18 0 1 28 1 0 12 8 1 2 2 71 0 9 7 14 1 9
-----
868
65-
-
69 1 5 7 4 3 2 23 1 0 14 38 2 62 94 3 74 16 22 2 24 122 2 3 2 13 2 0 3 0 1 85 0 1 9 1 0 35 0 1 12 8 0 1 1 50 0 7 4 22 1 7
-----
790
70-
-
74 1 5 6 0 3 4 10 4 0 11 31 5 71 91 2 63 11 16 2 17 107 1 1 3 8 1 0 1 1 1 91 0 1 16 1 1 27 0 0 8 2 1 0 3 32 0 7 3 15 2 10 -----
697
75+
0 2 12 2 0 5 8 0 1 13 31 1 54 75 1 40 5 13 2 11 87 0 0 1 28 0 1 1 1 3 88 2 0 7 0 0 39 1 1 7 2 0 1 2 24 0 5 2 16 0 5---
--60
0
% of
Total 0.1
0%0.9
0%1.1
0%0.5
0%0.4
0%0.4
0%6.1
0%0.2
0%0.1
0%1.7
0%3.8
0%0.4
0%7.8
0%9.7
0%0.3
0%8.8
0%1.4
0%2.5
0%0.5
0%2.1
0%12
.10%
0.20%
0.70%
0.30%
1.90%
0.10%
0.00%
0.60%
0.30%
0.20%
6.10%
1.10%
0.10%
1.90%
0.00%
0.00%
2.90%
0.00%
0.20%
2.70%
0.80%
0.00%
0.30%
1.30%
7.90%
0.00%
1.10%
2.20%
4.60%
0.20%
1.30% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
39:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
SE
LA
NG
OR
, AL
L R
ESI
DE
NT
S, M
AL
ES,
200
7-20
11
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
119
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
11 68 115 12 6 8
130 14 1 66 162 13 424
456 9
185 77 128 31 16 353 10 28 18 77 2 0 30
3159 18 12 53
733
6 68 508 9 1 62 2 2 58 1 6
131
210 7 14 74 338 0 59 101
227 22 72 -----
8484
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 1 0 0 2 0 0 0 0 1 7 0 0 0 0 2 0 0 13 8 0 0---
-- 37
5-
-
9 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 6 0 0 0 0 2 0 0 10 1 1 0---
-- 26
10-
-
14 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 7 0 0 1 0 0 0 0 1 2 2 0 1 0 7 0 0 4 6 2 0---
-- 38
15-
-
19 0 0 1 0 0 0 3 0 0 0 2 0 0 0 0 0 0 0 1 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 16 0 0 2 0 0 0 0 0 5 7 0 2 9 9 0 0 15 11 1 1---
-- 88
20-
-
24 0 0 1 1 0 0 6 0 0 0 1 0 4 2 0 0 1 0 1 0 0 1 2 1 0 0 0 2 9 0 0 3 0 0 13 0 0 0 0 0 0 0 0 5 16 0 0 16 19 0 0 9 16 0 3---
--13
2
25-
-
29 0 1 0 1 0 1 6 0 0 0 2 1 6 4 0 2 1 3 0 0 5 0 2 0 1 0 0 1 54 0 0 7 1 1 20 0 0 2 1 0 0 0 1 7 18 0 1 15 18 0 1 3 14 0 0---
--20
1
30-
-
34 0 3 0 0 0 0 4 0 0 0 5 1 11 7 0 5 1 1 0 1 4 1 3 1 2 0 0 414
9 0 0 14 15 4 13 0 0 3 0 0 0 0 0 9 16 0 0 12 17 0 0 5 18 2 1---
--33
2
35-
-
39 1 2 1 0 0 1 14 0 0 1 5 0 11 12 0 7 2 5 4 1 6 0 1 4 5 0 0 325
3 1 1 41 14 2 31 1 1 1 0 0 2 0 0 13 23 1 3 4 19 0 1 6 23 3 2---
--53
2
40-
-
44 0 5 5 2 0 0 18 0 0 5 7 1 23 19 2 10 3 5 1 0 20 1 7 1 6 0 0 143
2 0 0 55 31 4 58 2 0 4 0 0 2 0 1 9 27 3 1 5 20 0 7 4 13 2 5---
--82
7
45-
-
49 2 8 4 3 0 1 21 1 0 4 13 1 35 39 0 13 4 10 1 0 22 0 1 2 5 0 0 153
7 2 2 87 33 6 75 2 0 5 0 0 2 0 0 12 17 0 0 3 27 0 2 6 25 1 8---
--10
43
50-
-
54 2 10 15 3 0 1 16 1 0 4 17 3 37 58 0 23 4 18 2 1 44 2 2 1 7 0 0 153
0 1 0 82 51 15 88 2 0 10 0 0 4 0 0 12 18 1 1 4 49 0 3 9 19 6 5---
--11
82
55-
-
59 1 7 13 0 2 2 21 3 0 8 21 3 56 69 1 26 22 24 7 2 56 3 3 1 4 1 0 443
1 2 4 67 72 17 61 1 0 9 0 0 12 0 0 9 17 0 1 0 45 0 12 6 25 1 17 -----
1169
60-
-
64 0 12 22 0 1 0 6 2 0 11 23 1 73 63 2 20 9 24 2 2 46 1 0 3 7 0 0 228
5 2 0 63 60 5 43 0 0 8 0 0 8 1 2 11 14 1 2 2 28 0 12 7 22 1 8---
--91
7
65-
-
69 0 5 14 1 2 1 5 3 0 12 21 1 53 62 1 28 9 10 3 3 51 0 1 1 10 0 0 119
9 3 3 50 36 8 36 1 0 4 0 2 5 0 0 11 14 0 1 2 30 0 7 1 5 0 7---
--72
3
70-
-
74 2 11 23 1 1 1 8 2 0 10 17 0 57 60 0 20 11 17 1 3 42 1 1 2 11 1 0 315
6 3 1 40 12 2 22 0 0 4 0 0 8 0 0 9 10 1 1 0 21 0 9 1 12 0 7---
--62
5
75+
3 4 16 0 0 0 1 2 0 11 28 1 58 61 3 30 10 11 7 3 57 0 1 1 19 0 0 112
4 4 1 28 11 4 23 0 0 5 1 0 15 0 0 4 11 0 0 2 25 0 5 2 9 2 8---
--61
2
% of
Total
0.10%
0.80%
1.40%
0.10%
0.10%
0.10%
1.50%
0.20%
0.00%
0.80%
1.90%
0.20%
5.00%
5.40%
0.10%
2.20%
0.90%
1.50%
0.40%
0.20%
4.20%
0.10%
0.30%
0.20%
0.90%
0.00%
0.00%
0.40%
37.20
%0.2
0%0.1
0%6.3
0%4.0
0%0.8
0%6.0
0%0.1
0%0.0
0%0.7
0%0.0
0%0.0
0%0.7
0%0.0
0%0.1
0%1.5
0%2.5
0%0.1
0%0.2
0%0.9
0%4.0
0%0.0
0%0.7
0%1.2
0%2.7
0%0.3
0%0.8
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
40:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
SE
LA
NG
OR
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
200
7-20
11
120
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
7 55 71 33 22 24 382 15 4
106
237 24 487
605 16 550 90 159 30 134
759 14 44 16 120 5 3 40 16 14 383 71 5
118 3 2
183 2 10 168 53 2 17 83 492 0 68 138
286 15 80 -----
6261
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0.1 0 0 0 0 0.3 0.7 0 0 0 0.1 0.1 0 0 1.8 0.3 0.2 0---
-- 4
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0.1 0.2 0 0 1 0.3 0.1 0---
-- 3
10-
-
14 0 0 0.1 0 0 0 0.2 0 0 0 0 0 0 0 0 0.1 0 0 0.1 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0.2 0.2 0.5 0 0 0.8 0.8 0.1 0---
-- 4
15-
-
19 0 0.1 0 0 0 0.1 0.3 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0.2 0.6 0 0.1 0 0 0.2 0 0 0 0.6 0 0 0 0 0.1 0 0 0.4 0.1 0 0.3 0.9 1.3 0 0 0.8 2 0.2 0.1 ----- 8
20-
-
24 0 0.1 0 0.1 0 0 0.4 0 0 0.1 0.1 0.1 0.4 0.1 0 0.1 0 0 0.1 0 0.1 0.2 0.6 0.1 0 0 0.1 0.1 0 0 0.1 1 0 0.1 0 0 0 0 0 0.6 0.1 0 0 1.2 1.4 0 0 1.1 1.6 0.1 0.1 ----- 10
25-
-
29 0 0.1 0.1 0.1 0 0 0.8 0 0 0 0.4 0.1 0.4 0.4 0 0.4 0.1 0.1 0 0 0.3 0.1 0.2 0.1 0.1 0 0 0.1 0.1 0 0 1.4 0.1 0 0 0 0 0 0 0.4 0.3 0 0 0.7 1.8 0 0 0.6 1.4 0.1 0.1 ----- 11
30-
-
34 0 0.3 0 0.3 0 0 2.5 0 0 0 0.6 0.1 0.5 1.5 0 0.8 0 0.2 0 0 1 0.1 0 0 0.4 0 0 0.5 0.1 0 0.1 1.1 0 0.1 0 0 0 0 0.1 0.9 0.1 0 0.1 0.5 2.2 0 0.2 0.7 1.5 0 0.3 ----- 17
35-
-
39 0 0.1 0 0.2 0.2 0 3.3 0 0 0 0.7 0.1 1.3 1.8 0.1 1.4 0.1 0.3 0.3 0.3 2.5 0.1 0.4 0 0.1 0 0.1 0.1 0 0.3 0 0.8 0 0.6 0 0 0.2 0 0.2 2 0.2 0 0.2 0.6 2.1 0 0.3 0.8 2.2 0 0.5 ----- 25
40-
-
44 0 0.2 0.2 0.1 0 0.2 6.5 0 0 0.6 1.4 0 3.6 3 0.2 3.7 0.8 0.8 0.4 0.4 4.6 0 0.6 0.1 0.7 0.1 0 0.2 0 0.1 0.2 0.2 0 1 0 0 1 0 0 1.3 0.5 0 0.2 1 3.5 0 0.2 1.1 3.9 0.1 0.5 ----- 44
45-
-
49 0 1.2 1.6 1.2 0.4 0.1 8.8 0 0 1.4 2.2 0.1 4.8 6.9 0.1 6.7 1.1 1.6 0.3 1 6.9 0.1 0.1 0.1 1.9 0 0 0.4 0.3 0 0.7 0.1 0 1.6 0.1 0 0.5 0 0 1.8 1 0 0.3 0.8 6.9 0 1 0.8 3.7 0 1---
-- 70
50-
-
54 0.5 0.9 2.2 0.5 0.5 0.5 9.5 0.9 0 1.9 6.2 0 911
.6 0.2 14.7 2.1 3.8 0.7 4
14.3 0.2 0.3 0.3 1 0.2 0 0.7 0.7 0.3 1.6 0.5 0 2.4 0 0 2.6 0 0.2 3.3 1.2 0 0 0.7 9.7 0 1.6 0.9 2.9 0 2.4 -----
118
55-
-
59 0.2 2.1 2.6 0.7 0.5 0.5 12.8 0.7 0.2 4 5.6 1.6 18.9 17 0.9 20.7 3.3 7.2 1.4 3.7 23.8 0 0.5 0.5 4.2 0 0 2.1 0.7 0.2 8.9 0 0 5.8 0 0 5.6 0 0 3.5 1.2 0 0.2 1.2 15.6 0 4 2.8 5.8 0.2 2.8 -----
194
60-
-
64 0.3 3.3 2 1 2 1.3 10.5 0.7 0.7 7.9 9.2 1.3 24 29.9 0.3 28.6 4.9 9.9 1.3 9.9 42.4 0.3 1.6 0.3 6.3 0 0 1.3 1 0.7 20.7 1 0.3 5.9 0 0.3 9.2 0.3 0 3.9 2.6 0.3 0.7 0.7 23.4 0 3 2.3 4.6 0.3 3
-----
286
65-
-
69 0.6 2.8 3.9 2.2 1.7 1.1 12.8 0.6 0 7.8 21.2 1.1 34.5
52.4 1.7 41.2 8.9 12.3 1.1 13.4 68 1.1 1.7 1.1 7.2 1.1 0 1.7 0 0.6 47.4 0 0.6 5 0.6 0
19.5 0 0.6 6.7 4.5 0 0.6 0.6 27.9 0 3.9 2.2 12.3 0.6 3.9 -----
440
70-
-
74 0.8 3.9 4.7 0 2.3 3.1 7.8 3.1 0 8.6 24.2 3.9 55.5
71.1 1.6 49.2 8.6 12.5 1.6 13.3
83.6 0.8 0.8 2.3 6.3 0.8 0 0.8 0.8 0.8 71.1 0 0.8 12.5 0.8 0.8 21.1 0 0 6.3 1.6 0.8 0 2.3 25 0 5.5 2.3 11.7 1.6 7.8 -----
545
75+
0 1.6 9.3 1.6 0 3.9 6.2 0 0.8 10.1
24.1 0.8 42 58.4 0.8 31.1 3.9 10.1 1.6 8.6 67.7 0 0 0.8 21.8 0 0.8 0.8 0.8 2.3 68.5 1.6 0 5.4 0 0
30.4 0.8 0.8 5.4 1.6 0 0.8 1.6 18.7 0 3.9 1.6 12.5 0 3.9 -----
467
Crud
eRa
te 0.1 0.4 0.6 0.3 0.2 0.2 3 0.1 0 0.8 1.9 0.2 3.8 4.8 0.1 4.3 0.7 1.3 0.2 1.1 6 0.1 0.3 0.1 0.9 0 0 0.3 0.1 0.1 3 0.6 0 0.9 0 0 1.4 0 0.1 1.3 0.4 0 0.1 0.7 3.9 0 0.5 1.1 2.3 0.1 0.6 -----
49.3
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
41:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, S
EL
AN
GO
R, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011
ASR
Wor
ld 0.1 0.6 0.8 0.3 0.3 0.3 3.5 0.2 0.1 1.3 2.8 0.3 5.8 7.4 0.2 6.4 1.1 1.9 0.3 1.7 9.4 0.1 0.4 0.2 1.5 0.1 0 0.4 0.2 0.2 5.5 0.5 0.1 1.3 0 0 2.4 0 0.1 1.6 0.6 0 0.2 0.6 5.1 0 0.8 1.2 2.7 0.1 0.9 -----
71.3
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
121
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
11 68 115 12 6 8
130 14 1 66 162 13 424
456 9
185 77 128 31 16 353 10 28 18 77 2 0 30
3159 18 12 53
733
6 68 508 9 1 62 2 2 58 1 6
131
210 7 14 74 338 0 59 101
227 22 72 -----
8484
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.1 0 0 0.2 0 0 0 0 0.1 0.6 0 0 0 0 0.2 0 0 1.1 0.7 0 0---
-- 3
5-
-
9 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.1 0 0 0.2 0 0 0 0 0 0.5 0 0 0 0 0.2 0 0 0.9 0.1 0.1 0---
-- 2
10-
-
14 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0.2 0 0 0 0 0.1 0 0 0 0 0 0 0.7 0 0 0.1 0 0 0 0 0.1 0.2 0.2 0 0.1 0 0.7 0 0 0.4 0.6 0.2 0---
-- 4
15-
-
19 0 0 0.1 0 0 0 0.3 0 0 0 0.2 0 0 0 0 0 0 0 0.1 0 0 0 0.2 0 0 0 0 0.1 0 0 0 0 0 0 1.4 0 0 0.2 0 0 0 0 0 0.4 0.6 0 0.2 0.8 0.8 0 0 1.3 1 0.1 0.1 ----- 8
20-
-
24 0 0 0.1 0.1 0 0 0.4 0 0 0 0.1 0 0.3 0.1 0 0 0.1 0 0.1 0 0 0.1 0.1 0.1 0 0 0 0.1 0.6 0 0 0.2 0 0 0.9 0 0 0 0 0 0 0 0 0.3 1.1 0 0 1.1 1.3 0 0 0.6 1.1 0 0.2 ----- 9
25-
-
29 0 0.1 0 0.1 0 0.1 0.4 0 0 0 0.1 0.1 0.4 0.3 0 0.1 0.1 0.2 0 0 0.4 0 0.1 0 0.1 0 0 0.1 4 0 0 0.5 0.1 0.1 1.5 0 0 0.1 0.1 0 0 0 0.1 0.5 1.3 0 0.1 1.1 1.3 0 0.1 0.2 1 0 0---
-- 15
30-
-
34 0 0.3 0 0 0 0 0.4 0 0 0 0.5 0.1 1.1 0.7 0 0.5 0.1 0.1 0 0.1 0.4 0.1 0.3 0.1 0.2 0 0 0.4 14.7 0 0 1.4 1.5 0.4 1.3 0 0 0.3 0 0 0 0 0 0.9 1.6 0 0 1.2 1.7 0 0 0.5 1.8 0.2 0.1 ----- 33
35-
-
39 0.1 0.2 0.1 0 0 0.1 1.6 0 0 0.1 0.6 0 1.2 1.3 0 0.8 0.2 0.6 0.4 0.1 0.7 0 0.1 0.4 0.6 0 0 0.3 28.2 0.1 0.1 4.6 1.6 0.2 3.5 0.1 0.1 0.1 0 0 0.2 0 0 1.4 2.6 0.1 0.3 0.4 2.1 0 0.1 0.7 2.6 0.3 0.2 ----- 59
40-
-
44 0 0.6 0.6 0.3 0 0 2.3 0 0 0.6 0.9 0.1 3 2.5 0.3 1.3 0.4 0.6 0.1 0 2.6 0.1 0.9 0.1 0.8 0 0 0.1 56.1 0 0 7.1 4 0.5 7.5 0.3 0 0.5 0 0 0.3 0 0.1 1.2 3.5 0.4 0.1 0.6 2.6 0 0.9 0.5 1.7 0.3 0.6 -----
107
45-
-
49 0.3 1.2 0.6 0.5 0 0.2 3.2 0.2 0 0.6 2 0.2 5.4 6 0 2 0.6 1.5 0.2 0 3.4 0 0.2 0.3 0.8 0 0 0.2 82.6 0.3 0.3 13.4 5.1 0.9 11.5 0.3 0 0.8 0 0 0.3 0 0 1.8 2.6 0 0 0.5 4.2 0 0.3 0.9 3.8 0.2 1.2 -----
160
50-
-
54 0.4 1.9 2.9 0.6 0 0.2 3.1 0.2 0 0.8 3.2 0.6 7.1 11.1 0 4.4 0.8 3.4 0.4 0.2 8.4 0.4 0.4 0.2 1.3 0 0 0.2
101.3 0.2 0
15.7 9.7 2.9 16.8 0.4 0 1.9 0 0 0.8 0 0 2.3 3.4 0.2 0.2 0.8 9.4 0 0.6 1.7 3.6 1.1 1
-----
226
55-
-
59 0.2 1.7 3.2 0 0.5 0.5 5.2 0.7 0 2 5.2 0.7 14 17.2 0.2 6.5 5.5 6 1.7 0.5 14 0.7 0.7 0.2 1 0.2 0 1
107.5 0.5 1
16.7 18 4.2 15.2 0.2 0 2.2 0 0 3 0 0 2.2 4.2 0 0.2 0
11.2 0 3 1.5 6.2 0.2 4.2 -----
292
60-
-
64 0 3.9 7.1 0 0.3 0 1.9 0.6 0 3.5 7.4 0.3 23.5
20.3 0.6 6.4 2.9 7.7 0.6 0.6 14.8 0.3 0 1 2.3 0 0 0.6 91.8 0.6 0
20.3
19.3 1.6 13.9 0 0 2.6 0 0 2.6 0.3 0.6 3.5 4.5 0.3 0.6 0.6 9 0 3.9 2.3 7.1 0.3 2.6 -----
295
65-
-
69 0 2.9 8.2 0.6 1.2 0.6 2.9 1.8 0 712
.3 0.6 31.1
36.4 0.6 16.4 5.3 5.9 1.8 1.8 29.9 0 0.6 0.6 5.9 0 0 0.6
116.7 1.8 1.8 29.3
21.1 4.7 21.1 0.6 0 2.3 0 1.2 2.9 0 0 6.5 8.2 0 0.6 1.2 17.6 0 4.1 0.6 2.9 0 4.1 -----
424
70-
-
74 1.5 8.3 17.3 0.8 0.8 0.8 6 1.5 0 7.5 12.8 0
42.9
45.1 0 15 8.3 12.8 0.8 2.3 31.6 0.8 0.8 1.5 8.3 0.8 0 2.3
117.3 2.3 0.8 30.1 9 1.5 16.5 0 0 3 0 0 6 0 0 6.8 7.5 0.8 0.8 0
15.8 0 6.8 0.8 9 0 5.3 -----
470
75+ 1.9 2.5 10 0 0 0 0.6 1.2 0 6.9 17
.4 0.6 36.1 38 1.9 18.7 6.2 6.9 4.4 1.9 35.5 0 0.6 0.6 11.8 0 0 0.6 77.3 2.5 0.6 17.4 6.9 2.5 14.3 0 0 3.1 0.6 0 9.3 0 0 2.5 6.9 0 0 1.2 15.6 0 3.1 1.2 5.6 1.2 5
-----
381
Crud
eRa
te 0.1 0.6 0.9 0.1 0 0.1 1.1 0.1 0 0.5 1.3 0.1 3.5 3.7 0.1 1.5 0.6 1 0.3 0.1 2.9 0.1 0.2 0.1 0.6 0 0 0.2 25.8 0.1 0.1 4.4 2.7 0.6 4.1 0.1 0 0.5 0 0 0.5 0 0 1.1 1.7 0.1 0.1 0.6 2.8 0 0.5 0.8 1.9 0.2 0.6 -----
69.3
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
42:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, S
EL
AN
GO
R, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011
ASR
Wor
ld 0.1 0.8 1.4 0.1 0.1 0.1 1.2 0.2 0 0.8 1.9 0.1 5.1 5.5 0.1 2.2 0.9 1.5 0.3 0.2 4.3 0.1 0.2 0.2 0.9 0 0 0.3 31.7 0.2 0.1 5.7 3.7 0.7 5.1 0.1 0 0.7 0 0 0.7 0 0.1 1.3 1.9 0.1 0.1 0.5 3.4 0 0.7 0.9 2.1 0.2 0.8 -----
89.7
122
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
3 59 51 35 16 10 524 21 0
105
310 27 571
584 18 413 48 157 33 116
1289 28 59 18 20
6 2 2 84 21 17 548 82 7
144 1 6
250 4 9
172 79 6 9 49 407 0 82 103
191 98 128
-----
7202
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 1 1 0 0 0 3 0 0 0 5 1 2 0 0 0 0 6 17 0 2 0 0 5 0 0 23 18 24 2---
--11
7
5-
-
9 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 3 0 1 0 0 3 0 0 0 1 0 0 0 0 0 0 0 6 0 0 1 1 6 0 0 18 8 14 0---
-- 65
10-
-
14 0 0 1 0 0 0 4 0 0 0 0 0 0 0 0 2 0 0 0 0 0 3 9 0 1 0 0 0 0 0 0 4 0 3 0 0 0 0 0 5 0 1 1 0 5 0 0 12 4 12 1---
-- 68
15-
-
19 0 0 0 0 0 0 6 0 0 0 0 0 1 1 0 2 0 0 1 0 1 1 16 1 0 0 0 7 0 0 0 5 3 0 0 0 0 0 0 9 1 0 0 7 16 0 0 4 11 10 3---
--10
6
20-
-
24 0 1 0 4 0 0 3 0 0 0 0 1 1 3 0 0 0 0 0 0 6 2 3 1 1 0 0 0 0 1 0 9 0 0 0 0 0 0 0 6 4 0 1 9 23 0 0 6 13 5 2---
--10
5
25-
-
29 0 2 0 2 0 0 9 0 0 0 0 1 2 1 0 2 0 1 0 0 9 3 6 0 4 0 0 3 0 0 0 18 0 0 0 0 2 0 0 8 7 0 0 6 7 0 0 4 18 6 3---
--12
4
30-
-
34 0 2 0 3 0 0 30 0 0 1 6 1 10 8 0 9 0 4 0 0 12 2 1 0 5 0 0 2 0 0 0 8 1 5 0 0 0 0 0 8 3 0 0 4 14 0 0 4 11 1 2---
--15
7
35-
-
39 0 3 1 3 0 0 45 0 0 1 5 1 17 9 1 10 0 3 5 0 18 2 2 2 4 0 1 4 1 2 0 11 0 3 0 0 2 0 0 6 3 0 1 3 30 0 2 2 10 4 6---
--22
3
40-
-
44 1 8 6 0 1 0 66 1 0 5 10 1 28 15 2 28 4 7 1 3 45 3 2 0 4 0 0 6 2 1 4 9 0 7 0 0 9 0 0 13 5 0 1 3 27 0 7 6 15 3 4---
--36
3
45-
-
49 0 7 3 3 3 0 71 0 0 8 20 6 41 44 2 36 1 9 6 9 80 3 2 0 15 0 0 12 0 2 6 5 0 14 1 0 14 0 0 18 9 1 1 3 29 0 12 4 17 3 9---
--52
9
50-
-
54 0 9 4 1 3 0 99 0 0 13 22 1 60 63 6 66 6 17 4 10 138 1 2 1 18 0 0 10 2 2 13 2 1 17 0 0 14 0 1 11 10 0 2 4 52 0 10 5 21 1 19 -----
741
55-
-
59 1 4 4 5 4 2 62 3 0 16 30 4 84 66 1 71 7 18 3 19 166 2 6 2 18 0 0 7 2 1 40 1 0 23 0 0 26 2 0 27 14 1 1 1 48 0 13 6 12 3 14 -----
840
60-
-
64 0 6 10 6 3 1 52 5 0 20 49 4 77 116 3 69 9 36 5 26 205 2 2 3 31 1 0 12 4 0 88 0 0 32 0 2 39 1 0 11 6 0 0 1 45 0 16 2 11 2 19 -----
1032
65-
-
69 0 7 6 1 0 1 45 4 0 14 50 3 73 105 1 42 6 28 3 17 212 1 2 3 33 0 1 6 3 6
125 2 1 19 0 4 36 1 1 10 10 0 0 2 45 0 11 3 9 3 20 -----
975
70-
-
74 0 5 5 4 1 2 20 5 0 17 53 3 88 69 1 38 6 19 2 13 216 2 2 2 34 1 0 3 2 1
128 1 0 16 0 0 46 0 0 9 2 0 0 1 32 0 6 1 6 5 10 -----
877
75+
1 5 11 2 1 3 10 3 0 10 65 1 89 84 1 33 9 15 2 19 181 1 0 2 37 0 0 6 5 1
144 1 0 3 0 0 62 0 1 8 5 1 0 4 23 0 5 3 7 2 14 -----
880
% of
Total 0.0
0%0.8
0%0.7
0%0.5
0%0.2
0%0.1
0%7.3
0%0.3
0%0.0
0%1.5
0%4.3
0%0.4
0%7.9
0%8.1
0%0.2
0%5.7
0%0.7
0%2.2
0%0.5
0%1.6
0%17
.90%
0.40%
0.80%
0.20%
2.90%
0.00%
0.00%
1.20%
0.30%
0.20%
7.60%
1.10%
0.10%
2.00%
0.00%
0.10%
3.50%
0.10%
0.10%
2.40%
1.10%
0.10%
0.10%
0.70%
5.70%
0.00%
1.10%
1.40%
2.70%
1.40%
1.80% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
43:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
JO
HO
R, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
123
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
1 40 40 35 6 217
2 10 3 47 208 12 490
420 10 144 55 119 14 10 487 12 41 18 157 2 0 69
2792 18 19 51
832
6 52 446 7 8 62 0 1 58 1 9
124
265 7 5 35 285 1 55 66 148 74 104
-----
8110
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 2 0 0 0 1 0 0 2 0 1 0 0 1 0 0 0 0 0 0 2 0 0 1 0 0 0 0 3 7 0 1 0 0 8 0 0 14 8 20 2---
-- 74
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 1 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 9 1 1 0 0 3 0 0 13 3 12 1---
-- 49
10-
-
14 0 0 0 0 0 0 2 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 7 0 1 0 0 3 0 0 0 0 0 0 5 0 0 1 0 0 0 0 0 12 3 0 0 1 6 0 0 7 5 5 0---
-- 61
15-
-
19 0 0 0 3 0 0 0 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 5 0 1 0 0 6 0 0 0 0 0 0 11 0 0 0 0 0 0 0 0 5 5 1 0 4 19 0 0 3 5 7 0---
-- 78
20-
-
24 0 0 0 1 0 0 2 1 0 0 3 0 3 1 0 2 0 2 0 0 0 1 4 0 2 0 0 2 9 0 0 0 0 0 16 0 1 2 0 0 0 0 0 2 18 1 0 8 15 0 0 4 11 0 6---
--11
7
25-
-
29 0 1 0 2 0 0 5 1 0 0 3 0 6 2 0 1 0 1 0 0 2 2 3 1 2 0 0 8 34 0 1 10 5 1 13 0 0 0 0 0 0 0 0 7 25 1 0 6 15 0 0 4 8 3 5---
--17
8
30-
-
34 0 0 0 0 0 0 13 0 0 0 4 0 10 7 0 3 1 4 1 0 5 0 1 0 5 0 0 111
3 1 0 17 7 3 18 2 2 1 0 0 1 0 0 4 25 0 1 2 9 0 0 1 11 1 5---
--27
9
35-
-
39 0 2 0 1 0 0 17 0 0 0 5 0 21 20 0 8 1 2 1 0 12 1 1 2 2 0 0 422
1 1 0 29 20 4 24 0 2 2 0 0 0 0 0 6 30 1 0 0 15 0 2 1 14 0 5---
--47
7
40-
-
44 0 4 2 7 0 0 23 0 1 3 12 0 21 23 2 11 2 8 3 0 26 0 4 0 5 0 0 837
1 0 0 47 32 8 44 1 1 4 0 0 4 0 0 9 24 0 1 2 17 0 2 2 9 0 6---
--74
9
45-
-
49 0 4 1 3 2 0 28 0 0 2 16 0 23 36 1 9 2 4 1 0 51 3 1 1 4 0 0 850
3 0 2 85 36 10 68 1 2 9 0 0 6 0 2 13 23 0 2 4 29 0 5 4 14 5 8---
--10
31
50-
-
54 0 8 4 2 2 0 30 1 0 7 21 1 41 52 1 13 4 5 2 0 42 0 1 3 12 0 0 347
4 3 1 79 52 2 72 0 0 7 0 1 7 0 1 17 33 0 0 1 31 0 7 4 15 2 13 -----
1077
55-
-
59 0 4 5 5 0 0 20 1 1 4 22 2 69 51 1 14 8 23 0 0 63 1 2 3 16 1 0 643
2 4 2 86 62 7 65 2 0 11 0 0 7 0 1 7 25 0 1 3 19 0 8 4 17 4 11 -----
1100
60-
-
64 0 5 5 3 1 0 20 2 1 11 23 1 69 49 0 19 7 18 1 2 73 1 1 1 16 0 0 728
1 2 1 59 44 11 41 0 0 10 0 0 8 1 1 8 19 0 0 0 31 1 10 2 11 5 11 -----
893
65-
-
69 0 2 7 3 1 0 5 0 0 7 25 3 56 48 1 19 6 20 2 1 67 0 2 3 13 0 0 416
0 2 3 31 27 2 28 1 0 4 0 0 4 0 0 12 18 0 0 0 27 0 6 1 3 4 7---
--63
5
70-
-
74 1 5 5 4 0 1 2 4 0 3 28 1 68 59 2 16 9 11 2 4 65 1 2 1 25 1 0 310
4 3 5 40 24 2 25 0 0 3 0 0 10 0 0 4 8 0 0 1 21 0 7 1 4 2 13 -----
600
75+
0 5 11 1 0 1 4 0 0 10 44 410
1 71 2 26 15 21 1 2 81 0 4 3 52 0 0 3 90 2 4 35 17 2 14 0 0 7 0 0 11 0 0 2 8 1 0 3 20 0 8 1 10 4 11 -----
712
% of
Total
0.00%
0.50%
0.50%
0.40%
0.10%
0.00%
2.10%
0.10%
0.00%
0.60%
2.60%
0.10%
6.00%
5.20%
0.10%
1.80%
0.70%
1.50%
0.20%
0.10%
6.00%
0.10%
0.50%
0.20%
1.90%
0.00%
0.00%
0.90%
34.40
%0.2
0%0.2
0%6.4
0%4.0
0%0.6
0%5.5
0%0.1
0%0.1
0%0.8
0%0.0
0%0.0
0%0.7
0%0.0
0%0.1
0%1.5
0%3.3
0%0.1
0%0.1
0%0.4
0%3.5
0%0.0
0%0.7
0%0.8
0%1.8
0%0.9
0%1.3
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
44:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
JO
HO
R, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011
124
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
3 59 51 35 16 10 524 21 0
105
310 27 571
584 18 413 48 157 33 116
1289 28 59 18 20
6 2 2 84 21 17 548 82 7
144 1 6
250 4 9
172 79 6 9 49 407 0 82 103
191 98 128
-----
7202
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0.1 0.1 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0.1 0.1 0 0 0 0.4 0 0 0 0.7 0.1 0.3 0 0 0 0 0.8 2.3 0 0.3 0 0 0.7 0 0 3.2 2.5 3.3 0.3 ----- 16
5-
-
9 0 0 0 0.1 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0.4 0 0.1 0 0 0.4 0 0 0 0.1 0 0 0 0 0 0 0 0.8 0 0 0.1 0.1 0.8 0 0 2.3 1 1.8 0---
-- 8
10-
-
14 0 0 0.1 0 0 0 0.5 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0.4 1.1 0 0.1 0 0 0 0 0 0 0.5 0 0.4 0 0 0 0 0 0.6 0 0.1 0.1 0 0.6 0 0 1.5 0.5 1.5 0.1 ----- 9
15-
-
19 0 0 0 0 0 0 0.8 0 0 0 0 0 0.1 0.1 0 0.3 0 0 0.1 0 0.1 0.1 2.2 0.1 0 0 0 1 0 0 0 0.7 0.4 0 0 0 0 0 0 1.2 0.1 0 0 1 2.2 0 0 0.5 1.5 1.4 0.4 ----- 14
20-
-
24 0 0.1 0 0.6 0 0 0.4 0 0 0 0 0.1 0.1 0.4 0 0 0 0 0 0 0.8 0.3 0.4 0.1 0.1 0 0 0 0 0.1 0 1.2 0 0 0 0 0 0 0 0.8 0.6 0 0.1 1.2 3.2 0 0 0.8 1.8 0.7 0.3 ----- 15
25-
-
29 0 0.3 0 0.3 0 0 1.3 0 0 0 0 0.1 0.3 0.1 0 0.3 0 0.1 0 0 1.3 0.4 0.9 0 0.6 0 0 0.4 0 0 0 2.6 0 0 0 0 0.3 0 0 1.2 1 0 0 0.9 1 0 0 0.6 2.6 0.9 0.4 ----- 18
30-
-
34 0 0.3 0 0.5 0 0 5.2 0 0 0.2 1 0.2 1.7 1.4 0 1.6 0 0.7 0 0 2.1 0.3 0.2 0 0.9 0 0 0.3 0 0 0 1.4 0.2 0.9 0 0 0 0 0 1.4 0.5 0 0 0.7 2.4 0 0 0.7 1.9 0.2 0.3 ----- 27
35-
-
39 0 0.6 0.2 0.6 0 0 8.3 0 0 0.2 0.9 0.2 3.2 1.7 0.2 1.9 0 0.6 0.9 0 3.3 0.4 0.4 0.4 0.7 0 0.2 0.7 0.2 0.4 0 2 0 0.6 0 0 0.4 0 0 1.1 0.6 0 0.2 0.6 5.6 0 0.4 0.4 1.9 0.7 1.1 ----- 41
40-
-
44 0.2 1.6 1.2 0 0.2 013
.2 0.2 0 1 2 0.2 5.6 3 0.4 5.6 0.8 1.4 0.2 0.6 9 0.6 0.4 0 0.8 0 0 1.2 0.4 0.2 0.8 1.8 0 1.4 0 0 1.8 0 0 2.6 1 0 0.2 0.6 5.4 0 1.4 1.2 3 0.6 0.8 ----- 72
45-
-
49 0 1.5 0.7 0.7 0.7 015
.6 0 0 1.8 4.4 1.3 9 9.6 0.4 7.9 0.2 2 1.3 217
.5 0.7 0.4 0 3.3 0 0 2.6 0 0.4 1.3 1.1 0 3.1 0.2 0 3.1 0 0 3.9 2 0.2 0.2 0.7 6.4 0 2.6 0.9 3.7 0.7 2---
--11
6
50-
-
54 0 2.3 1 0.3 0.8 025
.6 0 0 3.4 5.7 0.3 15.5
16.3 1.6 17.1 1.6 4.4 1 2.6 35.7 0.3 0.5 0.3 4.7 0 0 2.6 0.5 0.5 3.4 0.5 0.3 4.4 0 0 3.6 0 0.3 2.8 2.6 0 0.5 1
13.4 0 2.6 1.3 5.4 0.3 4.9 -----
191
55-
-
59 0.3 1.3 1.3 1.6 1.3 0.6 20.1 1 0 5.2 9.7 1.3 27.3
21.4 0.3 23.1 2.3 5.8 1 6.2 53.9 0.6 1.9 0.6 5.8 0 0 2.3 0.6 0.3 13 0.3 0 7.5 0 0 8.4 0.6 0 8.8 4.5 0.3 0.3 0.3 15.6 0 4.2 1.9 3.9 1 4.5 -----
273
60-
-
64 0 2.6 4.3 2.6 1.3 0.4 22.3 2.1 0 8.6 21 1.7 33.1
49.8 1.3 29.6 3.9 15.5 2.1 11.2 88 0.9 0.9 1.3 13.3 0.4 0 5.2 1.7 0
37.8 0 0
13.7 0 0.9 16.7 0.4 0 4.7 2.6 0 0 0.4 19.3 0 6.9 0.9 4.7 0.9 8.2 -----
443
65-
-
69 0 4.5 3.8 0.6 0 0.6 28.8 2.6 0 8.9 32 1.9 46.7
67.1 0.6 26.8 3.8 17.9 1.9 10.9
135.5 0.6 1.3 1.9 21.1 0 0.6 3.8 1.9 3.8 79.9 1.3 0.6 12.1 0 2.6 23 0.6 0.6 6.4 6.4 0 0 1.3 28.8 0 7 1.9 5.8 1.9 12.8 -----
623
70-
-
74 0 4.3 4.3 3.4 0.9 1.7 17 4.3 014
.545
.1 2.6 74.9
58.7 0.9 32.3 5.1 16.2 1.7 11.1
183.9 1.7 1.7 1.7 28.9 0.9 0 2.6 1.7 0.9 109 0.9 0
13.6 0 0
39.2 0 0 7.7 1.7 0 0 0.9 27.2 0 5.1 0.9 5.1 4.3 8.5 -----
746
75+ 0.8 4.1 9 1.6 0.8 2.4 8.2 2.4 0 8.2 53
.1 0.8 72.7
68.6 0.8 26.9 7.3 12.2 1.6 15.5
147.8 0.8 0 1.6 30.2 0 0 4.9 4.1 0.8
117.6 0.8 0 2.4 0 0
50.6 0 0.8 6.5 4.1 0.8 0 3.3 18.8 0 4.1 2.4 5.7 1.6 11.4 -----
718
Crud
eRa
te 0 0.8 0.7 0.4 0.2 0.1 6.7 0.3 0 1.3 4 0.3 7.3 7.4 0.2 5.3 0.6 2 0.4 1.5 16.4 0.4 0.8 0.2 2.6 0 0 1.1 0.3 0.2 7 1 0.1 1.8 0 0.1 3.2 0.1 0.1 2.2 1 0.1 0.1 0.6 5.2 0 1 1.3 2.4 1.2 1.6 -----
91.8
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
45:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, J
OH
OR
, AL
L R
ESI
DE
NT
S, M
AL
ES,
200
7-20
11
ASR
Wor
ld 0 0.8 0.8 0.5 0.2 0.2 7.2 0.3 0 1.6 4.9 0.4 8.8 9.2 0.3 6.1 0.7 2.5 0.5 1.8 20.3 0.4 0.8 0.3 3.2 0 0 1.2 0.3 0.3 9.3 1 0.1 2.2 0 0.1 4 0.1 0.1 2.4 1.1 0.1 0.1 0.6 5.8 0 1.2 1.4 2.6 1.3 1.9 -----
109
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
125
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
1 40 40 35 6 217
2 10 3 47 208 12 490
420 10 144 55 119 14 10 487 12 41 18 157 2 0 69
2792 18 19 51
832
6 52 446 7 8 62 0 1 58 1 9
124
265 7 5 35 285 1 55 66 148 74 104
-----
8110
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.3 0 0 0 0.1 0 0 0.3 0 0.1 0 0 0.1 0 0 0 0 0 0 0.3 0 0 0.1 0 0 0 0 0.4 1 0 0.1 0 0 1.2 0 0 2.1 1.2 2.9 0.3 ----- 11
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0.1 0.1 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 1.2 0.1 0.1 0 0 0.4 0 0 1.8 0.4 1.6 0.1 ----- 7
10-
-
14 0 0 0 0 0 0 0.3 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.1 1 0 0.1 0 0 0.4 0 0 0 0 0 0 0.7 0 0 0.1 0 0 0 0 0 1.6 0.4 0 0 0.1 0.8 0 0 1 0.7 0.7 0---
-- 8
15-
-
19 0 0 0 0.4 0 0 0 0 0 0 0.3 0 0 0 0 0.1 0 0 0 0 0 0 0.7 0 0.1 0 0 0.9 0 0 0 0 0 0 1.6 0 0 0 0 0 0 0 0 0.7 0.7 0.1 0 0.6 2.8 0 0 0.4 0.7 1 0---
-- 11
20-
-
24 0 0 0 0.1 0 0 0.3 0.1 0 0 0.4 0 0.4 0.1 0 0.3 0 0.3 0 0 0 0.1 0.6 0 0.3 0 0 0.3 1.3 0 0 0 0 0 2.4 0 0.1 0.3 0 0 0 0 0 0.3 2.6 0.1 0 1.2 2.2 0 0 0.6 1.6 0 0.9 ----- 17
25-
-
29 0 0.2 0 0.3 0 0 0.8 0.2 0 0 0.5 0 0.9 0.3 0 0.2 0 0.2 0 0 0.3 0.3 0.5 0.2 0.3 0 0 1.2 5.2 0 0.2 1.5 0.8 0.2 2 0 0 0 0 0 0 0 0 1.1 3.9 0.2 0 0.9 2.3 0 0 0.6 1.2 0.5 0.8 ----- 27
30-
-
34 0 0 0 0 0 0 2.5 0 0 0 0.8 0 1.9 1.3 0 0.6 0.2 0.8 0.2 0 0.9 0 0.2 0 0.9 0 0 0.2 21.4 0.2 0 3.2 1.3 0.6 3.4 0.4 0.4 0.2 0 0 0.2 0 0 0.8 4.7 0 0.2 0.4 1.7 0 0 0.2 2.1 0.2 0.9 ----- 53
35-
-
39 0 0.4 0 0.2 0 0 3.3 0 0 0 1 0 4.1 3.9 0 1.6 0.2 0.4 0.2 0 2.4 0.2 0.2 0.4 0.4 0 0 0.8 43.3 0.2 0 5.7 3.9 0.8 4.7 0 0.4 0.4 0 0 0 0 0 1.2 5.9 0.2 0 0 2.9 0 0.4 0.2 2.7 0 1
----- 93
40-
-
44 0 0.8 0.4 1.5 0 0 4.8 0 0.2 0.6 2.5 0 4.4 4.8 0.4 2.3 0.4 1.7 0.6 0 5.4 0 0.8 0 1 0 0 1.7 77.1 0 0 9.8 6.6 1.7 9.1 0.2 0.2 0.8 0 0 0.8 0 0 1.9 5 0 0.2 0.4 3.5 0 0.4 0.4 1.9 0 1.2 -----
156
45-
-
49 0 0.9 0.2 0.7 0.5 0 6.6 0 0 0.5 3.8 0 5.5 8.5 0.2 2.1 0.5 0.9 0.2 012
.1 0.7 0.2 0.2 0.9 0 0 1.911
9.2 0 0.5 20.1 8.5 2.4 16.1 0.2 0.5 2.1 0 0 1.4 0 0.5 3.1 5.5 0 0.5 0.9 6.9 0 1.2 0.9 3.3 1.2 1.9 -----
244
50-
-
54 0 2.2 1.1 0.5 0.5 0 8.1 0.3 0 1.9 5.7 0.3 11 14 0.3 3.5 1.1 1.3 0.5 011
.3 0 0.3 0.8 3.2 0 0 0.812
7.6 0.8 0.3 21.3 14 0.5 19.4 0 0 1.9 0 0.3 1.9 0 0.3 4.6 8.9 0 0 0.3 8.3 0 1.9 1.1 4 0.5 3.5 -----
290
55-
-
59 0 1.4 1.7 1.7 0 0 6.9 0.3 0.3 1.4 7.6 0.7 23.7
17.5 0.3 4.8 2.7 7.9 0 0
21.7 0.3 0.7 1 5.5 0.3 0 2.1
148.5 1.4 0.7 29
.621
.3 2.4 22.3 0.7 0 3.8 0 0 2.4 0 0.3 2.4 8.6 0 0.3 1 6.5 0 2.7 1.4 5.8 1.4 3.8 -----
378
60-
-
64 0 2.2 2.2 1.3 0.4 0 8.9 0.9 0.4 4.9 10.2 0.4 30.7
21.8 0 8.5 3.1 8 0.4 0.9 32.5 0.4 0.4 0.4 7.1 0 0 3.1
125.2 0.9 0.4 26.3
19.6 4.9 18.3 0 0 4.5 0 0 3.6 0.4 0.4 3.6 8.5 0 0 0
13.8 0.4 4.5 0.9 4.9 2.2 4.9 -----
398
65-
-
69 0 1.4 4.8 2.1 0.7 0 3.4 0 0 4.8 17.1 2.1 38.4
32.9 0.7 13 4.1 13.7 1.4 0.7 45.9 0 1.4 2.1 8.9 0 0 2.7
109.6 1.4 2.1 21.2
18.5 1.4 19.2 0.7 0 2.7 0 0 2.7 0 0 8.2 12.3 0 0 0
18.5 0 4.1 0.7 2.1 2.7 4.8 -----
435
70-
-
74 0.9 4.3 4.3 3.4 0 0.9 1.7 3.4 0 2.6 23.8 0.9 57.9
50.2 1.7 13.6 7.7 9.4 1.7 3.4 55.3 0.9 1.7 0.9 21.3 0.9 0 2.6 88.5 2.6 4.3 34 20.4 1.7 21.3 0 0 2.6 0 0 8.5 0 0 3.4 6.8 0 0 0.9 17.9 0 6 0.9 3.4 1.7 11.1 -----
511
75+
0 3.5 7.6 0.7 0 0.7 2.8 0 0 6.9 30.5 2.8 69.9
49.1 1.4 18 10.4
14.5 0.7 1.4 56.1 0 2.8 2.1 36 0 0 2.1 62.3 1.4 2.8 24.2
11.8 1.4 9.7 0 0 4.8 0 0 7.6 0 0 1.4 5.5 0.7 0 2.1 13.8 0 5.5 0.7 6.9 2.8 7.6 -----
493
Crud
eRa
te
0 0.5 0.5 0.5 0.1 0 2.3 0.1 0 0.6 2.8 0.2 6.6 5.7 0.1 1.9 0.7 1.6 0.2 0.1 6.6 0.2 0.6 0.2 2.1 0 0 0.9 37.7 0.2 0.3 7 4.4 0.7 6 0.1 0.1 0.8 0 0 0.8 0 0.1 1.7 3.6 0.1 0.1 0.5 3.8 0 0.7 0.9 2 1 1.4 -----
109.5
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
46:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, J
OH
OR
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
200
7-20
11
ASR
Wor
ld 0 0.6 0.6 0.5 0.1 0 2.4 0.2 0 0.7 3.2 0.2 7.5 6.4 0.1 2.2 0.8 1.9 0.2 0.2 7.6 0.2 0.6 0.3 2.4 0 0 139
.8 0.3 0.3 7.6 4.8 0.8 6.4 0.1 0.1 0.9 0 0 0.9 0 0.1 1.8 3.6 0.1 0.1 0.5 4.2 0 0.9 0.9 2 1.1 1.5 -----
118.7
126
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
2 32 32 17 9 536
9 24 3 48 253 17 336
174 9
236 24 49 18 35 482 29 33 33 125 4 5 31 14 14 199 32 1 32 0 1 73 1 14 80 55 6 1 20 241 0 32 95 112 5 60 -----
3522
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 8 0 3 0 0 0 0 9 8 0 0 0 0 3 0 0 32 10 0 4---
-- 82
5-
-
9 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 3 0 0 0 0 8 0 0 24 6 1 2---
-- 49
10-
-
14 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 2 0 0 1 6 0 0 7 7 0 2---
-- 39
15-
-
19 0 1 0 1 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 7 1 0 0 0 1 0 0 1 2 0 0 0 0 1 0 0 5 0 0 0 2 12 0 0 8 6 0 0---
-- 57
20-
-
24 0 0 0 2 0 0 11 0 0 0 1 0 4 1 0 0 1 1 0 0 0 0 6 0 0 0 1 1 0 0 0 5 0 0 0 0 0 0 0 3 0 0 0 3 3 0 0 3 13 0 1---
-- 60
25-
-
29 0 1 3 1 0 0 12 0 0 0 4 0 11 2 0 2 1 0 1 0 5 0 1 1 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 6 2 1 0 0 9 0 1 5 5 0 0---
-- 77
30-
-
34 0 0 2 1 0 0 18 0 0 1 3 1 9 5 1 4 0 1 1 0 3 0 1 1 4 0 1 2 0 1 0 3 0 1 0 0 1 0 0 4 0 0 0 2 13 0 0 2 6 0 0---
-- 92
35-
-
39 0 0 3 2 0 0 23 0 0 0 7 0 13 6 0 7 0 1 0 1 12 4 0 2 6 0 0 3 0 1 0 5 0 1 0 0 1 0 0 3 2 0 0 1 11 0 0 4 7 1 2---
--12
9
40-
-
44 2 1 0 0 0 0 35 1 0 1 11 3 20 14 1 15 1 2 3 0 18 1 2 1 4 0 1 2 2 3 0 2 0 2 0 0 2 0 0 7 5 1 0 0 13 0 1 1 4 1 1---
--18
4
45-
-
49 0 2 3 0 1 0 64 0 0 3 20 1 18 20 1 19 2 5 1 3 42 2 2 1 6 1 0 2 3 2 0 0 1 1 0 0 6 0 3 4 5 0 0 3 23 0 4 1 6 0 1---
--28
2
50-
-
54 0 3 3 1 2 0 55 0 1 5 19 3 35 24 0 31 2 3 3 3 50 4 0 6 9 1 1 2 1 2 10 2 0 7 0 0 8 0 2 8 9 2 0 1 31 0 5 4 9 0 5---
--37
2
55-
-
59 0 4 3 2 0 0 48 1 1 8 32 2 41 19 0 33 4 7 0 5 68 2 3 3 12 0 1 3 3 3 19 1 0 5 0 0 8 0 0 8 8 0 1 2 22 0 6 2 11 1 16 -----
418
60-
-
64 0 3 4 2 2 1 31 3 0 1 29 3 44 15 1 40 3 6 2 7 78 3 1 6 13 0 0 2 0 0 26 0 0 5 0 0 3 0 0 4 3 1 0 2 27 0 3 1 3 0 7---
--38
5
65-
-
69 0 8 2 2 3 0 27 7 0 9 44 3 40 31 1 35 3 9 4 5 86 8 3 4 20 1 0 7 2 1 41 0 0 3 0 0 16 0 0 4 10 0 0 1 21 0 6 0 8 1 9---
--48
5
70-
-
74 0 5 3 2 1 3 19 6 0 10 40 1 40 13 3 25 4 5 2 7 56 2 2 3 25 0 0 0 3 0 42 1 0 3 0 1 13 0 0 6 6 1 0 0 21 0 3 0 7 0 4---
--38
8
75+
0 4 6 1 0 1 11 5 1 10 43 0 61 24 1 23 3 9 0 4 63 3 0 4 26 1 0 3 0 0 60 0 0 1 0 0 13 1 0 4 3 0 0 2 18 0 3 1 4 0 6---
--42
3
% of
Total 0.1
0%0.9
0%0.9
0%0.5
0%0.3
0%0.1
0%10
.50%
0.70%
0.10%
1.40%
7.20%
0.50%
9.50%
4.90%
0.30%
6.70%
0.70%
1.40%
0.50%
1.00%
13.70
%0.8
0%0.9
0%0.9
0%3.5
0%0.1
0%0.1
0%0.9
0%0.4
0%0.4
0%5.7
0%0.9
0%0.0
0%0.9
0%0.0
0%0.0
0%2.1
0%0.0
0%0.4
0%2.3
0%1.6
0%0.2
0%0.0
0%0.6
0%6.8
0%0.0
0%0.9
0%2.7
0%3.2
0%0.1
0%1.7
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
47:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
SA
BA
H, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
127
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages 17 22 41 18 3 415
2 10 0 28 183 14 253
104 10 84 16 40 7 6
294 27 27 16 148 1 0 35 805 7 18 471
119 81 259 4 9 17 0 0 30 4 10 68 135 9 1 18 177 0 31 64 87 2 59 -----
4045
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 1 0 0 2 0 0 0 0 7 4 0 1 0 0 1 0 0 19 9 0 3---
-- 53
5-
-
9 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 4 1 1 0 0 5 0 0 18 4 0 2---
-- 40
10-
-
14 0 1 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 0 0 0 0 3 0 0 0 0 0 0 4 0 0 1 0 0 0 0 0 5 0 0 0 0 6 0 0 9 2 0 1---
-- 41
15-
-
19 0 1 0 0 0 0 2 0 0 0 1 0 1 0 0 1 0 0 0 0 0 0 8 0 1 0 0 2 0 0 0 0 0 0 13 0 1 0 0 0 0 0 2 1 2 0 0 5 7 0 0 4 5 0 4---
-- 61
20-
-
24 0 0 1 3 0 0 6 1 0 0 4 1 4 1 1 1 0 1 0 0 1 0 1 0 1 0 0 2 6 0 0 2 0 2 18 0 2 2 0 0 0 0 0 5 9 0 0 4 10 0 0 0 8 0 3---
--10
0
25-
-
29 0 1 2 1 0 0 4 0 0 0 4 0 10 3 0 1 0 1 0 0 5 0 1 1 3 0 0 3 13 0 1 13 3 2 8 0 1 1 0 0 0 0 0 4 7 0 0 3 6 0 0 2 2 0 1---
--10
7
30-
-
34 0 1 1 1 0 0 4 0 0 0 3 0 5 1 0 1 2 1 0 0 4 1 1 0 3 0 0 1 35 1 0 21 5 1 9 0 2 0 0 0 3 0 0 3 8 1 0 1 7 0 0 0 5 0 2---
--13
4
35-
-
39 0 1 2 1 0 0 15 0 0 0 9 2 10 3 0 3 0 0 0 0 9 0 0 1 1 0 0 3 77 0 2 44 10 7 19 1 3 1 0 0 0 0 0 1 16 1 0 0 8 0 2 3 8 0 2---
--26
5
40-
-
44 1 2 2 1 0 0 15 0 0 1 8 0 13 7 0 1 1 6 1 0 9 2 1 1 4 0 0 012
6 0 3 75 10 14 28 1 0 1 0 0 1 0 0 5 15 0 0 0 12 0 3 3 10 0 5---
--38
8
45-
-
49 0 2 0 2 0 1 27 1 0 3 12 1 24 10 1 5 0 5 1 0 26 1 2 0 15 0 0 317
0 2 1 86 19 14 45 0 0 1 0 0 4 0 1 7 19 1 0 1 17 0 2 1 5 1 5---
--54
4
50-
-
54 2 6 4 1 0 0 28 2 0 2 21 2 33 14 3 4 2 3 1 1 30 4 1 2 12 0 0 212
8 1 0 83 22 15 36 1 0 2 0 0 3 1 0 8 17 1 0 0 24 0 6 1 10 1 8---
--54
8
55-
-
59 2 1 3 3 2 0 15 2 0 6 24 1 30 15 1 14 1 4 1 0 34 5 1 2 15 1 0 2 96 1 4 52 22 12 28 0 0 2 0 0 4 0 0 4 13 0 1 0 16 0 3 0 9 0 6---
--45
8
60-
-
64 3 1 2 1 0 1 8 2 0 3 13 1 28 9 0 16 1 4 1 2 37 2 2 2 12 0 0 0 55 1 1 32 9 5 19 0 0 1 0 0 6 1 0 3 5 0 0 1 17 0 6 0 6 0 5---
--32
4
65-
-
69 3 1 12 0 1 0 10 0 0 2 27 2 30 12 1 9 5 7 0 0 58 3 1 2 26 0 0 2 42 0 3 27 6 1 16 1 0 0 0 0 4 0 0 5 12 2 0 1 10 0 4 1 0 0 3---
--35
2
70-
-
74 4 2 7 2 0 1 10 2 0 6 22 2 30 11 2 18 0 4 0 1 43 5 0 2 18 0 0 4 33 0 2 21 6 5 6 0 0 2 0 0 1 0 0 6 4 1 0 1 14 0 4 0 3 0 3---
--30
8
75+
2 2 5 0 0 1 5 0 0 5 35 2 35 18 1 9 4 4 2 2 38 4 1 3 37 0 0 2 24 1 1 15 7 3 8 0 0 1 0 0 4 2 0 3 7 0 0 1 17 0 1 3 1 0 6---
--32
2
% of
Total
0.40%
0.50%
1.00%
0.40%
0.10%
0.10%
3.80%
0.20%
0.00%
0.70%
4.50%
0.30%
6.30%
2.60%
0.20%
2.10%
0.40%
1.00%
0.20%
0.10%
7.30%
0.70%
0.70%
0.40%
3.70%
0.00%
0.00%
0.90%
19.90
%0.2
0%0.4
0%11
.60%
2.90%
2.00%
6.40%
0.10%
0.20%
0.40%
0.00%
0.00%
0.70%
0.10%
0.20%
1.70%
3.30%
0.20%
0.00%
0.40%
4.40%
0.00%
0.80%
1.60%
2.20%
0.00%
1.50% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
48:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
SA
BA
H, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011
128
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
2 32 32 17 9 536
9 24 3 48 253 17 336
174 9
236 24 49 18 35 482 29 33 33 125 4 5 31 14 14 199 32 1 32 0 1 73 1 14 80 55 6 1 20 241 0 32 95 112 5 60 -----
3522
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0.1 0 1.1 0 0.4 0 0 0 0 1.3 1.1 0 0 0 0 0.4 0 0 4.6 1.4 0 0.6 ----- 12
5-
-
9 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.1 0 0 0.4 0 0 0 0 1.1 0 0 3.4 0.9 0.1 0.3 ----- 7
10-
-
14 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0 0 0.1 0 0 0.1 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0.3 0 0 0.1 0.9 0 0 1 1 0 0.3 ----- 6
15-
-
19 0 0.1 0 0.1 0 0 1.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 1 0.1 0 0 0 0.1 0 0 0.1 0.3 0 0 0 0 0.1 0 0 0.7 0 0 0 0.3 1.8 0 0 1.2 0.9 0 0---
-- 8
20-
-
24 0 0 0 0.3 0 0 1.9 0 0 0 0.2 0 0.7 0.2 0 0 0.2 0.2 0 0 0 0 1 0 0 0 0.2 0.2 0 0 0 0.9 0 0 0 0 0 0 0 0.5 0 0 0 0.5 0.5 0 0 0.5 2.3 0 0.2 ----- 10
25-
-
29 0 0.2 0.6 0.2 0 0 2.2 0 0 0 0.7 0 2.1 0.4 0 0.4 0.2 0 0.2 0 0.9 0 0.2 0.2 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 1.1 0.4 0.2 0 0 1.7 0 0.2 0.9 0.9 0 0---
-- 14
30-
-
34 0 0 0.5 0.3 0 0 4.7 0 0 0.3 0.8 0.3 2.4 1.3 0.3 1 0 0.3 0.3 0 0.8 0 0.3 0.3 1 0 0.3 0.5 0 0.3 0 0.8 0 0.3 0 0 0.3 0 0 1 0 0 0 0.5 3.4 0 0 0.5 1.6 0 0---
-- 24
35-
-
39 0 0 0.9 0.6 0 0 6.6 0 0 0 2 0 3.7 1.7 0 2 0 0.3 0 0.3 3.4 1.1 0 0.6 1.7 0 0 0.9 0 0.3 0 1.4 0 0.3 0 0 0.3 0 0 0.9 0.6 0 0 0.3 3.2 0 0 1.1 2 0.3 0.6 ----- 37
40-
-
44 0.6 0.3 0 0 0 010
.5 0.3 0 0.3 3.3 0.9 6 4.2 0.3 4.5 0.3 0.6 0.9 0 5.4 0.3 0.6 0.3 1.2 0 0.3 0.6 0.6 0.9 0 0.6 0 0.6 0 0 0.6 0 0 2.1 1.5 0.3 0 0 3.9 0 0.3 0.3 1.2 0.3 0.3 ----- 55
45-
-
49 0 0.7 1 0 0.3 020
.8 0 0 1 6.5 0.3 5.9 6.5 0.3 6.2 0.7 1.6 0.3 113
.7 0.7 0.7 0.3 2 0.3 0 0.7 1 0.7 0 0 0.3 0.3 0 0 2 0 1 1.3 1.6 0 0 1 7.5 0 1.3 0.3 2 0 0.3 ----- 92
50-
-
54 0 1.2 1.2 0.4 0.8 0 22 0 0.4 2 7.6 1.2 14 9.6 012
.4 0.8 1.2 1.2 1.2 20 1.6 0 2.4 3.6 0.4 0.4 0.8 0.4 0.8 4 0.8 0 2.8 0 0 3.2 0 0.8 3.2 3.6 0.8 0 0.4 12.4 0 2 1.6 3.6 0 2
-----
149
55-
-
59 0 2.4 1.8 1.2 0 028
.5 0.6 0.6 4.7 19 1.2 24.3
11.3 0
19.6 2.4 4.2 0 3
40.4 1.2 1.8 1.8 7.1 0 0.6 1.8 1.8 1.8 11.3 0.6 0 3 0 0 4.7 0 0 4.7 4.7 0 0.6 1.2 13.1 0 3.6 1.2 6.5 0.6 9.5 -----
248
60-
-
64 0 2.8 3.7 1.9 1.9 0.9 29 2.8 0 0.9 27.1 2.8 41.1 14 0.9 37.4 2.8 5.6 1.9 6.5 72.9 2.8 0.9 5.6 12.2 0 0 1.9 0 0
24.3 0 0 4.7 0 0 2.8 0 0 3.7 2.8 0.9 0 1.9 25.2 0 2.8 0.9 2.8 0 6.5 -----
360
65-
-
69 0 9.5 2.4 2.4 3.6 0 32 8.3 010
.752
.1 3.6 47.3
36.7 1.2 41.4 3.6 10.7 4.7 5.9
101.8 9.5 3.6 4.7 23.7 1.2 0 8.3 2.4 1.2 48.5 0 0 3.6 0 0
18.9 0 0 4.7 11.8 0 0 1.2 24.9 0 7.1 0 9.5 1.2 10.7 -----
574
70-
-
74 0 8.9 5.3 3.5 1.8 5.3 33.6
10.6 0
17.7
70.8 1.8 70.8 23 5.3 44.3 7.1 8.9 3.5 12.4
99.1 3.5 3.5 5.3 44.3 0 0 0 5.3 0
74.3 1.8 0 5.3 0 1.8 23 0 0
10.6
10.6 1.8 0 0
37.2 0 5.3 0
12.4 0 7.1 -----
687
75+
0 6.2 9.2 1.5 0 1.5 16.9 7.7 1.5 15.4
66.2 0
93.9
36.9 1.5 35.4 4.6 13.8 0 6.2 96.9 4.6 0 6.2 40 1.5 0 4.6 0 0
92.3 0 0 1.5 0 0 20 1.5 0 6.2 4.6 0 0 3.1 27.7 0 4.6 1.5 6.2 0 9.2 -----
651
Crud
eRa
te 0 0.5 0.5 0.3 0.2 0.1 6.2 0.4 0.1 0.8 4.2 0.3 5.6 2.9 0.2 3.9 0.4 0.8 0.3 0.6 8.1 0.5 0.6 0.6 2.1 0.1 0.1 0.5 0.2 0.2 3.3 0.5 0 0.5 0 0 1.2 0 0.2 1.3 0.9 0.1 0 0.3 4 0 0.5 1.6 1.9 0.1 1---
--58
.9
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
49:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, S
AB
AH
, AL
L R
ESI
DE
NT
S, M
AL
ES,
200
7-20
11
ASR
Wor
ld 0 0.9 0.8 0.4 0.3 0.2 8.5 0.8 0.1 1.4 7.4 0.5 9.3 4.7 0.3 6.6 0.7 1.4 0.5 1.1 14 0.8 0.6 0.9 3.7 0.1 0.1 0.8 0.4 0.3 6.4 0.5 0 0.8 0 0 2.1 0 0.3 1.7 1.4 0.1 0 0.4 5.9 0 0.9 1.5 2.3 0.1 1.6 -----
93.6
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
129
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages 17 22 41 18 3 415
2 10 0 28 183 14 253
104 10 84 16 40 7 6
294 27 27 16 148 1 0 35 805 7 18 471
119 81 259 4 9 17 0 0 30 4 10 68 135 9 1 18 177 0 31 64 87 2 59 -----
4045
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0 0 0.2 0 0 0.3 0 0 0 0 1.1 0.6 0 0.2 0 0 0.2 0 0 2.9 1.4 0 0.5 ----- 8
5-
-
9 0 0 0 0.1 0 0 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.1 0 0 0 0 0.1 0 0 0 0 0 0 0.1 0 0 0 0 0 0 0 0 0.6 0.1 0.1 0 0 0.7 0 0 2.7 0.6 0 0.3 ----- 6
10-
-
14 0 0.2 0 0.2 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0.5 0 0 0 0 0 0 0.6 0 0 0.2 0 0 0 0 0 0.8 0 0 0 0 0.9 0 0 1.4 0.3 0 0.2 ----- 6
15-
-
19 0 0.1 0 0 0 0 0.3 0 0 0 0.1 0 0.1 0 0 0.1 0 0 0 0 0 0 1.2 0 0.1 0 0 0.3 0 0 0 0 0 0 1.9 0 0.1 0 0 0 0 0 0.3 0.1 0.3 0 0 0.7 1 0 0 0.6 0.7 0 0.6 ----- 9
20-
-
24 0 0 0.2 0.5 0 0 1 0.2 0 0 0.7 0.2 0.7 0.2 0.2 0.2 0 0.2 0 0 0.2 0 0.2 0 0.2 0 0 0.3 1 0 0 0.3 0 0.3 3 0 0.3 0.3 0 0 0 0 0 0.8 1.5 0 0 0.7 1.7 0 0 0 1.3 0 0.5 ----- 17
25-
-
29 0 0.2 0.4 0.2 0 0 0.7 0 0 0 0.7 0 1.8 0.6 0 0.2 0 0.2 0 0 0.9 0 0.2 0.2 0.6 0 0 0.6 2.4 0 0.2 2.4 0.6 0.4 1.5 0 0.2 0.2 0 0 0 0 0 0.7 1.3 0 0 0.6 1.1 0 0 0.4 0.4 0 0.2 ----- 20
30-
-
34 0 0.3 0.3 0.3 0 0 1 0 0 0 0.8 0 1.3 0.3 0 0.3 0.5 0.3 0 0 1 0.3 0.3 0 0.8 0 0 0.3 9 0.3 0 5.4 1.3 0.3 2.3 0 0.5 0 0 0 0.8 0 0 0.8 2.1 0.3 0 0.3 1.8 0 0 0 1.3 0 0.5 ----- 35
35-
-
39 0 0.3 0.6 0.3 0 0 4.2 0 0 0 2.5 0.6 2.8 0.8 0 0.8 0 0 0 0 2.5 0 0 0.3 0.3 0 0 0.8 21.7 0 0.6 12.4 2.8 2 5.4 0.3 0.8 0.3 0 0 0 0 0 0.3 4.5 0.3 0 0 2.3 0 0.6 0.8 2.3 0 0.6 ----- 75
40-
-
44 0.3 0.6 0.6 0.3 0 0 4.7 0 0 0.3 2.5 0 4.1 2.2 0 0.3 0.3 1.9 0.3 0 2.8 0.6 0.3 0.3 1.3 0 0 039
.6 0 0.9 23.6 3.1 4.4 8.8 0.3 0 0.3 0 0 0.3 0 0 1.6 4.7 0 0 0 3.8 0 0.9 0.9 3.1 0 1.6 -----
122
45-
-
49 0 0.7 0 0.7 0 0.4 9.8 0.4 0 1.1 4.4 0.4 8.7 3.6 0.4 1.8 0 1.8 0.4 0 9.5 0.4 0.7 0 5.5 0 0 1.1 61.9 0.7 0.4 31.3 6.9 5.1 16.4 0 0 0.4 0 0 1.5 0 0.4 2.6 6.9 0.4 0 0.4 6.2 0 0.7 0.4 1.8 0.4 1.8 -----
198
50-
-
54 0.9 2.8 1.9 0.5 0 0 13 0.9 0 0.9 9.8 0.9 15.4 6.5 1.4 1.9 0.9 1.4 0.5 0.5 14 1.9 0.5 0.9 5.6 0 0 0.9 59.5 0.5 0
38.6
10.2 7
16.7 0.5 0 0.9 0 0 1.4 0.5 0 3.7 7.9 0.5 0 0
11.2 0 2.8 0.5 4.7 0.5 3.7 -----
255
55-
-
59 1.4 0.7 2.1 2.1 1.4 010
.5 1.4 0 4.2 16.8 0.7 21.1
10.5 0.7 9.8 0.7 2.8 0.7 0
23.9 3.5 0.7 1.4 10.5 0.7 0 1.4 67.4 0.7 2.8 36.5
15.4 8.4 19.7 0 0 1.4 0 0 2.8 0 0 2.8 9.1 0 0.7 0
11.2 0 2.1 0 6.3 0 4.2 -----
321
60-
-
64 3 1 2 1 0 1 8 2 0 313
.1 128
.1 9 016
.1 1 4 1 237
.2 2 2 212
.1 0 0 055
.3 1 132
.2 9 519
.1 0 0 1 0 0 6 1 0 3 5 0 0 117
.1 0 6 0 6 0 5---
--32
6
65-
-
69 4 1.3 16 0 1.3 013
.3 0 0 2.7 36 2.7 40 16 1.3 12 6.7 9.3 0 077
.3 4 1.3 2.7 34.7 0 0 2.7 56 0 4 36 8 1.3 21.3 1.3 0 0 0 0 5.3 0 0 6.7 16 2.7 0 1.3 13.3 0 5.3 1.3 0 0 4
-----
469
70-
-
74 7 3.5 12.3 3.5 0 1.8 17.5 3.5 0
10.5
38.6 3.5 52.6
19.3 3.5 31.6 0 7 0 1.8 75.4 8.8 0 3.5 31.6 0 0 7
57.9 0 3.5 36.8
10.5 8.8 10.5 0 0 3.5 0 0 1.8 0 0
10.5 7 1.8 0 1.8 24.6 0 7 0 5.3 0 5.3 -----
540
75+ 3.2 3.2 7.9 0 0 1.6 7.9 0 0 7.9 55
.6 3.2 55.6
28.6 1.6 14.3 6.4 6.4 3.2 3.2 60.3 6.4 1.6 4.8 58.7 0 0 3.2 38.1 1.6 1.6 23.8
11.1 4.8 12.7 0 0 1.6 0 0 6.4 3.2 0 4.8 11.1 0 0 1.6 27 0 1.6 4.8 1.6 0 9.5 -----
511
Crud
eRa
te 0.3 0.4 0.7 0.3 0.1 0.1 2.6 0.2 0 0.5 3.2 0.2 4.4 1.8 0.2 1.4 0.3 0.7 0.1 0.1 5.1 0.5 0.5 0.3 2.6 0 0 0.6 13.9 0.1 0.3 8.1 2.1 1.4 4.5 0.1 0.2 0.3 0 0 0.5 0.1 0.2 1.2 2.3 0.2 0 0.3 3.1 0 0.5 1.1 1.5 0 1
-----
69.8
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
50:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, S
AB
AH
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
200
7-20
11
ASR
Wor
ld 0.6 0.5 1.3 0.4 0.1 0.1 3.7 0.3 0 0.9 5.4 0.4 7.3 3 0.3 2.7 0.5 1.2 0.2 0.2 9.2 0.8 0.5 0.5 4.6 0 0 0.8 19.7 0.2 0.5 11.6 3.1 2 6.1 0.1 0.1 0.4 0 0 0.9 0.1 0.2 1.6 3.2 0.2 0 0.3 4.5 0 0.9 1.1 1.8 0 1.4 -----
105.4
130
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
1 32 23 28 7 166
5 9 2 57 337 6
349
288 1
289 54 88 18 75 619 8 48 30 110 1 2 57 11 26 206 54 1 67 0 0 95 0 9 96 41 9 11 49 310 0 38 96 121 31 73 -----
4549
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 11 0 5 0 0 0 0 7 5 0 5 3 1 4 0 0 28 7 6 0---
-- 83
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 1 14 0 2 0 5 10 0 0 10 3 0 0---
-- 50
10-
-
14 0 0 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 14 0 0 0 0 3 0 0 0 2 0 0 0 0 0 0 1 9 1 0 3 1 6 0 0 15 5 1 0---
-- 65
15-
-
19 0 0 0 1 0 0 14 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 7 0 0 0 0 4 0 0 0 5 0 0 0 0 0 0 0 4 1 0 3 2 12 0 0 3 4 1 0---
-- 63
20-
-
24 0 1 0 1 0 0 13 0 0 0 0 0 1 3 0 1 0 0 0 0 3 1 4 1 1 0 0 4 0 0 0 8 0 0 0 0 0 0 0 6 0 0 0 6 12 0 0 4 8 2 1---
-- 81
25-
-
29 0 1 0 2 0 0 20 0 0 0 2 0 5 2 0 2 1 0 0 0 2 1 2 0 1 0 0 1 0 0 0 7 0 0 0 0 0 0 0 2 3 0 0 6 9 0 0 2 6 1 1---
-- 79
30-
-
34 0 2 0 2 0 0 28 0 0 2 1 0 12 2 0 7 0 1 0 1 7 0 3 2 2 0 0 2 0 3 0 7 0 1 0 0 0 0 0 4 0 0 0 4 11 0 1 3 4 0 2---
--11
4
35-
-
39 0 4 0 4 1 0 69 0 0 0 14 0 9 12 0 10 4 0 0 0 11 2 2 1 1 0 0 6 2 1 0 3 0 1 0 0 2 0 0 8 3 1 1 1 8 0 0 4 11 2 3---
--20
1
40-
-
44 0 2 2 3 1 0 79 0 0 3 23 0 16 10 0 14 0 1 3 2 26 2 6 4 3 0 0 6 0 5 0 1 0 5 0 0 2 0 0 9 3 0 0 7 22 0 2 0 7 0 5---
--27
4
45-
-
49 0 6 2 5 1 0 99 1 1 6 19 2 28 22 0 11 3 11 5 3 44 0 3 2 9 0 0 2 1 4 4 2 0 5 0 0 7 0 0 7 3 0 1 2 20 0 5 1 9 2 7---
--36
5
50-
-
54 0 1 1 3 0 010
0 0 0 2 28 2 42 23 1 35 4 9 2 12 66 1 2 3 13 1 0 10 2 3 10 3 0 10 0 0 9 0 0 8 4 0 0 2 38 0 5 6 13 4 12 -----
490
55-
-
59 0 3 2 2 1 0 82 1 0 12 33 2 43 39 0 58 8 12 1 10 77 1 1 4 13 0 0 4 1 2 12 1 0 7 0 0 13 0 0 3 8 0 0 2 30 0 8 5 10 3 8---
--52
2
60-
-
64 0 3 4 0 0 0 67 1 1 9 59 0 47 43 0 63 7 11 1 12 123 0 1 2 14 0 0 5 2 3 45 0 0 9 0 0 16 0 0 7 6 1 0 2 46 0 5 3 14 2 8
-----
642
65-
-
69 0 4 4 1 0 0 46 3 0 5 50 0 44 39 0 31 14 22 3 13 114 0 1 7 14 0 1 7 2 2 43 0 0 10 0 0 11 0 0 6 4 0 0 2 34 0 5 3 12 2 10 -----
569
70-
-
74 0 2 3 1 2 0 25 3 0 5 43 0 42 42 0 26 7 14 0 8 67 0 0 1 11 0 0 0 0 2 35 1 0 11 0 0 18 0 0 3 3 0 0 3 24 0 2 6 3 2 7---
--42
2
75+
1 3 5 3 1 1 20 0 0 13 65 0 59 50 0 31 6 7 2 14 79 0 0 3 28 0 1 2 1 1 57 0 1 3 0 0 17 0 0 1 2 0 0 3 24 0 5 3 5 3 9---
--52
9
% of
Total 0.0
0%0.7
0%0.5
0%0.6
0%0.2
0%0.0
0%14
.60%
0.20%
0.00%
1.30%
7.40%
0.10%
7.70%
6.30%
0.00%
6.40%
1.20%
1.90%
0.40%
1.60%
13.60
%0.2
0%1.1
0%0.7
0%2.4
0%0.0
0%0.0
0%1.3
0%0.2
0%0.6
0%4.5
0%1.2
0%0.0
0%1.5
0%0.0
0%0.0
0%2.1
0%0.0
0%0.2
0%2.1
0%0.9
0%0.2
0%0.2
0%1.1
0%6.8
0%0.0
0%0.8
0%2.1
0%2.7
0%0.7
0%1.6
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
51:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
SA
RA
WA
K, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
131
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
0 30 30 44 8 025
8 4 1 34 195 2
275
229 5 88 52 51 12 19 347 12 31 24 90 4 1 40
1198 20 10 64
019
0 21 325 0 13 31 0 0 29 0 11 89 161 8 1 33 222 0 37 72 103 21 64 -----
5185
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 7 0 0 2 0 0 0 0 8 5 0 3 0 0 2 0 0 36 6 1 1---
-- 77
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 1 9 0 2 0 1 4 0 0 9 6 1 0---
-- 36
10-
-
14 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 1 0 0 0 0 0 0 9 0 0 0 0 0 0 0 0 7 2 0 0 1 6 0 0 5 6 3 0---
-- 45
15-
-
19 0 0 0 2 0 0 6 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 6 1 1 0 0 2 1 0 0 0 0 0 6 0 0 1 0 0 0 0 0 6 7 0 0 4 10 0 0 2 2 1 0---
-- 61
20-
-
24 0 0 0 1 0 0 12 0 0 0 1 0 1 1 0 1 0 0 1 0 2 1 4 0 0 0 0 1 5 0 0 4 1 0 16 0 1 1 0 0 0 0 0 3 5 0 0 7 7 0 0 0 7 1 1---
-- 85
25-
-
29 0 2 1 2 0 0 9 0 0 0 0 0 1 5 0 0 0 0 0 0 1 0 2 1 1 0 0 1 21 0 0 6 2 0 15 0 4 1 0 0 0 0 0 2 11 0 0 4 5 0 0 0 7 0 1---
--10
5
30-
-
34 0 1 1 2 1 0 20 0 0 0 3 1 9 3 0 4 2 0 0 0 4 0 4 1 0 0 0 2 36 0 0 27 8 1 16 0 1 1 0 0 1 0 1 3 11 0 0 4 7 0 0 0 3 0 2---
--18
0
35-
-
39 0 3 1 4 1 0 27 0 0 1 3 0 8 5 1 3 1 0 0 0 8 2 2 1 2 0 0 310
0 1 0 76 8 1 19 0 4 2 0 0 0 0 0 7 10 1 0 4 7 0 3 1 7 1 4---
--33
2
40-
-
44 0 2 1 5 0 0 33 0 0 1 7 0 13 10 1 7 0 5 3 0 14 0 2 4 3 0 0 119
8 2 0 86 18 2 31 0 1 0 0 0 0 0 1 8 18 1 0 1 19 0 1 2 4 1 1---
--50
7
45-
-
49 0 1 3 4 1 0 38 0 0 1 15 0 22 19 0 8 3 2 0 3 22 0 1 0 4 0 1 621
6 0 111
2 33 4 47 0 2 4 0 0 1 0 0 5 18 0 1 1 15 0 3 2 12 0 10 -----
641
50-
-
54 0 4 1 4 1 0 37 1 0 5 19 0 21 13 1 6 5 12 2 1 38 2 3 1 8 0 0 317
8 2 1 96 36 6 44 0 0 5 0 0 4 0 0 10 24 0 0 2 25 0 6 4 12 2 4---
--64
9
55-
-
59 0 3 6 4 0 0 22 1 1 5 25 0 54 34 1 10 6 8 2 1 45 0 0 3 6 0 0 517
6 3 2 68 33 4 44 0 0 3 0 0 2 0 0 10 19 0 0 0 34 0 5 2 11 1 7---
--66
6
60-
-
64 0 3 1 4 0 0 23 0 0 6 36 1 29 34 1 16 5 9 0 4 70 3 2 2 9 2 0 412
0 4 0 55 23 2 32 0 0 5 0 0 2 0 0 6 8 1 0 1 22 0 12 0 6 1 8---
--57
2
65-
-
69 0 2 4 3 0 0 17 1 0 4 26 0 33 34 0 13 12 3 0 6 66 2 0 3 12 1 0 5 68 3 2 37 14 0 14 0 0 4 0 0 10 0 0 5 19 0 0 0 26 0 5 4 7 2 5---
--47
2
70-
-
74 0 4 4 5 1 0 6 1 0 4 24 0 33 26 0 6 5 3 3 2 38 0 1 2 13 1 0 1 43 0 1 40 8 1 9 0 0 1 0 0 3 0 0 1 6 0 0 2 16 0 1 1 2 4 8---
--33
0
75+
0 5 7 2 3 0 8 0 0 7 35 0 51 45 0 10 13 9 1 2 38 1 1 4 31 0 0 3 36 5 3 33 6 0 14 0 0 1 0 0 6 0 0 2 3 0 0 1 17 0 1 4 5 2 12 -----
427
% of
Total
0.00%
0.60%
0.60%
0.80%
0.20%
0.00%
5.00%
0.10%
0.00%
0.70%
3.80%
0.00%
5.30%
4.40%
0.10%
1.70%
1.00%
1.00%
0.20%
0.40%
6.70%
0.20%
0.60%
0.50%
1.70%
0.10%
0.00%
0.80%
23.10
%0.4
0%0.2
0%12
.30%
3.70%
0.40%
6.30%
0.00%
0.30%
0.60%
0.00%
0.00%
0.60%
0.00%
0.20%
1.70%
3.10%
0.20%
0.00%
0.60%
4.30%
0.00%
0.70%
1.40%
2.00%
0.40%
1.20% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
52:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
SA
RA
WA
K, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011
132
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
1 32 23 28 7 166
5 9 2 57 337 6
349
288 1
289 54 88 18 75 619 8 48 30 110 1 2 57 11 26 206 54 1 67 0 0 95 0 9 96 41 9 11 49 310 0 38 96 121 31 73 -----
4549
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 1.9 0 0.9 0 0 0 0 1.2 0.9 0 0.9 0.5 0.2 0.7 0 0 4.8 1.2 1 0---
-- 14
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0.2 2.2 0 0.3 0 0.8 1.6 0 0 1.6 0.5 0 0---
-- 8
10-
-
14 0 0 0 0 0 0 0.5 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 2.3 0 0 0 0 0.5 0 0 0 0.3 0 0 0 0 0 0 0.2 1.5 0.2 0 0.5 0.2 1 0 0 2.4 0.8 0.2 0---
-- 11
15-
-
19 0 0 0 0.2 0 0 2.3 0 0 0 0 0 0 0.2 0 0 0 0 0.2 0 0 0 1.2 0 0 0 0 0.7 0 0 0 0.8 0 0 0 0 0 0 0 0.7 0.2 0 0.5 0.3 2 0 0 0.5 0.7 0.2 0---
-- 11
20-
-
24 0 0.2 0 0.2 0 0 2.6 0 0 0 0 0 0.2 0.6 0 0.2 0 0 0 0 0.6 0.2 0.8 0.2 0.2 0 0 0.8 0 0 0 1.6 0 0 0 0 0 0 0 1.2 0 0 0 1.2 2.4 0 0 0.8 1.6 0.4 0.2 ----- 16
25-
-
29 0 0.2 0 0.5 0 0 4.6 0 0 0 0.5 0 1.1 0.5 0 0.5 0.2 0 0 0 0.5 0.2 0.5 0 0.2 0 0 0.2 0 0 0 1.6 0 0 0 0 0 0 0 0.5 0.7 0 0 1.4 2.1 0 0 0.5 1.4 0.2 0.2 ----- 18
30-
-
34 0 0.5 0 0.5 0 0 7.3 0 0 0.5 0.3 0 3.1 0.5 0 1.8 0 0.3 0 0.3 1.8 0 0.8 0.5 0.5 0 0 0.5 0 0.8 0 1.8 0 0.3 0 0 0 0 0 1 0 0 0 1 2.9 0 0.3 0.8 1 0 0.5 ----- 30
35-
-
39 0 1 0 1 0.3 017
.3 0 0 0 3.5 0 2.3 3 0 2.5 1 0 0 0 2.8 0.5 0.5 0.3 0.3 0 0 1.5 0.5 0.3 0 0.8 0 0.3 0 0 0.5 0 0 2 0.8 0.3 0.3 0.3 2 0 0 1 2.8 0.5 0.8 ----- 50
40-
-
44 0 0.5 0.5 0.8 0.3 020
.2 0 0 0.8 5.9 0 4.1 2.6 0 3.6 0 0.3 0.8 0.5 6.6 0.5 1.5 1 0.8 0 0 1.5 0 1.3 0 0.3 0 1.3 0 0 0.5 0 0 2.3 0.8 0 0 1.8 5.6 0 0.5 0 1.8 0 1.3 ----- 70
45-
-
49 0 1.7 0.6 1.4 0.3 027
.4 0.3 0.3 1.7 5.3 0.6 7.7 6.1 0 3 0.8 3 1.4 0.8 12.2 0 0.8 0.6 2.5 0 0 0.6 0.3 1.1 1.1 0.6 0 1.4 0 0 1.9 0 0 1.9 0.8 0 0.3 0.6 5.5 0 1.4 0.3 2.5 0.6 1.9 -----
101
50-
-
54 0 0.3 0.3 1 0 0 33 0 0 0.7 9.2 0.7 13.8 7.6 0.3 11.5 1.3 3 0.7 4
21.7 0.3 0.7 1 4.3 0.3 0 3.3 0.7 1 3.3 1 0 3.3 0 0 3 0 0 2.6 1.3 0 0 0.7 12.5 0 1.6 2 4.3 1.3 4
-----
161
55-
-
59 0 1.3 0.8 0.8 0.4 034
.5 0.4 0 5.1 13.9 0.8 18.1
16.4 0
24.4 3.4 5.1 0.4 4.2 32.4 0.4 0.4 1.7 5.5 0 0 1.7 0.4 0.8 5.1 0.4 0 2.9 0 0 5.5 0 0 1.3 3.4 0 0 0.8 12.6 0 3.4 2.1 4.2 1.3 3.4 -----
220
60-
-
64 0 1.5 2 0 0 0 34 0.5 0.5 4.6 30 023
.921
.8 0 32 3.6 5.6 0.5 6.1 62.4 0 0.5 1 7.1 0 0 2.5 1 1.5 22.8 0 0 4.6 0 0 8.1 0 0 3.6 3 0.5 0 1
23.4 0 2.5 1.5 7.1 1 4.1 -----
326
65-
-
69 0 3.1 3.1 0.8 0 036
.1 2.4 0 3.9 39.2 0
34.5
30.6 0
24.3 11
17.3 2.4 10.2
89.4 0 0.8 5.5 11 0 0.8 5.5 1.6 1.6 33.7 0 0 7.8 0 0 8.6 0 0 4.7 3.1 0 0 1.6 26.7 0 3.9 2.4 9.4 1.6 7.8 -----
446
70-
-
74 0 2.4 3.7 1.2 2.4 030
.5 3.7 0 6.1 52.4 0
51.2
51.2 0
31.7 8.5 17.1 0 9.8 81.7 0 0 1.2 13.4 0 0 0 0 2.4 42.7 1.2 0
13.4 0 0 22 0 0 3.7 3.7 0 0 3.7 29.3 0 2.4 7.3 3.7 2.4 8.5 -----
515
75+ 0.9 2.8 4.7 2.8 0.9 0.9 18
.8 0 012
.2 61 055
.4 47 029
.1 5.6 6.6 1.9 13.1
74.2 0 0 2.8 26.3 0 0.9 1.9 0.9 0.9 53.5 0 0.9 2.8 0 0 16 0 0 0.9 1.9 0 0 2.8 22.5 0 4.7 2.8 4.7 2.8 8.5 -----
497
Crud
eRa
te 0 0.5 0.4 0.5 0.1 011
.2 0.2 0 1 5.7 0.1 5.9 4.8 0 4.9 0.9 1.5 0.3 1.3 10.4 0.1 0.8 0.5 1.8 0 0 1 0.2 0.4 3.5 0.9 0 1.1 0 0 1.6 0 0.2 1.6 0.7 0.2 0.2 0.8 5.2 0 0.6 1.6 2 0.5 1.2 -----
76.4
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
53:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, S
AR
AW
AK
, AL
L R
ESI
DE
NT
S, M
AL
ES,
200
7-20
11
ASR
Wor
ld 0 0.6 0.5 0.5 0.1 011
.6 0.2 0 1.1 6.6 0.1 6.7 5.6 0 5.5 1.1 1.8 0.3 1.5 12.2 0.1 0.8 0.6 2.1 0 0 1 0.2 0.5 4.3 0.9 0 1.3 0 0 1.9 0 0.2 1.6 0.8 0.2 0.2 0.9 5.7 0 0.7 1.7 2.2 0.6 1.4 -----
85.7
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
133
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
0 30 30 44 8 025
8 4 1 34 195 2
275
229 5 88 52 51 12 19 347 12 31 24 90 4 1 40
1198 20 10 64
019
0 21 325 0 13 31 0 0 29 0 11 89 161 8 1 33 222 0 37 72 103 21 64 -----
5185
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0 0 0 0 0 1.2 0 0 0.4 0 0 0 0 1.4 0.9 0 0.5 0 0 0.4 0 0 6.3 1.1 0.2 0.2 ----- 14
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0.2 1.5 0 0.3 0 0.2 0.6 0 0 1.5 1 0.2 0---
-- 6
10-
-
14 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0.2 0 0 0 0 0 0 1.5 0 0 0 0 0 0 0 0 1.2 0.3 0 0 0.2 1 0 0 0.8 1 0.5 0---
-- 7
15-
-
19 0 0 0 0.3 0 0 1 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.2 0.2 1 0.2 0.2 0 0 0.3 0.2 0 0 0 0 0 1 0 0 0.2 0 0 0 0 0 1 1.2 0 0 0.7 1.7 0 0 0.3 0.3 0.2 0---
-- 10
20-
-
24 0 0 0 0.2 0 0 2.3 0 0 0 0.2 0 0.2 0.2 0 0.2 0 0 0.2 0 0.4 0.2 0.8 0 0 0 0 0.2 1 0 0 0.8 0.2 0 3.1 0 0.2 0.2 0 0 0 0 0 0.6 1 0 0 1.4 1.4 0 0 0 1.4 0.2 0.2 ----- 16
25-
-
29 0 0.5 0.2 0.5 0 0 2.1 0 0 0 0 0 0.2 1.2 0 0 0 0 0 0 0.2 0 0.5 0.2 0.2 0 0 0.2 4.9 0 0 1.4 0.5 0 3.5 0 0.9 0.2 0 0 0 0 0 0.5 2.6 0 0 0.9 1.2 0 0 0 1.6 0 0.2 ----- 24
30-
-
34 0 0.3 0.3 0.5 0.3 0 5.3 0 0 0 0.8 0.3 2.4 0.8 0 1.1 0.5 0 0 0 1.1 0 1.1 0.3 0 0 0 0.5 9.5 0 0 7.2 2.1 0.3 4.2 0 0.3 0.3 0 0 0.3 0 0.3 0.8 2.9 0 0 1.1 1.9 0 0 0 0.8 0 0.5 ----- 48
35-
-
39 0 0.8 0.3 1 0.3 0 7 0 0 0.3 0.8 0 2.1 1.3 0.3 0.8 0.3 0 0 0 2.1 0.5 0.5 0.3 0.5 0 0 0.8 25.8 0.3 0
19.6 2.1 0.3 4.9 0 1 0.5 0 0 0 0 0 1.8 2.6 0.3 0 1 1.8 0 0.8 0.3 1.8 0.3 1
----- 86
40-
-
44 0 0.6 0.3 1.4 0 0 9.1 0 0 0.3 1.9 0 3.6 2.8 0.3 1.9 0 1.4 0.8 0 3.9 0 0.6 1.1 0.8 0 0 0.3 54.9 0.6 0
23.8 5 0.6 8.6 0 0.3 0 0 0 0 0 0.3 2.2 5 0.3 0 0.3 5.3 0 0.3 0.6 1.1 0.3 0.3 -----
140
45-
-
49 0 0.3 0.9 1.2 0.3 011
.8 0 0 0.3 4.7 0 6.8 5.9 0 2.5 0.9 0.6 0 0.9 6.8 0 0.3 0 1.2 0 0.3 1.9 67.2 0 0.3 34.8
10.3 1.2 14.6 0 0.6 1.2 0 0 0.3 0 0 1.6 5.6 0 0.3 0.3 4.7 0 0.9 0.6 3.7 0 3.1 -----
199
50-
-
54 0 1.5 0.4 1.5 0.4 013
.9 0.4 0 1.9 7.2 0 7.9 4.9 0.4 2.3 1.9 4.5 0.8 0.4 14.3 0.8 1.1 0.4 3 0 0 1.1 67.1 0.8 0.4 36.2
13.6 2.3 16.6 0 0 1.9 0 0 1.5 0 0 3.8 9 0 0 0.8 9.4 0 2.3 1.5 4.5 0.8 1.5 -----
244
55-
-
59 0 1.4 2.8 1.9 0 010
.2 0.5 0.5 2.3 11.6 0
25.1
15.8 0.5 4.6 2.8 3.7 0.9 0.5 20.9 0 0 1.4 2.8 0 0 2.3 81.7 1.4 0.9 31.6
15.3 1.9 20.4 0 0 1.4 0 0 0.9 0 0 4.6 8.8 0 0 0
15.8 0 2.3 0.9 5.1 0.5 3.2 -----
309
60-
-
64 0 1.8 0.6 2.4 0 014
.1 0 0 3.7 22 0.6 17.7
20.8 0.6 9.8 3.1 5.5 0 2.4 42.8 1.8 1.2 1.2 5.5 1.2 0 2.4 73.4 2.4 0
33.6
14.1 1.2 19.6 0 0 3.1 0 0 1.2 0 0 3.7 4.9 0.6 0 0.6 13.5 0 7.3 0 3.7 0.6 4.9 -----
350
65-
-
69 0 1.6 3.3 2.4 0 013
.8 0.8 0 3.3 21.1 0
26.8
27.6 0
10.6 9.8 2.4 0 4.9 53.7 1.6 0 2.4 9.8 0.8 0 4.1 55.3 2.4 1.6 30.1
11.4 0
11.4 0 0 3.3 0 0 8.1 0 0 4.1 15.4 0 0 0
21.1 0 4.1 3.3 5.7 1.6 4.1 -----
384
70-
-
74 0 4.7 4.7 5.9 1.2 0 7.1 1.2 0 4.7 28.4 0
39.1
30.8 0 7.1 5.9 3.6 3.6 2.4 45 0 1.2 2.4 15.4 1.2 0 1.2 50.9 0 1.2 47.3 9.5 1.2 10.7 0 0 1.2 0 0 3.6 0 0 1.2 7.1 0 0 2.4 18.9 0 1.2 1.2 2.4 4.7 9.5 -----
391
75+
0 4 5.6 1.6 2.4 0 6.4 0 0 5.6 28 040
.8 36 0 810
.4 7.2 0.8 1.6 30.4 0.8 0.8 3.2 24.8 0 0 2.4 28.8 4 2.4 26.4 4.8 0
11.2 0 0 0.8 0 0 4.8 0 0 1.6 2.4 0 0 0.8 13.6 0 0.8 3.2 4 1.6 9.6 -----
342
Crud
eRa
te
0 0.5 0.5 0.8 0.1 0 4.5 0.1 0 0.6 3.4 0 4.8 4 0.1 1.5 0.9 0.9 0.2 0.3 6 0.2 0.5 0.4 1.6 0.1 0 0.7 20.9 0.3 0.2 11.2 3.3 0.4 5.7 0 0.2 0.5 0 0 0.5 0 0.2 1.6 2.8 0.1 0 0.6 3.9 0 0.6 1.3 1.8 0.4 1.1 -----
90.4
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
54:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, S
AR
AW
AK
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
200
7-20
11
ASR
Wor
ld 0 0.6 0.6 0.8 0.1 0 4.8 0.1 0 0.7 4 0 5.4 4.6 0.1 1.8 1.1 1 0.2 0.4 7.3 0.2 0.5 0.5 1.8 0.1 0 0.8 22.7 0.4 0.2 12.1 3.7 0.4 6.1 0 0.2 0.6 0 0 0.6 0 0.2 1.6 3 0.2 0 0.6 4.3 0 0.8 1.4 1.9 0.4 1.3 -----
100.2
134
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
5 62 43 30 13 10 459 19 5 80 155 8
338
310 9
226 42 98 32 87 788 25 53 17 208 5 1 15 15 12 325 36 6 94 2 3
116 5 6
192 42 1 31 23 196 1 18 64 58 25 51 -----
4465
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 4 0 0 0 0 1 0 0 21 3 3 0---
-- 37
5-
-
9 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 2 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 2 0 0 0 0 6 0 0 12 6 1 0---
-- 34
10-
-
14 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 18 0 0 0 2 3 0 0 8 5 1 0---
-- 42
15-
-
19 0 0 0 0 0 0 3 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 8 0 2 0 0 2 0 0 0 2 0 0 0 0 0 0 0 13 0 0 2 3 4 0 0 8 5 1 1---
-- 56
20-
-
24 0 0 0 1 0 0 3 1 0 0 0 0 1 1 0 1 0 0 0 0 4 3 8 1 2 0 0 1 0 0 0 4 0 0 0 0 0 0 0 6 4 0 2 1 10 0 0 2 3 2 0---
-- 61
25-
-
29 0 0 1 3 1 0 8 0 0 1 1 0 4 3 0 0 0 1 0 1 2 3 6 0 1 0 0 2 0 0 0 6 0 1 0 0 0 0 0 3 0 0 1 2 10 0 0 3 3 2 0---
-- 69
30-
-
34 0 1 1 1 0 0 19 0 0 0 2 0 2 2 1 2 0 0 0 1 4 1 1 0 1 0 0 1 0 0 0 8 0 0 0 0 0 0 0 13 2 0 0 1 2 0 0 0 2 0 0---
-- 68
35-
-
39 0 2 6 2 0 0 40 0 0 0 2 0 7 5 0 3 1 0 0 0 7 0 2 1 4 0 0 1 0 0 0 5 0 0 0 0 3 0 1 9 4 0 2 1 9 0 0 1 1 0 2---
--12
1
40-
-
44 0 5 1 3 1 0 61 0 0 5 3 0 15 13 1 8 0 3 3 2 17 3 3 0 10 0 0 0 1 0 2 2 1 10 0 0 3 0 0 12 2 0 2 2 15 0 0 2 3 1 2---
--21
7
45-
-
49 1 14 3 3 2 3 65 2 0 4 7 0 27 21 0 18 4 10 3 3 45 2 1 0 9 0 1 1 1 1 1 2 1 6 0 0 1 1 0 19 1 0 4 2 16 0 3 0 4 1 3---
--31
6
50-
-
54 1 3 2 1 1 2 62 4 1 12 16 1 26 20 0 28 1 12 3 9 64 4 3 3 7 0 0 1 3 1 15 3 1 11 0 0 6 0 0 18 5 0 7 3 13 0 2 0 1 4 3---
--38
3
55-
-
59 0 8 6 5 2 0 68 0 0 13 23 1 50 54 1 41 7 9 5 9 83 1 4 5 22 2 0 2 1 1 20 1 0 11 1 0 7 0 0 21 9 0 5 3 23 0 4 0 6 2 6---
--54
2
60-
-
64 1 11 10 4 2 1 54 3 1 8 20 3 49 59 2 30 6 17 6 18 129 4 4 2 25 0 0 0 3 5 39 0 0 15 0 0 20 2 0 24 5 0 2 0 26 0 4 0 6 2 6
-----
628
65-
-
69 0 5 4 2 1 0 34 1 0 11 24 1 61 44 2 40 5 13 1 21 142 1 2 2 34 2 0 2 3 1 58 0 2 18 0 3 25 1 0 13 1 1 3 1 28 0 3 2 7 0 11 -----
636
70-
-
74 2 5 5 2 1 2 32 4 0 11 21 2 40 35 1 29 9 17 2 11 137 2 2 1 39 0 0 1 1 1 87 1 1 11 1 0 22 0 1 11 3 0 1 1 17 0 0 4 2 2 8
-----
588
75+
0 8 4 2 2 2 9 3 3 15 36 0 55 53 1 23 9 16 9 10 154 1 3 2 52 1 0 1 2 1
103 0 0 11 0 0 29 1 3 6 6 0 0 1 13 1 2 1 1 3 9
-----
667
% of
Total 0.1
0%1.4
0%1.0
0%0.7
0%0.3
0%0.2
0%10
.30%
0.40%
0.10%
1.80%
3.50%
0.20%
7.60%
6.90%
0.20%
5.10%
0.90%
2.20%
0.70%
1.90%
17.60
%0.6
0%1.2
0%0.4
0%4.7
0%0.1
0%0.0
0%0.3
0%0.3
0%0.3
0%7.3
0%0.8
0%0.1
0%2.1
0%0.0
0%0.1
0%2.6
0%0.1
0%0.1
0%4.3
0%0.9
0%0.0
0%0.7
0%0.5
0%4.4
0%0.0
0%0.4
0%1.4
0%1.3
0%0.6
0%1.1
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
55:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
PE
RA
K, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
135
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
3 46 70 18 3 614
1 9 2 47 121 6
287
240 5 73 49 98 15 8
299 7 50 13 163 4 0 11
1809 14 14 38
019
0 90 359 4 9 44 1 0 28 0 5
204
149 0 16 23 150 0 22 43 91 17 48 -----
5504
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 4 0 0 0 0 1 7 0 0 0 0 0 0 0 11 2 3 0---
-- 29
5-
-
9 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 12 0 0 0 0 1 0 0 9 6 0 1---
-- 32
10-
-
14 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 6 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 13 3 0 0 0 3 0 0 6 2 0 0---
-- 39
15-
-
19 0 0 0 1 0 0 3 0 0 0 0 0 1 0 0 2 0 0 0 0 0 0 3 0 0 0 0 1 0 0 0 0 0 0 9 0 0 0 0 0 0 0 0 5 3 0 1 3 0 0 0 6 7 1 0---
-- 46
20-
-
24 0 0 0 0 0 0 4 0 0 0 0 0 2 1 0 0 0 0 0 0 1 1 3 0 2 0 0 0 4 0 0 0 0 2 11 0 2 0 0 0 0 0 0 7 9 0 0 6 6 0 0 2 1 0 1---
-- 65
25-
-
29 0 1 0 0 0 0 0 0 0 0 2 0 6 1 0 2 0 1 0 0 3 0 0 0 1 0 0 0 15 0 0 3 1 2 15 0 3 0 0 0 0 0 0 5 8 0 0 3 6 0 0 2 5 1 1---
-- 87
30-
-
34 0 1 0 0 0 1 4 0 0 0 3 1 6 6 0 1 0 0 0 1 2 0 0 0 2 0 0 0 50 0 0 9 3 4 13 0 1 0 0 0 0 0 0 8 10 0 0 2 3 0 0 1 4 1 2---
--13
9
35-
-
39 0 2 2 2 0 0 5 0 0 1 2 0 7 10 0 2 1 3 0 0 8 1 2 1 1 1 0 111
3 0 0 17 8 0 13 1 0 2 0 0 0 0 0 17 8 0 1 0 10 0 0 0 10 2 2---
--25
6
40-
-
44 0 7 1 2 1 0 16 0 0 1 8 0 9 6 0 1 1 3 0 0 18 0 1 2 5 0 0 319
4 0 0 31 11 5 26 0 1 0 1 0 0 0 0 14 11 0 1 2 6 0 2 0 8 0 4---
--40
2
45-
-
49 0 3 4 3 0 0 17 1 0 2 10 0 22 7 0 4 2 5 1 1 27 1 1 0 6 0 0 030
6 1 0 51 19 9 56 1 1 5 0 0 0 0 0 25 22 0 2 3 16 0 0 1 8 1 2---
--64
6
50-
-
54 0 4 3 1 0 0 21 1 1 4 7 2 26 23 1 4 4 8 1 3 27 0 4 1 10 1 0 231
7 5 0 65 37 20 58 1 0 4 0 0 0 0 0 26 17 0 7 4 23 0 4 0 8 1 2---
--75
8
55-
-
59 0 6 6 2 1 0 20 1 1 5 15 0 36 33 1 9 9 15 3 1 31 1 3 2 15 2 0 031
4 1 2 47 28 12 56 0 0 6 0 0 3 0 0 24 18 0 2 0 17 0 5 1 11 3 8---
--77
6
60-
-
64 0 8 14 3 0 2 24 1 0 9 17 0 39 35 0 10 9 17 1 0 37 0 9 2 14 0 0 019
1 1 6 44 33 11 34 0 1 6 0 0 5 0 0 15 18 0 1 0 20 0 3 1 6 0 8---
--65
5
65-
-
69 0 5 8 1 0 1 11 2 0 4 13 1 29 31 0 11 4 13 2 1 43 0 6 2 25 0 0 113
5 2 1 44 24 7 28 0 0 4 0 0 3 0 1 13 13 0 1 0 13 0 5 1 2 1 5---
--51
7
70-
-
74 0 5 16 2 1 0 8 0 0 5 9 0 42 40 1 11 9 16 3 0 48 1 7 0 24 0 0 1 87 0 2 36 14 13 20 0 0 3 0 0 9 0 1 5 4 0 0 0 12 0 1 1 7 1 3---
--46
8
75+
3 4 15 0 0 2 8 3 0 16 35 2 62 47 2 16 10 17 3 1 54 0 4 3 57 0 0 1 83 4 2 33 12 5 19 1 0 10 0 0 8 0 2 8 5 0 0 0 14 0 2 1 4 2 9---
--58
9
% of
Total
0.10%
0.80%
1.30%
0.30%
0.10%
0.10%
2.60%
0.20%
0.00%
0.90%
2.20%
0.10%
5.20%
4.40%
0.10%
1.30%
0.90%
1.80%
0.30%
0.10%
5.40%
0.10%
0.90%
0.20%
3.00%
0.10%
0.00%
0.20%
32.90
%0.3
0%0.3
0%6.9
0%3.5
0%1.6
0%6.5
0%0.1
0%0.2
0%0.8
0%0.0
0%0.0
0%0.5
0%0.0
0%0.1
0%3.7
0%2.7
0%0.0
0%0.3
0%0.4
0%2.7
0%0.0
0%0.4
0%0.8
0%1.7
0%0.3
0%0.9
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
56:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
PE
RA
K, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011
136
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
5 62 43 30 13 10 459 19 5 80 155 8
338
310 9
226 42 98 32 87 788 25 53 17 208 5 1 15 15 12 325 36 6 94 2 3
116 5 6
192 42 1 31 23 196 1 18 64 58 25 51 -----
4465
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.2 0.8 0 0 0 0 0.2 0 0 4.4 0.6 0.6 0---
-- 8
5-
-
9 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0 0.3 0 0 0 0 0 0 0.2 0 0.2 0 0 0 0 0 0 0 0.3 0 0 0 0 1 0 0 2.1 1 0.2 0---
-- 6
10-
-
14 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0.3 0.5 0 0 1.3 0.8 0.2 0---
-- 7
15-
-
19 0 0 0 0 0 0 0.5 0.2 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 1.4 0 0.3 0 0 0.3 0 0 0 0.3 0 0 0 0 0 0 0 2.2 0 0 0.3 0.5 0.7 0 0 1.4 0.9 0.2 0.2 ----- 10
20-
-
24 0 0 0 0.2 0 0 0.6 0.2 0 0 0 0 0.2 0.2 0 0.2 0 0 0 0 0.8 0.6 1.6 0.2 0.4 0 0 0.2 0 0 0 0.8 0 0 0 0 0 0 0 1.2 0.8 0 0.4 0.2 2 0 0 0.4 0.6 0.4 0---
-- 12
25-
-
29 0 0 0.3 0.8 0.3 0 2.1 0 0 0.3 0.3 0 1.1 0.8 0 0 0 0.3 0 0.3 0.5 0.8 1.6 0 0.3 0 0 0.5 0 0 0 1.6 0 0.3 0 0 0 0 0 0.8 0 0 0.3 0.5 2.7 0 0 0.8 0.8 0.5 0---
-- 19
30-
-
34 0 0.3 0.3 0.3 0 0 5.7 0 0 0 0.6 0 0.6 0.6 0.3 0.6 0 0 0 0.3 1.2 0.3 0.3 0 0.3 0 0 0.3 0 0 0 2.4 0 0 0 0 0 0 0 3.9 0.6 0 0 0.3 0.6 0 0 0 0.6 0 0---
-- 20
35-
-
39 0 0.6 1.8 0.6 0 012
.2 0 0 0 0.6 0 2.1 1.5 0 0.9 0.3 0 0 0 2.1 0 0.6 0.3 1.2 0 0 0.3 0 0 0 1.5 0 0 0 0 0.9 0 0.3 2.7 1.2 0 0.6 0.3 2.7 0 0 0.3 0.3 0 0.6 ----- 37
40-
-
44 0 1.4 0.3 0.9 0.3 017
.4 0 0 1.4 0.9 0 4.3 3.7 0.3 2.3 0 0.9 0.9 0.6 4.8 0.9 0.9 0 2.8 0 0 0 0.3 0 0.6 0.6 0.3 2.8 0 0 0.9 0 0 3.4 0.6 0 0.6 0.6 4.3 0 0 0.6 0.9 0.3 0.6 ----- 62
45-
-
49 0.3 3.9 0.8 0.8 0.6 0.8 18.3 0.6 0 1.1 2 0 7.6 5.9 0 5.1 1.1 2.8 0.8 0.8 12.7 0.6 0.3 0 2.5 0 0.3 0.3 0.3 0.3 0.3 0.6 0.3 1.7 0 0 0.3 0.3 0 5.4 0.3 0 1.1 0.6 4.5 0 0.8 0 1.1 0.3 0.8 ----- 89
50-
-
54 0.3 0.9 0.6 0.3 0.3 0.6 18.7 1.2 0.3 3.6 4.8 0.3 7.8 6 0 8.4 0.3 3.6 0.9 2.7 19.3 1.2 0.9 0.9 2.1 0 0 0.3 0.9 0.3 4.5 0.9 0.3 3.3 0 0 1.8 0 0 5.4 1.5 0 2.1 0.9 3.9 0 0.6 0 0.3 1.2 0.9 -----
115
55-
-
59 0 2.8 2.1 1.8 0.7 024
.2 0 0 4.6 8.2 0.4 17.8
19.2 0.4 14.6 2.5 3.2 1.8 3.2 29.5 0.4 1.4 1.8 7.8 0.7 0 0.7 0.4 0.4 7.1 0.4 0 3.9 0.4 0 2.5 0 0 7.5 3.2 0 1.8 1.1 8.2 0 1.4 0 2.1 0.7 2.1 -----
193
60-
-
64 0.4 4.9 4.4 1.8 0.9 0.4 24 1.3 0.4 3.5 8.9 1.3 21.7
26.2 0.9 13.3 2.7 7.5 2.7 8
57.2 1.8 1.8 0.9 11.1 0 0 0 1.3 2.2 17.3 0 0 6.7 0 0 8.9 0.9 0
10.6 2.2 0 0.9 0
11.5 0 1.8 0 2.7 0.9 2.7 -----
279
65-
-
69 0 3.2 2.5 1.3 0.6 021
.6 0.6 0 715
.2 0.6 38.7
27.9 1.3 25.4 3.2 8.3 0.6 13.3
90.2 0.6 1.3 1.3 21.6 1.3 0 1.3 1.9 0.6 36.8 0 1.3 11.4 0 1.9 15.9 0.6 0 8.3 0.6 0.6 1.9 0.6 17.8 0 1.9 1.3 4.4 0 7
-----
404
70-
-
74 1.6 4 4 1.6 0.8 1.6 25.9 3.2 0 8.9 17 1.6 32.4
28.3 0.8 23.5 7.3 13.8 1.6 8.9
110.9 1.6 1.6 0.8 31.6 0 0 0.8 0.8 0.8 70.5 0.8 0.8 8.9 0.8 0
17.8 0 0.8 8.9 2.4 0 0.8 0.8 13.8 0 0 3.2 1.6 1.6 6.5 -----
476
75+
0 6.3 3.2 1.6 1.6 1.6 7.1 2.4 2.4 11.8
28.4 0
43.3
41.7 0.8 18.1 7.1 12.6 7.1 7.9
121.3 0.8 2.4 1.6 41 0.8 0 0.8 1.6 0.8 81.1 0 0 8.7 0 0
22.8 0.8 2.4 4.7 4.7 0 0 0.8 10.2 0.8 1.6 0.8 0.8 2.4 7.1 -----
525
Crud
eRa
te 0.1 1.1 0.8 0.5 0.2 0.2 8 0.3 0.1 1.4 2.7 0.1 5.9 5.4 0.2 3.9 0.7 1.7 0.6 1.5 13.7 0.4 0.9 0.3 3.6 0.1 0 0.3 0.3 0.2 5.7 0.6 0.1 1.6 0 0.1 2 0.1 0.1 3.3 0.7 0 0.5 0.4 3.4 0 0.3 1.1 1 0.4 0.9 -----
77.9
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
57:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, P
ER
AK
, AL
L R
ESI
DE
NT
S, M
AL
ES,
200
7-20
11
ASR
Wor
ld 0.1 1 0.7 0.5 0.2 0.2 7.7 0.3 0.1 1.3 2.6 0.1 5.6 5.1 0.2 3.7 0.7 1.6 0.5 1.5 13.1 0.4 0.9 0.3 3.5 0.1 0 0.3 0.3 0.2 5.4 0.6 0.1 1.6 0 0.1 2 0.1 0.1 3.2 0.7 0 0.5 0.4 3.3 0 0.3 1.2 1 0.4 0.9 -----
74.7
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
137
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
3 46 70 18 3 614
1 9 2 47 121 6
287
240 5 73 49 98 15 8
299 7 50 13 163 4 0 11
1809 14 14 38
019
0 90 359 4 9 44 1 0 28 0 5
204
149 0 16 23 150 0 22 43 91 17 48 -----
5504
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0.2 1.5 0 0 0 0 0 0 0 2.4 0.4 0.6 0---
-- 6
5-
-
9 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.1 0 0 0 0 0.2 0 0 1.6 1.1 0 0.2 ----- 6
10-
-
14 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.3 1 0 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0 0 0 0 0 0 0 2.2 0.5 0 0 0 0.5 0 0 1 0.3 0 0---
-- 7
15-
-
19 0 0 0 0.2 0 0 0.5 0 0 0 0 0 0.2 0 0 0.3 0 0 0 0 0 0 0.5 0 0 0 0 0.2 0 0 0 0 0 0 1.5 0 0 0 0 0 0 0 0 0.9 0.5 0 0.2 0.5 0 0 0 1 1.2 0.2 0---
-- 8
20-
-
24 0 0 0 0 0 0 0.9 0 0 0 0 0 0.4 0.2 0 0 0 0 0 0 0.2 0.2 0.6 0 0.4 0 0 0 0.9 0 0 0 0 0.4 2.4 0 0.4 0 0 0 0 0 0 1.5 1.9 0 0 1.3 1.3 0 0 0.4 0.2 0 0.2 ----- 14
25-
-
29 0 0.3 0 0 0 0 0 0 0 0 0.6 0 1.7 0.3 0 0.6 0 0.3 0 0 0.8 0 0 0 0.3 0 0 0 4.2 0 0 0.8 0.3 0.6 4.2 0 0.8 0 0 0 0 0 0 1.4 2.3 0 0 0.8 1.7 0 0 0.6 1.4 0.3 0.3 ----- 25
30-
-
34 0 0.3 0 0 0 0.3 1.2 0 0 0 0.9 0.3 1.8 1.8 0 0.3 0 0 0 0.3 0.6 0 0 0 0.6 0 0 015
.3 0 0 2.7 0.9 1.2 4 0 0.3 0 0 0 0 0 0 2.4 3.1 0 0 0.6 0.9 0 0 0.3 1.2 0.3 0.6 ----- 42
35-
-
39 0 0.6 0.6 0.6 0 0 1.5 0 0 0.3 0.6 0 2.1 3 0 0.6 0.3 0.9 0 0 2.4 0.3 0.6 0.3 0.3 0.3 0 0.3 34.2 0 0 5.2 2.4 0 3.9 0.3 0 0.6 0 0 0 0 0 5.2 2.4 0 0.3 0 3 0 0 0 3 0.6 0.6 ----- 78
40-
-
44 0 1.9 0.3 0.6 0.3 0 4.4 0 0 0.3 2.2 0 2.5 1.7 0 0.3 0.3 0.8 0 0 5 0 0.3 0.6 1.4 0 0 0.8 53.4 0 0 8.5 3 1.4 7.2 0 0.3 0 0.3 0 0 0 0 3.9 3 0 0.3 0.6 1.7 0 0.6 0 2.2 0 1.1 -----
111
45-
-
49 0 0.9 1.1 0.9 0 0 4.9 0.3 0 0.6 2.9 0 6.3 2 0 1.1 0.6 1.4 0.3 0.3 7.7 0.3 0.3 0 1.7 0 0 087
.4 0.3 014
.6 5.4 2.6 16 0.3 0.3 1.4 0 0 0 0 0 7.1 6.3 0 0.6 0.9 4.6 0 0 0.3 2.3 0.3 0.6 -----
185
50-
-
54 0 1.2 0.9 0.3 0 0 6.5 0.3 0.3 1.2 2.2 0.6 8 7.1 0.3 1.2 1.2 2.5 0.3 0.9 8.3 0 1.2 0.3 3.1 0.3 0 0.6 97.4 1.5 0 20 11.4 6.1 17.8 0.3 0 1.2 0 0 0 0 0 8 5.2 0 2.2 1.2 7.1 0 1.2 0 2.5 0.3 0.6 -----
233
55-
-
59 0 2.1 2.1 0.7 0.4 0 7.1 0.4 0.4 1.8 5.3 012
.711
.7 0.4 3.2 3.2 5.3 1.1 0.4 11 0.4 1.1 0.7 5.3 0.7 0 011
1 0.4 0.7 16.6 9.9 4.2 19.8 0 0 2.1 0 0 1.1 0 0 8.5 6.4 0 0.7 0 6 0 1.8 0.4 3.9 1.1 2.8 -----
274
60-
-
64 0 3.5 6.1 1.3 0 0.9 10.4 0.4 0 3.9 7.4 0
16.9
15.2 0 4.3 3.9 7.4 0.4 0 16 0 3.9 0.9 6.1 0 0 0
82.7 0.4 2.6 19.1
14.3 4.8 14.7 0 0.4 2.6 0 0 2.2 0 0 6.5 7.8 0 0.4 0 8.7 0 1.3 0.4 2.6 0 3.5 -----
284
65-
-
69 0 3.2 5 0.6 0 0.6 6.9 1.3 0 2.5 8.2 0.6 18.3
19.6 0 6.9 2.5 8.2 1.3 0.6 27.1 0 3.8 1.3 15.8 0 0 0.6 85.2 1.3 0.6 27.8
15.1 4.4 17.7 0 0 2.5 0 0 1.9 0 0.6 8.2 8.2 0 0.6 0 8.2 0 3.2 0.6 1.3 0.6 3.2 -----
326
70-
-
74 0 3.6 11.4 1.4 0.7 0 5.7 0 0 3.6 6.4 0
29.9
28.5 0.7 7.8 6.4 11.4 2.1 0
34.2 0.7 5 0
17.1 0 0 0.7 61.9 0 1.4 25.6 10 9.3 14.2 0 0 2.1 0 0 6.4 0 0.7 3.6 2.8 0 0 0 8.5 0 0.7 0.7 5 0.7 2.1 -----
333
75+ 1.9 2.5 9.5 0 0 1.3 5 1.9 0
10.1
22.1 1.3 39.1
29.7 1.3 10.1 6.3 10.7 1.9 0.6 34.1 0 2.5 1.9 36 0 0 0.6 52.4 2.5 1.3 20.8 7.6 3.2 12 0.6 0 6.3 0 0 5 0 1.3 5 3.2 0 0 0 8.8 0 1.3 0.6 2.5 1.3 5.7 -----
372
Crud
eRa
te 0.1 0.8 1.2 0.3 0.1 0.1 2.5 0.2 0 0.8 2.1 0.1 5 4.2 0.1 1.3 0.9 1.7 0.3 0.1 5.2 0.1 0.9 0.2 2.9 0.1 0 0.2 31.8 0.2 0.2 6.7 3.3 1.6 6.3 0.1 0.2 0.8 0 0 0.5 0 0.1 3.6 2.6 0 0.3 0.4 2.6 0 0.4 0.8 1.6 0.3 0.8 -----
96.6
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
58:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, P
ER
AK
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
200
7-20
11
ASR
Wor
ld 0 0.7 1.1 0.3 0 0.1 2.3 0.1 0 0.7 1.9 0.1 4.5 3.7 0.1 1.1 0.7 1.5 0.2 0.1 4.7 0.1 0.8 0.2 2.5 0.1 0 0.2 29.3 0.2 0.2 6.1 3.1 1.4 5.9 0.1 0.2 0.7 0 0 0.4 0 0.1 3.4 2.5 0 0.3 0.4 2.4 0 0.4 0.8 1.5 0.3 0.8 -----
88.5
138
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
2 41 39 24 17 918
2 18 10 61 80 334
120
1 312
8 14 61 25 53 400 6 39 4 88 0 0 22 6 0
216 40 2 69 0 0
130 0 7 59 38 4 2 8
145 1 14 19 72 61 10 -----
2774
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 3 0 5 0 0 0 0 3 9 0 2 0 0 3 0 0 7 6 12 0---
-- 56
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 6 0 0 0 0 2 0 0 3 3 12 0---
-- 29
10-
-
14 0 0 1 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 3 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 2 4 0 0 0 4 11 0---
-- 33
15-
-
19 0 0 0 0 0 0 3 0 0 0 2 0 1 0 0 0 0 0 0 0 0 1 5 0 2 0 0 2 0 0 1 5 0 0 0 0 0 0 0 5 2 0 0 2 5 0 0 1 1 3 0---
-- 41
20-
-
24 0 0 1 0 1 0 5 0 0 0 0 0 4 0 0 0 0 0 0 0 4 1 1 0 1 0 0 1 0 0 0 8 0 0 0 0 2 0 0 1 0 0 0 1 6 0 0 0 4 3 0---
-- 44
25-
-
29 0 0 2 0 0 1 3 0 0 0 0 0 8 2 0 1 0 2 0 0 2 0 2 0 0 0 0 1 0 0 1 8 0 0 0 0 2 0 0 1 1 0 0 0 2 0 1 0 6 2 0---
-- 48
30-
-
34 0 2 1 2 0 0 4 0 0 0 2 0 5 1 0 3 0 1 0 0 6 0 4 0 1 0 0 0 0 0 0 5 0 1 0 0 3 0 0 4 1 0 0 0 10 0 0 0 4 3 0---
-- 63
35-
-
39 0 2 1 0 0 0 14 0 0 1 3 0 12 7 0 3 0 3 3 0 10 1 2 0 2 0 0 1 0 0 0 2 0 2 0 0 1 0 0 4 1 0 0 0 3 0 0 0 5 2 1---
-- 86
40-
-
44 0 7 4 1 2 0 15 1 0 1 3 0 17 7 1 4 1 3 5 0 15 0 1 1 4 0 0 1 1 0 3 2 0 2 0 0 3 0 0 5 5 0 1 1 12 0 1 0 4 1 1---
--13
6
45-
-
49 0 2 2 1 2 1 31 1 0 4 5 2 29 15 0 11 1 4 3 2 18 0 3 1 6 0 0 0 0 0 2 2 0 7 0 0 2 0 0 5 8 0 0 0 11 0 0 1 3 2 4---
--19
1
50-
-
54 0 5 3 4 1 0 27 1 2 8 3 0 45 13 0 16 4 9 0 5 41 0 2 0 5 0 0 3 1 0 5 2 0 14 0 0 9 0 0 4 1 0 1 1 16 0 0 2 14 3 0---
--27
0
55-
-
59 0 5 3 1 1 0 26 1 2 3 13 1 43 34 1 21 3 10 1 8 45 1 1 0 16 0 0 4 3 0 11 0 0 8 0 0 14 0 0 4 5 1 0 1 11 0 3 2 3 0 1---
--31
1
60-
-
64 0 6 7 5 3 2 18 3 2 9 7 0 41 39 0 18 2 7 4 10 52 0 3 1 8 0 0 1 1 0 26 0 1 13 0 0 18 0 0 4 6 0 0 0 9 0 4 1 7 1 0---
--33
9
65-
-
69 2 2 4 2 1 1 15 3 3 9 8 0 43 33 0 16 0 7 3 12 70 2 5 0 13 0 0 2 0 0 39 1 0 9 0 0 22 0 0 3 2 0 0 0 20 0 2 1 5 3 1---
--36
4
70-
-
74 0 7 3 4 3 1 10 4 1 10 12 0 37 31 0 21 1 3 2 7 62 0 1 1 13 0 0 1 0 0 65 0 0 3 0 0 31 0 2 1 4 1 0 0 12 0 1 0 3 0 0---
--35
8
75+
0 3 7 4 3 3 7 4 0 16 22 0 56 19 1 11 2 12 4 8 75 0 5 0 16 0 0 2 0 0 63 1 1 4 0 0 23 0 2 1 2 0 0 0 19 1 2 1 0 3 2---
--40
5
% of
Total 0.1
0%1.5
0%1.4
0%0.9
0%0.6
0%0.3
0%6.6
0%0.6
0%0.4
0%2.2
0%2.9
0%0.1
0%12
.30%
7.20%
0.10%
4.60%
0.50%
2.20%
0.90%
1.90%
14.40
%0.2
0%1.4
0%0.1
0%3.2
0%0.0
0%0.0
0%0.8
0%0.2
0%0.0
0%7.8
0%1.4
0%0.1
0%2.5
0%0.0
0%0.0
0%4.7
0%0.0
0%0.3
0%2.1
0%1.4
0%0.1
0%0.1
0%0.3
0%5.2
0%0.0
0%0.5
0%0.7
0%2.6
0%2.2
0%0.4
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
59:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
KE
DA
H, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
139
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
5 40 46 28 9 1 48 8 1 43 77 429
112
9 2 66 18 31 8 619
3 3 29 3 48 0 1 1612
20 5 929
512
7 19 233 4 4 28 1 1 37 0 4 74 101 1 0 6 79 1 23 14 50 64 11 -----
3565
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 2 0 0 0 0 1 0 0 5 4 22 0---
-- 38
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 8 0 0 0 0 1 0 0 3 0 2 1---
-- 20
10-
-
14 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 3 0 0 0 0 1 0 0 0 0 0 0 5 0 0 0 0 0 0 0 0 9 0 0 0 0 5 0 0 1 4 7 0---
-- 37
15-
-
19 0 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 3 0 3 0 0 1 0 0 0 0 0 0 9 0 1 0 0 0 0 0 0 3 3 0 0 2 2 0 0 1 1 5 0---
-- 37
20-
-
24 0 1 0 0 0 0 3 0 0 0 0 0 4 0 0 0 0 2 0 0 1 0 2 0 0 0 0 1 8 0 0 1 1 0 5 0 0 0 0 0 0 0 0 6 3 0 0 0 6 0 0 1 1 4 1---
-- 51
25-
-
29 0 1 1 0 0 0 1 0 0 0 1 0 3 2 0 0 0 0 0 0 2 0 2 0 0 0 0 2 19 0 0 8 3 0 6 1 0 0 0 0 0 0 1 1 7 0 0 1 1 0 0 0 3 2 0---
-- 68
30-
-
34 0 2 0 1 0 0 4 0 0 0 1 0 3 3 0 1 1 1 1 0 2 0 0 0 0 0 0 1 57 0 0 4 2 0 3 0 0 1 0 0 0 0 0 3 11 0 0 1 7 0 0 1 2 0 0---
--11
3
35-
-
39 0 1 2 2 0 0 1 0 0 0 1 0 11 2 0 3 1 0 1 0 5 0 1 0 1 0 0 2 94 0 1 23 3 1 21 0 0 0 0 0 0 0 0 1 11 0 0 0 5 0 0 0 4 3 0---
--20
1
40-
-
44 0 6 3 1 0 0 7 2 0 1 2 0 16 5 0 4 0 3 0 1 10 0 2 0 4 0 0 017
0 3 0 39 14 2 18 1 2 2 0 0 2 0 0 8 13 0 0 0 3 0 1 0 4 6 0---
--35
5
45-
-
49 0 2 2 2 1 0 7 1 0 3 9 0 15 9 0 4 1 1 0 0 25 0 3 0 1 0 0 124
3 1 1 47 19 3 30 1 1 2 0 0 2 0 0 8 10 0 0 1 6 0 2 0 7 3 2---
--47
6
50-
-
54 0 2 3 5 0 0 4 0 0 6 13 0 35 12 0 8 0 3 1 1 20 0 1 0 3 0 0 219
8 0 1 42 19 2 44 0 0 4 1 0 3 0 1 9 13 0 0 0 4 0 4 0 4 2 0---
--47
0
55-
-
59 0 7 3 3 1 0 7 0 0 9 7 1 39 11 1 11 4 5 2 0 15 0 2 0 4 0 0 117
2 0 5 43 24 4 21 0 0 4 0 0 3 0 1 3 12 1 0 0 9 0 5 1 5 1 2---
--44
9
60-
-
64 0 5 6 5 1 1 4 0 0 6 9 0 40 11 0 11 1 3 0 1 30 1 3 1 0 0 0 0 95 0 0 24 17 5 24 1 0 4 0 0 6 0 0 7 3 0 0 1 4 1 2 0 5 2 1---
--34
1
65-
-
69 0 4 5 2 0 0 3 0 0 6 8 0 38 28 0 3 1 4 1 1 21 1 2 2 5 0 0 2 71 0 1 25 13 2 16 0 0 1 0 1 6 0 1 2 10 0 0 0 9 0 5 0 1 0 1---
--30
2
70-
-
74 2 2 8 3 3 0 6 4 1 7 14 1 46 23 0 11 4 5 2 1 30 1 1 0 14 0 1 0 50 0 0 25 9 0 15 0 0 4 0 0 6 0 0 3 4 0 0 0 11 0 3 1 3 1 2---
--32
7
75+
3 7 11 3 3 0 1 1 0 5 12 2 40 23 1 8 5 4 0 1 32 0 2 0 13 0 0 1 43 1 0 14 3 0 14 0 0 3 0 0 9 0 0 1 1 0 0 0 5 0 1 0 2 4 1---
--28
0
% of
Total
0.10%
1.10%
1.30%
0.80%
0.30%
0.00%
1.30%
0.20%
0.00%
1.20%
2.20%
0.10%
8.20%
3.60%
0.10%
1.90%
0.50%
0.90%
0.20%
0.20%
5.40%
0.10%
0.80%
0.10%
1.30%
0.00%
0.00%
0.40%
34.20
%0.1
0%0.3
0%8.3
0%3.6
0%0.5
0%6.5
0%0.1
0%0.1
0%0.8
0%0.0
0%0.0
0%1.0
0%0.0
0%0.1
0%2.1
0%2.8
0%0.0
0%0.0
0%0.2
0%2.2
0%0.0
0%0.6
0%0.4
0%1.4
0%1.8
0%0.3
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
60:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
KE
DA
H, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011
140
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
2 41 39 24 17 918
2 18 10 61 80 334
120
1 312
8 14 61 25 53 400 6 39 4 88 0 0 22 6 0
216 40 2 69 0 0
130 0 7 59 38 4 2 8
145 1 14 19 72 61 10 -----
2774
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0.2 0 0 0 0 0.5 0 0 0 0.7 0 1.1 0 0 0 0 0.7 2.1 0 0.5 0 0 0.7 0 0 1.6 1.4 2.7 0---
-- 13
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0.2 0 0 0 0 0 1.2 0 0 0 0 0.4 0 0 0.6 0.6 2.4 0---
-- 6
10-
-
14 0 0 0.2 0 0 0 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.5 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0.4 0.7 0 0 0 0.7 2 0---
-- 6
15-
-
19 0 0 0 0 0 0 0.6 0 0 0 0.4 0 0.2 0 0 0 0 0 0 0 0 0.2 1 0 0.4 0 0 0.4 0 0 0.2 1 0 0 0 0 0 0 0 1 0.4 0 0 0.4 1 0 0 0.2 0.2 0.6 0---
-- 9
20-
-
24 0 0 0.3 0 0.3 0 1.3 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0.3 0.3 0 0.3 0 0 0.3 0 0 0 2.1 0 0 0 0 0.5 0 0 0.3 0 0 0 0.3 1.6 0 0 0 1 0.8 0---
-- 11
25-
-
29 0 0 0.6 0 0 0.3 0.9 0 0 0 0 0 2.4 0.6 0 0.3 0 0.6 0 0 0.6 0 0.6 0 0 0 0 0.3 0 0 0.3 2.4 0 0 0 0 0.6 0 0 0.3 0.3 0 0 0 0.6 0 0.3 0 1.8 0.6 0---
-- 15
30-
-
34 0 0.7 0.3 0.7 0 0 1.4 0 0 0 0.7 0 1.7 0.3 0 1 0 0.3 0 0 2.1 0 1.4 0 0.3 0 0 0 0 0 0 1.7 0 0.3 0 0 1 0 0 1.4 0.3 0 0 0 3.5 0 0 0 1.4 1 0---
-- 22
35-
-
39 0 0.7 0.4 0 0 0 4.9 0 0 0.4 1.1 0 4.2 2.5 0 1.1 0 1.1 1.1 0 3.5 0.4 0.7 0 0.7 0 0 0.4 0 0 0 0.7 0 0.7 0 0 0.4 0 0 1.4 0.4 0 0 0 1.1 0 0 0 1.8 0.7 0.4 ----- 30
40-
-
44 0 2.4 1.4 0.3 0.7 0 5.2 0.3 0 0.3 1 0 5.9 2.4 0.3 1.4 0.3 1 1.7 0 5.2 0 0.3 0.3 1.4 0 0 0.3 0.3 0 1 0.7 0 0.7 0 0 1 0 0 1.7 1.7 0 0.3 0.3 4.2 0 0.3 0 1.4 0.3 0.3 ----- 47
45-
-
49 0 0.7 0.7 0.4 0.7 0.4 11.2 0.4 0 1.4 1.8 0.7 10.5 5.4 0 4 0.4 1.4 1.1 0.7 6.5 0 1.1 0.4 2.2 0 0 0 0 0 0.7 0.7 0 2.5 0 0 0.7 0 0 1.8 2.9 0 0 0 4 0 0 0.4 1.1 0.7 1.4 ----- 69
50-
-
54 0 2.1 1.2 1.7 0.4 011
.2 0.4 0.8 3.3 1.2 018
.6 5.4 0 6.6 1.7 3.7 0 2.1 17 0 0.8 0 2.1 0 0 1.2 0.4 0 2.1 0.8 0 5.8 0 0 3.7 0 0 1.7 0.4 0 0.4 0.4 6.6 0 0 0.8 5.8 1.2 0---
--11
2
55-
-
59 0 2.5 1.5 0.5 0.5 013
.1 0.5 1 1.5 6.5 0.5 21.6
17.1 0.5 10.6 1.5 5 0.5 4
22.6 0.5 0.5 0 8 0 0 2 1.5 0 5.5 0 0 4 0 0 7 0 0 2 2.5 0.5 0 0.5 5.5 0 1.5 1 1.5 0 0.5 -----
156
60-
-
64 0 4.1 4.8 3.4 2 1.4 12.3 2 1.4 6.1 4.8 0 28 26.6 0
12.3 1.4 4.8 2.7 6.8 35.5 0 2 0.7 5.5 0 0 0.7 0.7 0
17.7 0 0.7 8.9 0 0
12.3 0 0 2.7 4.1 0 0 0 6.1 0 2.7 0.7 4.8 0.7 0
-----
231
65-
-
69 2.1 2.1 4.1 2.1 1 115
.4 3.1 3.1 9.2 8.2 044
.133
.9 016
.4 0 7.2 3.1 12.3
71.8 2.1 5.1 0
13.3 0 0 2.1 0 0 40 1 0 9.2 0 0
22.6 0 0 3.1 2.1 0 0 0
20.5 0 2.1 1 5.1 3.1 1
-----
373
70-
-
74 0 8.5 3.6 4.8 3.6 1.2 12.1 4.8 1.2 12.1
14.5 0
44.9
37.6 0
25.5 1.2 3.6 2.4 8.5 75.2 0 1.2 1.2 15.8 0 0 1.2 0 0
78.8 0 0 3.6 0 0
37.6 0 2.4 1.2 4.8 1.2 0 0
14.5 0 1.2 0 3.6 0 0
-----
434
75+
0 3.7 8.6 4.9 3.7 3.7 8.6 4.9 019
.6 27 068
.723
.3 1.2 13.5 2.5 14.7 4.9 9.8 92 0 6.1 0
19.6 0 0 2.5 0 0
77.3 1.2 1.2 4.9 0 0
28.2 0 2.5 1.2 2.5 0 0 0
23.3 1.2 2.5 1.2 0 3.7 2.5 -----
497
Crud
eRa
te 0 0.9 0.8 0.5 0.4 0.2 3.9 0.4 0.2 1.3 1.7 0.1 7.3 4.3 0.1 2.8 0.3 1.3 0.5 1.1 8.6 0.1 0.8 0.1 1.9 0 0 0.5 0.1 0 4.6 0.9 0 1.5 0 0 2.8 0 0.2 1.3 0.8 0.1 0 0.2 3.1 0 0.3 0.4 1.5 1.3 0.2 -----
59.6
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
61:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, K
ED
AH
, AL
L R
ESI
DE
NT
S, M
AL
ES,
200
7-20
11
ASR
Wor
ld 0.1 0.9 0.9 0.6 0.4 0.2 4.1 0.5 0.3 1.5 1.9 0.1 8.1 4.9 0.1 3.1 0.3 1.4 0.6 1.3 9.8 0.1 0.9 0.1 2.1 0 0 0.5 0.1 0 5.5 0.9 0.1 1.7 0 0 3.2 0 0.2 1.3 0.9 0.1 0 0.2 3.4 0 0.3 0.5 1.6 1.3 0.2 -----
66.6
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
141
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
5 40 46 28 9 1 48 8 1 43 77 429
112
9 2 66 18 31 8 619
3 3 29 3 48 0 1 1612
20 5 929
512
7 19 233 4 4 28 1 1 37 0 4 74 101 1 0 6 79 1 23 14 50 64 11 -----
3565
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0.5 0 0 0 0 0.2 0 0 1.2 1 5.3 0---
-- 9
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.2 0 0 0 0 0.2 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 1.7 0 0 0 0 0.2 0 0 0.6 0 0.4 0.2 ----- 4
10-
-
14 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0.6 0 0 0 0 0.2 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1.8 0 0 0 0 1 0 0 0.2 0.8 1.4 0---
-- 7
15-
-
19 0 0 0.2 0.2 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0.6 0 0.6 0 0 0.2 0 0 0 0 0 0 1.9 0 0.2 0 0 0 0 0 0 0.6 0.6 0 0 0.4 0.4 0 0 0.2 0.2 1.1 0---
-- 8
20-
-
24 0 0.3 0 0 0 0 0.8 0 0 0 0 0 1.1 0 0 0 0 0.5 0 0 0.3 0 0.5 0 0 0 0 0.3 2.1 0 0 0.3 0.3 0 1.3 0 0 0 0 0 0 0 0 1.6 0.8 0 0 0 1.6 0 0 0.3 0.3 1.1 0.3 ----- 13
25-
-
29 0 0.3 0.3 0 0 0 0.3 0 0 0 0.3 0 0.9 0.6 0 0 0 0 0 0 0.6 0 0.6 0 0 0 0 0.6 5.8 0 0 2.5 0.9 0 1.8 0.3 0 0 0 0 0 0 0.3 0.3 2.2 0 0 0.3 0.3 0 0 0 0.9 0.6 0---
-- 21
30-
-
34 0 0.7 0 0.3 0 0 1.4 0 0 0 0.3 0 1 1 0 0.3 0.3 0.3 0.3 0 0.7 0 0 0 0 0 0 0.3 19.6 0 0 1.4 0.7 0 1 0 0 0.3 0 0 0 0 0 1 3.8 0 0 0.3 2.4 0 0 0.3 0.7 0 0
----- 39
35-
-
39 0 0.3 0.7 0.7 0 0 0.3 0 0 0 0.3 0 3.7 0.7 0 1 0.3 0 0.3 0 1.7 0 0.3 0 0.3 0 0 0.7 31.3 0 0.3 7.7 1 0.3 7 0 0 0 0 0 0 0 0 0.3 3.7 0 0 0 1.7 0 0 0 1.3 1 0
----- 67
40-
-
44 0 2 1 0.3 0 0 2.3 0.7 0 0.3 0.7 0 5.3 1.7 0 1.3 0 1 0 0.3 3.3 0 0.7 0 1.3 0 0 056
.4 1 012
.9 4.6 0.7 6 0.3 0.7 0.7 0 0 0.7 0 0 2.7 4.3 0 0 0 1 0 0.3 0 1.3 2 0---
--11
8
45-
-
49 0 0.7 0.7 0.7 0.4 0 2.5 0.4 0 1.1 3.2 0 5.4 3.2 0 1.4 0.4 0.4 0 0 8.9 0 1.1 0 0.4 0 0 0.4 86.8 0.4 0.4 16.8 6.8 1.1 10.7 0.4 0.4 0.7 0 0 0.7 0 0 2.9 3.6 0 0 0.4 2.1 0 0.7 0 2.5 1.1 0.7 -----
170
50-
-
54 0 0.8 1.2 2 0 0 1.6 0 0 2.4 5.1 013
.8 4.7 0 3.2 0 1.2 0.4 0.4 7.9 0 0.4 0 1.2 0 0 0.8 78.1 0 0.4 16.6 7.5 0.8 17.4 0 0 1.6 0.4 0 1.2 0 0.4 3.6 5.1 0 0 0 1.6 0 1.6 0 1.6 0.8 0
-----
185
55-
-
59 0 3.4 1.5 1.5 0.5 0 3.4 0 0 4.4 3.4 0.5 19.1 5.4 0.5 5.4 2 2.5 1 0 7.4 0 1 0 2 0 0 0.5 84.3 0 2.5 21.1
11.8 2
10.3 0 0 2 0 0 1.5 0 0.5 1.5 5.9 0.5 0 0 4.4 0 2.5 0.5 2.5 0.5 1
-----
220
60-
-
64 0 3.3 4 3.3 0.7 0.7 2.7 0 0 4 6 026
.8 7.4 0 7.4 0.7 2 0 0.7 20.1 0.7 2 0.7 0 0 0 0
63.6 0 0
16.1
11.4 3.3 16.1 0.7 0 2.7 0 0 4 0 0 4.7 2 0 0 0.7 2.7 0.7 1.3 0 3.3 1.3 0.7 -----
228
65-
-
69 0 3.7 4.7 1.9 0 0 2.8 0 0 5.6 7.5 035
.526
.2 0 2.8 0.9 3.7 0.9 0.9 19.6 0.9 1.9 1.9 4.7 0 0 1.9 66.4 0 0.9 23.4
12.2 1.9 15 0 0 0.9 0 0.9 5.6 0 0.9 1.9 9.3 0 0 0 8.4 0 4.7 0 0.9 0 0.9 -----
282
70-
-
74 2.1 2.1 8.5 3.2 3.2 0 6.4 4.2 1.1 7.4 14.8 1.1 48.7
24.3 0
11.6 4.2 5.3 2.1 1.1 31.8 1.1 1.1 0
14.8 0 1.1 0
52.9 0 0
26.5 9.5 0
15.9 0 0 4.2 0 0 6.4 0 0 3.2 4.2 0 0 0
11.6 0 3.2 1.1 3.2 1.1 2.1 -----
346
75+ 2.7 6.4 10 2.7 2.7 0 0.9 0.9 0 4.6 11 1.8 36
.5 21 0.9 7.3 4.6 3.7 0 0.9 29.2 0 1.8 0
11.9 0 0 0.9 39.3 0.9 0
12.8 2.7 0
12.8 0 0 2.7 0 0 8.2 0 0 0.9 0.9 0 0 0 4.6 0 0.9 0 1.8 3.7 0.9 -----
256
Crud
eRa
te 0.1 0.9 1 0.6 0.2 0 1 0.2 0 0.9 1.7 0.1 6.3 2.8 0 1.4 0.4 0.7 0.2 0.1 4.2 0.1 0.6 0.1 1 0 0 0.3 26.2 0.1 0.2 6.3 2.7 0.4 5 0.1 0.1 0.6 0 0 0.8 0 0.1 1.6 2.2 0 0 0.1 1.7 0 0.5 0.3 1.1 1.4 0.2 -----
76.7
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
62:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, K
ED
AH
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
200
7-20
11
ASR
Wor
ld 0.1 0.9 1 0.6 0.2 0 1 0.2 0 0.9 1.7 0.1 6.4 2.9 0 1.4 0.4 0.7 0.2 0.1 4.2 0.1 0.6 0.1 1 0 0 0.3 25.9 0.1 0.2 6.3 2.8 0.4 5 0.1 0.1 0.6 0 0 0.8 0 0.1 1.6 2.2 0 0 0.1 1.7 0 0.5 0.3 1.1 1.5 0.2 ----- 77
142
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
2 37 28 12 7 521
0 7 5 32 80 10 166
260 2 79 16 53 11 49 383 14 28 0 42 0 1 18 7 3
187 37 0 39 0 1 39 0 6 74 23 1 8 23 112 2 24 15 67 9 43 -----
2277
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 3 0 1 0 0 1 0 0 3 0 0 0---
-- 10
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 4 0 0 0 0 1 0 0 4 0 2 0---
-- 14
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 5 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0 1 3 0 0---
-- 14
15-
-
19 0 0 1 0 1 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 1 0 0 0 2 0 0 0 0 0 0 0 5 0 0 2 5 3 0 0 1 6 1 0---
-- 34
20-
-
24 0 1 0 0 0 0 2 0 0 0 0 0 2 0 0 0 0 0 0 0 2 2 1 0 0 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 0 0 0 2 4 0 0 2 7 0 0---
-- 31
25-
-
29 0 1 1 0 0 0 4 0 0 1 2 1 1 0 0 1 0 0 0 0 1 4 3 0 1 0 0 2 0 0 0 11 0 0 0 0 0 0 0 6 1 0 1 5 9 0 0 0 1 2 2---
-- 61
30-
-
34 0 3 0 1 1 0 18 1 0 0 3 0 1 3 0 1 1 1 2 1 2 2 1 0 0 0 0 3 0 0 0 6 0 1 0 0 2 0 1 8 2 0 0 1 3 0 0 1 4 1 0---
-- 75
35-
-
39 0 1 2 1 1 0 21 0 1 2 2 0 4 5 0 1 0 1 0 0 9 0 1 0 0 0 0 0 0 0 0 2 0 0 0 0 1 0 0 7 0 0 0 3 3 0 0 0 4 1 1---
-- 74
40-
-
44 0 0 1 1 0 0 18 0 0 3 1 1 4 17 1 5 0 1 1 0 10 0 0 0 0 0 1 4 1 0 0 1 0 2 0 0 1 0 0 3 2 0 0 1 9 0 1 0 3 0 7---
--10
0
45-
-
49 0 4 2 1 1 1 25 0 0 3 6 2 6 11 0 8 1 6 0 4 33 1 2 0 1 0 0 1 2 0 0 3 0 6 0 0 0 0 0 4 1 0 2 0 8 0 2 1 5 1 6---
--16
0
50-
-
54 1 5 4 1 1 0 30 2 0 2 7 1 20 28 0 14 1 4 3 6 51 2 1 0 0 0 0 2 0 0 8 2 0 10 0 0 5 0 2 8 5 0 0 2 12 1 6 0 2 0 3---
--25
2
55-
-
59 1 8 4 0 0 1 26 0 1 1 8 1 22 36 0 10 3 8 1 10 45 1 3 0 6 0 0 1 2 0 19 0 0 4 0 0 4 0 1 10 4 0 1 1 16 0 3 1 12 0 4---
--27
9
60-
-
64 0 4 5 3 1 1 26 2 1 4 7 2 28 48 0 17 3 11 2 2 60 0 2 0 4 0 0 0 2 0 31 1 0 6 0 0 5 0 0 6 2 0 1 0 14 0 6 0 5 1 8---
--32
1
65-
-
69 0 3 4 3 0 2 21 0 1 8 17 0 25 49 0 8 1 6 1 11 61 1 1 0 12 0 0 1 0 1 50 1 0 2 0 0 6 0 0 1 3 0 1 1 15 0 3 0 5 0 6---
--33
1
70-
-
74 0 4 3 1 1 0 5 1 0 4 12 2 23 38 1 10 2 10 0 8 55 0 2 0 5 0 0 0 0 1 47 0 0 4 0 0 6 0 1 6 3 0 0 2 8 0 1 1 5 0 3---
--27
5
75+
0 3 1 0 0 0 11 1 1 4 15 0 30 25 0 3 4 5 1 7 54 1 1 0 13 0 0 2 0 1 32 0 0 4 0 1 9 0 0 2 0 0 0 0 4 1 2 0 5 0 3---
--24
6
% of
Total 0.1
0%1.6
0%1.2
0%0.5
0%0.3
0%0.2
0%9.2
0%0.3
0%0.2
0%1.4
0%3.5
0%0.4
0%7.3
0%11
.40%
0.10%
3.50%
0.70%
2.30%
0.50%
2.20%
16.80
%0.6
0%1.2
0%0.0
0%1.8
0%0.0
0%0.0
0%0.8
0%0.3
0%0.1
0%8.2
0%1.6
0%0.0
0%1.7
0%0.0
0%0.0
0%1.7
0%0.0
0%0.3
0%3.2
0%1.0
0%0.0
0%0.4
0%1.0
0%4.9
0%0.1
0%1.1
0%0.7
0%2.9
0%0.4
0%1.9
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
63:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
WPK
L &
PU
TR
AJA
YA
, A
LL
RE
SID
EN
TS,
M
AL
ES,
200
7-20
11
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
143
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
1 42 40 10 4 0 71 1 1 14 65 515
918
4 5 24 10 35 13 917
5 3 21 4 33 1 0 1714
53 4 10 222
112 44 118 2 0 20 0 0 18 1 3 51 70 2 3 14 92 3 15 12 54 9 28 -----
3307
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 1 0 0 5 0 0 0---
-- 11
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 1 2 0---
-- 7
10-
-
14 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 2 0 0 1 2 1 0---
-- 11
15-
-
19 0 0 2 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 1 5 3 0 0 3 2 0 0 0 1 1 1---
-- 24
20-
-
24 0 1 0 1 0 0 2 0 0 0 0 0 1 1 0 0 0 0 0 0 1 0 0 1 0 0 0 0 3 0 0 2 0 0 1 0 0 0 0 0 0 0 0 0 7 0 0 4 5 1 0 0 4 1 0---
-- 36
25-
-
29 0 1 1 0 0 0 4 0 0 0 2 0 1 1 0 1 0 0 1 0 2 0 2 0 1 0 0 2 14 0 0 2 0 0 2 0 0 0 0 0 0 0 0 5 8 0 0 4 9 0 0 0 9 1 0---
-- 73
30-
-
34 0 2 1 0 0 0 4 0 0 0 2 1 0 2 0 1 1 2 0 0 3 0 1 0 0 0 0 2 64 0 0 10 4 1 7 0 0 0 0 0 0 0 0 0 3 0 0 0 1 0 0 0 3 0 2---
--11
7
35-
-
39 0 1 0 2 0 0 6 0 0 0 1 0 4 5 0 0 0 1 2 0 4 0 2 0 2 0 0 2 95 0 1 12 5 0 4 0 0 1 0 0 0 0 1 5 8 0 0 0 3 0 0 1 4 0 4---
--17
6
40-
-
44 0 2 3 2 0 0 6 0 0 1 8 0 8 9 0 2 1 0 0 1 9 0 1 1 0 0 0 219
0 0 1 23 6 3 12 0 0 0 0 0 0 0 0 3 3 0 0 0 3 0 1 1 5 0 3---
--31
0
45-
-
49 0 3 0 1 1 0 10 0 1 2 5 0 17 10 0 4 0 1 1 2 12 0 2 0 1 0 0 427
2 0 3 39 12 10 21 2 0 4 0 0 1 0 0 3 6 0 0 1 9 0 1 0 5 0 1---
--46
7
50-
-
54 1 8 1 0 0 0 11 0 0 1 1 2 12 17 0 3 0 1 2 1 19 0 0 0 2 0 0 024
2 0 1 33 27 6 22 0 0 1 0 0 3 1 0 5 8 1 1 1 8 1 2 0 6 1 5---
--45
7
55-
-
59 0 4 6 1 2 0 7 1 0 2 8 0 26 35 2 5 2 7 0 1 24 0 3 0 3 0 0 120
7 1 3 23 19 5 15 0 0 1 0 0 2 0 0 4 4 0 0 1 13 0 2 2 5 1 2---
--45
0
60-
-
64 0 6 6 1 0 0 6 0 0 1 8 1 23 30 1 4 2 9 2 1 29 0 2 0 4 0 0 015
3 0 0 18 17 3 9 0 0 3 0 0 4 0 1 3 3 0 1 0 10 0 3 1 2 1 1---
--36
9
65-
-
69 0 3 5 0 1 0 8 0 0 1 14 1 24 26 1 0 1 5 1 2 28 0 3 1 3 0 0 2 90 1 0 24 9 8 14 0 0 0 0 0 2 0 0 5 7 0 1 0 12 0 2 1 3 0 2---
--31
1
70-
-
74 0 5 6 1 0 0 1 0 0 3 6 0 19 23 0 2 1 3 1 0 20 1 1 0 4 0 0 0 71 1 1 15 8 6 5 0 0 7 0 0 0 0 0 6 5 0 0 0 10 0 3 0 4 0 2---
--24
1
75+
0 6 9 0 0 0 4 0 0 3 10 0 24 25 1 2 2 6 2 1 24 2 1 1 13 1 0 1 52 1 0 21 5 2 4 0 0 3 0 0 5 0 0 0 4 1 0 0 4 1 1 0 0 0 5---
--24
7
% of
Total
0.00%
1.30%
1.20%
0.30%
0.10%
0.00%
2.10%
0.00%
0.00%
0.40%
2.00%
0.20%
4.80%
5.60%
0.20%
0.70%
0.30%
1.10%
0.40%
0.30%
5.30%
0.10%
0.60%
0.10%
1.00%
0.00%
0.00%
0.50%
43.90
%0.1
0%0.3
0%6.7
0%3.4
0%1.3
0%3.6
0%0.1
0%0.0
0%0.6
0%0.0
0%0.0
0%0.5
0%0.0
0%0.1
0%1.5
0%2.1
0%0.1
0%0.1
0%0.4
0%2.8
0%0.1
0%0.5
0%0.4
0%1.6
0%0.3
0%0.8
0% -----
100.0
0%
IDC
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
64:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
WPK
L &
PU
TR
AJA
YA
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
20
07-2
011
144
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
2 37 28 12 7 521
0 7 5 32 80 10 166
260 2 79 16 53 11 49 383 14 28 0 42 0 1 18 7 3
187 37 0 39 0 1 39 0 6 74 23 1 8 23 112 2 24 15 67 9 43 -----
2277
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.3 0.9 0 0.3 0 0 0.3 0 0 0.9 0 0 0---
-- 3
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 1.2 0 0 0 0 0.3 0 0 1.2 0 0.6 0---
-- 4
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 1.7 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0.7 0 0 0.3 1 0 0---
-- 5
15-
-
19 0 0 0.3 0 0.3 0 0.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0.3 0 0 0 0.6 0 0 0 0 0 0 0 1.4 0 0 0.6 1.4 0.9 0 0 0.3 1.7 0.3 0---
-- 10
20-
-
24 0 0.3 0 0 0 0 0.5 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0.5 0.5 0.3 0 0 0 0 0 0 0 0 1.5 0 0 0 0 0 0 0 0 0 0 0 0.5 1 0 0 0.5 1.8 0 0---
-- 8
25-
-
29 0 0.3 0.3 0 0 0 1 0 0 0.3 0.5 0.3 0.3 0 0 0.3 0 0 0 0 0.3 1 0.8 0 0.3 0 0 0.5 0 0 0 2.8 0 0 0 0 0 0 0 1.5 0.3 0 0.3 1.3 2.3 0 0 0 0.3 0.5 0.5 ----- 15
30-
-
34 0 0.9 0 0.3 0.3 0 5.3 0.3 0 0 0.9 0 0.3 0.9 0 0.3 0.3 0.3 0.6 0.3 0.6 0.6 0.3 0 0 0 0 0.9 0 0 0 1.8 0 0.3 0 0 0.6 0 0.3 2.3 0.6 0 0 0.3 0.9 0 0 0.3 1.2 0.3 0---
-- 22
35-
-
39 0 0.4 0.7 0.4 0.4 0 7.5 0 0.4 0.7 0.7 0 1.4 1.8 0 0.4 0 0.4 0 0 3.2 0 0.4 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0.4 0 0 2.5 0 0 0 1.1 1.1 0 0 0 1.4 0.4 0.4 ----- 27
40-
-
44 0 0 0.4 0.4 0 0 7.4 0 0 1.2 0.4 0.4 1.6 7 0.4 2.1 0 0.4 0.4 0 4.1 0 0 0 0 0 0.4 1.6 0.4 0 0 0.4 0 0.8 0 0 0.4 0 0 1.2 0.8 0 0 0.4 3.7 0 0.4 0 1.2 0 2.9 ----- 41
45-
-
49 0 1.6 0.8 0.4 0.4 0.4 10 0 0 1.2 2.4 0.8 2.4 4.4 0 3.2 0.4 2.4 0 1.6 13.2 0.4 0.8 0 0.4 0 0 0.4 0.8 0 0 1.2 0 2.4 0 0 0 0 0 1.6 0.4 0 0.8 0 3.2 0 0.8 0.4 2 0.4 2.4 ----- 64
50-
-
54 0.5 2.5 2 0.5 0.5 015
.1 1 0 1 3.5 0.5 10.1
14.1 0 7.1 0.5 2 1.5 3
25.7 1 0.5 0 0 0 0 1 0 0 4 1 0 5 0 0 2.5 0 1 4 2.5 0 0 1 6 0.5 3 0 1 0 1.5 -----
127
55-
-
59 0.6 5.2 2.6 0 0 0.6 16.8 0 0.6 0.6 5.2 0.6 14.2
23.3 0 6.5 1.9 5.2 0.6 6.5 29.1 0.6 1.9 0 3.9 0 0 0.6 1.3 0
12.3 0 0 2.6 0 0 2.6 0 0.6 6.5 2.6 0 0.6 0.6 10.4 0 1.9 0.6 7.8 0 2.6 -----
181
60-
-
64 0 3.6 4.4 2.7 0.9 0.9 23.1 1.8 0.9 3.6 6.2 1.8 24.9
42.7 0
15.1 2.7 9.8 1.8 1.8 53.3 0 1.8 0 3.6 0 0 0 1.8 0
27.6 0.9 0 5.3 0 0 4.4 0 0 5.3 1.8 0 0.9 0
12.4 0 5.3 0 4.4 0.9 7.1 -----
285
65-
-
69 0 4.3 5.7 4.3 0 2.9 30 0 1.4 11.4
24.3 0
35.7 70 0
11.4 1.4 8.6 1.4 15.7
87.2 1.4 1.4 0
17.1 0 0 1.4 0 1.4 71.4 1.4 0 2.9 0 0 8.6 0 0 1.4 4.3 0 1.4 1.4 21.4 0 4.3 0 7.1 0 8.6 -----
473
70-
-
74 0 7.6 5.7 1.9 1.9 0 9.5 1.9 0 7.6 22.9 3.8 43.8
72.4 1.9 19.1 3.8 19.1 0
15.2
104.8 0 3.8 0 9.5 0 0 0 0 1.9 89.5 0 0 7.6 0 0
11.4 0 1.9 11.4 5.7 0 0 3.8 15.2 0 1.9 1.9 9.5 0 5.7 -----
524
75+
0 6.3 2.1 0 0 022
.9 2.1 2.1 8.3 31.3 0
62.5
52.1 0 6.3 8.3 10.4 2.1 14.6
112.5 2.1 2.1 0
27.1 0 0 4.2 0 2.1 66.7 0 0 8.3 0 2.1 18.8 0 0 4.2 0 0 0 0 8.3 2.1 4.2 0
10.4 0 6.3 -----
513
Crud
eRa
te 0.1 1 0.7 0.3 0.2 0.1 5.5 0.2 0.1 0.8 2.1 0.3 4.3 6.8 0.1 2.1 0.4 1.4 0.3 1.3 10 0.4 0.7 0 1.1 0 0 0.5 0.2 0.1 4.9 1 0 1 0 0 1 0 0.2 1.9 0.6 0 0.2 0.6 2.9 0.1 0.6 0.4 1.8 0.2 1.1 -----
59.5
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
65:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, W
PKL
& P
UT
RA
JAY
A, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011
ASR
Wor
ld 0.1 1.1 0.9 0.4 0.2 0.2 5.9 0.2 0.2 1.1 2.7 0.3 5.7 8.8 0.1 2.5 0.5 1.8 0.3 1.7 12.9 0.3 0.8 0 1.6 0 0 0.5 0.2 0.1 7.1 0.8 0 1.2 0 0 1.3 0 0.2 2 0.7 0 0.2 0.6 3.3 0.1 0.8 0.4 1.9 0.2 1.3 -----
73.1
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
145
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
1 42 40 10 4 0 71 1 1 14 65 515
918
4 5 24 10 35 13 917
5 3 21 4 33 1 0 1714
53 4 10 222
112 44 118 2 0 20 0 0 18 1 3 51 70 2 3 14 92 3 15 12 54 9 28 -----
3307
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.3 0 0 0 0 0.3 0 0 1.7 0 0 0---
-- 4
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0.3 0.7 0---
-- 2
10-
-
14 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0.3 0 0 0 0.7 0 0 0.3 0.7 0.3 0---
-- 4
15-
-
19 0 0 0.6 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0.3 1.4 0.9 0 0 0.9 0.6 0 0 0 0.3 0.3 0.3 ----- 7
20-
-
24 0 0.2 0 0.2 0 0 0.5 0 0 0 0 0 0.2 0.2 0 0 0 0 0 0 0.2 0 0 0.2 0 0 0 0 0.7 0 0 0.5 0 0 0.2 0 0 0 0 0 0 0 0 0 1.7 0 0 1 1.2 0.2 0 0 1 0.2 0---
-- 9
25-
-
29 0 0.2 0.2 0 0 0 1 0 0 0 0.5 0 0.2 0.2 0 0.2 0 0 0.2 0 0.5 0 0.5 0 0.2 0 0 0.5 3.4 0 0 0.5 0 0 0.5 0 0 0 0 0 0 0 0 1.2 2 0 0 1 2.2 0 0 0 2.2 0.2 0---
-- 18
30-
-
34 0 0.6 0.3 0 0 0 1.3 0 0 0 0.6 0.3 0 0.6 0 0.3 0.3 0.6 0 0 1 0 0.3 0 0 0 0 0.6 20.4 0 0 3.2 1.3 0.3 2.2 0 0 0 0 0 0 0 0 0 1 0 0 0 0.3 0 0 0 1 0 0.6 ----- 37
35-
-
39 0 0.4 0 0.7 0 0 2.2 0 0 0 0.4 0 1.5 1.8 0 0 0 0.4 0.7 0 1.5 0 0.7 0 0.7 0 0 0.7 34.9 0 0.4 4.4 1.8 0 1.5 0 0 0.4 0 0 0 0 0.4 1.8 2.9 0 0 0 1.1 0 0 0.4 1.5 0 1.5 ----- 65
40-
-
44 0 0.7 1.1 0.7 0 0 2.1 0 0 0.4 2.9 0 2.9 3.2 0 0.7 0.4 0 0 0.4 3.2 0 0.4 0.4 0 0 0 0.7 67.7 0 0.4 8.2 2.1 1.1 4.3 0 0 0 0 0 0 0 0 1.1 1.1 0 0 0 1.1 0 0.4 0.4 1.8 0 1.1 -----
111
45-
-
49 0 1.4 0 0.5 0.5 0 4.6 0 0.5 0.9 2.3 0 7.8 4.6 0 1.8 0 0.5 0.5 0.9 5.5 0 0.9 0 0.5 0 0 1.812
5.1 0 1.4 17.9 5.5 4.6 9.7 0.9 0 1.8 0 0 0.5 0 0 1.4 2.8 0 0 0.5 4.1 0 0.5 0 2.3 0 0.5 -----
215
50-
-
54 0.5 4.3 0.5 0 0 0 5.9 0 0 0.5 0.5 1.1 6.5 9.2 0 1.6 0 0.5 1.1 0.5 10.3 0 0 0 1.1 0 0 0
130.8 0 0.5 17
.814
.6 3.2 11.9 0 0 0.5 0 0 1.6 0.5 0 2.7 4.3 0.5 0.5 0.5 4.3 0.5 1.1 0 3.2 0.5 2.7 -----
247
55-
-
59 0 2.8 4.2 0.7 1.4 0 4.9 0.7 0 1.4 5.6 018
.224
.6 1.4 3.5 1.4 4.9 0 0.7 16.8 0 2.1 0 2.1 0 0 0.7
145.3 0.7 2.1 16
.113
.3 3.5 10.5 0 0 0.7 0 0 1.4 0 0 2.8 2.8 0 0 0.7 9.1 0 1.4 1.4 3.5 0.7 1.4 -----
316
60-
-
64 0 5.7 5.7 1 0 0 5.7 0 0 1 7.7 1 22 28.7 1 3.8 1.9 8.6 1.9 1
27.8 0 1.9 0 3.8 0 0 0
146.4 0 0
17.2
16.3 2.9 8.6 0 0 2.9 0 0 3.8 0 1 2.9 2.9 0 1 0 9.6 0 2.9 1 1.9 1 1
-----
353
65-
-
69 0 4.3 7.2 0 1.4 011
.5 0 0 1.4 20.1 1.4 34.5
37.4 1.4 0 1.4 7.2 1.4 2.9 40.3 0 4.3 1.4 4.3 0 0 2.9
129.5 1.4 0
34.5 13 11.5
20.1 0 0 0 0 0 2.9 0 0 7.2 10.1 0 1.4 0
17.3 0 2.9 1.4 4.3 0 2.9 -----
448
70-
-
74 010
.612
.8 2.1 0 0 2.1 0 0 6.4 12.8 0
40.4
48.9 0 4.3 2.1 6.4 2.1 0
42.6 2.1 2.1 0 8.5 0 0 0
151.1 2.1 2.1 31.9 17 12.8
10.6 0 0
14.9 0 0 0 0 0
12.8
10.6 0 0 0
21.3 0 6.4 0 8.5 0 4.3 -----
513
75+
010
.916
.4 0 0 0 7.3 0 0 5.5 18.2 0
43.6
45.5 1.8 3.6 3.6 10.9 3.6 1.8 43.6 3.6 1.8 1.8 23.6 1.8 0 1.8 94.6 1.8 0
38.2 9.1 3.6 7.3 0 0 5.5 0 0 9.1 0 0 0 7.3 1.8 0 0 7.3 1.8 1.8 0 0 0 9.1 -----
449
Crud
eRa
te
0 1.1 1.1 0.3 0.1 0 1.9 0 0 0.4 1.7 0.1 4.2 4.9 0.1 0.6 0.3 0.9 0.3 0.2 4.7 0.1 0.6 0.1 0.9 0 0 0.5 38.8 0.1 0.3 5.9 3 1.2 3.2 0.1 0 0.5 0 0 0.5 0 0.1 1.4 1.9 0.1 0.1 0.4 2.5 0.1 0.4 0.3 1.4 0.2 0.7 -----
88.3
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
66:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, W
PKL
& P
UT
RA
JAY
A, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011
ASR
Wor
ld 0 1.3 1.4 0.3 0.1 0 2 0 0 0.5 2.2 0.2 5.4 6.3 0.2 0.7 0.3 1.2 0.4 0.3 6 0.1 0.6 0.1 1.2 0 0 0.5 42.2 0.2 0.3 6.8 3.5 1.5 3.5 0.1 0 0.7 0 0 0.6 0 0.1 1.6 2 0.1 0.1 0.3 2.9 0.1 0.5 0.4 1.4 0.3 0.8 -----
101.2
146
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
0 21 7 15 4 0 77 4 0 33 35 815
220
4 116
6 18 43 14 35 333 9 38 12 64 0 0 12 4 5
170 27 3 30 0 1
124 0 12 56 46 4 7 1
131 0 31 26 73 46 3
-----
2105
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 1 0 0 0 0 0 0 0 0 2 0 1 0 2 0 0 0 0 1 0 8 10 0 0 0 0 2 0 0 11 5 11 0---
-- 57
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 2 5 1 0 0 0 4 0 0 9 3 10 0---
-- 36
10-
-
14 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 1 0 0 0 2 0 0 0 0 0 0 0 5 1 0 1 0 11 0 0 3 2 4 0---
-- 36
15-
-
19 0 0 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 9 0 1 0 0 0 0 0 0 2 0 2 0 0 0 0 0 5 1 0 0 0 4 0 0 1 4 4 1---
-- 39
20-
-
24 0 1 1 0 0 0 2 0 0 0 0 0 0 0 0 2 0 0 1 0 1 0 6 0 1 0 0 0 0 0 2 3 0 1 0 0 0 0 0 4 0 0 0 0 8 0 0 1 6 2 1---
-- 43
25-
-
29 0 1 1 1 0 0 6 0 0 0 1 0 4 2 0 3 0 0 0 0 2 1 2 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 2 0 0 0 6 0 0 0 2 2 0---
-- 40
30-
-
34 0 1 0 1 0 0 4 0 0 0 1 0 4 6 0 4 0 0 0 2 4 0 1 0 2 0 0 1 1 0 0 1 0 0 0 0 0 0 0 3 1 0 0 0 4 0 0 1 5 2 0---
-- 49
35-
-
39 0 0 0 0 0 0 1 0 0 0 3 0 7 6 0 8 2 4 0 1 6 1 1 0 4 0 0 1 0 0 1 3 0 0 0 0 1 0 0 2 3 0 0 0 8 0 1 0 4 1 0---
-- 69
40-
-
44 0 1 1 0 1 0 8 0 0 1 1 0 7 9 0 7 1 2 1 1 14 1 1 0 2 0 0 2 0 0 1 0 0 3 0 0 2 0 0 3 3 1 1 0 14 0 3 0 3 1 0---
-- 96
45-
-
49 0 2 1 2 0 0 11 0 0 3 4 0 18 17 0 20 2 5 0 0 27 0 0 2 6 0 0 0 0 0 4 1 0 1 0 0 11 0 0 2 5 0 2 0 10 0 2 0 7 0 0---
--16
5
50-
-
54 0 2 0 0 0 0 11 1 0 2 6 1 18 19 0 28 3 5 5 8 35 1 3 3 4 0 0 2 0 0 10 1 0 4 0 0 9 0 0 5 3 0 0 0 11 0 3 0 7 4 0---
--21
4
55-
-
59 0 3 0 1 0 0 6 0 0 5 4 2 22 30 0 23 2 3 0 4 46 1 0 3 4 0 0 1 0 3 12 4 2 4 0 0 10 0 1 4 3 1 1 1 15 0 9 0 9 1 0---
--24
0
60-
-
64 0 3 0 4 1 0 8 0 0 7 4 2 16 33 1 28 1 7 3 9 65 1 5 0 6 0 0 0 3 0 26 1 0 5 0 0 26 0 0 2 6 1 2 0 16 0 5 0 5 3 0---
--30
5
65-
-
69 0 2 0 1 0 0 6 0 0 2 2 1 22 29 0 21 3 11 0 2 46 1 2 3 10 0 0 1 0 1 31 3 0 6 0 0 21 0 0 1 7 1 0 0 10 0 4 0 3 0 0---
--25
3
70-
-
74 0 3 0 3 1 0 6 0 0 3 2 2 14 22 0 7 3 3 1 5 38 1 2 0 10 0 0 1 0 0 36 3 1 1 0 1 14 0 0 2 9 0 0 0 4 0 3 0 2 0 0---
--20
3
75+
0 2 3 2 1 0 3 3 0 10 7 0 19 31 0 12 1 3 0 3 49 1 2 1 12 0 0 0 0 0 47 0 0 3 0 0 29 0 1 1 1 0 0 0 4 0 1 0 6 1 1---
--26
0
% of
Total 0.0
0%1.0
0%0.3
0%0.7
0%0.2
0%0.0
0%3.7
0%0.2
0%0.0
0%1.6
0%1.7
0%0.4
0%7.2
0%9.7
0%0.0
0%7.9
0%0.9
0%2.0
0%0.7
0%1.7
0%15
.80%
0.40%
1.80%
0.60%
3.00%
0.00%
0.00%
0.60%
0.20%
0.20%
8.10%
1.30%
0.10%
1.40%
0.00%
0.00%
5.90%
0.00%
0.60%
2.70%
2.20%
0.20%
0.30%
0.00%
6.20%
0.00%
1.50%
1.20%
3.50%
2.20%
0.10% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
67:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
KE
LA
NTA
N, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
147
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
0 17 5 9 2 2 28 3 0 27 23 512
414
0 2 69 12 29 7 814
1 9 22 10 54 0 0 14 594 7 4
132 88 24 184 1 1 21 1 0 22 1 4 49 170 0 3 2 80 0 14 11 65 40 1
-----
2281
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 3 0 0 1 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 4 0 0 0 0 3 0 0 6 7 9 0---
-- 39
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 3 0 0 2 0 7 0---
-- 15
10-
-
14 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 1 0 0 0 8 0 2 0 0 1 0 0 0 0 0 0 3 0 0 1 0 0 0 0 0 3 0 0 0 0 4 0 0 2 3 6 0---
-- 36
15-
-
19 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 3 0 1 0 0 2 0 0 0 0 0 0 6 0 0 2 0 0 1 0 0 1 8 0 0 0 3 0 0 1 3 1 0---
-- 35
20-
-
24 0 0 0 1 0 0 1 0 0 0 0 0 2 3 0 1 0 0 0 0 0 0 1 0 1 0 0 1 1 0 0 1 0 0 4 0 0 0 1 0 1 0 0 4 4 0 1 0 4 0 0 0 8 1 1---
-- 42
25-
-
29 0 1 0 1 0 0 1 0 0 0 1 0 3 0 0 1 0 0 0 0 0 0 1 0 2 0 0 1 13 0 0 2 0 0 10 0 0 0 0 0 0 0 0 0 9 0 0 0 4 0 0 0 3 2 0---
-- 55
30-
-
34 0 1 0 0 0 0 1 0 0 0 1 1 3 3 0 1 0 1 0 0 4 0 2 0 1 0 0 1 24 0 0 4 2 0 12 0 0 1 0 0 0 0 0 2 7 0 0 0 3 0 0 0 3 0 0---
-- 78
35-
-
39 0 0 1 1 0 0 0 0 0 0 1 0 5 4 0 0 0 2 1 0 2 0 0 0 1 0 0 0 51 0 1 8 10 2 8 0 1 0 0 0 0 0 0 1 19 0 0 0 3 0 0 0 2 3 0---
--12
7
40-
-
44 0 1 0 0 0 0 0 1 0 0 0 0 2 6 0 1 0 1 0 1 9 1 0 0 4 0 0 1 90 0 0 19 10 2 23 0 0 2 0 0 1 0 0 3 23 0 1 0 2 0 1 0 4 1 0---
--21
0
45-
-
49 0 2 0 0 0 0 3 1 0 1 2 0 16 9 0 7 0 3 0 1 10 1 2 1 5 0 0 212
2 2 0 19 8 4 16 0 0 5 0 0 2 0 1 12 19 0 0 1 6 0 1 0 6 3 0---
--29
3
50-
-
54 0 3 1 2 0 0 5 0 0 3 4 2 16 10 1 8 2 4 0 0 16 1 1 1 1 0 0 0 91 1 0 19 14 5 33 0 0 2 0 0 2 0 1 4 24 0 0 0 2 0 2 0 5 0 0---
--28
6
55-
-
59 0 0 1 0 1 0 3 1 0 4 2 0 14 27 0 12 3 2 1 1 25 0 0 0 3 0 0 1 75 1 1 23 16 4 19 0 0 2 0 0 4 0 0 3 17 0 1 1 10 0 5 0 5 2 0---
--29
0
60-
-
64 0 2 1 2 1 1 2 0 0 1 1 0 15 15 0 8 3 6 0 1 15 2 2 2 8 0 0 0 45 0 0 16 11 3 13 0 0 2 0 0 1 1 0 1 16 0 0 0 14 0 2 0 6 1 0---
--22
0
65-
-
69 0 2 0 1 0 0 4 0 0 3 4 1 11 17 1 10 3 2 0 1 26 1 0 3 5 0 0 1 41 0 0 9 9 2 17 1 0 1 0 0 4 0 0 7 15 0 0 0 9 0 1 0 4 1 0---
--21
7
70-
-
74 0 3 1 0 0 0 5 0 0 5 0 1 16 26 0 7 0 6 0 1 12 1 0 1 10 0 0 1 26 1 1 7 2 2 12 0 0 2 0 0 2 0 0 1 5 0 0 0 2 0 1 0 4 2 0---
--16
6
75+
0 2 0 1 0 1 1 0 0 10 5 0 20 20 0 9 1 2 3 2 22 2 1 2 9 0 0 1 15 2 1 5 6 0 8 0 0 0 0 0 4 0 0 1 4 0 0 0 8 0 1 0 2 1 0---
--17
2
% of
Total
0.00%
0.70%
0.20%
0.40%
0.10%
0.10%
1.20%
0.10%
0.00%
1.20%
1.00%
0.20%
5.40%
6.10%
0.10%
3.00%
0.50%
1.30%
0.30%
0.40%
6.20%
0.40%
1.00%
0.40%
2.40%
0.00%
0.00%
0.60%
26.00
%0.3
0%0.2
0%5.8
0%3.9
0%1.1
0%8.1
0%0.0
0%0.0
0%0.9
0%0.0
0%0.0
0%1.0
0%0.0
0%0.2
0%2.1
0%7.5
0%0.0
0%0.1
0%0.1
0%3.5
0%0.0
0%0.6
0%0.5
0%2.8
0%1.8
0%0.0
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
68:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
KE
LA
NTA
N, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011
148
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
0 21 7 15 4 0 77 4 0 33 35 815
220
4 116
6 18 43 14 35 333 9 38 12 64 0 0 12 4 5
170 27 3 30 0 1
124 0 12 56 46 4 7 1
131 0 31 26 73 46 3
-----
2105
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0.2 0 0 0 0 0 0 0 0 0.5 0 0.2 0 0.5 0 0 0 0 0.2 0 1.8 2.3 0 0 0 0 0.5 0 0 2.5 1.2 2.5 0---
-- 13
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 1.1 0.2 0 0 0 0.9 0 0 1.9 0.6 2.1 0---
-- 8
10-
-
14 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0.2 0 0 0 0.4 0 0 0 0 0 0 0 1 0.2 0 0.2 0 2.2 0 0 0.6 0.4 0.8 0---
-- 7
15-
-
19 0 0 0 0 0 0 0.6 0 0 0 0 0 0.2 0 0 0 0 0 0.2 0 0 0 1.9 0 0.2 0 0 0 0 0 0 0.4 0 0.4 0 0 0 0 0 1.1 0.2 0 0 0 0.8 0 0 0.2 0.8 0.8 0.2 ----- 8
20-
-
24 0 0.3 0.3 0 0 0 0.7 0 0 0 0 0 0 0 0 0.7 0 0 0.3 0 0.3 0 2 0 0.3 0 0 0 0 0 0.7 1 0 0.3 0 0 0 0 0 1.3 0 0 0 0 2.6 0 0 0.3 2 0.7 0.3 ----- 14
25-
-
29 0 0.4 0.4 0.4 0 0 2.3 0 0 0 0.4 0 1.6 0.8 0 1.2 0 0 0 0 0.8 0.4 0.8 0 0.4 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0.8 0.8 0 0 0 2.3 0 0 0 0.8 0.8 0---
-- 16
30-
-
34 0 0.5 0 0.5 0 0 2 0 0 0 0.5 0 2 3 0 2 0 0 0 1 2 0 0.5 0 1 0 0 0.5 0.5 0 0 0.5 0 0 0 0 0 0 0 1.5 0.5 0 0 0 2 0 0 0.5 2.5 1 0---
-- 25
35-
-
39 0 0 0 0 0 0 0.5 0 0 0 1.6 0 3.8 3.3 0 4.4 1.1 2.2 0 0.5 3.3 0.5 0.5 0 2.2 0 0 0.5 0 0 0.5 1.6 0 0 0 0 0.5 0 0 1.1 1.6 0 0 0 4.4 0 0.5 0 2.2 0.5 0---
-- 38
40-
-
44 0 0.5 0.5 0 0.5 0 4 0 0 0.5 0.5 0 3.5 4.5 0 3.5 0.5 1 0.5 0.5 7.1 0.5 0.5 0 1 0 0 1 0 0 0.5 0 0 1.5 0 0 1 0 0 1.5 1.5 0.5 0.5 0 7.1 0 1.5 0 1.5 0.5 0---
-- 48
45-
-
49 0 1 0.5 1 0 0 5.6 0 0 1.5 2 0 9.2 8.7 010
.2 1 2.6 0 013
.8 0 0 1 3.1 0 0 0 0 0 2 0.5 0 0.5 0 0 5.6 0 0 1 2.6 0 1 0 5.1 0 1 0 3.6 0 0---
-- 84
50-
-
54 0 1.2 0 0 0 0 6.4 0.6 0 1.2 3.5 0.6 10.5 11 0
16.3 1.7 2.9 2.9 4.7 20.4 0.6 1.7 1.7 2.3 0 0 1.2 0 0 5.8 0.6 0 2.3 0 0 5.2 0 0 2.9 1.7 0 0 0 6.4 0 1.7 0 4.1 2.3 0
-----
124
55-
-
59 0 2.2 0 0.7 0 0 4.3 0 0 3.6 2.9 1.4 15.8
21.5 0
16.5 1.4 2.2 0 2.9 33 0.7 0 2.2 2.9 0 0 0.7 0 2.2 8.6 2.9 1.4 2.9 0 0 7.2 0 0.7 2.9 2.2 0.7 0.7 0.7 10.8 0 6.5 0 6.5 0.7 0
-----
172
60-
-
64 0 2.6 0 3.5 0.9 0 6.9 0 0 6.1 3.5 1.7 13.9
28.6 0.9 24.2 0.9 6.1 2.6 7.8 56.3 0.9 4.3 0 5.2 0 0 0 2.6 0
22.5 0.9 0 4.3 0 0
22.5 0 0 1.7 5.2 0.9 1.7 0
13.9 0 4.3 0 4.3 2.6 0
-----
264
65-
-
69 0 2.8 0 1.4 0 0 8.3 0 0 2.8 2.8 1.4 30.6
40.3 0
29.2 4.2 15.3 0 2.8 63.9 1.4 2.8 4.2 13.9 0 0 1.4 0 1.4 43.1 4.2 0 8.3 0 0
29.2 0 0 1.4 9.7 1.4 0 0
13.9 0 5.6 0 4.2 0 0
-----
351
70-
-
74 0 5.7 0 5.7 1.9 011
.4 0 0 5.7 3.8 3.8 26.7
41.9 0
13.3 5.7 5.7 1.9 9.5 72.4 1.9 3.8 0
19.1 0 0 1.9 0 0
68.6 5.7 1.9 1.9 0 1.9 26.7 0 0 3.8 17.1 0 0 0 7.6 0 5.7 0 3.8 0 0
-----
387
75+
0 3.2 4.8 3.2 1.6 0 4.8 4.8 015
.911
.1 030
.249
.2 019
.1 1.6 4.8 0 4.8 77.8 1.6 3.2 1.6 19.1 0 0 0 0 0
74.6 0 0 4.8 0 0 46 0 1.6 1.6 1.6 0 0 0 6.4 0 1.6 0 9.5 1.6 1.6 -----
413
Crud
eRa
te 0 0.5 0.2 0.4 0.1 0 2 0.1 0 0.9 0.9 0.2 4 5.3 0 4.3 0.5 1.1 0.4 0.9 8.7 0.2 1 0.3 1.7 0 0 0.3 0.1 0.1 4.4 0.7 0.1 0.8 0 0 3.2 0 0.3 1.5 1.2 0.1 0.2 0 3.4 0 0.8 0.7 1.9 1.2 0.1 -----
54.8
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
69:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, K
EL
AN
TAN
, AL
L R
ESI
DE
NT
S, M
AL
ES,
200
7-20
11
ASR
Wor
ld 0 0.7 0.2 0.5 0.1 0 2.4 0.1 0 1.1 1.1 0.3 5 6.8 0 5.4 0.6 1.5 0.4 1.2 11.2 0.3 1 0.4 2.2 0 0 0.4 0.1 0.2 5.9 0.8 0.1 1 0 0 4.2 0 0.3 1.5 1.5 0.1 0.2 0 3.9 0 1 0.6 2.1 1.2 0.1 ----- 68
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
149
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
0 17 5 9 2 2 28 3 0 27 23 512
414
0 2 69 12 29 7 814
1 9 22 10 54 0 0 14 594 7 4
132 88 24 184 1 1 21 1 0 22 1 4 49 170 0 3 2 80 0 14 11 65 40 1
-----
2281
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0.7 0 0 0.2 0 0 0 0 0 0.2 0 0 0.2 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0.5 1 0 0 0 0 0.7 0 0 1.5 1.7 2.2 0---
-- 10
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0.7 0 0 0.4 0 1.6 0---
-- 3
10-
-
14 0 0 0 0 0 0 0 0 0 0 0.2 0 0.2 0 0 0 0 0 0.2 0 0 0 1.7 0 0.4 0 0 0.2 0 0 0 0 0 0 0.6 0 0 0.2 0 0 0 0 0 0.6 0 0 0 0 0.8 0 0 0.4 0.6 1.3 0---
-- 8
15-
-
19 0 0 0 0 0 0 0.2 0 0 0 0.2 0 0 0 0 0.2 0 0 0 0 0 0 0.7 0 0.2 0 0 0.5 0 0 0 0 0 0 1.4 0 0 0.5 0 0 0.2 0 0 0.2 1.8 0 0 0 0.7 0 0 0.2 0.7 0.2 0---
-- 8
20-
-
24 0 0 0 0.4 0 0 0.4 0 0 0 0 0 0.7 1.1 0 0.4 0 0 0 0 0 0 0.4 0 0.4 0 0 0.4 0.4 0 0 0.4 0 0 1.4 0 0 0 0.4 0 0.4 0 0 1.4 1.4 0 0.4 0 1.4 0 0 0 2.8 0.4 0.4 ----- 15
25-
-
29 0 0.4 0 0.4 0 0 0.4 0 0 0 0.4 0 1.3 0 0 0.4 0 0 0 0 0 0 0.4 0 0.9 0 0 0.4 5.6 0 0 0.9 0 0 4.3 0 0 0 0 0 0 0 0 0 3.9 0 0 0 1.7 0 0 0 1.3 0.9 0---
-- 24
30-
-
34 0 0.5 0 0 0 0 0.5 0 0 0 0.5 0.5 1.5 1.5 0 0.5 0 0.5 0 0 2 0 1 0 0.5 0 0 0.5 11.7 0 0 2 1 0 5.9 0 0 0.5 0 0 0 0 0 1 3.4 0 0 0 1.5 0 0 0 1.5 0 0
----- 38
35-
-
39 0 0 0.5 0.5 0 0 0 0 0 0 0.5 0 2.3 1.9 0 0 0 0.9 0.5 0 0.9 0 0 0 0.5 0 0 023
.6 0 0.5 3.7 4.6 0.9 3.7 0 0.5 0 0 0 0 0 0 0.5 8.8 0 0 0 1.4 0 0 0 0.9 1.4 0---
-- 59
40-
-
44 0 0.4 0 0 0 0 0 0.4 0 0 0 0 0.9 2.6 0 0.4 0 0.4 0 0.4 4 0.4 0 0 1.8 0 0 0.4 39.7 0 0 8.4 4.4 0.9 10.2 0 0 0.9 0 0 0.4 0 0 1.3 10.2 0 0.4 0 0.9 0 0.4 0 1.8 0.4 0
----- 93
45-
-
49 0 0.9 0 0 0 0 1.4 0.5 0 0.5 0.9 0 7.4 4.1 0 3.2 0 1.4 0 0.5 4.6 0.5 0.9 0.5 2.3 0 0 0.9 56.1 0.9 0 8.7 3.7 1.8 7.4 0 0 2.3 0 0 0.9 0 0.5 5.5 8.7 0 0 0.5 2.8 0 0.5 0 2.8 1.4 0
-----
135
50-
-
54 0 1.6 0.5 1.1 0 0 2.6 0 0 1.6 2.1 1.1 8.4 5.3 0.5 4.2 1.1 2.1 0 0 8.4 0.5 0.5 0.5 0.5 0 0 047
.9 0.5 0 10 7.4 2.6 17.4 0 0 1.1 0 0 1.1 0 0.5 2.1 12.6 0 0 0 1.1 0 1.1 0 2.6 0 0
-----
151
55-
-
59 0 0 0.7 0 0.7 0 2.1 0.7 0 2.7 1.4 0 9.6 18.6 0 8.2 2.1 1.4 0.7 0.7 17.2 0 0 0 2.1 0 0 0.7 51.6 0.7 0.7 15.8 11 2.7 13.1 0 0 1.4 0 0 2.7 0 0 2.1 11.7 0 0.7 0.7 6.9 0 3.4 0 3.4 1.4 0
-----
199
60-
-
64 0 1.7 0.9 1.7 0.9 0.9 1.7 0 0 0.9 0.9 012
.912
.9 0 6.9 2.6 5.2 0 0.9 12.9 1.7 1.7 1.7 6.9 0 0 0
38.8 0 0
13.8 9.5 2.6 11.2 0 0 1.7 0 0 0.9 0.9 0 0.9 13.8 0 0 0
12.1 0 1.7 0 5.2 0.9 0
-----
190
65-
-
69 0 2.4 0 1.2 0 0 4.7 0 0 3.6 4.7 1.2 13 20.1 1.2 11.8 3.6 2.4 0 1.2 30.8 1.2 0 3.6 5.9 0 0 1.2 48.5 0 0
10.7
10.7 2.4 20.1 1.2 0 1.2 0 0 4.7 0 0 8.3 17.8 0 0 0
10.7 0 1.2 0 4.7 1.2 0
-----
257
70-
-
74 0 5 1.7 0 0 0 8.3 0 0 8.3 0 1.7 26.4 43 0
11.6 0 9.9 0 1.7 19.8 1.7 0 1.7 16.5 0 0 1.7 43 1.7 1.7 11.6 3.3 3.3 19.8 0 0 3.3 0 0 3.3 0 0 1.7 8.3 0 0 0 3.3 0 1.7 0 6.6 3.3 0
-----
274
75+
0 2.4 0 1.2 0 1.2 1.2 0 0 12 6 0 24 24 010
.8 1.2 2.4 3.6 2.4 26.4 2.4 1.2 2.4 10.8 0 0 1.2 18 2.4 1.2 6 7.2 0 9.6 0 0 0 0 0 4.8 0 0 1.2 4.8 0 0 0 9.6 0 1.2 0 2.4 1.2 0
-----
206
Crud
eRa
te
0 0.4 0.1 0.2 0.1 0.1 0.7 0.1 0 0.7 0.6 0.1 3.2 3.7 0.1 1.8 0.3 0.8 0.2 0.2 3.7 0.2 0.6 0.3 1.4 0 0 0.4 15.5 0.2 0.1 3.5 2.3 0.6 4.8 0 0 0.5 0 0 0.6 0 0.1 1.3 4.4 0 0.1 0.1 2.1 0 0.4 0.3 1.7 1 0
-----
59.6
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
70:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, K
EL
AN
TAN
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
200
7-20
11
ASR
Wor
ld 0 0.5 0.1 0.3 0.1 0.1 0.8 0.1 0 0.8 0.6 0.2 3.6 4.2 0.1 2 0.4 0.9 0.2 0.2 4.2 0.3 0.5 0.3 1.6 0 0 0.4 17 0.2 0.1 3.8 2.5 0.7 5.3 0 0 0.6 0 0 0.6 0 0.1 1.4 4.9 0 0.1 0.1 2.3 0 0.4 0.3 1.9 1.1 0---
--65
.8
150
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
5 38 33 38 15 739
4 20 3 85 238 19 442
357 11 361 38 145 28 106
861 22 42 11 184 0 3 45 17 10 447 31 4
146 5 3
177 2 11 90 50 6 8 28 244 1 28 86 101 30 169
-----
5245
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 4 0 4 0 0 0 0 3 8 0 2 1 0 4 0 0 21 3 9 0---
-- 65
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 1 0 0 1 10 0 0 11 1 4 3---
-- 37
10-
-
14 0 0 0 0 0 0 4 0 0 0 1 0 1 0 0 1 0 0 1 0 0 0 6 0 0 0 0 2 0 0 0 3 0 0 0 0 0 0 0 9 0 0 0 0 10 0 0 8 3 0 0---
-- 49
15-
-
19 0 0 2 1 0 0 5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 1 0 0 0 0 0 0 2 0 0 0 0 1 0 0 4 2 0 0 4 7 0 0 5 5 1 1---
-- 45
20-
-
24 0 0 0 0 0 1 7 0 0 1 0 0 1 0 1 1 0 0 1 1 2 2 6 0 1 0 0 3 0 1 0 3 0 0 0 0 0 0 0 5 2 0 2 4 8 0 0 5 9 0 1---
-- 68
25-
-
29 0 1 1 1 1 0 9 0 0 0 0 0 0 2 0 1 0 0 0 0 7 0 1 0 2 0 1 6 0 0 0 3 0 3 0 0 0 0 0 2 1 0 0 2 5 0 1 5 9 1 3---
-- 68
30-
-
34 0 0 0 1 0 0 19 0 0 1 1 1 2 3 0 4 0 0 0 1 4 0 2 0 3 0 0 3 1 0 1 5 0 1 0 0 2 0 0 6 2 0 1 2 7 0 0 2 3 0 2---
-- 80
35-
-
39 0 2 0 3 0 0 37 0 0 0 5 0 6 8 0 8 0 3 2 1 14 2 0 0 2 0 0 2 0 0 0 6 0 6 0 0 2 0 0 5 4 0 1 2 16 0 1 1 8 1 4---
--15
2
40-
-
44 0 2 1 3 1 0 49 0 0 1 4 1 18 11 0 13 2 8 2 3 19 1 5 0 7 0 2 3 0 0 0 1 0 12 0 0 8 1 0 9 6 0 2 0 9 0 0 3 10 1 9---
--22
7
45-
-
49 0 3 0 4 1 0 58 0 1 8 17 3 29 25 0 21 2 12 3 4 47 1 1 1 10 0 0 3 2 0 4 1 0 21 1 0 8 0 0 7 6 0 0 3 22 0 2 2 6 0 7---
--34
6
50-
-
54 0 5 2 4 1 0 55 1 1 4 25 0 37 46 0 39 5 6 7 9 72 2 4 0 14 0 0 5 0 0 7 1 0 7 0 1 14 0 0 9 4 1 0 5 28 0 1 3 9 2 10 -----
446
55-
-
59 0 8 3 5 3 0 53 3 0 9 20 2 52 44 2 65 9 20 2 11 102 6 4 3 15 0 0 5 1 2 24 0 1 23 1 0 18 0 1 5 4 1 1 3 21 0 3 4 8 1 27 -----
595
60-
-
64 0 5 7 5 5 3 36 1 0 20 37 3 60 57 3 64 3 20 5 19 140 3 2 3 27 0 0 4 2 4 59 2 2 17 0 1 18 0 1 2 5 0 0 0 24 0 6 5 4 3 21 -----
708
65-
-
69 1 3 6 5 1 1 33 2 0 18 32 6 67 52 2 46 5 28 1 22 163 2 1 3 36 0 0 2 3 2
106 0 0 24 1 1 34 0 1 7 9 1 0 2 35 1 5 6 7 2 21 -----
806
70-
-
74 1 3 1 4 1 2 19 7 0 8 35 3 70 39 0 41 5 18 1 19 141 0 0 1 25 0 0 2 4 0
104 0 0 14 0 0 30 1 2 2 1 0 0 0 14 0 5 3 11 3 23 -----
663
75+
3 6 10 2 1 0 10 6 1 15 61 0 99 70 3 54 7 30 3 15 150 2 4 0 41 0 0 3 4 1
142 0 1 14 2 0 42 0 3 7 3 1 0 0 24 0 4 2 5 2 37 -----
890
% of
Total 0.1
0%0.7
0%0.6
0%0.7
0%0.3
0%0.1
0%7.5
0%0.4
0%0.1
0%1.6
0%4.5
0%0.4
0%8.4
0%6.8
0%0.2
0%6.9
0%0.7
0%2.8
0%0.5
0%2.0
0%16
.40%
0.40%
0.80%
0.20%
3.50%
0.00%
0.10%
0.90%
0.30%
0.20%
8.50%
0.60%
0.10%
2.80%
0.10%
0.10%
3.40%
0.00%
0.20%
1.70%
1.00%
0.10%
0.20%
0.50%
4.70%
0.00%
0.50%
1.60%
1.90%
0.60%
3.20% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
71:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
PE
NA
NG
, AL
L R
ESI
DE
NT
S, M
AL
ES,
200
7-20
11
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
151
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
6 32 43 15 9 212
7 9 3 44 184 14 451
248 21 135 52 119 3 10 341 27 31 19 125 2 0 45
1958 12 11 39
927
3 50 332 3 6 79 3 6 53 1 5 83 124 3 3 15 176 0 24 60 99 24 166
-----
6085
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 3 0 0 1 0 0 0 0 0 0 2 0 0 0 0 1 9 0 1 0 0 1 0 0 16 10 4 3---
-- 53
5-
-
9 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7 0 0 0 0 3 0 0 11 4 1 0---
-- 29
10-
-
14 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 0 0 1 1 0 0 0 0 0 4 0 0 0 0 0 0 0 0 5 2 0 0 2 4 0 0 7 1 1 1---
-- 37
15-
-
19 0 0 0 1 0 0 4 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 4 0 1 0 0 2 1 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 3 0 0 3 5 0 0 2 6 2 0---
-- 38
20-
-
24 0 0 0 1 0 1 5 0 0 0 0 1 4 2 0 0 0 0 0 0 0 0 1 1 2 0 0 3 4 0 0 1 0 0 7 0 1 0 0 0 0 0 0 4 5 0 1 3 6 0 0 3 5 0 2---
-- 63
25-
-
29 0 1 0 3 0 0 10 0 0 0 0 0 5 1 0 0 0 1 0 0 2 0 0 0 0 0 0 2 20 0 0 7 8 2 13 0 1 1 0 0 0 0 0 5 10 0 0 0 8 0 0 0 1 0 3---
--10
4
30-
-
34 1 1 0 1 0 0 2 0 0 0 4 2 1 5 0 1 0 1 1 0 1 2 4 2 5 0 0 1 60 0 0 9 2 1 4 0 2 2 0 0 0 0 0 4 15 0 0 2 6 0 0 3 2 1 1---
--14
9
35-
-
39 0 0 0 0 0 0 4 0 0 0 5 0 7 3 0 4 1 2 1 2 8 0 1 0 2 0 0 411
0 0 0 36 10 4 16 0 2 4 0 0 3 0 0 4 17 0 0 0 10 0 0 4 5 2 6---
--27
7
40-
-
44 0 5 1 1 2 0 17 0 0 2 8 1 19 11 0 2 0 3 0 0 9 1 5 3 4 0 0 220
7 1 1 42 25 6 21 0 0 1 0 0 0 0 0 6 12 0 0 1 9 0 1 2 9 3 6---
--44
9
45-
-
49 0 1 0 1 0 0 15 3 0 3 15 3 31 15 2 6 4 5 0 0 23 2 3 1 3 0 0 731
5 1 0 44 37 5 64 2 0 8 0 0 4 0 0 5 18 1 0 0 8 0 0 3 9 1 11 -----
679
50-
-
54 1 2 1 1 1 0 12 0 1 4 19 2 45 26 0 7 2 17 0 2 35 1 1 2 4 0 0 331
3 0 1 56 44 3 51 0 0 10 0 1 2 0 1 6 8 1 1 0 24 0 2 1 11 1 13 -----
739
55-
-
59 0 4 5 0 2 0 21 2 0 6 18 2 55 33 1 12 4 12 0 2 53 5 2 1 14 0 0 026
9 2 1 54 44 9 48 0 0 6 0 0 5 1 0 6 9 0 1 2 20 0 4 2 10 2 17 -----
766
60-
-
64 0 5 4 0 2 0 14 0 1 2 17 1 52 29 6 19 10 16 0 1 47 3 1 2 12 1 0 324
7 2 1 43 43 8 39 0 0 13 1 0 9 0 0 8 6 0 0 1 18 0 5 2 7 0 22 -----
723
65-
-
69 0 2 11 0 0 0 10 1 1 7 20 0 60 22 3 20 8 17 0 0 49 5 1 2 24 1 0 515
1 1 2 29 20 1 32 0 0 11 1 2 10 0 1 5 9 0 0 0 18 0 6 1 5 2 21 -----
597
70-
-
74 2 5 11 2 1 1 9 1 0 8 26 0 63 40 3 26 13 13 0 2 39 2 1 2 18 0 0 511
8 4 1 44 19 5 12 0 0 7 1 1 6 0 0 4 2 0 0 1 20 0 4 1 3 1 24 -----
571
75+
1 6 8 3 1 0 4 2 0 12 52 210
8 61 6 37 10 32 1 1 75 5 1 3 35 0 0 414
2 1 3 34 21 6 19 1 0 14 0 2 14 0 2 4 8 0 0 0 16 0 2 2 11 3 36 -----
811
% of
Total
0.10%
0.50%
0.70%
0.20%
0.10%
0.00%
2.10%
0.10%
0.00%
0.70%
3.00%
0.20%
7.40%
4.10%
0.30%
2.20%
0.90%
2.00%
0.00%
0.20%
5.60%
0.40%
0.50%
0.30%
2.10%
0.00%
0.00%
0.70%
32.20
%0.2
0%0.2
0%6.6
0%4.5
0%0.8
0%5.5
0%0.0
0%0.1
0%1.3
0%0.0
0%0.1
0%0.9
0%0.0
0%0.1
0%1.4
0%2.0
0%0.0
0%0.0
0%0.2
0%2.9
0%0.0
0%0.4
0%1.0
0%1.6
0%0.4
0%2.7
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
72:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
PE
NA
NG
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
200
7-20
11
152
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
5 38 33 38 15 739
4 20 3 85 238 19 442
357 11 361 38 145 28 106
861 22 42 11 184 0 3 45 17 10 447 31 4
146 5 3
177 2 11 90 50 6 8 28 244 1 28 86 101 30 169
-----
5245
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0.3 0 0 0 0 0.7 0 0 0 1.4 0 1.4 0 0 0 0 1 2.7 0 0.7 0.3 0 1.4 0 0 7.2 1 3.1 0---
-- 22
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0.3 0 0 0.3 3.2 0 0 3.5 0.3 1.3 1---
-- 12
10-
-
14 0 0 0 0 0 0 1.2 0 0 0 0.3 0 0.3 0 0 0.3 0 0 0.3 0 0 0 1.8 0 0 0 0 0.6 0 0 0 0.9 0 0 0 0 0 0 0 2.8 0 0 0 0 3.1 0 0 2.5 0.9 0 0---
-- 15
15-
-
19 0 0 0.6 0.3 0 0 1.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.9 0 0.3 0 0 0 0 0 0 0.6 0 0 0 0 0.3 0 0 1.2 0.6 0 0 1.2 2.1 0 0 1.5 1.5 0.3 0.3 ----- 14
20-
-
24 0 0 0 0 0 0.3 2.3 0 0 0.3 0 0 0.3 0 0.3 0.3 0 0 0.3 0.3 0.7 0.7 2 0 0.3 0 0 1 0 0.3 0 1 0 0 0 0 0 0 0 1.7 0.7 0 0.7 1.3 2.7 0 0 1.7 3 0 0.3 ----- 23
25-
-
29 0 0.3 0.3 0.3 0.3 0 2.9 0 0 0 0 0 0 0.6 0 0.3 0 0 0 0 2.3 0 0.3 0 0.6 0 0.3 1.9 0 0 0 1 0 1 0 0 0 0 0 0.6 0.3 0 0 0.6 1.6 0 0.3 1.6 2.9 0.3 1---
-- 22
30-
-
34 0 0 0 0.4 0 0 6.7 0 0 0.4 0.4 0.4 0.7 1.1 0 1.4 0 0 0 0.4 1.4 0 0.7 0 1.1 0 0 1.1 0.4 0 0.4 1.8 0 0.4 0 0 0.7 0 0 2.1 0.7 0 0.4 0.7 2.5 0 0 0.7 1.1 0 0.7 ----- 28
35-
-
39 0 0.7 0 1.1 0 013
.6 0 0 0 1.8 0 2.2 2.9 0 2.9 0 1.1 0.7 0.4 5.1 0.7 0 0 0.7 0 0 0.7 0 0 0 2.2 0 2.2 0 0 0.7 0 0 1.8 1.5 0 0.4 0.7 5.9 0 0.4 0.4 2.9 0.4 1.5 ----- 56
40-
-
44 0 0.8 0.4 1.2 0.4 019
.4 0 0 0.4 1.6 0.4 7.1 4.3 0 5.1 0.8 3.2 0.8 1.2 7.5 0.4 2 0 2.8 0 0.8 1.2 0 0 0 0.4 0 4.7 0 0 3.2 0.4 0 3.6 2.4 0 0.8 0 3.6 0 0 1.2 4 0.4 3.6 ----- 90
45-
-
49 0 1.3 0 1.7 0.4 024
.7 0 0.4 3.4 7.2 1.3 12.3
10.6 0 8.9 0.9 5.1 1.3 1.7 20 0.4 0.4 0.4 4.3 0 0 1.3 0.9 0 1.7 0.4 0 8.9 0.4 0 3.4 0 0 3 2.6 0 0 1.3 9.4 0 0.9 0.9 2.6 0 3
-----
147
50-
-
54 0 2.5 1 2 0.5 0 27 0.5 0.5 212
.3 018
.222
.6 019
.2 2.5 2.9 3.4 4.4 35.4 1 2 0 6.9 0 0 2.5 0 0 3.4 0.5 0 3.4 0 0.5 6.9 0 0 4.4 2 0.5 0 2.5 13.8 0 0.5 1.5 4.4 1 4.9 -----
219
55-
-
59 0 4.7 1.8 3 1.8 031
.5 1.8 0 5.3 11.9 1.2 30.9
26.1 1.2 38.6 5.3 11.9 1.2 6.5 60.5 3.6 2.4 1.8 8.9 0 0 3 0.6 1.2 14.2 0 0.6 13.7 0.6 0
10.7 0 0.6 3 2.4 0.6 0.6 1.8 12.5 0 1.8 2.4 4.7 0.6 16 -----
353
60-
-
64 0 3.7 5.2 3.7 3.7 2.2 26.6 0.7 0
14.8
27.3 2.2 44.3
42.1 2.2 47.2 2.2 14.8 3.7 14
103.3 2.2 1.5 2.2 19.9 0 0 3 1.5 3
43.5 1.5 1.5 12.5 0 0.7 13.3 0 0.7 1.5 3.7 0 0 0
17.7 0 4.4 3.7 3 2.2 15.5 -----
523
65-
-
69 1.1 3.4 6.9 5.7 1.1 1.1 37.9 2.3 0
20.7
36.8 6.9 77 59.8 2.3 52.9 5.7 32.2 1.1 25.3
187.4 2.3 1.1 3.4 41.4 0 0 2.3 3.4 2.3
121.9 0 0
27.6 1.1 1.1 39.1 0 1.1 8
10.3 1.1 0 2.3 40.2 1.1 5.7 6.9 8 2.3 24.1 -----
927
70-
-
74 1.5 4.5 1.5 6.1 1.5 328
.810
.6 012
.1 53 4.510
6.1 59.1 0
62.1 7.6 27.3 1.5 28.8
213.7 0 0 1.5 37.9 0 0 3 6.1 0
157.6 0 0
21.2 0 0
45.5 1.5 3 3 1.5 0 0 0
21.2 0 7.6 4.5 16.7 4.5 34.9 -----
1005
75+ 4.6 9.2 15
.4 3.1 1.5 015
.4 9.2 1.5 23.1
93.9 0
152.3
107.7 4.6 83.1
10.8
46.2 4.6 23.1
230.8 3.1 6.2 0
63.1 0 0 4.6 6.2 1.5
218.5 0 1.5 21.5 3.1 0
64.6 0 4.6 10.8 4.6 1.5 0 0
36.9 0 6.2 3.1 7.7 3.1 56.9 -----
1369
Crud
eRa
te 0.1 1 0.9 1 0.4 0.2 10.8 0.5 0.1 2.3 6.5 0.5 12.1 9.8 0.3 9.9 1 4 0.8 2.9 23.7 0.6 1.2 0.3 5.1 0 0.1 1.2 0.5 0.3 12.3 0.9 0.1 4 0.1 0.1 4.9 0.1 0.3 2.5 1.4 0.2 0.2 0.8 6.7 0 0.8 2.4 2.8 0.8 4.6 -----
144.1
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
73:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, P
EN
AN
G, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011
ASR
Wor
ld 0.2 1 1 1 0.4 0.2 10.2 0.6 0.1 2.5 6.9 0.6 12.8
10.2 0.3 10.2 1.1 4.2 0.7 3.1 25.1 0.6 1.1 0.3 5.4 0 0.1 1.2 0.5 0.3 13.8 0.8 0.1 4.1 0.1 0.1 5.2 0.1 0.4 2.5 1.4 0.2 0.2 0.7 6.8 0 0.8 2.7 2.7 1 4.8 -----
150.5
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
153
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
6 32 43 15 9 212
7 9 3 44 184 14 451
248 21 135 52 119 3 10 341 27 31 19 125 2 0 45
1958 12 11 39
927
3 50 332 3 6 79 3 6 53 1 5 83 124 3 3 15 176 0 24 60 99 24 166
-----
6085
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0.4 0 0 0 0 1.1 0 0 0.4 0 0 0 0 0 0 0.7 0 0 0 0 0.4 3.2 0 0.4 0 0 0.4 0 0 5.8 3.6 1.4 1.1 ----- 19
5-
-
9 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.3 0 0 0 0 1 0 0 3.7 1.3 0.3 0---
-- 10
10-
-
14 0.3 0 0.3 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.6 0 0 0 0 0.3 0.3 0 0 0 0 0 1.3 0 0 0 0 0 0 0 0 1.6 0.6 0 0 0.6 1.3 0 0 2.2 0.3 0.3 0.3 ----- 12
15-
-
19 0 0 0 0.3 0 0 1.2 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 1.2 0 0.3 0 0 0.6 0.3 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0.3 0.9 0 0 0.9 1.6 0 0 0.6 1.9 0.6 0---
-- 12
20-
-
24 0 0 0 0.3 0 0.3 1.6 0 0 0 0 0.3 1.3 0.6 0 0 0 0 0 0 0 0 0.3 0.3 0.6 0 0 1 1.3 0 0 0.3 0 0 2.3 0 0.3 0 0 0 0 0 0 1.3 1.6 0 0.3 1 1.9 0 0 1 1.6 0 0.6 ----- 20
25-
-
29 0 0.3 0 1 0 0 3.2 0 0 0 0 0 1.6 0.3 0 0 0 0.3 0 0 0.6 0 0 0 0 0 0 0.6 6.4 0 0 2.2 2.5 0.6 4.1 0 0.3 0.3 0 0 0 0 0 1.6 3.2 0 0 0 2.5 0 0 0 0.3 0 1---
-- 33
30-
-
34 0.4 0.4 0 0.4 0 0 0.7 0 0 0 1.4 0.7 0.4 1.8 0 0.4 0 0.4 0.4 0 0.4 0.7 1.4 0.7 1.8 0 0 0.4 21.3 0 0 3.2 0.7 0.4 1.4 0 0.7 0.7 0 0 0 0 0 1.4 5.3 0 0 0.7 2.1 0 0 1.1 0.7 0.4 0.4 ----- 53
35-
-
39 0 0 0 0 0 0 1.5 0 0 0 1.8 0 2.6 1.1 0 1.5 0.4 0.7 0.4 0.7 2.9 0 0.4 0 0.7 0 0 1.5 40.2 0 0
13.1 3.7 1.5 5.8 0 0.7 1.5 0 0 1.1 0 0 1.5 6.2 0 0 0 3.7 0 0 1.5 1.8 0.7 2.2 -----
101
40-
-
44 0 1.9 0.4 0.4 0.8 0 6.6 0 0 0.8 3.1 0.4 7.4 4.3 0 0.8 0 1.2 0 0 3.5 0.4 1.9 1.2 1.6 0 0 0.8 80.2 0.4 0.4 16.3 9.7 2.3 8.1 0 0 0.4 0 0 0 0 0 2.3 4.7 0 0 0.4 3.5 0 0.4 0.8 3.5 1.2 2.3 -----
174
45-
-
49 0 0.4 0 0.4 0 0 6.6 1.3 0 1.3 6.6 1.3 13.5 6.6 0.9 2.6 1.7 2.2 0 0 10 0.9 1.3 0.4 1.3 0 0 3.1
137.6 0.4 0
19.2
16.2 2.2 28 0.9 0 3.5 0 0 1.7 0 0 2.2 7.9 0.4 0 0 3.5 0 0 1.3 3.9 0.4 4.8 -----
297
50-
-
54 0.5 1 0.5 0.5 0.5 0 5.8 0 0.5 1.9 9.2 121
.912
.7 0 3.4 1 8.3 0 1 17 0.5 0.5 1 1.9 0 0 1.515
2.3 0 0.5 27.3
21.4 1.5 24.8 0 0 4.9 0 0.5 1 0 0.5 2.9 3.9 0.5 0.5 0
11.7 0 1 0.5 5.4 0.5 6.3 -----
360
55-
-
59 0 2.3 2.9 0 1.2 012
.3 1.2 0 3.5 10.5 1.2 32.2
19.3 0.6 7 2.3 7 0 1.2 31 2.9 1.2 0.6 8.2 0 0 0
157.3 1.2 0.6 31
.625
.7 5.3 28.1 0 0 3.5 0 0 2.9 0.6 0 3.5 5.3 0 0.6 1.2 11.7 0 2.3 1.2 5.8 1.2 9.9 -----
448
60-
-
64 0 3.7 3 0 1.5 010
.3 0 0.7 1.5 12.5 0.7 38.4
21.4 4.4 14 7.4 11.8 0 0.7 34.7 2.2 0.7 1.5 8.9 0.7 0 2.2
182.3 1.5 0.7 31.7
31.7 5.9 28.8 0 0 9.6 0.7 0 6.6 0 0 5.9 4.4 0 0 0.7 13.3 0 3.7 1.5 5.2 0
16.2 -----
534
65-
-
69 0 2.2 11.8 0 0 0
10.8 1.1 1.1 7.5 21.5 0
64.5
23.7 3.2 21.5 8.6 18.3 0 0
52.7 5.4 1.1 2.2 25.8 1.1 0 5.4
162.4 1.1 2.2 31.2
21.5 1.1 34.4 0 0
11.8 1.1 2.2 10.8 0 1.1 5.4 9.7 0 0 0
19.4 0 6.5 1.1 5.4 2.2 22.6 -----
642
70-
-
74 2.8 715
.4 2.8 1.4 1.4 12.6 1.4 0
11.2
36.4 0
88.1 56 4.2 36.4
18.2
18.2 0 2.8 54.6 2.8 1.4 2.8 25.2 0 0 7
165.1 5.6 1.4 61.5
26.6 7
16.8 0 0 9.8 1.4 1.4 8.4 0 0 5.6 2.8 0 0 1.4 28 0 5.6 1.4 4.2 1.4 33.6 -----
799
75+ 1.1 6.7 9 3.4 1.1 0 4.5 2.2 0
13.5
58.4 2.2
121.4 68
.5 6.7 41.6
11.2 36 1.1 1.1 84.3 5.6 1.1 3.4 39.3 0 0 4.5
159.6 1.1 3.4 38.2
23.6 6.7 21.4 1.1 0
15.7 0 2.2 15.7 0 2.2 4.5 9 0 0 0 18 0 2.2 2.2 12.4 3.4 40.5 -----
911
Crud
eRa
te 0.2 0.9 1.2 0.4 0.2 0.1 3.5 0.2 0.1 1.2 5 0.4 12.4 6.8 0.6 3.7 1.4 3.3 0.1 0.3 9.3 0.7 0.8 0.5 3.4 0.1 0 1.2 53.6 0.3 0.3 10.9 7.5 1.4 9.1 0.1 0.2 2.2 0.1 0.2 1.5 0 0.1 2.3 3.4 0.1 0.1 0.4 4.8 0 0.7 1.6 2.7 0.7 4.5 -----
166.7
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
74:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, P
EN
AN
G, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011
ASR
Wor
ld 0.2 0.8 1.2 0.4 0.2 0.1 3.3 0.2 0.1 1.1 4.7 0.3 11.7 6.4 0.6 3.6 1.4 3.1 0.1 0.2 8.9 0.7 0.8 0.5 3.3 0.1 0 1.2 50 0.3 0.3 10.1 7 1.3 8.6 0.1 0.1 2.1 0.1 0.2 1.4 0 0.1 2.3 3.1 0.1 0.1 0.4 4.6 0 0.7 1.9 2.7 0.7 4.4 -----
157.8
154
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
0 16 34 12 5 313
5 7 2 37 65 816
818
5 215
0 18 38 25 33 444 3 38 9 60 2 0 33 6 5
106 20 1 50 0 0 69 1 5 51 41 3 2 11 149 0 13 38 56 22 12 -----
2193
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 2 0 2 0 0 0 0 1 3 0 0 0 0 4 0 0 3 5 4 0---
-- 25
5-
-
9 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0 2 0 0 8 1 1 0---
-- 19
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 1 0 0 0 2 0 2 0 0 2 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 2 2 0 0 2 1 1 0---
-- 19
15-
-
19 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 9 0 0 0 0 4 0 0 0 2 0 0 0 0 0 0 0 6 0 1 0 1 4 0 0 6 3 0 0---
-- 38
20-
-
24 0 0 0 1 0 0 2 0 0 0 0 0 1 0 0 1 0 0 1 0 0 0 3 0 0 0 0 2 0 0 0 4 0 0 0 0 0 0 0 1 0 0 0 0 4 0 0 1 6 1 0---
-- 28
25-
-
29 0 0 0 0 0 0 3 0 0 0 0 0 1 3 0 1 0 0 0 0 1 0 4 0 0 0 0 1 0 0 1 3 0 1 0 0 0 0 0 1 5 0 0 3 4 0 1 4 5 1 0---
-- 43
30-
-
34 0 1 0 0 0 0 2 0 0 0 1 0 4 4 0 2 0 0 0 0 7 0 2 0 0 0 0 0 0 0 0 3 0 0 0 0 1 0 0 5 2 0 0 1 9 0 0 1 2 1 0---
-- 48
35-
-
39 0 0 1 0 0 0 5 0 0 0 3 0 7 2 0 5 1 0 2 2 8 0 2 0 0 0 0 3 0 0 0 2 0 2 0 0 1 0 0 4 1 0 0 0 6 0 0 0 2 3 0---
-- 62
40-
-
44 0 0 0 3 0 0 12 0 0 1 2 1 11 6 0 15 0 0 1 0 12 0 1 1 1 0 0 3 1 0 0 2 0 0 0 0 2 0 1 3 4 0 0 1 5 0 0 2 3 1 1---
-- 96
45-
-
49 0 1 3 1 1 0 28 1 0 2 6 0 19 12 0 13 2 1 3 0 33 1 2 1 3 1 0 4 0 0 0 0 0 5 0 0 5 0 1 2 3 0 0 1 11 0 0 1 4 1 3---
--17
5
50-
-
54 0 5 6 2 0 3 25 0 0 2 5 2 23 26 0 22 1 6 2 0 47 0 1 3 3 0 0 3 1 0 1 1 0 5 0 0 10 0 1 9 4 0 1 1 14 0 1 1 5 0 2---
--24
4
55-
-
59 0 3 6 1 1 0 18 1 0 5 12 1 21 25 0 30 2 5 2 4 50 1 4 0 6 0 0 4 0 0 12 1 1 7 0 0 7 1 0 1 3 0 0 1 15 0 2 5 3 2 0---
--26
3
60-
-
64 0 1 2 1 2 0 17 1 1 5 6 1 24 33 0 23 5 12 8 10 79 1 3 0 7 0 0 3 0 2 18 0 0 7 0 0 10 0 1 7 8 0 0 0 20 0 5 1 8 2 2---
--33
6
65-
-
69 0 2 7 1 1 0 16 2 0 7 12 2 22 35 0 12 2 8 1 7 79 0 1 1 6 0 0 0 2 0 19 0 0 4 0 0 12 0 0 3 2 1 1 0 20 0 1 1 2 2 3---
--29
7
70-
-
74 0 2 6 2 0 0 5 1 0 9 11 1 19 21 2 14 3 3 2 5 68 0 3 1 19 1 0 2 1 2 27 0 0 12 0 0 13 0 0 1 3 1 0 0 12 0 2 2 4 1 1---
--28
2
75+
0 1 3 0 0 0 1 1 0 6 7 0 14 18 0 10 2 3 2 5 59 0 0 2 13 0 0 1 1 1 28 0 0 4 0 0 8 0 0 2 5 0 0 0 17 0 1 0 2 1 0---
--21
8
% of
Total 0.0
0%0.7
0%1.6
0%0.5
0%0.2
0%0.1
0%6.2
0%0.3
0%0.1
0%1.7
0%3.0
0%0.4
0%7.7
0%8.4
0%0.1
0%6.8
0%0.8
0%1.7
0%1.1
0%1.5
0%20
.20%
0.10%
1.70%
0.40%
2.70%
0.10%
0.00%
1.50%
0.30%
0.20%
4.80%
0.90%
0.00%
2.30%
0.00%
0.00%
3.10%
0.00%
0.20%
2.30%
1.90%
0.10%
0.10%
0.50%
6.80%
0.00%
0.60%
1.70%
2.60%
1.00%
0.50% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
75:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
PA
HA
NG
, AL
L R
ESI
DE
NT
S, M
AL
ES,
200
7-20
11
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
155
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
2 15 21 9 8 1 40 4 1 19 45 313
010
7 2 57 17 27 13 516
4 2 20 8 40 0 0 27 790 3 6
193 78 33 158 2 3 21 0 1 23 0 1 63 96 4 1 6
100 0 16 21 56 19 18 -----
2499
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 3 0 0 0 0 0 5 1 1 0---
-- 14
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 1 1 0 0---
-- 9
10-
-
14 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 3 1 0 0 0 3 0 0 1 5 0 0---
-- 20
15-
-
19 0 0 0 0 1 0 0 0 0 0 1 0 2 0 0 0 0 0 1 0 0 0 2 0 0 0 0 3 1 0 0 0 0 0 2 0 0 1 0 0 0 0 0 1 3 0 0 1 1 0 0 2 4 1 0---
-- 27
20-
-
24 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 4 0 0 0 0 0 3 0 0 1 0 0 1 0 0 5 7 0 0 2 7 0 0 1 2 2 1---
-- 41
25-
-
29 0 1 0 1 0 0 0 0 0 0 1 0 3 3 0 0 0 0 2 0 0 1 1 0 1 0 0 2 10 0 0 1 3 0 5 0 0 0 0 0 0 0 0 6 12 0 0 1 5 0 0 2 3 1 0---
-- 65
30-
-
34 0 0 0 1 1 0 0 0 0 0 1 0 5 2 0 3 0 1 0 0 1 0 3 1 0 0 0 3 39 0 0 2 2 1 8 0 1 1 0 0 1 0 0 0 3 0 0 1 2 0 0 0 10 1 0---
-- 94
35-
-
39 0 0 0 1 0 0 3 0 0 2 3 0 5 2 0 4 0 0 1 1 5 0 1 1 3 0 0 3 65 0 1 20 2 4 10 0 1 1 0 0 0 0 0 3 6 0 0 0 3 0 0 2 3 1 0---
--15
7
40-
-
44 0 0 0 0 0 0 5 0 0 1 0 0 5 10 0 3 0 1 2 0 6 1 4 0 1 0 0 3 95 0 1 26 4 4 20 0 0 0 0 0 1 0 0 8 5 0 0 0 8 0 0 1 5 1 1---
--22
2
45-
-
49 0 4 1 0 1 0 4 0 0 1 1 0 17 12 0 2 3 2 0 0 10 0 0 1 4 0 0 115
5 0 0 28 12 5 22 1 1 0 0 0 2 0 0 5 19 0 0 0 13 0 3 0 5 1 2---
--33
8
50-
-
54 0 3 1 0 1 0 8 0 0 1 6 1 15 8 0 12 0 3 1 0 22 0 1 0 0 0 0 213
9 0 3 33 14 8 27 0 0 4 0 0 2 0 0 5 11 1 0 0 11 0 2 3 4 1 3---
--35
6
55-
-
59 0 1 1 1 1 0 9 0 0 1 4 1 19 14 0 11 6 2 3 1 17 0 2 0 3 0 0 2 97 1 0 27 19 5 25 0 0 2 0 1 1 0 0 9 8 0 1 0 9 0 1 0 5 1 3---
--31
4
60-
-
64 0 1 4 0 0 0 4 1 0 3 7 0 18 20 1 5 3 8 0 0 19 0 1 2 5 0 0 2 59 0 0 22 9 4 12 0 0 3 0 0 1 0 0 4 9 0 0 0 12 0 1 0 3 2 5---
--25
0
65-
-
69 0 0 6 1 1 1 3 0 0 2 9 0 6 10 1 5 1 4 2 2 31 0 0 0 6 0 0 2 70 0 0 14 4 1 8 0 0 2 0 0 0 0 0 0 6 0 0 1 9 0 3 2 2 3 0---
--21
8
70-
-
74 0 4 1 1 1 0 3 2 0 5 4 0 15 16 0 5 2 2 1 0 21 0 0 2 6 0 0 0 29 1 0 12 4 1 8 1 0 1 0 0 5 0 0 6 4 0 0 0 9 0 4 1 3 1 2---
--18
3
75+
2 1 7 2 1 0 1 1 1 3 8 0 19 9 0 7 2 4 0 1 31 0 0 1 11 0 0 1 27 1 1 8 5 0 6 0 0 4 0 0 9 0 0 2 2 0 0 0 8 0 2 0 0 2 1---
--19
1
% of
Total
0.10%
0.60%
0.80%
0.40%
0.30%
0.00%
1.60%
0.20%
0.00%
0.80%
1.80%
0.10%
5.20%
4.30%
0.10%
2.30%
0.70%
1.10%
0.50%
0.20%
6.60%
0.10%
0.80%
0.30%
1.60%
0.00%
0.00%
1.10%
31.60
%0.1
0%0.2
0%7.7
0%3.1
0%1.3
0%6.3
0%0.1
0%0.1
0%0.8
0%0.0
0%0.0
0%0.9
0%0.0
0%0.0
0%2.5
0%3.8
0%0.2
0%0.0
0%0.2
0%4.0
0%0.0
0%0.6
0%0.8
0%2.2
0%0.8
0%0.7
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
76:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
PA
HA
NG
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
200
7-20
11
156
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
0 16 34 12 5 313
5 7 2 37 65 816
818
5 215
0 18 38 25 33 444 3 38 9 60 2 0 33 6 5
106 20 1 50 0 0 69 1 5 51 41 3 2 11 149 0 13 38 56 22 12 -----
2193
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.5 0 0.5 0 0 0 0 0.3 0.8 0 0 0 0 1.1 0 0 0.8 1.3 1.1 0---
-- 7
5-
-
9 0 0 0 0 0 0 0.3 0 0.3 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0.3 0 0 0 0 0 0.5 0 0 0 0 0.5 0 0 2.1 0.3 0.3 0---
-- 5
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0.2 0 0 0.2 0 0 0 0.5 0 0.5 0 0 0.5 0 0 0 0 0 0 0 0 0 0 0 0.2 0.2 0 0 0.5 0.5 0 0 0.5 0.2 0.2 0---
-- 5
15-
-
19 0 0 0 0 0 0 0 0 0 0 0 0 0.2 0 0 0 0 0 0 0 0.2 0 2.2 0 0 0 0 1 0 0 0 0.5 0 0 0 0 0 0 0 1.5 0 0.2 0 0.2 1 0 0 1.5 0.7 0 0---
-- 9
20-
-
24 0 0 0 0.3 0 0 0.6 0 0 0 0 0 0.3 0 0 0.3 0 0 0.3 0 0 0 0.9 0 0 0 0 0.6 0 0 0 1.2 0 0 0 0 0 0 0 0.3 0 0 0 0 1.2 0 0 0.3 1.8 0.3 0---
-- 8
25-
-
29 0 0 0 0 0 0 1 0 0 0 0 0 0.3 1 0 0.3 0 0 0 0 0.3 0 1.3 0 0 0 0 0.3 0 0 0.3 1 0 0.3 0 0 0 0 0 0.3 1.6 0 0 1 1.3 0 0.3 1.3 1.6 0.3 0---
-- 14
30-
-
34 0 0.4 0 0 0 0 0.9 0 0 0 0.4 0 1.8 1.8 0 0.9 0 0 0 0 3.1 0 0.9 0 0 0 0 0 0 0 0 1.3 0 0 0 0 0.4 0 0 2.2 0.9 0 0 0.4 4 0 0 0.4 0.9 0.4 0---
-- 21
35-
-
39 0 0 0.5 0 0 0 2.5 0 0 0 1.5 0 3.5 1 0 2.5 0.5 0 1 1 4 0 1 0 0 0 0 1.5 0 0 0 1 0 1 0 0 0.5 0 0 2 0.5 0 0 0 3 0 0 0 1 1.5 0---
-- 31
40-
-
44 0 0 0 1.6 0 0 6.5 0 0 0.5 1.1 0.5 5.9 3.2 0 8.1 0 0 0.5 0 6.5 0 0.5 0.5 0.5 0 0 1.6 0.5 0 0 1.1 0 0 0 0 1.1 0 0.5 1.6 2.2 0 0 0.5 2.7 0 0 1.1 1.6 0.5 0.5 ----- 52
45-
-
49 0 0.6 1.8 0.6 0.6 016
.6 0.6 0 1.2 3.6 011
.3 7.1 0 7.7 1.2 0.6 1.8 019
.6 0.6 1.2 0.6 1.8 0.6 0 2.4 0 0 0 0 0 3 0 0 3 0 0.6 1.2 1.8 0 0 0.6 6.5 0 0 0.6 2.4 0.6 1.8 -----
104
50-
-
54 0 2.9 3.5 1.2 0 1.7 14.5 0 0 1.2 2.9 1.2 13.3 15 0
12.7 0.6 3.5 1.2 0
27.2 0 0.6 1.7 1.7 0 0 1.7 0.6 0 0.6 0.6 0 2.9 0 0 5.8 0 0.6 5.2 2.3 0 0.6 0.6 8.1 0 0.6 0.6 2.9 0 1.2 -----
141
55-
-
59 0 2.1 4.2 0.7 0.7 012
.7 0.7 0 3.5 8.5 0.7 14.8
17.6 0
21.1 1.4 3.5 1.4 2.8 35.2 0.7 2.8 0 4.2 0 0 2.8 0 0 8.5 0.7 0.7 4.9 0 0 4.9 0.7 0 0.7 2.1 0 0 0.7 10.6 0 1.4 3.5 2.1 1.4 0
-----
185
60-
-
64 0 0.9 1.7 0.9 1.7 014
.8 0.9 0.9 4.4 5.2 0.9 21 28.8 0
20.1 4.4 10.5 7 8.7 69 0.9 2.6 0 6.1 0 0 2.6 0 1.7 15.7 0 0 6.1 0 0 8.7 0 0.9 6.1 7 0 0 0
17.5 0 4.4 0.9 7 1.7 1.7 -----
293
65-
-
69 0 2.7 9.5 1.4 1.4 021
.6 2.7 0 9.5 16.2 2.7 29.7
47.3 0
16.2 2.7 10.8 1.4 9.5
106.8 0 1.4 1.4 8.1 0 0 0 2.7 0
25.7 0 0 5.4 0 0
16.2 0 0 4.1 2.7 1.4 1.4 0 27 0 1.4 1.4 2.7 2.7 4.1 -----
401
70-
-
74 0 3.8 11.3 3.8 0 0 9.4 1.9 0 17 20.8 1.9 35.9
39.6 3.8 26.4 5.7 5.7 3.8 9.4
128.3 0 5.7 1.9 35.9 1.9 0 3.8 1.9 3.8 51 0 0
22.6 0 0
24.5 0 0 1.9 5.7 1.9 0 0
22.6 0 3.8 3.8 7.5 1.9 1.9 -----
532
75+
0 2.2 6.5 0 0 0 2.2 2.2 012
.915
.1 030
.138
.7 021
.5 4.3 6.5 4.3 10.8
126.9 0 0 4.3 28 0 0 2.2 2.2 2.2 60.2 0 0 8.6 0 0
17.2 0 0 4.3 10.8 0 0 0
36.6 0 2.2 0 4.3 2.2 0
-----
469
Crud
eRa
te 0 0.4 0.9 0.3 0.1 0.1 3.7 0.2 0.1 1 1.8 0.2 4.7 5.1 0.1 4.2 0.5 1.1 0.7 0.9 12.3 0.1 1.1 0.2 1.7 0.1 0 0.9 0.2 0.1 2.9 0.6 0 1.4 0 0 1.9 0 0.1 1.4 1.1 0.1 0.1 0.3 4.1 0 0.4 1.1 1.6 0.6 0.3 -----
60.9
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
77:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, P
AH
AN
G, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011
ASR
Wor
ld 0 0.5 1.2 0.4 0.2 0.1 4.4 0.3 0.1 1.4 2.3 0.3 5.7 6.5 0.1 5 0.6 1.3 0.8 1.2 15.9 0.1 1.1 0.3 2.2 0.1 0 1 0.2 0.2 4 0.5 0 1.7 0 0 2.5 0 0.2 1.6 1.4 0.1 0.1 0.3 5 0 0.4 1.1 1.7 0.7 0.4 -----
75.1
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
157
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
2 15 21 9 8 1 40 4 1 19 45 313
010
7 2 57 17 27 13 516
4 2 20 8 40 0 0 27 790 3 6
193 78 33 158 2 3 21 0 1 23 0 1 63 96 4 1 6
100 0 16 21 56 19 18 -----
2499
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.9 0 0.9 0 0 0 0 0 1.5 0.3 0.3 0---
-- 4
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0.3 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0 0 0 0.3 0.3 0 0---
-- 3
10-
-
14 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0.3 0 0 0 0 0 0.8 0.3 0 0 0 0.8 0 0 0.3 1.3 0 0---
-- 5
15-
-
19 0 0 0 0 0.3 0 0 0 0 0 0.3 0 0.6 0 0 0 0 0 0.3 0 0 0 0.6 0 0 0 0 0.8 0.3 0 0 0 0 0 0.6 0 0 0.3 0 0 0 0 0 0.3 0.8 0 0 0.3 0.3 0 0 0.6 1.1 0.3 0---
-- 7
20-
-
24 0 0 0 0 0 0 0 0 0 0 0 0.3 0.3 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0.7 1.3 0 0 0 0 0 1 0 0 0.3 0 0 0.3 0 0 1.7 2.4 0 0 0.7 2.4 0 0 0.3 0.7 0.7 0.3 ----- 14
25-
-
29 0 0.3 0 0.3 0 0 0 0 0 0 0.3 0 1 1 0 0 0 0 0.7 0 0 0.3 0.3 0 0.3 0 0 0.7 3.5 0 0 0.3 1 0 1.7 0 0 0 0 0 0 0 0 2.1 4.2 0 0 0.3 1.7 0 0 0.7 1 0.3 0---
-- 23
30-
-
34 0 0 0 0.5 0.5 0 0 0 0 0 0.5 0 2.5 1 0 1.5 0 0.5 0 0 0.5 0 1.5 0.5 0 0 0 1.5 19.5 0 0 1 1 0.5 4 0 0.5 0.5 0 0 0.5 0 0 0 1.5 0 0 0.5 1 0 0 0 5 0.5 0
----- 47
35-
-
39 0 0 0 0.5 0 0 1.5 0 0 1 1.5 0 2.5 1 0 2 0 0 0.5 0.5 2.5 0 0.5 0.5 1.5 0 0 1.5 32.3 0 0.5 9.9 1 2 5 0 0.5 0.5 0 0 0 0 0 1.5 3 0 0 0 1.5 0 0 1 1.5 0.5 0
----- 78
40-
-
44 0 0 0 0 0 0 2.5 0 0 0.5 0 0 2.5 5.1 0 1.5 0 0.5 1 0 3 0.5 2 0 0.5 0 0 1.5 48.2 0 0.5 13.2 2 2
10.2 0 0 0 0 0 0.5 0 0 4.1 2.5 0 0 0 4.1 0 0 0.5 2.5 0.5 0.5 -----
113
45-
-
49 0 2 0.5 0 0.5 0 2 0 0 0.5 0.5 0 8.7 6.1 0 1 1.5 1 0 0 5.1 0 0 0.5 2 0 0 0.5 79.1 0 0
14.3 6.1 2.6 11.2 0.5 0.5 0 0 0 1 0 0 2.6 9.7 0 0 0 6.6 0 1.5 0 2.6 0.5 1
-----
172
50-
-
54 0 1.7 0.6 0 0.6 0 4.7 0 0 0.6 3.5 0.6 8.7 4.7 0 7 0 1.7 0.6 012
.8 0 0.6 0 0 0 0 1.2 81.1 0 1.7 19.2 8.2 4.7 15.7 0 0 2.3 0 0 1.2 0 0 2.9 6.4 0.6 0 0 6.4 0 1.2 1.7 2.3 0.6 1.7 -----
208
55-
-
59 0 0.7 0.7 0.7 0.7 0 6.7 0 0 0.7 3 0.7 14.2
10.4 0 8.2 4.5 1.5 2.2 0.7 12.7 0 1.5 0 2.2 0 0 1.5 72.4 0.7 0
20.2
14.2 3.7 18.7 0 0 1.5 0 0.7 0.7 0 0 6.7 6 0 0.7 0 6.7 0 0.7 0 3.7 0.7 2.2 -----
234
60-
-
64 0 0.9 3.8 0 0 0 3.8 0.9 0 2.8 6.6 0 17 18.9 0.9 4.7 2.8 7.5 0 0
17.9 0 0.9 1.9 4.7 0 0 1.9 55.7 0 0
20.8 8.5 3.8 11.3 0 0 2.8 0 0 0.9 0 0 3.8 8.5 0 0 0
11.3 0 0.9 0 2.8 1.9 4.7 -----
236
65-
-
69 0 0 9.3 1.6 1.6 1.6 4.7 0 0 3.1 14 0 9.3 15.5 1.6 7.8 1.6 6.2 3.1 3.1 48.1 0 0 0 9.3 0 0 3.1
108.5 0 0
21.7 6.2 1.6 12.4 0 0 3.1 0 0 0 0 0 0 9.3 0 0 1.6 14 0 4.7 3.1 3.1 4.7 0
-----
338
70-
-
74 0 7.6 1.9 1.9 1.9 0 5.7 3.8 0 9.5 7.6 028
.630
.5 0 9.5 3.8 3.8 1.9 0 40 0 0 3.8 11.4 0 0 0
55.2 1.9 0
22.9 7.6 1.9 15.2 1.9 0 1.9 0 0 9.5 0 0
11.4 7.6 0 0 0
17.1 0 7.6 1.9 5.7 1.9 3.8 -----
349
75+ 3.6 1.8 12
.7 3.6 1.8 0 1.8 1.8 1.8 5.5 14.5 0
34.6
16.4 0
12.7 3.6 7.3 0 1.8 56.4 0 0 1.8 20 0 0 1.8 49.1 1.8 1.8 14.5 9.1 0
10.9 0 0 7.3 0 0
16.4 0 0 3.6 3.6 0 0 0
14.5 0 3.6 0 0 3.6 1.8 -----
347
Crud
eRa
te 0.1 0.4 0.6 0.3 0.2 0 1.2 0.1 0 0.6 1.3 0.1 3.8 3.2 0.1 1.7 0.5 0.8 0.4 0.1 4.8 0.1 0.6 0.2 1.2 0 0 0.8 23.3 0.1 0.2 5.7 2.3 1 4.7 0.1 0.1 0.6 0 0 0.7 0 0 1.9 2.8 0.1 0 0.2 2.9 0 0.5 0.6 1.7 0.6 0.5 -----
73.7
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
78:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, P
AH
AN
G, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011
ASR
Wor
ld 0.1 0.5 0.8 0.3 0.3 0 1.3 0.2 0 0.7 1.6 0.1 4.4 3.7 0.1 1.9 0.6 1 0.4 0.2 5.9 0.1 0.6 0.3 1.5 0 0 0.8 25.7 0.1 0.2 6.3 2.5 1 5 0.1 0.1 0.7 0 0 0.8 0 0 1.9 3 0.1 0 0.2 3.3 0 0.6 0.7 1.7 0.6 0.6 -----
82.7
158
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
1 16 5 11 0 2 70 5 1 21 35 411
311
0 415
7 18 36 10 21 313 1 35 5 58 0 0 28 2 0 96 12 1 27 1 1 69 0 5 39 26 2 4 14 93 0 10 11 57 63 55 -----
1668
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 3 1 0 0 0 5 7 0 1 0 1 2 0 0 4 9 12 0---
-- 49
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 1 0 0 0 0 0 0 0 0 2 0 0 0 0 0 5 0 1 0 1 0 0 0 2 3 9 1---
-- 28
10-
-
14 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 4 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 4 0 0 1 2 4 0 0 1 7 4 3---
-- 35
15-
-
19 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 1 4 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 1 1 6 0 0 2 4 8 3---
-- 42
20-
-
24 0 0 1 1 0 0 1 0 0 1 1 0 0 1 0 2 0 0 0 0 3 0 3 0 3 0 0 1 0 0 0 4 0 0 0 0 0 0 0 1 0 0 0 1 6 0 0 0 1 4 2---
-- 37
25-
-
29 0 1 0 0 0 0 2 0 0 0 3 0 1 0 0 1 0 0 0 0 3 0 1 1 2 0 0 3 0 0 0 5 0 0 0 0 0 0 0 3 1 0 1 0 2 0 0 0 3 5 1---
-- 39
30-
-
34 1 1 0 0 0 0 0 0 0 0 0 0 3 5 0 5 0 1 0 0 2 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 4 0 0 1 3 0 0---
-- 30
35-
-
39 0 1 0 2 0 0 3 0 0 1 0 0 1 2 0 8 1 1 1 0 2 0 2 0 1 0 0 0 0 0 0 1 0 0 0 0 2 0 0 1 1 0 0 1 3 0 0 0 2 1 1---
-- 39
40-
-
44 0 0 0 1 0 0 8 0 0 1 1 1 7 7 0 10 0 4 1 0 15 0 2 1 2 0 0 1 0 0 0 0 0 0 0 0 2 0 0 1 3 0 0 2 10 0 1 0 5 3 4---
-- 93
45-
-
49 0 3 1 1 0 1 6 1 0 0 3 0 8 9 0 18 2 7 0 2 28 0 2 0 4 0 0 5 0 0 0 0 0 4 0 0 6 0 0 4 4 0 1 1 8 0 0 0 5 0 5---
--13
9
50-
-
54 0 2 0 2 0 0 18 0 1 1 3 0 9 14 1 28 3 4 4 2 38 1 2 0 3 0 0 0 0 0 5 0 1 7 0 0 5 0 0 6 4 0 0 1 4 0 2 0 1 8 1---
--18
1
55-
-
59 0 1 0 3 0 0 10 2 0 1 3 2 15 15 1 25 4 3 1 3 36 0 1 1 4 0 0 3 2 0 9 0 0 3 0 0 9 0 0 1 3 0 0 0 13 0 2 1 5 3 8---
--19
3
60-
-
64 0 1 0 0 0 0 3 0 0 5 2 0 18 13 2 24 3 7 1 3 46 0 2 0 13 0 0 2 0 0 14 0 0 4 0 0 7 0 0 3 3 0 0 0 10 0 1 0 4 0 7---
--19
8
65-
-
69 0 3 2 1 0 1 4 1 0 3 8 0 16 20 0 10 1 5 1 3 51 0 3 0 7 0 0 4 0 0 18 0 0 3 0 0 13 0 0 2 3 0 0 2 8 0 3 0 0 1 5---
--20
2
70-
-
74 0 1 1 0 0 0 5 1 0 4 7 1 18 17 0 15 3 3 1 2 51 0 1 0 4 0 0 1 0 0 25 0 0 0 0 0 14 0 0 1 1 0 0 0 8 0 1 0 1 1 5---
--19
3
75+
0 2 0 0 0 0 5 0 0 4 4 0 16 7 0 10 1 1 0 6 38 0 4 1 6 0 0 3 0 0 25 1 0 1 0 1 11 0 0 0 1 0 0 0 5 0 0 0 4 4 9---
--17
0
% of
Total 0.1
0%1.0
0%0.3
0%0.7
0%0.0
0%0.1
0%4.2
0%0.3
0%0.1
0%1.3
0%2.1
0%0.2
0%6.8
0%6.6
0%0.2
0%9.4
0%1.1
0%2.2
0%0.6
0%1.3
0%18
.80%
0.10%
2.10%
0.30%
3.50%
0.00%
0.00%
1.70%
0.10%
0.00%
5.80%
0.70%
0.10%
1.60%
0.10%
0.10%
4.10%
0.00%
0.30%
2.30%
1.60%
0.10%
0.20%
0.80%
5.60%
0.00%
0.60%
0.70%
3.40%
3.80%
3.30% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
79:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
TE
RE
NG
GA
NU
, AL
L R
ESI
DE
NT
S, M
AL
ES,
200
7-20
11
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
159
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
1 12 12 5 1 1 35 5 2 15 33 2 90 83 2 49 14 23 3 211
3 5 29 4 35 0 0 28 534 4 0
120 97 37 173 0 6 19 0 0 15 0 7 41 111 0 1 4 56 0 15 8 52 36 37 -----
1977
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 1 0 0 1 0 2 0 0 0 0 2 0 0 0 0 0 0 0 0 0 4 0 0 0 0 3 3 0 0 0 0 3 0 0 5 5 6 0---
-- 37
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 1 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 4 0 0 0 0 0 0 0 0 3 6 1---
-- 21
10-
-
14 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 4 0 0 0 1 3 0---
-- 20
15-
-
19 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 5 0 2 0 0 7 0 0 0 0 0 0 8 0 0 0 0 0 0 0 0 3 6 0 0 0 3 0 0 1 6 0 1---
-- 44
20-
-
24 0 1 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 0 0 2 1 3 0 0 0 0 0 12 0 0 0 0 0 10 0 1 0 0 0 1 0 0 1 12 0 0 2 3 0 0 0 2 2 3---
-- 60
25-
-
29 0 0 0 0 0 0 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 1 0 0 2 13 0 0 3 3 1 4 0 0 0 0 0 1 0 1 1 6 0 0 0 4 0 0 1 1 3 1---
-- 50
30-
-
34 0 2 0 0 0 0 1 1 2 0 0 0 4 1 0 1 0 0 0 0 1 1 1 0 2 0 0 2 25 1 0 2 5 2 11 0 1 0 0 0 0 0 0 2 4 0 0 1 3 0 0 0 4 1 1---
-- 82
35-
-
39 0 1 1 1 0 0 2 0 0 0 2 0 1 3 0 1 0 1 1 0 6 0 1 0 0 0 0 0 39 0 0 4 7 4 9 0 1 2 0 0 2 0 0 3 5 0 0 1 3 0 1 0 4 0 1---
--10
7
40-
-
44 0 2 0 0 0 0 2 1 0 0 1 1 10 6 1 2 0 1 0 0 8 0 1 0 3 0 0 2 72 0 0 14 18 8 14 0 1 1 0 0 0 0 0 1 15 0 1 0 1 0 2 0 2 1 3---
--19
5
45-
-
49 0 1 0 2 0 0 5 1 0 0 3 0 8 6 0 3 1 0 0 0 11 0 3 1 3 0 0 210
6 0 0 24 16 12 26 0 1 1 0 0 1 0 0 5 11 0 0 0 4 0 1 0 2 2 4---
--26
6
50-
-
54 0 2 3 2 0 0 3 0 0 1 6 0 10 15 0 4 3 3 0 0 13 0 2 0 3 0 0 2 95 2 0 19 16 4 24 0 1 2 0 0 1 0 0 5 11 0 0 0 2 0 3 0 5 3 4---
--26
9
55-
-
59 0 0 0 0 0 0 7 0 0 2 4 0 14 8 0 7 2 6 2 2 18 1 1 1 1 0 0 2 72 0 0 18 14 2 17 0 0 1 0 0 0 0 0 1 3 0 0 0 8 0 4 0 5 3 4---
--23
0
60-
-
64 0 1 2 0 0 0 4 1 0 2 4 0 13 14 0 5 1 3 0 0 14 1 0 0 4 0 0 1 41 0 0 15 10 3 13 0 0 2 0 0 0 0 0 4 15 0 0 0 8 0 1 0 4 3 5---
--19
4
65-
-
69 0 0 2 0 0 0 0 1 0 4 2 0 5 13 0 6 3 2 0 0 15 1 0 2 4 0 0 1 26 0 0 8 5 1 22 0 0 4 0 0 4 0 0 5 8 0 0 0 0 0 0 0 2 1 3---
--15
0
70-
-
74 0 0 3 0 0 0 5 0 0 2 3 1 12 10 0 7 3 5 0 0 15 0 2 0 4 0 0 1 16 1 0 8 2 0 7 0 0 2 0 0 2 0 1 0 7 0 0 0 6 0 2 0 3 1 4---
--13
5
75+
1 1 1 0 1 0 1 0 0 4 6 0 12 6 1 11 1 1 0 0 9 0 1 0 7 0 0 1 16 0 0 5 1 0 7 0 0 0 0 0 3 0 0 1 7 0 0 0 4 0 1 1 3 1 2---
--11
7
% of
Total
0.10%
0.60%
0.60%
0.30%
0.10%
0.10%
1.80%
0.30%
0.10%
0.80%
1.70%
0.10%
4.60%
4.20%
0.10%
2.50%
0.70%
1.20%
0.20%
0.10%
5.70%
0.30%
1.50%
0.20%
1.80%
0.00%
0.00%
1.40%
27.00
%0.2
0%0.0
0%6.1
0%4.9
0%1.9
0%8.8
0%0.0
0%0.3
0%1.0
0%0.0
0%0.0
0%0.8
0%0.0
0%0.4
0%2.1
0%5.6
0%0.0
0%0.1
0%0.2
0%2.8
0%0.0
0%0.8
0%0.4
0%2.6
0%1.8
0%1.9
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
80:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
TE
RE
NG
GA
NU
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
200
7-20
11
160
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
1 16 5 11 0 2 70 5 1 21 35 411
311
0 415
7 18 36 10 21 313 1 35 5 58 0 0 28 2 0 96 12 1 27 1 1 69 0 5 39 26 2 4 14 93 0 10 11 57 63 55 -----
1668
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0.3 0 0 0.7 0 0 0 0 0 1 0.3 0 0 0 1.7 2.4 0 0.3 0 0.3 0.7 0 0 1.4 3.1 4.2 0---
-- 17
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0.3 0 0 0 0 0 0 0 0 0.7 0 0 0 0 0 1.6 0 0.3 0 0.3 0 0 0 0.7 1 3 0.3 ----- 9
10-
-
14 0 0 0 0 0 0 0.3 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 1.3 0 0.3 0 0 0.7 0 0 0 0 0 0 0 0 0 0 0 1.3 0 0 0.3 0.7 1.3 0 0 0.3 2.3 1.3 1---
-- 11
15-
-
19 0 0 0 0 0 0 1.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.6 0.3 1.3 0 0 0.3 0 0 0 0.3 0 0 0 0 0 0 0 0 0.3 0 0.3 0.3 2 0 0 0.7 1.3 2.6 1---
-- 14
20-
-
24 0 0 0.4 0.4 0 0 0.4 0 0 0.4 0.4 0 0 0.4 0 0.8 0 0 0 0 1.2 0 1.2 0 1.2 0 0 0.4 0 0 0 1.6 0 0 0 0 0 0 0 0.4 0 0 0 0.4 2.4 0 0 0 0.4 1.6 0.8 ----- 15
25-
-
29 0 0.5 0 0 0 0 1 0 0 0 1.6 0 0.5 0 0 0.5 0 0 0 0 1.6 0 0.5 0.5 1 0 0 1.6 0 0 0 2.6 0 0 0 0 0 0 0 1.6 0.5 0 0.5 0 1 0 0 0 1.6 2.6 0.5 ----- 20
30-
-
34 0.7 0.7 0 0 0 0 0 0 0 0 0 0 2 3.3 0 3.3 0 0.7 0 0 1.3 0 0 0 1.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0 0.7 2.7 0 0 0.7 2 0 0---
-- 20
35-
-
39 0 0.7 0 1.5 0 0 2.2 0 0 0.7 0 0 0.7 1.5 0 5.8 0.7 0.7 0.7 0 1.5 0 1.5 0 0.7 0 0 0 0 0 0 0.7 0 0 0 0 1.5 0 0 0.7 0.7 0 0 0.7 2.2 0 0 0 1.5 0.7 0.7 ----- 28
40-
-
44 0 0 0 0.7 0 0 5.8 0 0 0.7 0.7 0.7 5.1 5.1 0 7.3 0 2.9 0.7 010
.9 0 1.5 0.7 1.5 0 0 0.7 0 0 0 0 0 0 0 0 1.5 0 0 0.7 2.2 0 0 1.5 7.3 0 0.7 0 3.6 2.2 2.9 ----- 68
45-
-
49 0 2.2 0.7 0.7 0 0.7 4.5 0.7 0 0 2.2 0 5.9 6.7 013
.4 1.5 5.2 0 1.5 20.8 0 1.5 0 3 0 0 3.7 0 0 0 0 0 3 0 0 4.5 0 0 3 3 0 0.7 0.7 5.9 0 0 0 3.7 0 3.7 -----
103
50-
-
54 0 1.4 0 1.4 0 012
.4 0 0.7 0.7 2.1 0 6.2 9.6 0.7 19.2 2.1 2.7 2.7 1.4 26.1 0.7 1.4 0 2.1 0 0 0 0 0 3.4 0 0.7 4.8 0 0 3.4 0 0 4.1 2.7 0 0 0.7 2.7 0 1.4 0 0.7 5.5 0.7 -----
124
55-
-
59 0 1.1 0 3.4 0 011
.2 2.2 0 1.1 3.4 2.2 16.9
16.9 1.1 28.1 4.5 3.4 1.1 3.4 40.5 0 1.1 1.1 4.5 0 0 3.4 2.2 0
10.1 0 0 3.4 0 0
10.1 0 0 1.1 3.4 0 0 0
14.6 0 2.2 1.1 5.6 3.4 9
-----
217
60-
-
64 0 1.5 0 0 0 0 4.5 0 0 7.5 3 026
.919
.4 335
.8 4.5 10.4 1.5 4.5 68.7 0 3 0
19.4 0 0 3 0 0
20.9 0 0 6 0 0
10.4 0 0 4.5 4.5 0 0 0
14.9 0 1.5 0 6 0
10.4 -----
296
65-
-
69 0 6.6 4.4 2.2 0 2.2 8.8 2.2 0 6.6 17.6 0
35.2 44 0 22 2.2 11 2.2 6.6
112.1 0 6.6 0
15.4 0 0 8.8 0 0
39.6 0 0 6.6 0 0
28.6 0 0 4.4 6.6 0 0 4.4 17.6 0 6.6 0 0 2.2 11 -----
444
70-
-
74 0 3.1 3.1 0 0 015
.6 3.1 012
.521
.9 3.1 56.3
53.1 0
46.9 9.4 9.4 3.1 6.3
159.4 0 3.1 0
12.5 0 0 3.1 0 0
78.1 0 0 0 0 0
43.8 0 0 3.1 3.1 0 0 0 25 0 3.1 0 3.1 3.1 15.6 -----
603
75+
0 5.8 0 0 0 014
.5 0 011
.611
.6 046
.420
.3 0 29 2.9 2.9 017
.411
0.2 011
.6 2.9 17.4 0 0 8.7 0 0
72.5 2.9 0 2.9 0 2.9 31.9 0 0 0 2.9 0 0 0
14.5 0 0 0
11.6
11.6
26.1 -----
493
Crud
eRa
te 0 0.6 0.2 0.4 0 0.1 2.7 0.2 0 0.8 1.3 0.2 4.3 4.2 0.2 6 0.7 1.4 0.4 0.8 11.9 0 1.3 0.2 2.2 0 0 1.1 0.1 0 3.7 0.5 0 1 0 0 2.6 0 0.2 1.5 1 0.1 0.2 0.5 3.5 0 0.4 0.4 2.2 2.4 2.1 -----
63.7
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
81:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, T
ER
EN
GG
AN
U, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011
ASR
Wor
ld 0 0.8 0.3 0.5 0 0.1 3.1 0.3 0 1.2 1.9 0.2 6.1 5.7 0.2 7.6 0.9 1.8 0.5 1.1 16.7 0 1.5 0.2 2.9 0 0 1.4 0.1 0 5.6 0.5 0 1.2 0 0.1 3.8 0 0.2 1.6 1.2 0.1 0.1 0.6 4.4 0 0.5 0.4 2.4 2.4 2.7 -----
83.2
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
161
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
1 12 12 5 1 1 35 5 2 15 33 2 90 83 2 49 14 23 3 211
3 5 29 4 35 0 0 28 534 4 0
120 97 37 173 0 6 19 0 0 15 0 7 41 111 0 1 4 56 0 15 8 52 36 37 -----
1977
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.7 0 0.4 0 0 0.4 0 0.7 0 0 0 0 0.7 0 0 0 0 0 0 0 0 0 1.5 0 0 0 0 1.1 1.1 0 0 0 0 1.1 0 0 1.8 1.8 2.2 0---
-- 14
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0.3 0 0 0.3 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0.3 1.4 0 0 0 0 0 0 0 0 1 2.1 0.3 ----- 7
10-
-
14 0 0.3 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0.7 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0.7 0.3 0 0 0 1.4 0 0 0 0.3 1 0---
-- 7
15-
-
19 0 0 0 0 0 0 0.3 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 1.7 0 0.7 0 0 2.4 0 0 0 0 0 0 2.7 0 0 0 0 0 0 0 0 1 2.1 0 0 0 1 0 0 0.3 2.1 0 0.3 ----- 15
20-
-
24 0 0.4 0 0 0 0 1.3 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0.9 0.4 1.3 0 0 0 0 0 5.1 0 0 0 0 0 4.3 0 0.4 0 0 0 0.4 0 0 0.4 5.1 0 0 0.9 1.3 0 0 0 0.9 0.9 1.3 ----- 26
25-
-
29 0 0 0 0 0 0 0.6 0 0 0 0.6 0 0 0.6 0 0 0 0 0 0 0 0 0.6 0 0.6 0 0 1.2 7.6 0 0 1.7 1.7 0.6 2.3 0 0 0 0 0 0.6 0 0.6 0.6 3.5 0 0 0 2.3 0 0 0.6 0.6 1.7 0.6 ----- 29
30-
-
34 0 1.4 0 0 0 0 0.7 0.7 1.4 0 0 0 2.8 0.7 0 0.7 0 0 0 0 0.7 0.7 0.7 0 1.4 0 0 1.4 17.7 0.7 0 1.4 3.5 1.4 7.8 0 0.7 0 0 0 0 0 0 1.4 2.8 0 0 0.7 2.1 0 0 0 2.8 0.7 0.7 ----- 58
35-
-
39 0 0.7 0.7 0.7 0 0 1.4 0 0 0 1.4 0 0.7 2.1 0 0.7 0 0.7 0.7 0 4.2 0 0.7 0 0 0 0 027
.2 0 0 2.8 4.9 2.8 6.3 0 0.7 1.4 0 0 1.4 0 0 2.1 3.5 0 0 0.7 2.1 0 0.7 0 2.8 0 0.7 ----- 75
40-
-
44 0 1.4 0 0 0 0 1.4 0.7 0 0 0.7 0.7 6.9 4.2 0.7 1.4 0 0.7 0 0 5.5 0 0.7 0 2.1 0 0 1.4 49.8 0 0 9.7 12.5 5.5 9.7 0 0.7 0.7 0 0 0 0 0 0.7 10.4 0 0.7 0 0.7 0 1.4 0 1.4 0.7 2.1 -----
135
45-
-
49 0 0.7 0 1.5 0 0 3.7 0.7 0 0 2.2 0 5.9 4.4 0 2.2 0.7 0 0 0 8.1 0 2.2 0.7 2.2 0 0 1.5 77.7 0 0
17.6
11.7 8.8 19.1 0 0.7 0.7 0 0 0.7 0 0 3.7 8.1 0 0 0 2.9 0 0.7 0 1.5 1.5 2.9 -----
195
50-
-
54 0 1.8 2.6 1.8 0 0 2.6 0 0 0.9 5.3 0 8.8 13.2 0 3.5 2.6 2.6 0 0
11.5 0 1.8 0 2.6 0 0 1.8 83.7 1.8 0
16.7
14.1 3.5 21.1 0 0.9 1.8 0 0 0.9 0 0 4.4 9.7 0 0 0 1.8 0 2.6 0 4.4 2.6 3.5 -----
237
55-
-
59 0 0 0 0 0 0 8.3 0 0 2.4 4.8 016
.7 9.5 0 8.3 2.4 7.1 2.4 2.4 21.4 1.2 1.2 1.2 1.2 0 0 2.4 85.7 0 0
21.4
16.7 2.4 20.2 0 0 1.2 0 0 0 0 0 1.2 3.6 0 0 0 9.5 0 4.8 0 6 3.6 4.8 -----
274
60-
-
64 0 1.6 3.2 0 0 0 6.4 1.6 0 3.2 6.4 020
.622
.2 0 7.9 1.6 4.8 0 022
.2 1.6 0 0 6.4 0 0 1.6 65.1 0 0
23.8
15.9 4.8 20.6 0 0 3.2 0 0 0 0 0 6.4 23.8 0 0 0
12.7 0 1.6 0 6.4 4.8 7.9 -----
308
65-
-
69 0 0 4.1 0 0 0 0 2.1 0 8.2 4.1 010
.326
.8 012
.4 6.2 4.1 0 030
.9 2.1 0 4.1 8.2 0 0 2.1 53.6 0 0
16.5
10.3 2.1 45.4 0 0 8.2 0 0 8.2 0 0
10.3
16.5 0 0 0 0 0 0 0 4.1 2.1 6.2 -----
309
70-
-
74 0 0 8.5 0 0 014
.1 0 0 5.6 8.5 2.8 33.8
28.2 0
19.7 8.5 14.1 0 0
42.3 0 5.6 0
11.3 0 0 2.8 45.1 2.8 0
22.5 5.6 0
19.7 0 0 5.6 0 0 5.6 0 2.8 0
19.7 0 0 0
16.9 0 5.6 0 8.5 2.8 11.3 -----
380
75+ 2.3 2.3 2.3 0 2.3 0 2.3 0 0 9.1 13
.6 027
.313
.6 2.3 25 2.3 2.3 0 020
.5 0 2.3 015
.9 0 0 2.3 36.4 0 0
11.4 2.3 0
15.9 0 0 0 0 0 6.8 0 0 2.3 15.9 0 0 0 9.1 0 2.3 2.3 6.8 2.3 4.5 -----
266
Crud
eRa
te
0 0.5 0.5 0.2 0 0 1.4 0.2 0.1 0.6 1.3 0.1 3.6 3.3 0.1 2 0.6 0.9 0.1 0.1 4.5 0.2 1.2 0.2 1.4 0 0 1.1 21.4 0.2 0 4.8 3.9 1.5 6.9 0 0.2 0.8 0 0 0.6 0 0.3 1.6 4.4 0 0 0.2 2.2 0 0.6 0.3 2.1 1.4 1.5 -----
79.1
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
82:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, T
ER
EN
GG
AN
U, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011 AS
RW
orld 0 0.5 0.6 0.2 0 0 1.7 0.3 0.1 0.8 1.6 0.1 4.5 4.3 0.1 2.5 0.7 1.2 0.1 0.1 5.7 0.2 1.1 0.2 1.7 0 0 1.2 24.8 0.2 0 5.8 4.6 1.7 8.1 0 0.2 1 0 0 0.7 0 0.3 1.9 5.2 0 0 0.2 2.6 0 0.7 0.3 2.3 1.6 1.8 -----
93.8
162
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
1 24 17 5 6 214
3 9 1 48 98 12 153
240 7
127 14 43 10 35 270 2 13 6 52 0 0 18 8 4
100 24 0 30 0 0 45 0 5 47 19 0 3 22 117 0 15 31 42 13 36 -----
1917
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 3 1 0 0 0 0 2 0 0 5 0 2 0---
-- 14
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0 4 0 0 3 1 1 0---
-- 13
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 1 0 0 0 0 0 0 6 2 1 0---
-- 14
15-
-
19 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 3 2 0 0 3 2 0 0---
-- 17
20-
-
24 0 1 0 0 0 0 0 0 0 0 0 1 0 2 0 1 0 0 0 0 0 0 1 0 0 0 0 4 0 0 0 6 0 0 0 0 0 0 0 4 1 0 0 4 6 0 0 1 1 1 1---
-- 35
25-
-
29 0 0 0 0 0 0 3 0 0 1 1 0 1 1 0 3 0 1 1 0 0 0 0 0 1 0 0 1 0 0 0 5 0 0 0 0 1 0 0 0 1 0 0 4 4 0 0 3 1 1 1---
-- 35
30-
-
34 0 0 0 0 0 0 6 0 0 0 2 1 2 1 0 0 0 1 0 0 2 0 2 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 4 0 0 1 0 0 0---
-- 25
35-
-
39 0 2 0 1 0 0 7 0 0 1 3 0 7 5 0 1 0 0 1 0 5 0 0 0 1 0 0 0 0 0 0 4 0 0 0 0 1 0 0 3 0 0 0 2 8 0 0 0 2 0 0---
-- 54
40-
-
44 0 2 0 1 0 0 18 0 0 0 5 0 5 7 0 8 1 3 1 1 10 1 0 1 3 0 0 3 2 0 0 0 0 3 0 0 2 0 0 1 1 0 1 0 14 0 0 0 3 0 0---
-- 97
45-
-
49 1 2 1 0 0 0 30 0 0 2 5 1 11 15 0 14 1 3 0 4 13 0 2 0 2 0 0 2 2 0 0 4 0 3 0 0 1 0 0 9 1 0 0 0 9 0 4 2 4 0 2---
--15
0
50-
-
54 0 4 3 1 0 0 26 2 0 7 9 2 16 20 0 16 2 8 2 2 29 1 0 0 5 0 0 0 2 0 4 0 0 4 0 0 3 0 0 4 0 0 0 2 12 0 2 3 6 2 6---
--20
5
55-
-
59 0 2 4 0 2 1 16 0 1 12 8 1 20 31 0 20 1 8 1 7 35 0 0 2 7 0 0 1 0 1 9 0 0 6 0 0 4 0 0 5 5 0 0 2 18 0 2 1 2 0 2---
--23
7
60-
-
64 0 5 4 1 1 1 13 2 0 7 11 0 26 38 2 20 4 9 1 9 35 0 0 0 6 0 0 0 0 1 13 2 0 2 0 0 6 0 0 3 0 0 0 2 12 0 4 1 7 1 8---
--25
7
65-
-
69 0 2 0 0 0 0 14 5 0 9 17 3 18 51 2 11 2 3 2 6 46 0 2 2 5 0 0 2 0 0 28 0 0 4 0 0 5 0 0 3 2 0 1 1 8 0 2 1 4 3 4---
--26
8
70-
-
74 0 1 1 0 1 0 6 0 0 2 15 1 28 33 2 16 3 3 1 2 41 0 0 0 6 0 0 3 0 0 26 0 0 4 0 0 7 0 1 4 4 0 0 0 5 0 0 0 3 1 6---
--22
6
75+
0 3 4 1 2 0 3 0 0 7 22 2 19 36 1 17 0 4 0 4 54 0 2 0 16 0 0 0 2 2 20 1 0 3 0 0 15 0 0 5 2 0 0 2 9 0 1 1 4 0 6---
--27
0
% of
Total 0.1
0%1.3
0%0.9
0%0.3
0%0.3
0%0.1
0%7.5
0%0.5
0%0.1
0%2.5
0%5.1
0%0.6
0%8.0
0%12
.50%
0.40%
6.60%
0.70%
2.20%
0.50%
1.80%
14.10
%0.1
0%0.7
0%0.3
0%2.7
0%0.0
0%0.0
0%0.9
0%0.4
0%0.2
0%5.2
0%1.3
0%0.0
0%1.6
0%0.0
0%0.0
0%2.3
0%0.0
0%0.3
0%2.5
0%1.0
0%0.0
0%0.2
0%1.1
0%6.1
0%0.0
0%0.8
0%1.6
0%2.2
0%0.7
0%1.9
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
83:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
NE
GE
RI
SEM
BIL
AN
, AL
L R
ESI
DE
NT
S, M
AL
ES,
20
07-2
011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
163
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
4 18 42 8 3 2 38 5 1 31 75 517
214
3 7 49 13 36 2 712
2 1 16 7 34 1 0 17 883 3 1
190 96 27 168 2 1 10 0 0 10 0 1 33 43 0 0 19 72 0 11 25 44 7 23 -----
2528
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 0 0 4 2 2 0---
-- 12
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 2 0 0---
-- 10
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 2 0 0 0 0 2 0 0 10 1 0 0---
-- 17
15-
-
19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 2 0 0 3 1 0 0 0 5 1 0---
-- 19
20-
-
24 0 0 0 0 0 0 1 0 0 0 1 0 1 1 0 0 0 1 0 0 1 0 0 0 0 0 0 1 1 0 0 2 0 0 8 0 0 0 0 0 0 0 0 3 2 0 0 2 3 0 0 1 2 0 1---
-- 32
25-
-
29 0 1 0 3 0 0 0 0 0 0 1 0 2 0 1 2 0 0 0 0 4 0 0 0 0 0 0 0 15 0 0 2 0 0 6 0 0 1 0 0 0 0 0 1 1 0 0 7 1 0 0 1 3 0 1---
-- 53
30-
-
34 0 2 0 0 0 0 2 0 0 0 1 0 2 3 0 0 0 1 0 0 3 1 1 0 1 0 0 1 27 0 0 9 1 0 8 0 0 0 0 0 0 0 0 2 3 0 0 1 4 0 0 1 2 0 1---
-- 77
35-
-
39 0 0 0 0 0 0 1 0 0 0 4 0 2 1 0 0 1 1 0 0 3 0 0 0 0 0 0 2 52 0 0 12 3 0 8 1 0 1 0 0 0 0 0 0 4 0 0 1 2 0 0 1 2 1 1---
--10
4
40-
-
44 0 1 1 0 1 0 3 0 0 2 7 2 3 3 0 1 0 0 0 0 2 0 1 2 2 0 0 110
9 0 0 7 2 2 14 0 0 0 0 0 0 0 0 1 3 0 0 1 0 0 0 2 4 0 3---
--18
0
45-
-
49 0 2 1 1 0 0 9 0 0 0 6 1 7 18 0 4 2 4 0 0 14 0 0 0 1 0 0 216
0 1 0 24 14 3 25 0 0 0 0 0 1 0 0 2 4 0 0 0 7 0 1 0 4 0 1---
--31
9
50-
-
54 0 4 7 1 1 0 8 1 0 9 6 1 12 20 3 3 1 2 0 0 9 0 0 1 2 1 0 216
2 0 0 28 20 7 35 0 0 1 0 0 1 0 0 3 3 0 0 0 5 0 0 1 4 0 3---
--36
7
55-
-
59 2 0 4 0 0 0 7 1 0 4 10 0 24 16 1 7 1 4 0 2 16 0 5 2 4 0 0 113
6 1 0 35 25 4 18 0 1 1 0 0 0 0 1 4 7 0 0 0 11 0 3 1 3 0 3---
--36
5
60-
-
64 0 1 7 2 1 0 4 3 0 6 11 0 18 13 0 7 1 6 0 2 13 0 1 0 1 0 0 2 86 0 0 26 11 5 14 0 0 0 0 0 0 0 0 3 2 0 0 3 16 0 2 0 4 0 3---
--27
4
65-
-
69 0 2 4 1 0 1 0 0 0 4 11 0 25 28 0 11 2 5 1 0 15 0 2 1 8 0 0 0 54 0 0 18 8 1 13 1 0 1 0 0 1 0 0 5 5 0 0 1 6 0 2 1 1 2 1---
--24
2
70-
-
74 0 3 7 0 0 0 0 0 0 3 9 1 26 23 0 6 4 7 0 1 22 0 0 1 3 0 0 1 40 1 1 16 7 4 10 0 0 3 0 0 3 0 0 1 4 0 0 0 6 0 2 0 3 0 2---
--22
0
75+
2 2 11 0 0 1 3 0 0 3 8 0 50 17 2 7 1 5 1 2 20 0 2 0 11 0 0 3 41 0 0 11 5 1 3 0 0 2 0 0 4 0 0 1 3 0 0 0 8 0 1 0 2 1 3---
--23
7
% of
Total
0.20%
0.70%
1.70%
0.30%
0.10%
0.10%
1.50%
0.20%
0.00%
1.20%
3.00%
0.20%
6.80%
5.70%
0.30%
1.90%
0.50%
1.40%
0.10%
0.30%
4.80%
0.00%
0.60%
0.30%
1.30%
0.00%
0.00%
0.70%
34.90
%0.1
0%0.0
0%7.5
0%3.8
0%1.1
0%6.6
0%0.1
0%0.0
0%0.4
0%0.0
0%0.0
0%0.4
0%0.0
0%0.0
0%1.3
0%1.7
0%0.0
0%0.0
0%0.8
0%2.8
0%0.0
0%0.4
0%1.0
0%1.7
0%0.3
0%0.9
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
84:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
NE
GE
RI S
EM
BIL
AN
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
20
07-2
011
164
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
1 24 17 5 6 214
3 9 1 48 98 12 153
240 7
127 14 43 10 35 270 2 13 6 52 0 0 18 8 4
100 24 0 30 0 0 45 0 5 47 19 0 3 22 117 0 15 31 42 13 36 -----
1917
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 1.3 0.4 0 0 0 0 0.9 0 0 2.2 0 0.9 0---
-- 6
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0.8 0 0 0 0 1.6 0 0 1.2 0.4 0.4 0---
-- 5
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0.8 0.4 0 0 0 0 0 0 2.4 0.8 0.4 0---
-- 6
15-
-
19 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.8 0.4 0 0 0 0.4 0 0 0 0.4 0 0 0 0 0 0 0 0 0.4 0 0 1.2 0.8 0 0 1.2 0.8 0 0---
-- 7
20-
-
24 0 0.4 0 0 0 0 0 0 0 0 0 0.4 0 0.9 0 0.4 0 0 0 0 0 0 0.4 0 0 0 0 1.8 0 0 0 2.6 0 0 0 0 0 0 0 1.8 0.4 0 0 1.8 2.6 0 0 0.4 0.4 0.4 0.4 ----- 15
25-
-
29 0 0 0 0 0 0 1.6 0 0 0.5 0.5 0 0.5 0.5 0 1.6 0 0.5 0.5 0 0 0 0 0 0.5 0 0 0.5 0 0 0 2.7 0 0 0 0 0.5 0 0 0 0.5 0 0 2.2 2.2 0 0 1.6 0.5 0.5 0.5 ----- 19
30-
-
34 0 0 0 0 0 0 3.8 0 0 0 1.3 0.6 1.3 0.6 0 0 0 0.6 0 0 1.3 0 1.3 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0.6 0 2.5 0 0 0.6 0 0 0---
-- 16
35-
-
39 0 1.4 0 0.7 0 0 4.9 0 0 0.7 2.1 0 4.9 3.5 0 0.7 0 0 0.7 0 3.5 0 0 0 0.7 0 0 0 0 0 0 2.8 0 0 0 0 0.7 0 0 2.1 0 0 0 1.4 5.6 0 0 0 1.4 0 0---
-- 38
40-
-
44 0 1.4 0 0.7 0 012
.8 0 0 0 3.5 0 3.5 5 0 5.7 0.7 2.1 0.7 0.7 7.1 0.7 0 0.7 2.1 0 0 2.1 1.4 0 0 0 0 2.1 0 0 1.4 0 0 0.7 0.7 0 0.7 0 9.9 0 0 0 2.1 0 0---
-- 69
45-
-
49 0.7 1.4 0.7 0 0 021
.2 0 0 1.4 3.5 0.7 7.8 10.6 0 9.9 0.7 2.1 0 2.8 9.2 0 1.4 0 1.4 0 0 1.4 1.4 0 0 2.8 0 2.1 0 0 0.7 0 0 6.4 0.7 0 0 0 6.4 0 2.8 1.4 2.8 0 1.4 -----
106
50-
-
54 0 3 2.3 0.8 0 019
.6 1.5 0 5.3 6.8 1.5 12 15 0 12 1.5 6 1.5 1.5 21.8 0.8 0 0 3.8 0 0 0 1.5 0 3 0 0 3 0 0 2.3 0 0 3 0 0 0 1.5 9 0 1.5 2.3 4.5 1.5 4.5 -----
154
55-
-
59 0 1.8 3.6 0 1.8 0.9 14.4 0 0.9 10.8 7.2 0.9 18 27.9 0 18 0.9 7.2 0.9 6.3 31.5 0 0 1.8 6.3 0 0 0.9 0 0.9 8.1 0 0 5.4 0 0 3.6 0 0 4.5 4.5 0 0 1.8 16.2 0 1.8 0.9 1.8 0 1.8 -----
214
60-
-
64 0 6.5 5.2 1.3 1.3 1.3 16.9 2.6 0 9.1 14.3 0
33.8
49.4 2.6 26 5.2 11.7 1.3 11.7
45.5 0 0 0 7.8 0 0 0 0 1.3 16.9 2.6 0 2.6 0 0 7.8 0 0 3.9 0 0 0 2.6 15.6 0 5.2 1.3 9.1 1.3 10.4 -----
334
65-
-
69 0 4 0 0 0 027
.7 9.9 017
.833
.7 5.9 35.6 101 4
21.8 4 5.9 4
11.9
91.1 0 4 4 9.9 0 0 4 0 0
55.5 0 0 7.9 0 0 9.9 0 0 5.9 4 0 2 2
15.8 0 4 2 7.9 5.9 7.9 -----
531
70-
-
74 0 2.5 2.5 0 2.5 0 15 0 0 537
.5 2.5 70 82.5 5 40 7.5 7.5 2.5 5
102.5 0 0 0 15 0 0 7.5 0 0 65 0 0 10 0 0
17.5 0 2.5 10 10 0 0 0
12.5 0 0 0 7.5 2.5 15 -----
565
75+
0 7.5 10 2.5 5 0 7.5 0 017
.5 55 547
.5 90 2.5 42.5 0 10 0 10 135 0 5 0 40 0 0 0 5 5 50 2.5 0 7.5 0 0
37.5 0 0
12.5 5 0 0 5
22.5 0 2.5 2.5 10 0 15 -----
675
Crud
eRa
te 0 1 0.7 0.2 0.2 0.1 5.9 0.4 0 2 4 0.5 6.3 9.9 0.3 5.2 0.6 1.8 0.4 1.4 11.1 0.1 0.5 0.2 2.1 0 0 0.7 0.3 0.2 4.1 1 0 1.2 0 0 1.9 0 0.2 1.9 0.8 0 0.1 0.9 4.8 0 0.6 1.3 1.7 0.5 1.5 ----- 79
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
85:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, N
EG
ER
I SE
MB
ILA
N, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011 AS
RW
orld 0 1.1 0.8 0.2 0.3 0.1 6.2 0.5 0 2.2 4.7 0.6 7.2 11.6 0.4 5.8 0.7 1.9 0.5 1.7 12.9 0.1 0.6 0.3 2.4 0 0 0.8 0.3 0.2 5.1 1 0 1.4 0 0 2.2 0 0.2 2 0.8 0 0.1 0.9 5.1 0 0.7 1.3 1.9 0.6 1.7 -----
89.2
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
165
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
4 18 42 8 3 2 38 5 1 31 75 517
214
3 7 49 13 36 2 712
2 1 16 7 34 1 0 17 883 3 1
190 96 27 168 2 1 10 0 0 10 0 1 33 43 0 0 19 72 0 11 25 44 7 23 -----
2528
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.4 0 0 0 0 0 0 0 1.9 1 1 0---
-- 6
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0.4 0 0 0.4 0 0 0 0 0 0 0.9 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 0 0.9 0.9 0 0---
-- 4
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0 0 0 0 0.9 0 0 0 0 0.9 0 0 4.3 0.4 0 0---
-- 7
15-
-
19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.4 0 0 0 0 0 0 1.2 0 0 0 0 0 0 0 0 0 0 0 0.8 0 0 0 0 0 0 0 0 0.4 0.8 0 0 1.2 0.4 0 0 0 2.1 0.4 0---
-- 8
20-
-
24 0 0 0 0 0 0 0.5 0 0 0 0.5 0 0.5 0.5 0 0 0 0.5 0 0 0.5 0 0 0 0 0 0 0.5 0.5 0 0 0.9 0 0 3.7 0 0 0 0 0 0 0 0 1.4 0.9 0 0 0.9 1.4 0 0 0.5 0.9 0 0.5 ----- 15
25-
-
29 0 0.6 0 1.7 0 0 0 0 0 0 0.6 0 1.1 0 0.6 1.1 0 0 0 0 2.3 0 0 0 0 0 0 0 8.6 0 0 1.1 0 0 3.4 0 0 0.6 0 0 0 0 0 0.6 0.6 0 0 4 0.6 0 0 0.6 1.7 0 0.6 ----- 30
30-
-
34 0 1.3 0 0 0 0 1.3 0 0 0 0.6 0 1.3 1.9 0 0 0 0.6 0 0 1.9 0.6 0.6 0 0.6 0 0 0.6 17.5 0 0 5.8 0.6 0 5.2 0 0 0 0 0 0 0 0 1.3 1.9 0 0 0.6 2.6 0 0 0.6 1.3 0 0.6 ----- 50
35-
-
39 0 0 0 0 0 0 0.7 0 0 0 2.7 0 1.4 0.7 0 0 0.7 0.7 0 0 2 0 0 0 0 0 0 1.4 35.5 0 0 8.2 2 0 5.5 0.7 0 0.7 0 0 0 0 0 0 2.7 0 0 0.7 1.4 0 0 0.7 1.4 0.7 0.7 ----- 71
40-
-
44 0 0.7 0.7 0 0.7 0 2 0 0 1.3 4.7 1.3 2 2 0 0.7 0 0 0 0 1.3 0 0.7 1.3 1.3 0 0 0.7 72.7 0 0 4.7 1.3 1.3 9.3 0 0 0 0 0 0 0 0 0.7 2 0 0 0.7 0 0 0 1.3 2.7 0 2
-----
120
45-
-
49 0 1.4 0.7 0.7 0 0 6.1 0 0 0 4.1 0.7 4.7 12.2 0 2.7 1.4 2.7 0 0 9.5 0 0 0 0.7 0 0 1.4
108.5 0.7 0
16.3 9.5 2 17 0 0 0 0 0 0.7 0 0 1.4 2.7 0 0 0 4.7 0 0.7 0 2.7 0 0.7 -----
216
50-
-
54 0 2.9 5.1 0.7 0.7 0 5.9 0.7 0 6.6 4.4 0.7 8.8 14.7 2.2 2.2 0.7 1.5 0 0 6.6 0 0 0.7 1.5 0.7 0 1.5
118.7 0 0
20.5
14.7 5.1 25.6 0 0 0.7 0 0 0.7 0 0 2.2 2.2 0 0 0 3.7 0 0 0.7 2.9 0 2.2 -----
269
55-
-
59 1.9 0 3.8 0 0 0 6.6 0.9 0 3.8 9.4 022
.5 15 0.9 6.6 0.9 3.8 0 1.9 15 0 4.7 1.9 3.8 0 0 0.912
7.7 0.9 032
.923
.5 3.8 16.9 0 0.9 0.9 0 0 0 0 0.9 3.8 6.6 0 0 0
10.3 0 2.8 0.9 2.8 0 2.8 -----
343
60-
-
64 0 1.3 9.3 2.6 1.3 0 5.3 4 0 7.9 14.6 0
23.8
17.2 0 9.3 1.3 7.9 0 2.6 17.2 0 1.3 0 1.3 0 0 2.6
113.9 0 0
34.4
14.6 6.6 18.5 0 0 0 0 0 0 0 0 4 2.6 0 0 4
21.2 0 2.6 0 5.3 0 4
-----
363
65-
-
69 0 3.9 7.8 1.9 0 1.9 0 0 0 7.8 21.4 0
48.6
54.4 0
21.4 3.9 9.7 1.9 0
29.1 0 3.9 1.9 15.5 0 0 0
104.9 0 0 35 15.5 1.9 25.2 1.9 0 1.9 0 0 1.9 0 0 9.7 9.7 0 0 1.9 11.7 0 3.9 1.9 1.9 3.9 1.9 -----
470
70-
-
74 0 6.8 15.9 0 0 0 0 0 0 6.8 20.5 2.3 59.1
52.3 0
13.6 9.1 15.9 0 2.3 50 0 0 2.3 6.8 0 0 2.3 90.9 2.3 2.3 36.4
15.9 9.1 22.7 0 0 6.8 0 0 6.8 0 0 2.3 9.1 0 0 0
13.6 0 4.5 0 6.8 0 4.5 -----
500
75+
4 422
.2 0 0 2 6.1 0 0 6.1 16.2 0
101
34.3 4
14.1 2
10.1 2 4
40.4 0 4 0
22.2 0 0 6.1 82.8 0 0
22.2
10.1 2 6.1 0 0 4 0 0 8.1 0 0 2 6.1 0 0 0
16.2 0 2 0 4 2 6.1 -----
479
Crud
eRa
te 0.2 0.8 1.8 0.3 0.1 0.1 1.6 0.2 0 1.3 3.2 0.2 7.3 6 0.3 2.1 0.5 1.5 0.1 0.3 5.2 0 0.7 0.3 1.4 0 0 0.7 37.4 0.1 0 8 4.1 1.1 7.1 0.1 0 0.4 0 0 0.4 0 0 1.4 1.8 0 0 0.8 3 0 0.5 1.1 1.9 0.3 1
-----
107
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
86:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, N
EG
ER
I SE
MB
ILA
N, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011
ASR
Wor
ld 0.2 0.8 1.9 0.4 0.1 0.1 1.5 0.2 0.1 1.4 3.4 0.2 7.6 6.4 0.3 2.3 0.6 1.6 0.1 0.3 5.4 0 0.7 0.3 1.5 0 0 0.7 37 0.1 0 8.2 4.1 1.2 7.1 0.1 0 0.4 0 0 0.4 0 0 1.5 1.8 0 0 0.8 3.2 0 0.5 1.1 1.9 0.4 1---
--10
8.9
166
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
1 21 6 12 6 011
2 11 1 12 65 414
414
9 512
6 14 46 13 30 343 3 16 3 52 1 0 25 6 4
101 21 0 37 1 1 63 2 3 34 25 3 4 37 108 0 12 44 62 12 10 -----
1811
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 0 1 3 0 1 0 0 0 0 0 15 2 3 0---
-- 29
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 3 0 0 5 2 0 0---
-- 12
10-
-
14 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 1 1 4 1 0 0 2 5 0 0---
-- 22
15-
-
19 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 0 0 0 5 0 0 0 3 2 2 0---
-- 19
20-
-
24 0 0 0 1 0 0 1 0 0 0 1 0 0 1 0 0 0 0 0 0 1 0 2 0 0 0 0 0 0 0 0 5 0 0 0 0 0 0 0 1 2 0 0 3 2 0 1 2 4 0 0---
-- 27
25-
-
29 0 0 1 1 0 0 1 0 0 0 1 0 0 0 0 2 0 0 0 0 0 0 3 0 1 0 0 2 0 0 0 4 0 0 0 0 0 0 0 1 1 1 0 3 3 0 0 4 3 0 0---
-- 32
30-
-
34 0 1 0 1 0 0 5 0 0 0 0 1 3 3 0 1 0 1 0 1 2 0 0 0 2 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 3 2 0 0 2 5 1 0---
-- 36
35-
-
39 0 0 0 1 0 0 12 0 0 1 2 0 4 1 1 3 0 0 0 0 7 1 1 0 1 0 0 1 0 0 0 2 0 0 0 1 0 0 0 1 4 0 0 4 6 0 1 1 6 1 0---
-- 63
40-
-
44 1 2 0 1 0 0 12 0 0 0 2 0 7 8 1 8 0 0 1 1 10 0 1 0 1 0 0 0 1 1 2 3 0 1 0 0 1 0 0 3 3 0 0 1 10 0 0 3 3 0 1---
-- 89
45-
-
49 0 1 1 0 0 0 13 2 0 0 2 0 5 15 1 10 1 3 5 1 16 0 0 1 0 0 0 6 0 0 0 2 0 2 0 0 4 0 0 0 3 0 1 1 9 0 1 1 2 1 1---
--11
1
50-
-
54 0 3 0 2 1 0 16 1 0 1 7 1 12 17 1 24 1 5 3 5 30 0 1 1 4 0 0 0 2 0 1 0 0 1 0 0 7 0 0 7 2 0 1 4 13 0 2 0 7 1 0---
--18
4
55-
-
59 0 4 2 3 0 0 20 2 0 1 7 1 23 26 0 19 5 12 2 4 44 0 0 1 7 0 0 2 0 3 2 0 0 4 0 0 7 0 0 7 3 0 0 3 21 0 1 1 6 1 3---
--24
7
60-
-
64 0 2 0 0 1 0 13 1 0 0 7 0 23 26 0 16 3 9 1 5 58 0 2 0 7 1 0 3 1 0 20 1 0 8 0 0 13 1 0 0 2 0 0 2 11 0 1 2 4 0 0---
--24
4
65-
-
69 0 2 0 0 1 0 6 2 0 1 6 0 17 23 0 15 1 5 1 4 49 0 2 0 8 0 0 4 0 0 19 0 0 9 1 0 9 1 1 3 1 0 0 1 11 0 2 2 4 0 2---
--21
3
70-
-
74 0 3 2 2 0 0 4 2 1 6 14 0 20 17 1 13 1 8 0 2 58 0 0 0 7 0 0 3 1 0 20 0 0 6 0 0 7 0 0 2 2 0 0 3 7 0 2 1 3 0 1---
--21
9
75+
0 3 0 0 3 0 6 1 0 2 16 1 30 12 0 13 2 3 0 7 68 1 0 0 13 0 0 2 1 0 37 2 0 4 0 0 14 0 0 2 2 0 1 0 9 0 1 0 4 2 2---
--26
4
% of
Total 0.1
0%1.2
0%0.3
0%0.7
0%0.3
0%0.0
0%6.2
0%0.6
0%0.1
0%0.7
0%3.6
0%0.2
0%8.0
0%8.2
0%0.3
0%7.0
0%0.8
0%2.5
0%0.7
0%1.7
0%18
.90%
0.20%
0.90%
0.20%
2.90%
0.10%
0.00%
1.40%
0.30%
0.20%
5.60%
1.20%
0.00%
2.00%
0.10%
0.10%
3.50%
0.10%
0.20%
1.90%
1.40%
0.20%
0.20%
2.00%
6.00%
0.00%
0.70%
2.40%
3.40%
0.70%
0.60% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
87:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
ME
LA
KA
, AL
L R
ESI
DE
NT
S, M
AL
ES,
200
7-20
11
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
167
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
2 9 14 9 2 1 53 3 2 7 58 315
3 93 5 35 18 39 5 3 92 3 16 7 33 2 0 22 731 5 5
162
109 19 161 2 3 12 0 0 13 0 0 27 62 3 3 19 78 2 18 18 58 7 8
-----
2214
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 0 0 6 4 3 1---
-- 21
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 4 0 0 0 0 0 0 0 3 1 1 0---
-- 13
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 2 1 0 0---
-- 7
15-
-
19 0 0 0 1 0 0 2 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 4 0 2 0 0 2 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 1 2 0 0 1 0 0 0 1 2 1 0---
-- 27
20-
-
24 0 0 0 1 0 0 3 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 3 0 0 0 0 0 3 0 1 1 0 0 0 0 0 0 3 0 0 4 5 0 0 1 4 1 0---
-- 33
25-
-
29 0 0 0 1 0 0 1 1 0 0 4 0 1 1 0 1 0 0 0 0 1 0 1 0 0 0 0 0 9 0 0 0 0 0 10 0 1 0 0 0 0 0 0 0 6 0 0 3 6 0 0 1 3 0 0---
-- 51
30-
-
34 0 0 0 1 0 0 0 0 0 0 0 0 4 2 0 0 2 1 0 0 1 0 0 0 0 0 0 0 19 0 0 5 2 0 7 0 0 0 0 0 0 0 0 1 6 0 0 1 3 0 0 0 4 0 0---
-- 59
35-
-
39 0 0 0 1 0 0 6 0 0 0 0 0 2 1 0 0 1 3 1 0 1 0 0 0 0 0 0 0 39 0 0 9 3 2 12 0 1 0 0 0 0 0 0 1 5 0 1 0 2 0 0 1 6 0 0---
-- 98
40-
-
44 0 1 0 1 0 0 9 0 0 1 3 0 4 8 0 1 0 1 0 0 5 0 1 2 2 0 0 3 75 0 1 17 8 0 15 0 0 1 0 0 0 0 0 4 3 0 0 1 5 0 1 1 4 0 0---
--17
8
45-
-
49 0 2 1 1 0 0 4 0 0 0 1 0 6 5 0 3 0 2 0 0 3 0 2 2 1 0 0 513
2 1 3 22 15 6 26 1 0 1 0 0 0 0 0 4 7 0 1 2 8 0 1 0 5 0 1---
--27
4
50-
-
54 0 1 5 0 1 0 8 0 0 1 3 0 15 12 1 3 3 4 1 0 12 1 0 0 3 0 0 311
6 0 1 26 25 5 17 1 0 1 0 0 0 0 0 0 7 0 1 2 9 0 5 1 7 1 1---
--30
3
55-
-
59 0 1 2 0 0 1 7 0 1 1 7 2 23 14 2 5 1 3 1 1 6 1 0 0 1 0 0 212
3 1 0 30 24 3 27 0 0 1 0 0 6 0 0 2 2 0 0 3 10 1 1 0 3 0 1---
--32
0
60-
-
64 0 2 1 1 0 0 5 1 0 1 8 0 23 10 0 5 0 3 0 1 9 0 0 0 3 0 0 110
6 0 0 23 15 1 21 0 0 2 0 0 0 0 0 2 5 1 0 1 7 0 4 0 2 0 0---
--26
4
65-
-
69 1 0 1 1 0 0 4 0 0 0 9 0 18 10 1 2 3 7 1 0 17 1 1 0 4 0 0 2 49 0 0 10 7 1 7 0 0 2 0 0 2 0 0 4 4 0 0 0 8 0 0 0 8 0 1---
--18
6
70-
-
74 0 0 2 0 0 0 3 0 0 1 9 0 23 14 0 5 2 8 0 0 16 0 2 1 9 1 0 0 34 2 0 12 3 1 6 0 0 1 0 0 2 0 0 1 6 0 0 0 6 0 5 1 2 0 0---
--17
8
75+
1 2 2 0 1 0 1 1 1 2 13 1 31 16 1 8 6 7 0 1 21 0 2 1 8 1 0 2 26 1 0 8 7 0 3 0 0 1 0 0 2 0 0 2 6 0 0 1 8 1 1 0 2 0 3---
--20
2
% of
Total
0.10%
0.40%
0.60%
0.40%
0.10%
0.00%
2.40%
0.10%
0.10%
0.30%
2.60%
0.10%
6.90%
4.20%
0.20%
1.60%
0.80%
1.80%
0.20%
0.10%
4.20%
0.10%
0.70%
0.30%
1.50%
0.10%
0.00%
1.00%
33.00
%0.2
0%0.2
0%7.3
0%4.9
0%0.9
0%7.3
0%0.1
0%0.1
0%0.5
0%0.0
0%0.0
0%0.6
0%0.0
0%0.0
0%1.2
0%2.8
0%0.1
0%0.1
0%0.9
0%3.5
0%0.1
0%0.8
0%0.8
0%2.6
0%0.3
0%0.4
0% -----
100.0
0%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
88:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
ME
LA
KA
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
200
7-20
11
168
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
1 21 6 12 6 011
2 11 1 12 65 414
414
9 512
6 14 46 13 30 343 3 16 3 52 1 0 25 6 4
101 21 0 37 1 1 63 2 3 34 25 3 4 37 108 0 12 44 62 12 10 -----
1811
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 1.1 0 0 0 0 0 0 0 0 0.6 0 0.6 1.7 0 0.6 0 0 0 0 0 8.6 1.1 1.7 0---
-- 17
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0.5 0 0 0 0 1.6 0 0 2.6 1.1 0 0---
-- 6
10-
-
14 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0.5 0 0.5 0.5 2 0.5 0 0 1 2.4 0 0---
-- 11
15-
-
19 0 0 0 0 0 0 0.9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0.5 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0.9 0 0 0 2.3 0 0 0 1.4 0.9 0.9 0---
-- 9
20-
-
24 0 0 0 0.6 0 0 0.6 0 0 0 0.6 0 0 0.6 0 0 0 0 0 0 0.6 0 1.1 0 0 0 0 0 0 0 0 2.9 0 0 0 0 0 0 0 0.6 1.1 0 0 1.7 1.1 0 0.6 1.1 2.3 0 0---
-- 15
25-
-
29 0 0 0.7 0.7 0 0 0.7 0 0 0 0.7 0 0 0 0 1.3 0 0 0 0 0 0 2 0 0.7 0 0 1.3 0 0 0 2.7 0 0 0 0 0 0 0 0.7 0.7 0.7 0 2 2 0 0 2.7 2 0 0---
-- 22
30-
-
34 0 0.8 0 0.8 0 0 4.2 0 0 0 0 0.8 2.5 2.5 0 0.8 0 0.8 0 0.8 1.7 0 0 0 1.7 0 0 0 0 0 0 0 0 1.7 0 0 0 0 0 0 0 0 0 2.5 1.7 0 0 1.7 4.2 0.8 0---
-- 30
35-
-
39 0 0 0 0.9 0 010
.4 0 0 0.9 1.7 0 3.5 0.9 0.9 2.6 0 0 0 0 6.1 0.9 0.9 0 0.9 0 0 0.9 0 0 0 1.7 0 0 0 0.9 0 0 0 0.9 3.5 0 0 3.5 5.2 0 0.9 0.9 5.2 0.9 0---
-- 55
40-
-
44 0.9 1.7 0 0.9 0 010
.5 0 0 0 1.7 0 6.1 7 0.9 7 0 0 0.9 0.9 8.7 0 0.9 0 0.9 0 0 0 0.9 0.9 1.7 2.6 0 0.9 0 0 0.9 0 0 2.6 2.6 0 0 0.9 8.7 0 0 2.6 2.6 0 0.9 ----- 78
45-
-
49 0 0.9 0.9 0 0 011
.1 1.7 0 0 1.7 0 4.3 12.8 0.9 8.5 0.9 2.6 4.3 0.9 13.6 0 0 0.9 0 0 0 5.1 0 0 0 1.7 0 1.7 0 0 3.4 0 0 0 2.6 0 0.9 0.9 7.7 0 0.9 0.9 1.7 0.9 0.9 ----- 94
50-
-
54 0 3 0 2 1 016
.2 1 0 1 7.1 112
.217
.3 124
.4 1 5.1 3 5.1 30.5 0 1 1 4.1 0 0 0 2 0 1 0 0 1 0 0 7.1 0 0 7.1 2 0 1 4.1 13.2 0 2 0 7.1 1 0
-----
187
55-
-
59 0 5 2.5 3.7 0 024
.8 2.5 0 1.2 8.7 1.2 28.6
32.3 0
23.6 6.2 14.9 2.5 5
54.7 0 0 1.2 8.7 0 0 2.5 0 3.7 2.5 0 0 5 0 0 8.7 0 0 8.7 3.7 0 0 3.7 26.1 0 1.2 1.2 7.5 1.2 3.7 -----
307
60-
-
64 0 3.2 0 0 1.6 020
.6 1.6 0 011
.1 036
.541
.3 025
.4 4.8 14.3 1.6 7.9 92.1 0 3.2 0
11.1 1.6 0 4.8 1.6 0
31.8 1.6 0
12.7 0 0
20.6 1.6 0 0 3.2 0 0 3.2 17.5 0 1.6 3.2 6.4 0 0
-----
387
65-
-
69 0 5 0 0 2.5 0 15 5 0 2.5 15 042
.557
.5 037
.5 2.5 12.5 2.5 10
122.5 0 5 0 20 0 0 10 0 0
47.5 0 0
22.5 2.5 0
22.5 2.5 2.5 7.5 2.5 0 0 2.5 27.5 0 5 5 10 0 5
-----
533
70-
-
74 0 9 6 6 0 011
.9 6 317
.941
.8 059
.750
.8 338
.8 323
.9 0 617
3.2 0 0 020
.9 0 0 9 3 059
.7 0 017
.9 0 020
.9 0 0 6 6 0 0 920
.9 0 6 3 9 0 3---
--65
4
75+
0 9 0 0 9 017
.9 3 0 647
.8 389
.635
.8 038
.8 6 9 020
.9 203 3 0 0
38.8 0 0 6 3 0
110.5 6 0
11.9 0 0
41.8 0 0 6 6 0 3 0
26.9 0 3 0
11.9 6 6
-----
788
Crud
eRa
te 0.1 1.1 0.3 0.6 0.3 0 5.8 0.6 0.1 0.6 3.4 0.2 7.5 7.8 0.3 6.6 0.7 2.4 0.7 1.6 17.8 0.2 0.8 0.2 2.7 0.1 0 1.3 0.3 0.2 5.3 1.1 0 1.9 0.1 0.1 3.3 0.1 0.2 1.8 1.3 0.2 0.2 1.9 5.6 0 0.6 2.3 3.2 0.6 0.5 -----
94.2
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
89:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, M
EL
AK
A, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011
ASR
Wor
ld 0.1 1.2 0.3 0.6 0.4 0 6.1 0.6 0.1 0.7 3.8 0.2 8.5 8.7 0.3 7.2 0.8 2.7 0.7 1.8 20.4 0.2 0.9 0.2 3.1 0.1 0 1.5 0.3 0.2 6.4 1.1 0 2.3 0.1 0.1 3.8 0.1 0.2 1.9 1.4 0.2 0.2 1.9 6 0 0.7 2.6 3.3 0.7 0.6 -----
104.7
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
169
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
2 9 14 9 2 1 53 3 2 7 58 315
3 93 5 35 18 39 5 3 92 3 16 7 33 2 0 22 731 5 5
162
109 19 161 2 3 12 0 0 13 0 0 27 62 3 3 19 78 2 18 18 58 7 8
-----
2214
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.2 0 0 0.6 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 1.2 0 0 0 0 0 3.6 2.4 1.8 0.6 ----- 13
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 1.1 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 2.3 0 0 0 0 0 0 0 1.7 0.6 0.6 0---
-- 7
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0 0 0 0 0.6 0 0 0 0 0.6 0 0 1.1 0.6 0 0---
-- 4
15-
-
19 0 0 0 0.4 0 0 0.9 0 0 0 0.4 0 0.4 0 0 0 0 0 0 0 0 0 1.8 0 0.9 0 0 0.9 0 0 0 0 0 0 2.7 0 0 0 0 0 0 0 0 0.4 0.9 0 0 0.4 0 0 0 0.4 0.9 0.4 0---
-- 12
20-
-
24 0 0 0 0.5 0 0 1.6 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0.5 0 0 0 0 1.6 0 0 0 0 0 1.6 0 0.5 0.5 0 0 0 0 0 0 1.6 0 0 2.1 2.6 0 0 0.5 2.1 0.5 0---
-- 17
25-
-
29 0 0 0 0.6 0 0 0.6 0.6 0 0 2.4 0 0.6 0.6 0 0.6 0 0 0 0 0.6 0 0.6 0 0 0 0 0 5.4 0 0 0 0 0 6 0 0.6 0 0 0 0 0 0 0 3.6 0 0 1.8 3.6 0 0 0.6 1.8 0 0---
-- 31
30-
-
34 0 0 0 0.8 0 0 0 0 0 0 0 0 3.1 1.5 0 0 1.5 0.8 0 0 0.8 0 0 0 0 0 0 014
.7 0 0 3.9 1.5 0 5.4 0 0 0 0 0 0 0 0 0.8 4.6 0 0 0.8 2.3 0 0 0 3.1 0 0---
-- 46
35-
-
39 0 0 0 0.9 0 0 5.2 0 0 0 0 0 1.7 0.9 0 0 0.9 2.6 0.9 0 0.9 0 0 0 0 0 0 033
.6 0 0 7.8 2.6 1.7 10.3 0 0.9 0 0 0 0 0 0 0.9 4.3 0 0.9 0 1.7 0 0 0.9 5.2 0 0
----- 84
40-
-
44 0 0.8 0 0.8 0 0 6.8 0 0 0.8 2.3 0 3 6 0 0.8 0 0.8 0 0 3.8 0 0.8 1.5 1.5 0 0 2.3 56.4 0 0.8 12.8 6 0
11.3 0 0 0.8 0 0 0 0 0 3 2.3 0 0 0.8 3.8 0 0.8 0.8 3 0 0
-----
134
45-
-
49 0 1.7 0.8 0.8 0 0 3.3 0 0 0 0.8 0 5 4.1 0 2.5 0 1.7 0 0 2.5 0 1.7 1.7 0.8 0 0 4.110
9.1 0.8 2.5 18.2
12.4 5
21.5 0.8 0 0.8 0 0 0 0 0 3.3 5.8 0 0.8 1.7 6.6 0 0.8 0 4.1 0 0.8 -----
226
50-
-
54 0 0.9 4.6 0 0.9 0 7.4 0 0 0.9 2.8 013
.811
.1 0.9 2.8 2.8 3.7 0.9 011
.1 0.9 0 0 2.8 0 0 2.810
6.9 0 0.9 24 23 4.6 15.7 0.9 0 0.9 0 0 0 0 0 0 6.5 0 0.9 1.8 8.3 0 4.6 0.9 6.5 0.9 0.9 -----
279
55-
-
59 0 1.1 2.3 0 0 1.1 7.9 0 1.1 1.1 7.9 2.3 26 15.8 2.3 5.7 1.1 3.4 1.1 1.1 6.8 1.1 0 0 1.1 0 0 2.3 139 1.1 0
33.9
27.1 3.4 30.5 0 0 1.1 0 0 6.8 0 0 2.3 2.3 0 0 3.4 11.3 1.1 1.1 0 3.4 0 1.1 -----
362
60-
-
64 0 2.6 1.3 1.3 0 0 6.6 1.3 0 1.3 10.5 0
30.3
13.2 0 6.6 0 3.9 0 1.3 11.8 0 0 0 3.9 0 0 1.3
139.5 0 0
30.3
19.7 1.3 27.6 0 0 2.6 0 0 0 0 0 2.6 6.6 1.3 0 1.3 9.2 0 5.3 0 2.6 0 0
-----
347
65-
-
69 2 0 2 2 0 0 8 0 0 0 18 0 36 20 2 4 6 14 2 0 34 2 2 0 8 0 0 4 98 0 0 20 14 2 14 0 0 4 0 0 4 0 0 8 8 0 0 0 16 0 0 0 16 0 2---
--37
2
70-
-
74 0 0 5.3 0 0 0 7.9 0 0 2.6 23.7 0
60.5
36.8 0
13.2 5.3 21.1 0 0
42.1 0 5.3 2.6 23.7 2.6 0 0
89.5 5.3 0
31.6 7.9 2.6 15.8 0 0 2.6 0 0 5.3 0 0 2.6 15.8 0 0 0
15.8 0
13.2 2.6 5.3 0 0
-----
468
75+ 2.1 4.1 4.1 0 2.1 0 2.1 2.1 2.1 4.1 26
.8 2.1 63.9 33 2.1 16.5
12.4
14.4 0 2.1 43.3 0 4.1 2.1 16.5 2.1 0 4.1 53.6 2.1 0
16.5
14.4 0 6.2 0 0 2.1 0 0 4.1 0 0 4.1 12.4 0 0 2.1 16.5 2.1 2.1 0 4.1 0 6.2 -----
417
Crud
eRa
te 0.1 0.4 0.7 0.4 0.1 0 2.6 0.1 0.1 0.3 2.9 0.1 7.6 4.6 0.2 1.7 0.9 1.9 0.2 0.1 4.6 0.1 0.8 0.3 1.6 0.1 0 1.1 36.4 0.2 0.2 8.1 5.4 0.9 8 0.1 0.1 0.6 0 0 0.6 0 0 1.3 3.1 0.1 0.1 0.9 3.9 0.1 0.9 0.9 2.9 0.3 0.4 -----
110.2
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
90:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, M
EL
AK
A, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011
ASR
Wor
ld 0.1 0.4 0.7 0.4 0.1 0 2.6 0.1 0.1 0.3 2.8 0.1 7.4 4.5 0.2 1.7 0.9 2 0.3 0.1 4.5 0.2 0.8 0.3 1.6 0.1 0 1.1 35.7 0.2 0.2 7.9 5.2 0.9 7.8 0.1 0.1 0.6 0 0 0.7 0 0 1.4 3 0.2 0.1 0.9 3.8 0.1 0.9 1 2.9 0.4 0.4 -----
108.2
170
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
0 4 1 0 0 3 23 2 0 8 12 2 34 34 1 20 2 13 3 11 69 1 3 1 5 1 0 3 2 1 24 3 0 7 0 0 26 0 0 9 7 0 0 9 15 0 7 10 16 6 7---
--40
5
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 5 1 2 0---
-- 10
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0---
-- 3
10-
-
14 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0---
-- 3
15-
-
19 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 2 0 0---
-- 6
20-
-
24 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0---
-- 9
25-
-
29 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0---
-- 2
30-
-
34 0 0 0 0 0 0 1 0 0 0 0 0 0 2 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0---
-- 7
35-
-
39 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 2 0 0---
-- 7
40-
-
44 0 0 0 0 0 0 1 0 0 0 0 0 3 0 0 0 0 2 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 1 0 0---
-- 12
45-
-
49 0 0 0 0 0 1 5 0 0 0 0 2 4 4 0 4 0 2 1 2 4 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 4 0 0 0 1 0 0 0 2 0 0 0 0 0 0---
-- 37
50-
-
54 0 0 1 0 0 0 0 0 0 1 1 0 3 2 0 4 0 4 1 0 5 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 2 0 0 1 0 0 0 1 1 0 0 0 3 0 0---
-- 32
55-
-
59 0 2 0 0 0 0 6 1 0 0 0 0 6 4 0 3 0 1 0 2 6 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 0 0 2 0 2 0 3 0 0---
-- 42
60-
-
64 0 0 0 0 0 1 0 0 0 1 1 0 5 3 0 3 0 1 1 4 10 0 1 0 1 0 0 0 0 0 1 0 0 0 0 0 4 0 0 1 2 0 0 1 2 0 2 2 0 1 3---
-- 51
65-
-
69 0 1 0 0 0 0 4 0 0 1 2 0 6 9 0 3 1 1 0 1 12 0 0 0 1 0 0 2 1 1 5 1 0 2 0 0 4 0 0 1 1 0 0 1 2 0 0 1 1 0 0---
-- 65
70-
-
74 0 0 0 0 0 0 2 0 0 2 3 0 3 5 0 1 1 1 0 1 14 0 0 1 1 0 0 0 0 0 7 0 0 1 0 0 6 0 0 0 2 0 0 4 3 0 1 0 1 0 2---
-- 62
75+
0 1 0 0 0 1 1 1 0 3 5 0 4 3 1 1 0 1 0 1 12 0 0 0 2 1 0 1 0 0 7 0 0 0 0 0 5 0 0 0 0 0 0 0 1 0 1 1 0 1 2---
-- 57
% of
Total 0.0
0%1.0
0%0.2
0%0.0
0%0.0
0%0.7
0%5.7
0%0.5
0%0.0
0%2.0
0%3.0
0%0.5
0%8.4
0%8.4
0%0.2
0%4.9
0%0.5
0%3.2
0%0.7
0%2.7
0%17
.00%
0.20%
0.70%
0.20%
1.20%
0.20%
0.00%
0.70%
0.50%
0.20%
5.90%
0.70%
0.00%
1.70%
0.00%
0.00%
6.40%
0.00%
0.00%
2.20%
1.70%
0.00%
0.00%
2.20%
3.70%
0.00%
1.70%
2.50%
4.00%
1.50%
1.70% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
91:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
PE
RL
IS, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
171
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
1 9 4 5 3 0 3 0 1 3 6 0 29 18 0 11 4 8 4 3 27 1 0 3 4 0 0 415
1 2 1 55 20 13 23 1 1 4 0 0 4 0 1 14 20 1 0 8 5 0 5 4 3 4 4---
--49
5
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 0 0 0 1 0 0 1 0 3 0---
-- 9
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0---
-- 2
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0---
-- 2
15-
-
19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 1 1 0 0 2 0 0 0 0 0 0 0---
-- 6
20-
-
24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0---
-- 4
25-
-
29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 3 0 0 1 0 0 0 0 0 0 0---
-- 8
30-
-
34 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 1 1 1 1 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 1---
-- 14
35-
-
39 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 13 0 0 5 1 2 0 0 0 3 0 0 0 0 0 0 3 0 0 0 0 0 0 0 0 0 0---
-- 28
40-
-
44 0 1 0 1 0 0 0 0 0 0 0 0 0 2 0 1 0 1 0 0 0 1 0 0 0 0 0 0 18 0 0 7 0 0 1 0 0 0 0 0 1 0 0 1 3 0 0 1 0 0 0 0 0 0 0---
-- 39
45-
-
49 0 0 1 1 0 0 2 0 0 0 0 0 2 1 0 1 0 0 0 1 2 0 0 0 0 0 0 1 27 0 0 9 1 4 2 1 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 0 1 1 0---
-- 61
50-
-
54 1 2 0 0 1 0 0 0 1 0 0 0 5 3 0 0 0 0 1 0 3 0 0 0 1 0 0 0 22 1 0 10 3 0 4 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 1 1 0 0---
-- 62
55-
-
59 0 2 1 0 0 0 0 0 0 1 2 0 3 3 0 0 1 1 1 0 1 0 0 0 0 0 0 1 24 0 0 9 4 4 3 0 0 1 0 0 1 0 0 3 2 1 0 0 1 0 2 0 0 0 0---
-- 72
60-
-
64 0 0 2 2 0 0 1 0 0 0 0 0 4 3 0 2 2 1 1 0 9 0 0 0 0 0 0 0 19 0 0 8 4 1 3 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 2 0 0 0 0---
-- 66
65-
-
69 0 0 0 1 0 0 0 0 0 1 1 0 1 3 0 1 0 0 0 1 2 0 0 0 0 0 0 1 10 0 0 3 2 1 3 0 0 0 0 0 1 0 0 1 2 0 0 0 0 0 1 0 0 0 0---
-- 36
70-
-
74 0 1 0 0 0 0 0 0 0 0 2 0 4 2 0 3 0 1 1 0 4 0 0 1 0 0 0 0 8 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 1 0 0 1 2 0 0 0 0 0 2---
-- 36
75+
0 2 0 0 2 0 0 0 0 1 1 0 9 0 0 3 1 3 0 1 6 0 0 1 3 0 0 0 4 1 1 2 3 0 0 0 0 0 0 0 1 0 0 1 0 0 0 1 1 0 0 0 1 0 1---
-- 50
% of
Total
0.20%
1.80%
0.80%
1.00%
0.60%
0.00%
0.60%
0.00%
0.20%
0.60%
1.20%
0.00%
5.90%
3.60%
0.00%
2.20%
0.80%
1.60%
0.80%
0.60%
5.50%
0.20%
0.00%
0.60%
0.80%
0.00%
0.00%
0.80%
30.50
%0.4
0%0.2
0%11
.10%
4.00%
2.60%
4.60%
0.20%
0.20%
0.80%
0.00%
0.00%
0.80%
0.00%
0.20%
2.80%
4.00%
0.20%
0.00%
1.60%
1.00%
0.00%
1.00%
0.80%
0.60%
0.80%
0.80% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
92:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
PE
RL
IS, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011
172
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
0 4 1 0 0 3 23 2 0 8 12 2 34 34 1 20 2 13 3 11 69 1 3 1 5 1 0 3 2 1 24 3 0 7 0 0 26 0 0 9 7 0 0 9 15 0 7 10 16 6 7---
--40
5
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 2 0 0 0 0 0 0 010
.1 2 4 0---
-- 20
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.9 3.8 0---
-- 6
10-
-
14 0 0 0 0 0 0 1.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.4 0 0 0 0 0 0 0 0 0 0 0---
-- 5
15-
-
19 0 0 0 0 0 0 1.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.4 0 0 0 0 0 0 0 0 1.4 0 0 0 1.4 0 0 0 0 2.8 0 0---
-- 8
20-
-
24 0 0 0 0 0 0 1.9 0 0 0 0 0 0 0 0 0 0 0 0 0 3.7 1.9 3.7 0 0 0 0 0 0 0 0 1.9 0 1.9 0 0 0 0 0 0 0 0 0 0 0 0 0 1.9 0 0 0---
-- 17
25-
-
29 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0---
-- 1
30-
-
34 0 0 0 0 0 0 3.5 0 0 0 0 0 0 7 0 3.5 0 0 0 0 3.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.5 0 0 0 0 3.5 0 0 0 0 0 0---
-- 25
35-
-
39 0 0 0 0 0 0 0 0 0 0 0 0 0 3.6 0 0 0 0 0 0 7.3 0 0 0 0 0 0 0 3.6 0 0 0 0 0 0 0 0 0 0 0 3.6 0 0 0 0 0 0 0 7.3 0 0---
-- 25
40-
-
44 0 0 0 0 0 0 3.1 0 0 0 0 0 9.4 0 0 0 0 6.3 0 0 3.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3.1 0 0 0 3.1 3.1 0 3.1 0 3.1 0 0---
-- 38
45-
-
49 0 0 0 0 0 3.1 15.4 0 0 0 0 6.2 12.3
12.3 0
12.3 0 6.2 3.1 6.2 12.3 0 0 0 0 0 0 0 0 0 0 0 0 3.1 0 0
12.3 0 0 0 3.1 0 0 0 6.2 0 0 0 0 0 0
-----
114
50-
-
54 0 0 3.3 0 0 0 0 0 0 3.3 3.3 0 10 6.7 013
.3 013
.3 3.3 016
.7 0 0 0 0 0 0 0 0 0 0 0 0 6.7 0 0 6.7 0 0 3.3 0 0 0 3.3 3.3 0 0 0 10 0 0---
--10
7
55-
-
59 0 7.8 0 0 0 023
.5 3.9 0 0 0 023
.515
.7 011
.8 0 3.9 0 7.8 23.5 0 0 0 0 0 0 0 0 0
11.8 0 0 0 0 0 3.9 0 0 0 0 0 0 0 7.8 0 7.8 0
11.8 0 0
-----
165
60-
-
64 0 0 0 0 0 4.9 0 0 0 4.9 4.9 024
.414
.6 014
.6 0 4.9 4.9 19.5
48.8 0 4.9 0 4.9 0 0 0 0 0 4.9 0 0 0 0 0
19.5 0 0 4.9 9.8 0 0 4.9 9.8 0 9.8 9.8 0 4.9 14.6 -----
249
65-
-
69 0 6.7 0 0 0 026
.7 0 0 6.7 13.3 0 40 60 0 20 6.7 6.7 0 6.7 80 0 0 0 6.7 0 0
13.3 6.7 6.7 33.3 6.7 0
13.3 0 0
26.7 0 0 6.7 6.7 0 0 6.7 13.3 0 0 6.7 6.7 0 0
-----
433
70-
-
74 0 0 0 0 0 017
.4 0 017
.426
.1 026
.143
.5 0 8.7 8.7 8.7 0 8.712
1.8 0 0 8.7 8.7 0 0 0 0 060
.9 0 0 8.7 0 052
.2 0 0 017
.4 0 034
.826
.1 0 8.7 0 8.7 017
.4 -----
539
75+
0 8.3 0 0 0 8.3 8.3 8.3 0 25 41.7 0
33.3 25 8.3 8.3 0 8.3 0 8.3 100 0 0 0
16.7 8.3 0 8.3 0 0
58.3 0 0 0 0 0
41.7 0 0 0 0 0 0 0 8.3 0 8.3 8.3 0 8.3 16.7 -----
475
Crud
eRa
te 0 0.5 0.1 0 0 0.3 2.6 0.2 0 0.9 1.4 0.2 3.9 3.9 0.1 2.3 0.2 1.5 0.3 1.3 7.9 0.1 0.3 0.1 0.6 0.1 0 0.3 0.2 0.1 2.7 0.3 0 0.8 0 0 3 0 0 1 0.8 0 0 1 1.7 0 0.8 1.1 1.8 0.7 0.8 -----
46.2
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
93:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, P
ER
LIS
, AL
L R
ESI
DE
NT
S, M
AL
ES,
200
7-20
11
ASR
Wor
ld 0 0.7 0.2 0 0 0.5 4 0.3 0 1.4 2.1 0.4 6.1 6.1 0.2 3.6 0.4 2.3 0.5 212
.4 0.1 0.5 0.2 0.9 0.2 0 0.6 0.4 0.2 4.2 0.6 0 1.2 0 0 4.7 0 0 1.6 1.3 0 0 1.6 2.7 0 1.2 2.1 2.7 1.2 1.3 -----
72.8
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
173
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
1 9 4 5 3 0 3 0 1 3 6 0 29 18 0 11 4 8 4 3 27 1 0 3 4 0 0 415
1 2 1 55 20 13 23 1 1 4 0 0 4 0 1 14 20 1 0 8 5 0 5 4 3 4 4---
--49
5
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.1 4.2 0 0 0 0 2.1 0 0 2.1 0 6.3 0---
-- 19
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0---
-- 4
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1.7 0 0 0---
-- 3
15-
-
19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.5 0 0 0 0 0 0 0 0 1.3 1.3 0 0 2.5 0 0 0 0 0 0 0---
-- 8
20-
-
24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0---
-- 8
25-
-
29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2.7 0 0 0 0 0 2.7 0 0 0 0 2.7 0 0 0 2.7 0 0 0 0 0 0 0 0 0 0 0 8.1 0 0 2.7 0 0 0 0 0 0 0---
-- 22
30-
-
34 0 3.4 0 0 0 0 0 0 0 0 0 0 0 3.4 0 0 0 0 0 0 0 0 0 0 0 0 0 013
.6 0 0 3.4 3.4 3.4 3.4 0 3.4 0 0 0 0 0 0 0 3.4 0 0 0 0 0 0 3.4 0 0 3.4 ----- 47
35-
-
39 0 0 0 0 0 0 0 0 0 0 0 0 3.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 044
.1 0 0 17 3.4 6.8 0 0 010
.2 0 0 0 0 0 010
.2 0 0 0 0 0 0 0 0 0 0---
-- 95
40-
-
44 0 2.9 0 2.9 0 0 0 0 0 0 0 0 0 5.9 0 2.9 0 2.9 0 0 0 2.9 0 0 0 0 0 052
.9 0 020
.6 0 0 2.9 0 0 0 0 0 2.9 0 0 2.9 8.8 0 0 2.9 0 0 0 0 0 0 0---
--11
5
45-
-
49 0 0 2.9 2.9 0 0 5.9 0 0 0 0 0 5.9 2.9 0 2.9 0 0 0 2.9 5.9 0 0 0 0 0 0 2.9 79.4 0 0
26.5 2.9 11.8 5.9 2.9 0 0 0 0 0 0 0 2.9 2.9 0 0 2.9 0 0 0 0 2.9 2.9 0
-----
179
50-
-
54 3.2 6.4 0 0 3.2 0 0 0 3.2 0 0 015
.9 9.5 0 0 0 0 3.2 0 9.5 0 0 0 3.2 0 0 069
.9 3.2 031
.8 9.5 012
.7 0 0 0 0 0 0 0 0 3.2 0 0 0 3.2 0 0 0 3.2 3.2 0 0---
--19
7
55-
-
59 0 7.5 3.8 0 0 0 0 0 0 3.8 7.5 011
.311
.3 0 0 3.8 3.8 3.8 0 3.8 0 0 0 0 0 0 3.8 90.6 0 0 34 15.1
15.1
11.3 0 0 3.8 0 0 3.8 0 0
11.3 7.5 3.8 0 0 3.8 0 7.5 0 0 0 0
-----
272
60-
-
64 0 0 10 10 0 0 5 0 0 0 0 0 20 15 0 10 10 5 5 0 45 0 0 0 0 0 0 0 95 0 0 40 20 5 15 0 0 0 0 0 0 0 0 0 10 0 0 0 0 0 10 0 0 0 0---
--33
0
65-
-
69 0 0 0 6.7 0 0 0 0 0 6.7 6.7 0 6.7 20 0 6.7 0 0 0 6.7 13.3 0 0 0 0 0 0 6.7 66.7 0 0 20 13.3 6.7 20 0 0 0 0 0 6.7 0 0 6.7 13.3 0 0 0 0 0 6.7 0 0 0 0
-----
240
70-
-
74 0 8 0 0 0 0 0 0 0 0 16 0 32 16 0 24 0 8 8 0 32 0 0 8 0 0 0 0 64 0 0 8 0 0 8 0 0 0 0 0 0 0 0 8 8 0 0 8 16 0 0 0 0 0 16 -----
288
75+
011
.8 0 011
.8 0 0 0 0 5.9 5.9 052
.9 0 017
.6 5.9 17.6 0 5.9 35.3 0 0 5.9 17.6 0 0 0
23.5 5.9 5.9 11.8
17.6 0 0 0 0 0 0 0 5.9 0 0 5.9 0 0 0 5.9 5.9 0 0 0 5.9 0 5.9 -----
294
Crud
eRa
te 0.2 1.6 0.7 0.9 0.5 0 0.5 0 0.2 0.5 1 0 5.1 3.1 0 1.9 0.7 1.4 0.7 0.5 4.7 0.2 0 0.5 0.7 0 0 0.7 26.4 0.3 0.2 9.6 3.5 2.3 4 0.2 0.2 0.7 0 0 0.7 0 0.2 2.4 3.5 0.2 0 1.4 0.9 0 0.9 0.7 0.5 0.7 0.7 -----
86.4
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
94:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, P
ER
LIS
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
200
7-20
11
ASR
Wor
ld 0.2 1.4 0.7 1 0.4 0 0.6 0 0.2 0.5 0.9 0 4.5 3.2 0 1.8 0.7 1.3 0.7 0.5 4.5 0.2 0 0.5 0.5 0 0 0.8 26.4 0.3 0.1 9.6 3.4 2.3 3.9 0.2 0.2 0.8 0 0 0.6 0 0.3 2.5 3.7 0.2 0 1.2 0.8 0 0.9 0.8 0.5 0.9 0.6 ----- 85
174
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
0 0 0 0 0 0 9 0 0 2 3 0 5 5 0 2 0 2 0 1 5 0 0 0 1 0 0 0 0 0 2 3 0 0 0 0 2 0 1 3 0 0 0 0 5 0 0 0 0 0 2---
-- 53
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 1
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0---
-- 1
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
15-
-
19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0---
-- 2
20-
-
24 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 1
25-
-
29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
30-
-
34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0---
-- 1
35-
-
39 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0---
-- 4
40-
-
44 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 3
45-
-
49 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1---
-- 4
50-
-
54 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0---
-- 4
55-
-
59 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0---
-- 7
60-
-
64 0 0 0 0 0 0 3 0 0 0 1 0 1 1 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 8
65-
-
69 0 0 0 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0---
-- 7
70-
-
74 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 5
75+
0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1---
-- 5
% of
Total 0.0
0%0.0
0%0.0
0%0.0
0%0.0
0%0.0
0%17
.00%
0.00%
0.00%
3.80%
5.70%
0.00%
9.40%
9.40%
0.00%
3.80%
0.00%
3.80%
0.00%
1.90%
9.40%
0.00%
0.00%
0.00%
1.90%
0.00%
0.00%
0.00%
0.00%
0.00%
3.80%
5.70%
0.00%
0.00%
0.00%
0.00%
3.80%
0.00%
1.90%
5.70%
0.00%
0.00%
0.00%
0.00%
9.40%
0.00%
0.00%
0.00%
0.00%
0.00%
3.80% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
95:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
W.P
. LA
BU
AN
, AL
L R
ESI
DE
NT
S, M
AL
ES,
200
7-20
11
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
175
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
1 0 0 0 0 0 1 0 0 2 2 0 2 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 17 0 0 7 2 0 2 0 0 0 0 0 0 0 0 1 0 0 0 1 5 0 0 0 4 0 1---
-- 51
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0---
-- 1
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0---
-- 1
15-
-
19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
20-
-
24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 1
25-
-
29 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 1
30-
-
34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0---
-- 4
35-
-
39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 1---
-- 5
40-
-
44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 1 0 0---
-- 5
45-
-
49 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 0 0 1 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0---
-- 9
50-
-
54 0 0 0 0 0 0 0 0 0 0 1 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 7
55-
-
59 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0---
-- 7
60-
-
64 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 3
65-
-
69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0---
-- 2
70-
-
74 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 3
75+
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 2
% of
Total
2.00%
0.00%
0.00%
0.00%
0.00%
0.00%
2.00%
0.00%
0.00%
3.90%
3.90%
0.00%
3.90%
2.00%
0.00%
0.00%
0.00%
2.00%
0.00%
0.00%
2.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
33.30
%0.0
0%0.0
0%13
.70%
3.90%
0.00%
3.90%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
2.00%
0.00%
0.00%
0.00%
2.00%
9.80%
0.00%
0.00%
0.00%
7.80%
0.00%
2.00% ---
--10
0.00%
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
96:
NU
MB
ER
OF
NE
W C
AN
CE
R C
ASE
S B
Y S
ITE
S A
ND
AG
E G
RO
UP,
W.P
. LA
BU
AN
, AL
L R
ESI
DE
NT
S, F
EM
AL
ES,
200
7-20
11
176
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stPe
nisPr
ostat
eTe
stis
Othe
r male
genit
alKi
dney
Rena
l Pelv
isUr
eter
Blad
der
Othe
r Urin
ary o
rgan
sEy
eBr
ain, N
ervo
us sy
stem
Thyro
idAd
rena
l glan
dOt
her E
ndoc
rine
Hodg
kin di
seas
eNo
n-Ho
dgkin
lymp
homa
Immu
nopr
olifer
ative
dis.
Multip
le My
eloma
Lymp
hoid
Leuk
aemi
aMy
eloid
Leuk
aemi
aLe
ukae
mia u
nspe
c.Ot
her &
unsp
ecifie
d
All s
ites T
otal
All
Ages
0 0 0 0 0 0 9 0 0 2 3 0 5 5 0 2 0 2 0 1 5 0 0 0 1 0 0 0 0 0 2 3 0 0 0 0 2 0 1 3 0 0 0 0 5 0 0 0 0 0 2---
-- 53
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 4
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.9 0 0 0 0 0 0 0 0 0 0 0---
-- 5
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
15-
-
19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5.4 0 0 0 0 0 0 0 5.4 0 0 0 0 0 0 0 0 0 0 0---
-- 11
20-
-
24 0 0 0 0 0 0 4.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 5
25-
-
29 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
30-
-
34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6.9 0 0 0 0 0 0 0 0 0 0 0 0---
-- 7
35-
-
39 0 0 0 0 0 0 8 0 0 0 0 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 0 0 0---
-- 32
40-
-
44 0 0 0 0 0 0 8.3 0 0 0 0 0 8.3 0 0 0 0 8.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 25
45-
-
49 0 0 0 0 0 0 0 0 0 8.7 0 0 0 0 0 8.7 0 8.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8.7 ----- 35
50-
-
54 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0---
-- 50
55-
-
59 0 0 0 0 0 0 0 0 0 20 20 0 0 20 0 0 0 0 0 20 20 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 20 0 0 0 0 20 0 0 0 0 0 0---
--14
0
60-
-
64 0 0 0 0 0 010
0 0 0 033
.3 033
.333
.3 0 0 0 0 0 066
.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
--26
7
65-
-
69 0 0 0 0 0 0 50 0 0 0 0 0 50 50 0 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 50 0 0 0 0 0 50 0 0 0 0 0 0 0 50 0 0 0 0 0 0---
--35
0
70-
-
74 0 0 0 0 0 0 0 0 0 066
.7 066
.7 0 0 0 0 0 0 0 0 0 0 066
.7 0 0 0 0 066
.7 0 0 0 0 066
.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
--33
3
75+
0 0 0 0 0 0 0 0 0 0 0 066
.766
.7 066
.7 0 0 0 066
.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 066
.7 -----
333
Crud
eRa
te 0 0 0 0 0 0 4.5 0 0 1 1.5 0 2.5 2.5 0 1 0 1 0 0.5 2.5 0 0 0 0.5 0 0 0 0 0 1 1.5 0 0 0 0 1 0 0.5 1.5 0 0 0 0 2.5 0 0 0 0 0 1---
--26
.5
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C6
0C6
1C6
2C6
3C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
97:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, W
.P. L
AB
UA
N, A
LL
RE
SID
EN
TS,
MA
LE
S, 2
007-
2011
ASR
Wor
ld 0 0 0 0 0 0 8.1 0 0 1.3 3.5 0 6 5.4 0 1.9 0 1 0 0.8 6.3 0 0 0 1.3 0 0 0 0 0 2.8 1.5 0 0 0 0 2.8 0 0.4 1.8 0 0 0 0 4 0 0 0 0 0 1.9 -----
50.9
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
177
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Site Lip Tong
ueMo
uthSa
livar
y glan
dsTo
nsil
Othe
r Oro
phar
ynx
Naso
phar
ynx
Hypo
phar
ynx
Phar
ynx u
nspe
c.Oe
soph
agus
Stom
ach
Small
intes
tine
Colon
Rectu
mAn
usLiv
erGa
llblad
der e
tc.Pa
ncre
asNo
se, s
inuse
s etc.
Laryn
xTr
ache
a,Bro
nchu
s,Lun
gOt
her T
hora
cic or
gans
Bone
Melan
oma o
f Skin
Othe
r Skin
Meso
thelio
maKa
posi
sarco
maCo
nnec
tive,S
oft tis
sue
Brea
stVu
lvaVa
gina
Cervi
x Uter
iCo
rpus
Uter
iUt
erus
unsp
ec.
Ovar
yOt
her F
emale
Gen
ital
Plac
enta
Kidn
eyRe
nal P
elvis
Urete
rBl
adde
rOt
her U
rinar
y org
ans
Eye
Brain
, Ner
vous
syste
mTh
yroid
Adre
nal g
land
Othe
r End
ocrin
eHo
dgkin
dise
ase
Non-
Hodg
kin ly
mpho
maIm
muno
proli
ferati
ve di
s.Mu
ltiple
Myelo
maLy
mpho
id Le
ukae
mia
Myelo
id Le
ukae
mia
Leuk
aemi
a uns
pec.
Othe
r & un
spec
ified
All s
ites T
otal
All
Ages
1 0 0 0 0 0 1 0 0 2 2 0 2 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 17 0 0 7 2 0 2 0 0 0 0 0 0 0 0 1 0 0 0 1 5 0 0 0 4 0 1---
-- 51
Age
Unk.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
0-
-
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.8 0 0---
-- 5
5-
-
9 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
10-
-
14 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5.1 0 0 0 0 0 0---
-- 5
15-
-
19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 0
20-
-
24 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 5
25-
-
29 0 0 0 0 0 0 0 0 0 0 4.3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 4
30-
-
34 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7.4 0 014
.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 7.4 0 0 0 0 0 0 0---
-- 30
35-
-
39 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 8 0 0 0 8 0 8---
-- 40
40-
-
44 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 9.5 0 0 9.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 019
.1 0 0 0 9.5 0 0---
-- 48
45-
-
49 0 0 0 0 0 011
.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 055
.6 0 011
.1 0 011
.1 0 0 0 0 0 0 0 011
.1 0 0 0 0 0 0 0 0 0 0 0---
--10
0
50-
-
54 0 0 0 0 0 0 0 0 0 011
.8 023
.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 047
.1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
-- 82
55-
-
59 0 0 0 0 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 75 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0---
--17
5
60-
-
64 0 0 0 0 0 0 0 0 0 0 0 0 0 40 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 80 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
--12
0
65-
-
69 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50 0 0---
--10
0
70-
-
74 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 010
0 0 0 0 0 0 0 0 0 0 010
0 0 0 010
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
--30
0
75+ 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 50 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0---
--10
0
Crud
eRa
te 0.5 0 0 0 0 0 0.5 0 0 1.1 1.1 0 1.1 0.5 0 0 0 0.5 0 0 0.5 0 0 0 0 0 0 0 8.9 0 0 3.7 1.1 0 1.1 0 0 0 0 0 0 0 0 0.5 0 0 0 0.5 2.6 0 0 0 2.1 0 0.5 -----
26.8
ICD
(10th
)
C00
C01-
C02
C03-
C06
C07-
C08
C09
C10
C11
C12-
C13
C14
C15
C16
C17
C18
C19-
C20
C21
C22
C23-
C24
C25
C30-
C31
C32
C33-
C34
C37-
C38
C40-
C41
C43
C44
C45
C46
C47;C
49C5
0C5
1C5
2C5
3C5
4C5
5C5
6C5
7C5
8C6
4C6
5C6
6C6
7C6
8C6
9C7
0-C7
2C7
3C7
4C7
5C8
1C8
2-C8
5;C96
C88
C90
C91
C92-
C94
C95
Othe
r
All
APP
EN
DIX
98:
CA
NC
ER
IN
CID
EN
CE
BY
SIT
ES
AN
D A
GE
GR
OU
P, W
.P. L
AB
UA
N, A
LL
RE
SID
EN
TS,
FE
MA
LE
S, 2
007-
2011
ASR
Wor
ld 1 0 0 0 0 0 0.7 0 0 2 0.9 0 1.2 1.6 0 0 0 2 0 0 1.5 0 0 0 0 0 0 012
.6 0 0 6.3 2.5 0 1.7 0 0 0 0 0 0 0 0 0.7 0 0 0 0.4 3.1 0 0 0 3.1 0 0.5 -----
41.7
178
APPENDIX 99: MORPHOLOGICALLY VERIFIED CASES BY HISTOLOGY TYPES, ALL SITES, MALAYSIA, 2007-2011
ICD10C00 LIP
41
65241311111
85
4.71.2
76.52.44.71.23.51.21.21.21.21.2
100.0
8010 Carcinoma, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8140 Adenocarcinoma, NOS8147 Basal cell adenocarcinoma8200 Adenoid cystic carcinoma8430 Mucoepidermoid carcinoma8480 Mucinous adenocarcinoma8550 Acinar cell carcinoma8800 Sarcoma, NOS8850 Liposarcoma, NOS
C01-C02 TONGUE1
381
25213
7299215
25112112112
854
0.14.40.12.90.20.10.4
85.41.10.20.10.62.90.10.10.20.10.10.20.10.10.2
100.0
8001 Tumor cells, malignant8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8032 Spindle cell carcinoma, NOS8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8260 Papillary adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8810 Fibrosarcoma, NOS8852 Myxoid liposarcoma8900 Rhabdomyosarcoma, NOS8980 Carcinosarcoma, NOS
C03-C06 MOUTH1
3427
17
71011532111
381
1812
261312311211111211
913
0.13.73.00.10.8
77.81.20.50.30.20.10.10.14.20.12.00.10.22.80.10.30.10.20.30.10.10.20.10.10.10.10.10.20.10.1
100.0
8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8032 Spindle cell carcinoma, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8076 Squamous cell carcinoma, microinvasive8082 Lymphoepithelial carcinoma8083 Basaloid squamous cell carcinoma8140 Adenocarcinoma, NOS8147 Basal cell adenocarcinoma8200 Adenoid cystic carcinoma8263 Adenocarcinoma in tubulovillous adenoma8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8480 Mucinous adenocarcinoma8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8562 Epithelial-myoepithelial carcinoma8800 Sarcoma, NOS8802 Giant cell sarcoma8830 Malignant fibrous histiocytoma8850 Liposarcoma, NOS8851 Liposarcoma, well differentiated8852 Myxoid liposarcoma8920 Alveolar rhabdomyosarcoma8940 Mixed tumor, malignant, NOS8941 Carcinoma in pleomorphic adenoma8980 Carcinosarcoma, NOS9170 Lymphangiosarcoma9581 Alveolar soft part sarcoma
Sites No. %Histology
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
179
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
C07-C08 SALIVARY GLANDS18
4221
21151
87131
1063
542
162
65151
271511
1857
11
487
0.21.68.60.40.24.30.21.00.2
17.90.20.60.22.1
12.91.08.60.21.20.4
13.30.21.00.25.50.21.00.20.23.7
11.70.20.2
100.0
8000 Neoplasm, malignant8001 Tumor cells, malignant8010 Carcinoma, NOS8011 Epithelioma, malignant8013 Large cell neuroendocrine carcinoma8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8022 Pleomorphic carcinoma8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8075 Squamous cell carcinoma, adenoid8082 Lymphoepithelial carcinoma8140 Adenocarcinoma, NOS8147 Basal cell adenocarcinoma8200 Adenoid cystic carcinoma8201 Cribriform carcinoma, NOS8290 Oxyphilic adenocarcinoma8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8500 Infiltrating duct carcinoma, NOS8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8562 Epithelial-myoepithelial carcinoma8802 Giant cell sarcoma8830 Malignant fibrous histiocytoma8940 Mixed tumor, malignant, NOS8941 Carcinoma in pleomorphic adenoma8980 Carcinosarcoma, NOS8982 Malignant myoepithelioma
C09 TONSIL941
149442
142111
192
4.72.10.5
77.62.12.11.07.31.00.50.50.5
100.0
8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8800 Sarcoma, NOS8801 Spindle cell sarcoma9581 Alveolar soft part sarcoma
C10 OTHER OROPHARYNX13
277
217111131
110
11.81.8
70.01.80.96.40.90.90.90.92.70.9
100.0
8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8070 Squamous cell carcinoma, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8076 Squamous cell carcinoma, microinvasive8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8890 Leiomyosarcoma, NOS8980 Carcinosarcoma, NOS9120 Hemangiosarcoma
C11 NASOPHARYNX131
8872,143
4151
22594
77
0.00.10.0
17.742.7
0.10.00.10.00.4
11.81.5
8000 Neoplasm, malignant8001 Tumor cells, malignant8002 Malignant tumor, small cell type8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8022 Pleomorphic carcinoma8032 Spindle cell carcinoma, NOS8033 Pseudosarcomatous carcinoma8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS
180
C12-C13 HYPOPHARYNX1517
111
19349191
252
6.06.70.40.40.4
76.61.63.60.43.60.4
100.0
8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8032 Spindle cell carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8075 Squamous cell carcinoma, adenoid8140 Adenocarcinoma, NOS8900 Rhabdomyosarcoma, NOS
C14 PHARYNX UNSPEC145
3227111
54
1.97.49.3
59.33.7
13.01.91.91.9
100.0
8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8070 Squamous cell carcinoma, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8140 Adenocarcinoma, NOS8810 Fibrosarcoma, NOS8890 Leiomyosarcoma, NOS8910 Embryonal rhabdomyosarcoma, NOS
C15 OESOPHAGUS1
10932
11
5677
1111
3811311163
10323
1,146
0.19.52.80.10.1
49.50.61.00.10.1
33.20.10.30.10.10.10.50.30.90.30.20.3
100.0
8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8033 Pseudosarcomatous carcinoma8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8076 Squamous cell carcinoma, microinvasive8140 Adenocarcinoma, NOS8144 Adenocarcinoma, intestinal type8145 Carcinoma, diffuse type8200 Adenoid cystic carcinoma8240 Carcinoid tumor, NOS8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8480 Mucinous adenocarcinoma8490 Signet ring cell carcinoma8560 Adenosquamous carcinoma8936 Gastrointestinal stromal sarcoma8980 Carcinosarcoma, NOS
94154
115
111
21410
12113121311
305,024
18.71.10.00.30.00.00.04.30.20.00.00.00.00.10.00.00.00.10.00.00.6
100.0
8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8082 Lymphoepithelial carcinoma8083 Basaloid squamous cell carcinoma8120 Transitional cell carcinoma, NOS8121 Schneiderian carcinoma8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8230 Solid carcinoma, NOS8260 Papillary adenocarcinoma, NOS8440 Cystadenocarcinoma, NOS8490 Signet ring cell carcinoma8800 Sarcoma, NOS8840 Myxosarcoma8851 Liposarcoma, well differentiated8890 Leiomyosarcoma, NOS8900 Rhabdomyosarcoma, NOS8910 Embryonal rhabdomyosarcoma, NOS8920 Alveolar rhabdomyosarcoma8980 Carcinosarcoma, NOS
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
181
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
C16 STOMACH922
2271
6712
92321
2,4331
5262
73226321
353
1372154111117
185127
3,377
0.30.10.16.70.02.00.00.12.70.10.10.0
72.00.01.51.80.20.10.10.10.20.10.10.01.00.14.10.10.00.10.10.00.00.00.00.00.25.50.00.10.2
100.0
8001 Tumor cells, malignant8002 Malignant tumor, small cell type8003 Malignant tumor, giant cell type8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8032 Spindle cell carcinoma, NOS8070 Squamous cell carcinoma, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8140 Adenocarcinoma, NOS8141 Scirrhous adenocarcinoma8144 Adenocarcinoma, intestinal type8145 Carcinoma, diffuse type8153 Gastrinoma, malignant8211 Tubular adenocarcinoma8214 Parietal cell carcinoma8240 Carcinoid tumor, NOS8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8263 Adenocarcinoma in tubulovillous adenoma8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8481 Mucin-producing adenocarcinoma8490 Signet ring cell carcinoma8510 Medullary carcinoma, NOS8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8800 Sarcoma, NOS8801 Spindle cell sarcoma8810 Fibrosarcoma, NOS8830 Malignant fibrous histiocytoma8852 Myxoid liposarcoma8853 Round cell liposarcoma8890 Leiomyosarcoma, NOS8936 Gastrointestinal stromal sarcoma8941 Carcinoma in pleomorphic adenoma8963 Malignant rhabdoid tumor8980 Carcinosarcoma, NOS
C17 SMALL INTESTINE1
23413
13821118132353
40240
0.49.61.70.41.3
57.50.80.40.40.43.30.41.30.81.32.11.3
16.7100.0
8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8070 Squamous cell carcinoma, NOS8140 Adenocarcinoma, NOS8144 Adenocarcinoma, intestinal type8145 Carcinoma, diffuse type8153 Gastrinoma, malignant8211 Tubular adenocarcinoma8240 Carcinoid tumor, NOS8245 Adenocarcinoid tumor8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8480 Mucinous adenocarcinoma8800 Sarcoma, NOS8890 Leiomyosarcoma, NOS8936 Gastrointestinal stromal sarcoma
C18-C21 COLORECTAL10
11
90311
2271
153
2181
0.10.00.06.70.00.01.70.00.10.01.60.0
8001 Tumor cells, malignant8003 Malignant tumor, giant cell type8004 Malignant tumor, spindle cell type8010 Carcinoma, NOS8013 Large cell neuroendocrine carcinoma8014 Large cell carcinoma with rhabdoid phenotype8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS
182
C22 LIVER3
10228
112
1411
120289
332
2,52431
243
162111111131
0.13.10.90.00.00.10.40.00.03.78.90.11.0
77.41.00.11.30.00.20.10.00.00.00.00.00.00.00.10.0
8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8030 Giant cell and spindle cell carcinoma8033 Pseudosarcomatous carcinoma8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8082 Lymphoepithelial carcinoma8140 Adenocarcinoma, NOS8160 Cholangiocarcinoma8161 Bile duct cystadenocarcinoma8162 Klatskin tumor8170 Hepatocellular carcinoma, NOS8171 Hepatocellular carcinoma, fibrolamellar8172 Hepatocellular carcinoma, scirrhous8180 Combined hepatocellular carcinoma and cholangiocarcinoma8200 Adenoid cystic carcinoma8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8480 Mucinous adenocarcinoma8500 Infiltrating duct carcinoma, NOS8560 Adenosquamous carcinoma8800 Sarcoma, NOS8805 Undifferentiated sarcoma8852 Myxoid liposarcoma8890 Leiomyosarcoma, NOS8891 Epithelioid leiomyosarcoma
1311333
11,4434
1842
2028
482
56122
1426
61044
117
2617
51311
1151125181
3113,490
0.00.00.00.00.00.00.0
84.80.00.10.00.00.10.20.00.10.00.40.00.00.00.10.20.00.10.30.00.00.11.90.10.40.00.00.00.10.00.00.00.00.00.00.10.00.2
100.0
8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8075 Squamous cell carcinoma, adenoid8076 Squamous cell carcinoma, microinvasive8082 Lymphoepithelial carcinoma8084 Squamous cell carcinoma, clear cell type8120 Transitional cell carcinoma, NOS8123 Basaloid carcinoma8140 Adenocarcinoma, NOS8141 Scirrhous adenocarcinoma8144 Adenocarcinoma, intestinal type8145 Carcinoma, diffuse type8147 Basal cell adenocarcinoma8210 Adenocarcinoma in adenomatous polyp8211 Tubular adenocarcinoma8215 Adenocarcinoma of anal glands8220 Adenocarcinoma in adenomatous polyposis 8221 Adenocarcinoma in multiple adenomatous polyps8240 Carcinoid tumor, NOS8243 Goblet cell carcinoid8244 Composite carcinoid8245 Adenocarcinoid tumor8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8261 Adenocarcinoma in villous adenoma8262 Villous adenocarcinoma8263 Adenocarcinoma in situ tubulovillous adenoma8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8481 Mucin-producing adenocarcinoma8490 Signet ring cell carcinoma8560 Adenosquamous carcinoma8573 Adenocarcinoma with apocrine metaplasia8574 Adenocarcinoma with neuroendocrine differentiation8720 Malignant melanoma, NOS8800 Sarcoma, NOS8804 Epithelioid sarcoma8821 Aggressive fibromatosis8851 Liposarcoma, well differentiated8890 Leiomyosarcoma, NOS8900 Rhabdomyosarcoma, NOS8936 Gastrointestinal stromal sarcoma8941 Carcinoma in pleomorphic adenoma8980 Carcinosarcoma, NOS
183
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
3411412
3,260
1.00.00.00.10.00.1
100.0
8970 Hepatoblastoma8981 Carcinosarcoma, embryonal8991 Embryonal sarcoma9120 Hemangiosarcoma9130 Hemangioendothelioma, malignant9170 Lymphangiosarcoma
C23-C24 GALLBLADDER ETC.1
1022
267
25317
1274
36112111161
779
0.113.1
0.33.30.93.2
40.70.1
35.20.40.80.10.10.30.10.10.10.10.80.1
100.0
8001 Tumor cells, malignant8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8140 Adenocarcinoma, NOS8141 Scirrhous adenocarcinoma8160 Cholangiocarcinoma8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8262 Villous adenocarcinoma8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8490 Signet ring cell carcinoma8500 Infiltrating duct carcinoma, NOS8503 Intraductal papillary adenocarcinoma with invasion8504 Intracystic carcinoma, NOS8560 Adenosquamous carcinoma8800 Sarcoma, NOS
C25 PANCREAS12
3281
932231
531
943243434
236211
1062
151
1081
217
1,573
0.820.9
0.15.90.10.10.20.13.40.1
59.90.10.30.20.30.20.31.50.40.10.10.10.60.40.11.00.10.60.50.11.30.4
100.0
8001 Tumor cells, malignant8010 Carcinoma, NOS8013 Large cell neuroendocrine carcinoma8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8033 Pseudosarcomatous carcinoma8050 Papillary carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8140 Adenocarcinoma, NOS8141 Scirrhous adenocarcinoma8150 Islet cell carcinoma8152 Glucagonoma, malignant8154 Mixed islet cell and exocrine adenocarcinoma8200 Adenoid cystic carcinoma8240 Carcinoid tumor, NOS8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8263 Adenocarcinoma in tubulovillous adenoma8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8440 Cystadenocarcinoma, NOS8452 Solid pseudopapillary carcinoma8453 Intraductal papillary-mucinous carcinoma, invasive8480 Mucinous adenocarcinoma8490 Signet ring cell carcinoma8500 Infiltrating duct carcinoma, NOS8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8971 Pancreatoblastoma8980 Carcinosarcoma, NOS
C30- C31 NOSE, SINUSES ETC.3148
3155
1011411
7.812.0
0.838.8
2.52.81.00.30.3
8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8074 Squamous cell carcinoma, spindle cell8076 Squamous cell carcinoma, microinvasive
184
C32 LARYNX121
6627
542
7418
112211
3912311111
924
0.10.20.17.12.90.50.40.2
80.20.91.20.20.20.10.14.20.10.20.30.10.10.10.10.1
100.0
8000 Neoplasm, malignant8001 Tumor cells, malignant8004 Malignant tumor, spindle cell type8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8076 Squamous cell carcinoma, microinvasive8083 Basaloid squamous cell carcinoma8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8560 Adenosquamous carcinoma8800 Sarcoma, NOS8810 Fibrosarcoma, NOS8890 Leiomyosarcoma, NOS8894 Angiomyosarcoma8941 Carcinoma in pleomorphic adenoma8980 Carcinosarcoma, NOS
1149
437
23231351113132112
162
400
0.30.31.02.3
10.81.85.80.50.80.30.81.30.30.30.30.80.30.80.50.30.30.54.00.5
100.0
8082 Lymphoepithelial carcinoma8083 Basaloid squamous cell carcinoma8120 Transitional cell carcinoma, NOS8121 Schneiderian carcinoma8140 Adenocarcinoma, NOS8147 Basal cell adenocarcinoma8200 Adenoid cystic carcinoma8260 Papillary adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8510 Medullary carcinoma, NOS8720 Malignant melanoma, NOS8800 Sarcoma, NOS8801 Spindle cell sarcoma8803 Small cell sarcoma8813 Fascial fibrosarcoma8900 Rhabdomyosarcoma, NOS8910 Embryonal rhabdomyosarcoma, NOS8980 Carcinosarcoma, NOS9120 Hemangiosarcoma9371 Chondroid chordoma9520 Olfactory neurogenic tumor9521 Olfactory neurocytoma9522 Olfactory neuroblastoma9523 Olfactory neuroepithelioma
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
C33- C34 TRACHEA, BRONCHUS, LUNG1
18221
1,16520
1148
3083179
823941
38503
3311
0.00.20.00.00.0
11.90.21.20.13.10.00.00.10.18.40.10.00.00.45.10.30.00.0
8000 Neoplasm, malignant8001 Tumor cells, malignant8002 Malignant tumor, small cell type8003 Malignant tumor, giant cell type8004 Malignant tumor, spindle cell type8010 Carcinoma, NOS8011 Epithelioma, malignant8012 Large cell carcinoma, NOS8013 Large cell neuroendocrine carcinoma8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8030 Giant cell and spindle cell carcinoma8032 Spindle cell carcinoma, NOS8033 Pseudosarcomatous carcinoma8041 Small cell carcinoma, NOS8042 Oat cell carcinoma8043 Small cell carcinoma, fusiform cell8044 Small cell carcinoma, intermediate cell8045 Combined small cell carcinoma8046 Non-small cell carcinoma8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8052 Papillary squamous cell carcinoma
185
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
C37-C38 OTHER THORACIC ORGANS51
17141
2411
1021116511
57128131121
10
1.80.46.00.41.40.48.50.40.4
35.90.40.40.42.11.80.40.4
20.10.40.72.80.41.10.40.40.70.43.5
8001 Tumor cells, malignant8002 Malignant tumor, small cell type8010 Carcinoma, NOS8013 Large cell neuroendocrine carcinoma8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8082 Lymphoepithelial carcinoma8140 Adenocarcinoma, NOS8141 Scirrhous adenocarcinoma8231 Carcinoma simplex8240 Carcinoid tumor, NOS8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8490 Signet ring cell carcinoma8560 Adenosquamous carcinoma8580 Thymoma, malignant, NOS8581 Thymoma, type A, malignant8584 Thymoma, type B2, malignant8586 Thymic carcinoma, NOS8589 Carcinoma showing thymus-like element8800 Sarcoma, NOS8805 Undifferentiated sarcoma8830 Malignant fibrous histiocytoma8900 Rhabdomyosarcoma, NOS8980 Carcinosarcoma, NOS9064 Germinoma
1,909123718
2811
4,445316
1118
2138
532
2810
41
11121
24217111111412
221211
9,826
19.40.10.40.20.00.10.00.0
45.20.00.00.10.10.20.01.40.10.00.00.30.10.00.00.10.00.00.00.20.00.00.10.00.00.00.00.00.00.00.00.00.20.00.00.00.0
100.0
8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8074 Squamous cell carcinoma, spindle cell8075 Squamous cell carcinoma, adenoid8082 Lymphoepithelial carcinoma8083 Basaloid squamous cell carcinoma8140 Adenocarcinoma, NOS8141 Scirrhous adenocarcinoma8147 Basal cell adenocarcinoma8200 Adenoid cystic carcinoma8240 Carcinoid tumor, NOS8246 Neuroendocrine carcinoma, NOS8249 Atypical carcinoid tumor8250 Bronchiolo-alveolar adenocarcinoma, NOS8251 Alveolar adenocarcinoma8252 Bronchiolo-alveolar carcinoma, non-mucinous8253 Bronchiolo-alveolar carcinoma, mucinous8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8481 Mucin-producing adenocarcinoma8490 Signet ring cell carcinoma8510 Medullary carcinoma, NOS8560 Adenosquamous carcinoma8570 Adenocarcinoma with squamous metaplasia8574 Adenocarcinoma with neuroendocrine differentiation8800 Sarcoma, NOS8803 Small cell sarcoma8830 Malignant fibrous histiocytoma8850 Liposarcoma, NOS8851 Liposarcoma, well differentiated8854 Pleomorphic liposarcoma8890 Leiomyosarcoma, NOS8900 Rhabdomyosarcoma, NOS8963 Malignant rhabdoid tumor8972 Pulmonary blastoma8980 Carcinosarcoma, NOS9130 Hemangioendothelioma, malignant9133 Epithelioid hemangioendothelioma, malignant9364 Peripheral neuroectodermal tumor9580 Granular cell tumor, malignant
186
C43 MELANOMA OF SKIN294
617321321
320
91.91.90.32.20.90.60.30.90.60.3
100.0
8720 Malignant melanoma, NOS8721 Nodular melanoma8730 Amelanotic melanoma8742 Lentigo maligna melanoma8744 Acral lentiginous melanoma, malignant8745 Desmoplastic melanoma, malignant8761 Malignant melanoma in giant pigmented nevus8770 Mixed epithelioid and spindle cell melanoma8772 Spindle cell melanoma, NOS8780 Blue nevus, malignant
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
115319112
284
0.40.41.81.10.43.20.40.40.7
100.0
9065 Germ cell tumor, nonseminomatous9070 Embryonal carcinoma, NOS9071 Yolk sac tumor9080 Teratoma, malignant, NOS9082 Malignant teratoma, undifferentiated9085 Mixed germ cell tumor9120 Hemangiosarcoma9150 Hemangiopericytoma, malignant9540 Malignant peripheral nerve sheath tumor
C40-C41 BONE1
10221
245212888
122361218111
4036213511
2261
124312
501
811
161124411
802
0.11.20.20.20.13.00.60.20.10.21.01.01.01.50.20.40.70.10.20.11.00.10.10.1
50.20.70.20.10.40.60.10.12.77.60.10.20.50.40.10.26.20.1
10.10.12.01.40.20.50.50.10.1
100.0
8000 Neoplasm, malignant8001 Tumor cells, malignant8002 Malignant tumor, small cell type8004 Malignant tumor, spindle cell type8012 Large cell carcinoma, NOS8800 Sarcoma, NOS8801 Spindle cell sarcoma8803 Small cell sarcoma8804 Epithelioid sarcoma8806 Desmoplastic small round cell tumor8810 Fibrosarcoma, NOS8812 Periosteal fibrosarcoma8830 Malignant fibrous histiocytoma8850 Liposarcoma, NOS8852 Myxoid liposarcoma8854 Pleomorphic liposarcoma8890 Leiomyosarcoma, NOS8895 Myosarcoma8900 Rhabdomyosarcoma, NOS8910 Embryonal rhabdomyosarcoma, NOS9040 Synovial sarcoma, NOS9120 Hemangiosarcoma9130 Hemangioendothelioma, malignant9133 Epithelioid hemangioendothelioma, malignant9180 Osteosarcoma, NOS9181 Chondroblastic osteosarcoma9182 Fibroblastic osteosarcoma9183 Telangiectatic osteosarcoma9184 Osteosarcoma in Paget disease of bone9185 Small cell osteosarcoma9186 Central osteosarcoma9192 Parosteal osteosarcoma9200 Aggressive osteoblastoma9220 Chondrosarcoma, NOS9221 Juxtacortical chondrosarcoma9230 Chondroblastoma, malignant9231 Myxoid chondrosarcoma9240 Mesenchymal chondrosarcoma9242 Clear cell chondrosarcoma9243 Dedifferentiated chondrosarcoma9250 Giant cell tumor of bone, malignant9251 Malignant giant cell tumor of soft parts9260 Ewing sarcoma9261 Adamantinoma of long bones9270 Odontogenic tumor, malignant9310 Ameloblastoma, malignant9330 Ameloblastic fibrosarcoma9364 Peripheral neuroectodermal tumor9370 Chordoma, NOS9371 Chondroid chordoma9581 Alveolar soft part sarcoma
187
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
C47, C49 CONNECTIVE, SOFT TISSUE311
20312
71823
46
0.40.10.1
26.01.50.90.11.00.30.45.9
8001 Tumor cells, malignant8002 Malignant tumor, small cell type8003 Malignant tumor, giant cell type8800 Sarcoma, NOS8801 Spindle cell sarcoma8802 Giant cell sarcoma8803 Small cell sarcoma8804 Epithelioid sarcoma8805 Undifferentiated sarcoma8806 Desmoplastic small round cell tumor8810 Fibrosarcoma, NOS
C46 KAPOSI SARCOMA1818
100.0100.0
9140 Kaposi sarcoma
C45 MESOTHELIOMA35
33
41
85.47.37.3
100.0
9050 Mesothelioma, malignant9051 Fibrous mesothelioma, malignant9053 Mesothelioma, biphasic, malignant
C44 OTHER SKIN3
5615
151719
14773
1315
42
1915
1,246344
101124
4519
16111541
2552213113
673241
2,423
0.12.30.60.00.20.00.30.00.40.6
31.90.50.60.20.10.80.00.2
51.40.10.20.20.40.00.00.10.21.90.80.00.20.00.00.00.20.20.01.00.20.10.10.00.10.00.00.12.80.10.10.20.0
100.0
8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8022 Pleomorphic carcinoma8031 Giant cell carcinoma8032 Spindle cell carcinoma, NOS8033 Pseudosarcomatous carcinoma8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8081 Bowen disease8082 Lymphoepithelial carcinoma8083 Basaloid squamous cell carcinoma8090 Basal cell carcinoma, NOS8091 Multifocal superficial basal cell carcinoma8092 Infiltrating basal cell carcinoma, NOS8093 Basal cell carcinoma, fibroepithelial8094 Basosquamous carcinoma8095 Metatypical carcinoma8098 Adenoid basal carcinoma8102 Trichilemmocarcinoma8110 Pilomatrix carcinoma8140 Adenocarcinoma, NOS8147 Basal cell adenocarcinoma8200 Adenoid cystic carcinoma8247 Merkel cell carcinoma8260 Papillary adenocarcinoma, NOS8263 Adenocarcinoma in tubulovillous adenoma8310 Clear cell adenocarcinoma, NOS8390 Skin appendage carcinoma8402 Nodular hidradenoma, malignant8403 Malignant eccrine spiradenoma8410 Sebaceous adenocarcinoma8430 Mucoepidermoid carcinoma8480 Mucinous adenocarcinoma8542 Paget disease, extramammary8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8562 Epithelial-myoepithelial carcinoma8821 Aggressive fibromatosis8830 Malignant fibrous histiocytoma8832 Dermatofibrosarcoma, NOS8833 Pigmented dermatofibrosarcoma protuberans8940 Mixed tumor, malignant, NOS8980 Carcinosarcoma, NOS9364 Peripheral neuroectodermal tumor
188
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
734
493
969
261
103
5123
4710
111611
2332813711
274215225
3514
22
781
0.90.40.56.30.4
12.31.23.30.11.30.46.50.30.46.01.30.11.40.80.10.12.90.40.31.00.10.40.90.10.13.50.50.30.10.60.30.30.64.51.80.30.3
100.0
8811 Fibromyxosarcoma8814 Infantile fibrosarcoma8821 Aggressive fibromatosis8830 Malignant fibrous histiocytoma8840 Myxosarcoma8850 Liposarcoma, NOS8851 Liposarcoma, well differentiated8852 Myxoid liposarcoma8853 Round cell liposarcoma8854 Pleomorphic liposarcoma8858 Dedifferentiated liposarcoma8890 Leiomyosarcoma, NOS8894 Angiomyosarcoma8895 Myosarcoma8900 Rhabdomyosarcoma, NOS8901 Pleomorphic rhabdomyosarcoma, adult type8902 Mixed type rhabdomyosarcoma8910 Embryonal rhabdomyosarcoma, NOS8920 Alveolar rhabdomyosarcoma8963 Malignant rhabdoid tumor8990 Mesenchymoma, malignant9040 Synovial sarcoma, NOS9041 Synovial sarcoma, spindle cell9043 Synovial sarcoma, biphasic9044 Clear cell sarcoma, NOS9064 Germinoma9071 Yolk sac tumor9080 Teratoma, malignant, NOS9082 Malignant teratoma, undifferentiated9085 Mixed germ cell tumor9120 Hemangiosarcoma9150 Hemangiopericytoma, malignant9240 Mesenchymal chondrosarcoma9251 Malignant giant cell tumor of soft parts9252 Malignant tenosynovial giant cell tumor9364 Peripheral neuroectodermal tumor9370 Chordoma, NOS9500 Neuroblastoma, NOS9540 Malignant peripheral nerve sheath tumor9560 Neurilemoma, malignant9580 Granular cell tumor, malignant9581 Alveolar soft part sarcoma
C50 BREAST1111
5421
71332111
671
7211121
328861
142116112
0.10.00.03.00.00.40.00.00.00.00.00.00.40.00.40.00.00.00.00.01.80.00.00.00.10.00.00.00.00.00.00.0
8001 Tumor cells, malignant8003 Malignant tumor, giant cell type8004 Malignant tumor, spindle cell type8010 Carcinoma, NOS8013 Large cell neuroendocrine carcinoma8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8022 Pleomorphic carcinoma8032 Spindle cell carcinoma, NOS8033 Pseudosarcomatous carcinoma8034 Polygonal cell carcinoma8050 Papillary carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8074 Squamous cell carcinoma, spindle cell8075 Squamous cell carcinoma, adenoid8076 Squamous cell carcinoma, microinvasive8123 Basaloid carcinoma8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8201 Cribriform carcinoma, NOS8210 Adenocarcinoma in adenomatous polyp8211 Tubular adenocarcinoma8230 Solid carcinoma, NOS8246 Neuroendocrine carcinoma, NOS8251 Alveolar adenocarcinoma8260 Papillary adenocarcinoma, NOS8315 Glycogen-rich carcinoma8430 Mucoepidermoid carcinoma8440 Cystadenocarcinoma, NOS
189
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
C52 VAGINA1158
382111
2112111111
8.947.2
2.46.51.60.80.80.8
17.10.81.60.80.80.80.80.80.8
8010 Carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8076 Squamous cell carcinoma, microinvasive8083 Basaloid squamous cell carcinoma8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8560 Adenosquamous carcinoma8800 Sarcoma, NOS8890 Leiomyosarcoma, NOS
1511
14,882113
642
10212
2671,267
11626
288213154131123712
5794
218,258
0.80.0
81.50.10.00.40.00.60.00.01.56.90.60.10.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.30.50.0
100.0
8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8481 Mucin-producing adenocarcinoma8500 Infiltrating duct carcinoma, NOS8501 Comedocarcinoma, NOS8502 Secretory carcinoma of breast8503 Intraductal papillary adenocarcinoma with invasion8504 Intracystic carcinoma, NOS8510 Medullary carcinoma, NOS8512 Medullary carcinoma with lymphoid stroma8513 Atypical medullary carcinoma8520 Lobular carcinoma, NOS8521 Infiltrating ductular carcinoma8522 Infiltrating duct and lobular carcinoma8523 Infiltrating duct mixed with other types of carcinoma8530 Inflammatory carcinoma8540 Paget disease, mammary8541 Paget disease and infiltrating duct carcinoma8543 Paget disease and intraductal carcinoma 8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8573 Adenocarcinoma with apocrine metaplasia8575 Metaplastic carcinoma, NOS8800 Sarcoma, NOS8802 Giant cell sarcoma8810 Fibrosarcoma, NOS8821 Aggressive fibromatosis8850 Liposarcoma, NOS8851 Liposarcoma, well differentiated8852 Myxoid liposarcoma8890 Leiomyosarcoma, NOS8894 Angiomyosarcoma8935 Stromal sarcoma, NOS8980 Carcinosarcoma, NOS9020 Phyllodes tumor, malignant9120 Hemangiosarcoma
C51 VULVA92
722215811131
102111
123
7.31.6
58.51.61.60.84.16.50.80.80.82.40.88.11.60.80.80.8
100.0
8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8083 Basaloid squamous cell carcinoma8090 Basal cell carcinoma, NOS8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8430 Mucoepidermoid carcinoma8481 Mucin-producing adenocarcinoma8542 Paget disease, extramammary8560 Adenosquamous carcinoma8720 Malignant melanoma, NOS8804 Epithelioid sarcoma8830 Malignant fibrous histiocytoma8890 Leiomyosarcoma, NOS9580 Granular cell tumor, malignant
190
C54 CORPUS UTERI121
135
111
191
38182
7801723
2955
8
5.60.01.60.00.00.00.90.01.80.00.40.1
35.90.81.10.1
44.00.4
8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8022 Pleomorphic carcinoma8032 Spindle cell carcinoma, NOS8050 Papillary carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8140 Adenocarcinoma, NOS8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8320 Granular cell carcinoma8380 Endometrioid adenocarcinoma, NOS8381 Endometrioid adenofibroma, malignant
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
14111
123
0.83.30.80.80.8
100.0
8901 Pleomorphic rhabdomyosarcoma, adult type8980 Carcinosarcoma, NOS8990 Mesenchymoma, malignant9071 Yolk sac tumor9364 Peripheral neuroectodermal tumor
C53 CERVIC UTERI31
24441
931111
1416
1,673195862
4215
37321
857111
2742
311
47112
2611
745218125
214,324
0.10.05.60.10.02.20.00.00.00.00.30.00.1
38.74.5
19.91.00.00.10.90.10.00.0
19.80.00.00.00.60.10.00.70.01.10.30.00.60.00.01.70.10.00.00.20.00.00.10.5
100.0
8001 Tumor cells, malignant8003 Malignant tumor, giant cell type8010 Carcinoma, NOS8013 Large cell neuroendocrine carcinoma8015 Glassy cell carcinoma8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8032 Spindle cell carcinoma, NOS8033 Pseudosarcomatous carcinoma8041 Small cell carcinoma, NOS8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8074 Squamous cell carcinoma, spindle cell8075 Squamous cell carcinoma, adenoid8076 Squamous cell carcinoma, microinvasive8083 Basaloid squamous cell carcinoma8098 Adenoid basal carcinoma8123 Basaloid carcinoma8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8231 Carcinoma simplex8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8262 Villous adenocarcinoma8263 Adenocarcinoma in tubulovillous adenoma8310 Clear cell adenocarcinoma, NOS8320 Granular cell carcinoma8380 Endometrioid adenocarcinoma, NOS8384 Adenocarcinoma, endocervical type8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8481 Mucin-producing adenocarcinoma8482 Mucinous adenocarcinoma, endocervical type8560 Adenosquamous carcinoma8570 Adenocarcinoma with squamous metaplasia8800 Sarcoma, NOS8810 Fibrosarcoma, NOS8890 Leiomyosarcoma, NOS8900 Rhabdomyosarcoma, NOS8933 Adenosarcoma8950 Mullerian mixed tumor8980 Carcinosarcoma, NOS
191
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
C56 OVARY
2111
3112
891256
7411
766311
0.60.00.09.10.12.60.41.60.20.10.00.0
22.50.10.00.0
8001 Tumor cells, malignant8002 Malignant tumor, small cell type8003 Malignant tumor, giant cell type8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8075 Squamous cell carcinoma, adenoid8076 Squamous cell carcinoma, microinvasive8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8210 Adenocarcinoma in adenomatous polyp8211 Tubular adenocarcinoma
14
112911211
166012
111
1811
132,171
0.00.20.50.10.40.00.00.10.00.00.72.80.60.00.00.00.80.00.00.6
100.0
8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8560 Adenosquamous carcinoma8570 Adenocarcinoma with squamous metaplasia8800 Sarcoma, NOS8803 Small cell sarcoma8804 Epithelioid sarcoma8810 Fibrosarcoma, NOS8814 Infantile fibrosarcoma8850 Liposarcoma, NOS8890 Leiomyosarcoma, NOS8930 Endometrial stromal sarcoma, NOS8931 Endometrial stromal sarcoma, low grade8933 Adenosarcoma8935 Stromal sarcoma, NOS8940 Mixed tumor, malignant, NOS8950 Mullerian mixed tumor8951 Mesodermal mixed tumor8963 Malignant rhabdoid tumor8980 Carcinosarcoma, NOS
C55 UTERUS UNSPEC.11
42732
26141
1957181
11011171
11111
1011321417
20575
0.20.27.31.20.50.34.50.20.70.2
33.91.20.21.40.2
19.10.20.20.21.20.21.90.20.20.2
17.60.20.50.30.20.70.21.23.5
100.0
8001 Tumor cells, malignant8002 Malignant tumor, small cell type8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8140 Adenocarcinoma, NOS8260 Papillary adenocarcinoma, NOS8262 Villous adenocarcinoma8310 Clear cell adenocarcinoma, NOS8323 Mixed cell adenocarcinoma8380 Endometrioid adenocarcinoma, NOS8381 Endometrioid adenofibroma, malignant8384 Adenocarcinoma, endocervical type8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8560 Adenosquamous carcinoma8800 Sarcoma, NOS8805 Undifferentiated sarcoma8840 Myxosarcoma8852 Myxoid liposarcoma8890 Leiomyosarcoma, NOS8891 Epithelioid leiomyosarcoma8896 Myxoid leiomyosarcoma8900 Rhabdomyosarcoma, NOS8901 Pleomorphic rhabdomyosarcoma, adult type8933 Adenosarcoma8940 Mixed tumor, malignant, NOS8950 Mullerian mixed tumor8980 Carcinosarcoma, NOS
192
C57 OTHER FEMALE GENITAL51
141613413
39
12.82.6
35.92.6
15.42.67.7
10.32.67.7
100.0
8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8140 Adenocarcinoma, NOS8260 Papillary adenocarcinoma, NOS8380 Endometrioid adenocarcinoma, NOS8440 Cystadenocarcinoma, NOS8441 Serous cystadenocarcinoma, NOS8460 Papillary serous cystadenocarcinoma8480 Mucinous adenocarcinoma9100 Choriocarcinoma, NOS
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
316
42225
54
24131
270356
28191
29199
26122
262211
682732211
1011263
101234
2718
22
6085
215
1349215
3,408
0.10.00.21.26.60.10.17.10.10.07.9
10.40.85.60.95.80.83.60.10.20.10.10.00.02.00.10.20.10.10.10.00.00.30.00.00.10.20.10.30.00.10.10.10.80.50.10.11.82.50.10.00.10.40.10.30.10.00.1
100.0
8240 Carcinoid tumor, NOS8243 Goblet cell carcinoid8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8313 Clear cell adenocarcinofibroma8320 Granular cell carcinoma8380 Endometrioid adenocarcinoma, NOS8381 Endometrioid adenofibroma, malignant8384 Adenocarcinoma, endocervical type8440 Cystadenocarcinoma, NOS8441 Serous cystadenocarcinoma, NOS8450 Papillary cystadenocarcinoma, NOS8460 Papillary serous cystadenocarcinoma8461 Serous surface papillary carcinoma8470 Mucinous cystadenocarcinoma, NOS8471 Papillary mucinous cystadenocarcinoma8480 Mucinous adenocarcinoma8481 Mucin-producing adenocarcinoma8490 Signet ring cell carcinoma8560 Adenosquamous carcinoma8562 Epithelial-myoepithelial carcinoma8570 Adenocarcinoma with squamous metaplasia8600 Thecoma, malignant8620 Granulosa cell tumor, malignant8621 Granulosa cell-theca cell tumor8631 Sertoli-Leydig cell tumor, poorly differentiated8640 Sertoli cell carcinoma8670 Steroid cell tumor, malignant8800 Sarcoma, NOS8810 Fibrosarcoma, NOS8850 Liposarcoma, NOS8890 Leiomyosarcoma, NOS8891 Epithelioid leiomyosarcoma8935 Stromal sarcoma, NOS8940 Mixed tumor, malignant, NOS8950 Mullerian mixed tumor8951 Mesodermal mixed tumor8980 Carcinosarcoma, NOS8990 Mesenchymoma, malignant9000 Brenner tumor, malignant9014 Serous adenocarcinofibroma9015 Mucinous adenocarcinofibroma9060 Dysgerminoma9064 Germinoma9065 Germ cell tumor, nonseminomatous9070 Embryonal carcinoma, NOS9071 Yolk sac tumor9080 Teratoma, malignant, NOS9082 Malignant teratoma, undifferentiated9083 Malignant teratoma, intermediate9084 Teratoma with malignant transformation9085 Mixed germ cell tumor9090 Struma ovarii, malignant9100 Choriocarcinoma, NOS9101 Choriocarcinoma combined with other germ cell elements9110 Mesonephroma, malignant9580 Granular cell tumor, malignant
193
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
12
14421
695
194149
51
0.20.4
29.50.40.2
14.11.03.98.4
10.01.00.2
8910 Embryonal rhabdomyosarcoma, NOS8940 Mixed tumor, malignant, NOS9061 Seminoma, NOS9062 Seminoma, anaplastic9063 Spermatocytic seminoma9064 Germinoma9065 Germ cell tumor, nonseminomatous9070 Embryonal carcinoma, NOS9071 Yolk sac tumor9080 Teratoma, malignant, NOS9081 Teratocarcinoma9082 Malignant teratoma, undifferentiated
C58 PLACENTA12
5225
62
1.63.2
83.93.28.1
100.0
8010 Carcinoma, NOS8890 Leiomyosarcoma, NOS9100 Choriocarcinoma, NOS9101 Choriocarcinoma combined with other germ cell elements9104 Placental site trophoblastic tumor
C60 PENIS1823
84312421111
114
0.97.01.82.6
73.72.60.91.83.51.80.90.90.90.9
100.0
8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8081 Bowen disease8090 Basal cell carcinoma, NOS8140 Adenocarcinoma, NOS8542 Paget disease, extramammary8720 Malignant melanoma, NOS8800 Sarcoma, NOS8832 Dermatofibrosarcoma, NOS8910 Embryonal rhabdomyosarcoma, NOS
C62 TESTIS3
256
2229
112
1012125
0.65.11.24.55.90.20.20.42.00.20.40.20.41.0
8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8070 Squamous cell carcinoma, NOS8140 Adenocarcinoma, NOS8480 Mucinous adenocarcinoma8550 Acinar cell carcinoma8631 Sertoli-Leydig cell tumor, poorly differentiated8640 Sertoli cell carcinoma8650 Leydig cell tumor, malignant8800 Sarcoma, NOS8830 Malignant fibrous histiocytoma8890 Leiomyosarcoma, NOS8900 Rhabdomyosarcoma, NOS
C61 PROSTATE8
2352
60111
291
202
2,645111229
64112
3,089
0.37.60.11.90.00.00.00.90.00.60.1
85.60.00.00.00.10.10.32.10.00.00.1
100.0
8001 Tumor cells, malignant8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8041 Small cell carcinoma, NOS8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8120 Transitional cell carcinoma, NOS8130 Papillary transitional cell carcinoma8140 Adenocarcinoma, NOS8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8320 Granular cell carcinoma8480 Mucinous adenocarcinoma8490 Signet ring cell carcinoma8500 Infiltrating duct carcinoma, NOS8550 Acinar cell carcinoma8802 Giant cell sarcoma8810 Fibrosarcoma, NOS8900 Rhabdomyosarcoma, NOS
194
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
C65 RENAL PELVIS11392211
20
5.05.0
15.045.010.010.0
5.05.0
100.0
8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8070 Squamous cell carcinoma, NOS8120 Transitional cell carcinoma, NOS8130 Papillary transitional cell carcinoma8310 Clear cell adenocarcinoma, NOS8800 Sarcoma, NOS8810 Fibrosarcoma, NOS
C66 URETER23
222
29
6.910.375.9
6.9100.0
8010 Carcinoma, NOS8070 Squamous cell carcinoma, NOS8120 Transitional cell carcinoma, NOS8130 Papillary transitional cell carcinoma
34311
488
7.00.60.20.2
100.0
9085 Mixed germ cell tumor9100 Choriocarcinoma, NOS9102 Malignant teratoma, trophoblastic9120 Hemangiosarcoma
C63 OTHER MALE GENITAL311627122111111
31
9.73.23.2
19.46.5
22.63.26.56.53.23.23.23.23.23.2
100.0
8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8090 Basal cell carcinoma, NOS8140 Adenocarcinoma, NOS8480 Mucinous adenocarcinoma8542 Paget disease, extramammary8850 Liposarcoma, NOS8858 Dedifferentiated liposarcoma8910 Embryonal rhabdomyosarcoma, NOS9061 Seminoma, NOS9064 Germinoma9071 Yolk sac tumor9081 Teratocarcinoma
C64 KIDNEY15
7918
819
12
744
3915
122818
410
41411211112
5017213
1,302
0.10.46.11.40.61.50.10.25.70.33.01.29.4
62.80.30.80.30.10.30.10.10.20.10.10.10.10.23.80.10.50.20.10.2
100.0
8000 Neoplasm, malignant8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8120 Transitional cell carcinoma, NOS8130 Papillary transitional cell carcinoma8140 Adenocarcinoma, NOS8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8312 Renal cell carcinoma, NOS8317 Renal cell carcinoma, chromophobe type8318 Renal cell carcinoma, sarcomatoid8320 Granular cell carcinoma8510 Medullary carcinoma, NOS8800 Sarcoma, NOS8801 Spindle cell sarcoma8840 Myxosarcoma8850 Liposarcoma, NOS8858 Dedifferentiated liposarcoma8860 Angiomyolipoma8900 Rhabdomyosarcoma, NOS8901 Pleomorphic rhabdomyosarcoma, adult type8959 Malignant cystic nephroma8960 Nephroblastoma, NOS8963 Malignant rhabdoid tumor8964 Clear cell sarcoma of kidney8980 Carcinosarcoma, NOS9110 Mesonephroma, malignant9364 Peripheral neuroectodermal tumor
195
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
C67 BLADDER8
1383
5112
551
5333
1,20511
146135
173213121111112131111
1,842
0.47.50.22.80.10.13.00.12.90.20.2
65.40.10.17.97.30.10.40.20.10.10.20.10.10.10.10.10.10.10.10.10.10.20.10.10.10.1
100.0
8001 Tumor cells, malignant8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8032 Spindle cell carcinoma, NOS8033 Pseudosarcomatous carcinoma8050 Papillary carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8120 Transitional cell carcinoma, NOS8122 Transitional cell carcinoma, spindle cell8123 Basaloid carcinoma8130 Papillary transitional cell carcinoma8140 Adenocarcinoma, NOS8210 Adenocarcinoma in adenomatous polyp8260 Papillary adenocarcinoma, NOS8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8481 Mucin-producing adenocarcinoma8490 Signet ring cell carcinoma8550 Acinar cell carcinoma8570 Adenocarcinoma with squamous metaplasia8800 Sarcoma, NOS8804 Epithelioid sarcoma8851 Liposarcoma, well differentiated8852 Myxoid liposarcoma8890 Leiomyosarcoma, NOS8900 Rhabdomyosarcoma, NOS8910 Embryonal rhabdomyosarcoma, NOS8980 Carcinosarcoma, NOS9130 Hemangioendothelioma, malignant9580 Granular cell tumor, malignant9581 Alveolar soft part sarcoma
C68 OTHER URINARY ORGAN411231
122
26
15.43.83.87.7
11.53.8
46.27.7
100.0
8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8050 Papillary carcinoma, NOS8070 Squamous cell carcinoma, NOS8120 Transitional cell carcinoma, NOS8130 Papillary transitional cell carcinoma8140 Adenocarcinoma, NOS8980 Carcinosarcoma, NOS
C69 EYE11514
2913
2421
10311112
69211
155
0.60.63.20.62.6
18.78.41.32.61.30.66.51.90.60.60.60.61.3
44.51.30.60.6
100.0
8001 Tumor cells, malignant8003 Malignant tumor, giant cell type8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8070 Squamous cell carcinoma, NOS8140 Adenocarcinoma, NOS8147 Basal cell adenocarcinoma8200 Adenoid cystic carcinoma8430 Mucoepidermoid carcinoma8480 Mucinous adenocarcinoma8720 Malignant melanoma, NOS8900 Rhabdomyosarcoma, NOS8901 Pleomorphic rhabdomyosarcoma, adult type9120 Hemangiosarcoma9150 Hemangiopericytoma, malignant9170 Lymphangiosarcoma9500 Neuroblastoma, NOS9510 Retinoblastoma, NOS9511 Retinoblastoma, differentiated9512 Retinoblastoma, undifferentiated9513 Retinoblastoma, diffuse
196
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
C73 THYROID1
121195351
212
0.05.40.82.42.30.10.00.1
8001 Tumor cells, malignant8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8030 Giant cell and spindle cell carcinoma8032 Spindle cell carcinoma, NOS8033 Pseudosarcomatous carcinoma
C70-C72 BRAIN, NERVOUS SYSTEM64
321
1312231
6814926418181
1626
1114
62742
23652
6814
34311425719
493
73
3412
273
1196
32415
210
91651
4
61,925
3.30.20.10.10.70.10.10.10.20.13.50.10.20.50.10.30.20.10.40.10.40.18.40.30.60.10.23.20.40.20.1
12.32.70.30.40.10.2
17.80.62.23.01.00.24.80.40.21.80.60.13.80.10.10.50.3
16.80.80.10.50.50.82.60.2
0.3100.0
8001 Tumor cells, malignant8002 Malignant tumor, small cell type8003 Malignant tumor, giant cell type8720 Malignant melanoma, NOS8800 Sarcoma, NOS8801 Spindle cell sarcoma8802 Giant cell sarcoma8806 Desmoplastic small round cell tumor8963 Malignant rhabdoid tumor9060 Dysgerminoma9064 Germinoma9070 Embryonal carcinoma, NOS9071 Yolk sac tumor9080 Teratoma, malignant, NOS9081 Teratocarcinoma9085 Mixed germ cell tumor9120 Hemangiosarcoma9130 Hemangioendothelioma, malignant9150 Hemangiopericytoma, malignant9170 Lymphangiosarcoma9364 Peripheral neuroectodermal tumor9370 Chordoma, NOS9380 Glioma, malignant9381 Gliomatosis cerebri9382 Mixed glioma9383 Subependymoma9390 Choroid plexus carcinoma9391 Ependymoma, NOS9392 Ependymoma, anaplastic9393 Papillary ependymoma9394 Myxopapillary ependymoma9400 Astrocytoma, NOS9401 Astrocytoma, anaplastic9411 Gemistocytic astrocytoma9420 Fibrillary astrocytoma9423 Polar spongioblastoma9430 Astroblastoma9440 Glioblastoma, NOS9441 Giant cell glioblastoma9442 Gliosarcoma9450 Oligodendroglioma, NOS9451 Oligodendroglioma, anaplastic9460 Oligodendroblastoma9470 Medulloblastoma, NOS9471 Desmoplastic nodular medulloblastoma9472 Medullomyoblastoma9473 Primitive neuroectodermal tumor, NOS9480 Cerebellar sarcoma, NOS9490 Ganglioneuroblastoma9500 Neuroblastoma, NOS9501 Medulloepithelioma, NOS9503 Neuroepithelioma, NOS9505 Ganglioglioma, anaplastic9508 Atypical teratoid/rhabdoid tumor9530 Meningioma, malignant9531 Meningothelial meningioma9537 Transitional meningioma9538 Papillary meningioma9539 Meningeal sarcomatosis9540 Malignant peripheral nerve sheath tumor9560 Neurilemoma, malignant9561 Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation9580 Granular cell tumor, malignant
197
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
9561
1136
111
101111
24625
4204
101
13923
3
42.50.00.51.60.00.00.04.50.00.00.0
10.90.10.2
18.70.20.40.06.21.00.1
8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8052 Papillary squamous cell carcinoma8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8076 Squamous cell carcinoma, microinvasive8140 Adenocarcinoma, NOS8190 Trabecular adenocarcinoma8241 Enterochromaffin cell carcinoid8246 Neuroendocrine carcinoma, NOS8260 Papillary adenocarcinoma, NOS8263 Adenocarcinoma in tubulovillous adenoma8290 Oxyphilic adenocarcinoma8330 Follicular adenocarcinoma, NOS8331 Follicular adenocarcinoma, well differentiated8332 Follicular adenocarcinoma, trabecular8335 Follicular carcinoma, minimally invasive8340 Papillary carcinoma, follicular variant8341 Papillary microcarcinoma8346 Mixed medullary-follicular carcinoma
213
22124
2,249
0.10.00.11.00.00.10.2
100.0
8350 Nonencapsulated sclerosing carcinoma8440 Cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8510 Medullary carcinoma, NOS8550 Acinar cell carcinoma8850 Liposarcoma, NOS8980 Carcinosarcoma, NOS
C75 OTHER ENDOCRINE39122
551311
3211211
101112
19111
153
2.05.90.71.31.3
35.90.72.00.70.7
20.90.70.71.30.70.76.50.70.70.71.3
12.40.70.70.7
100.0
8001 Tumor cells, malignant8010 Carcinoma, NOS8020 Carcinoma, undifferentiated, NOS8022 Pleomorphic carcinoma8070 Squamous cell carcinoma, NOS8140 Adenocarcinoma, NOS8200 Adenoid cystic carcinoma8210 Adenocarcinoma in adenomatous polyp8263 Adenocarcinoma in tubulovillous adenoma8270 Chromophobe carcinoma8272 Pituitary carcinoma, NOS8280 Acidophil carcinoma8281 Mixed acidophil-basophil carcinoma8430 Mucoepidermoid carcinoma8710 Glomangiosarcoma8711 Glomus tumor, malignant9064 Germinoma9070 Embryonal carcinoma, NOS9080 Teratoma, malignant, NOS9085 Mixed germ cell tumor9361 Pineocytoma9362 Pineoblastoma9380 Glioma, malignant9400 Astrocytoma, NOS9580 Granular cell tumor, malignant
C74 ADRENAL GLAND1913191
171
1311
2987
1.110.3
1.13.41.1
10.31.1
19.51.1
14.91.11.1
33.3100.0
8000 Neoplasm, malignant8010 Carcinoma, NOS8011 Epithelioma, malignant8020 Carcinoma, undifferentiated, NOS8070 Squamous cell carcinoma, NOS8140 Adenocarcinoma, NOS8260 Papillary adenocarcinoma, NOS8370 Adrenal cortical carcinoma8510 Medullary carcinoma, NOS8700 Pheochromocytoma, malignant8850 Liposarcoma, NOS9120 Hemangiosarcoma9500 Neuroblastoma, NOS
198
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
27411
789125
3293
1591,362
559130
0.60.10.00.0
17.32.70.72.03.5
29.812.2
2.8
9827 Adult T-cell leukemia/lymphoma (HTLV-1 positive)9832 Prolymphocytic leukemia, NOS9833 Prolymphocytic leukemia, B-cell type9834 Prolymphocytic leukemia, T-cell type9835 Precursor cell lymphoblastic leukemia, NOS9836 Precursor B-cell lymphoblastic leukemia9837 Precursor T-cell lymphoblastic leukemia9840 Acute myeloid leukemia, M6 type9860 Myeloid leukemia, NOS9861 Acute myeloid leukemia, NOS9863 Chronic myeloid leukemia, NOS9866 Acute promyelocytic leukemia
C81-C85, C96 LYMPHOMA1
7011,652
152528
271315
313
5918
478
4574
1,3951733
4163
0.013.130.9
2.89.90.50.20.30.10.00.11.10.00.10.90.10.80.10.1
26.10.30.60.13.0
9530 Meningioma, malignant9590 Malignant lymphoma, NOS9591 Malignant lymphoma, non-Hodgkin, NOS9596 Composite Hodgkin and non-Hodgkin lymphoma9650 Hodgkin lymphoma, NOS9651 Hodgkin lymphoma, lymphocyte-rich9652 Hodgkin lymphoma, mixed cellularity, NOS9653 Hodgkin lymphoma, lymphocyte depletion, NOS9659 Hodgkin lymphoma, nodular lymphocyte predominance9661 Hodgkin granuloma9662 Hodgkin sarcoma9663 Hodgkin lymphoma, nodular sclerosis, NOS9664 Hodgkin lymphoma, nodular sclerosis, cellular phase9665 Hodgkin lymphoma, nodular sclerosis, grade 19670 Malignant lymphoma, small B lymphocytic, NOS9671 Malignant lymphoma, lymphoplasmacytic9673 Mantle cell lymphoma9675 Malignant lymphoma, mixed small and large cell, diffuse9679 Mediastinal large B-cell lymphoma9680 Malignant lymphoma, large B-cell, diffuse, NOS9684 Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS9687 Burkitt lymphoma, NOS9689 Splenic marginal zone B-cell lymphoma9690 Follicular lymphoma, NOS9691 Follicular lymphoma, grade 29695 Follicular lymphoma, grade 19698 Follicular lymphoma, grade 3
66
163044
3167
1915
971479
19641
11311
5,348
0.10.10.30.60.80.13.10.40.00.11.80.00.10.10.20.40.10.10.00.20.10.00.0
100.0
9699 Marginal zone B-cell lymphoma, NOS9700 Mycosis fungoides9701 Sezary syndrome9702 Mature T-cell lymphoma, NOS9705 Angioimmunoblastic T-cell lymphoma9708 Subcutaneous panniculitis-like T-cell lymphoma9709 Cutaneous T-cell lymphoma, NOS9714 Anaplastic large cell lymphoma, T cell and Null cell type9717 Intestinal T-cell lymphoma9718 Primary cutaneous CD30+ T-cell lymphoproliferative disorder9719 NK/T-cell lymphoma, nasal and nasal-type9727 Precursor cell lymphoblastic lymphoma, NOS9728 Precursor B-cell lymphoblastic lymphoma9729 Precursor T-cell lymphoblastic lymphoma9740 Mast cell sarcoma9741 Malignant mastocytosis9754 Langerhans cell histiocytosis, disseminated9755 Histiocytic sarcoma9756 Langerhans cell sarcoma9758 Follicular dendritic cell sarcoma
C90 MULTIPLE MYELOMA40
67942
725
5.593.7
0.60.3
100.0
9731 Plasmacytoma, NOS9732 Multiple myeloma9733 Plasma cell leukemia9734 Plasmacytoma, extramedullary
C91-C95 LEUKAEMIA126659
4105124
85
2.814.4
0.12.32.71.9
9800 Leukemia, NOS9801 Acute leukemia, NOS9805 Acute biphenotypic leukemia9820 Lymphoid leukemia, NOS9823 B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma9826 Burkitt cell leukemia
199
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
111519111113
133
0.10.10.10.50.10.80.10.10.10.10.10.31.20.3
8500 Infiltrating duct carcinoma, NOS8521 Infiltrating ductular carcinoma8550 Acinar cell carcinoma8560 Adenosquamous carcinoma8680 Paraganglioma, malignant8800 Sarcoma, NOS8801 Spindle cell sarcoma8802 Giant cell sarcoma8803 Small cell sarcoma8810 Fibrosarcoma, NOS8821 Aggressive fibromatosis8830 Malignant fibrous histiocytoma8850 Liposarcoma, NOS8851 Liposarcoma, well differentiated
3626
121159
26768
211811115
4,570
0.80.00.10.30.00.00.10.20.60.20.10.20.50.40.20.20.1
100.0
9867 Acute myelomonocytic leukemia9870 Acute basophilic leukemia9871 Acute myeloid leukemia, with abnormal marrow eosinophils9872 Acute myeloid leukemia, minimal differentiation9873 Acute myeloid leukemia without maturation9874 Acute myeloid leukemia with maturation9875 Chronic myelogenous leukemia, BCR/ABL positive9876 Atypical chronic myeloid leukemia, BCR/ABL negative9891 Acute monocytic leukemia9895 Acute myeloid leukemia with multilineage dysplasia9896 Acute myeloid leukemia, t(8;21)(q22;q22)9910 Acute megakaryoblastic leukemia9930 Myeloid sarcoma9931 Acute panmyelosis with myelofibrosis9940 Hairy cell leukemia9945 Chronic myelomonocytic leukemia, NOS9946 Juvenile myelomonocytic leukemia
71
654113
1331
1853
1111123
285114113
101522521
171
134
0.60.16.00.40.10.10.31.20.30.1
17.10.31.00.10.10.10.20.3
26.30.10.10.40.10.10.30.90.10.50.20.20.50.20.11.60.11.20.4
8012 Large cell carcinoma, NOS8013 Large cell neuroendocrine carcinoma8020 Carcinoma, undifferentiated, NOS8021 Carcinoma, anaplastic, NOS8022 Pleomorphic carcinoma8031 Giant cell carcinoma8032 Spindle cell carcinoma, NOS8041 Small cell carcinoma, NOS8050 Papillary carcinoma, NOS8051 Verrucous carcinoma, NOS8070 Squamous cell carcinoma, NOS8071 Squamous cell carcinoma, keratinizing, NOS8072 Squamous cell carcinoma, large cell, nonkeratinizing, NOS8073 Squamous cell carcinoma, small cell, nonkeratinizing8075 Squamous cell carcinoma, adenoid8082 Lymphoepithelial carcinoma8083 Basaloid squamous cell carcinoma8120 Transitional cell carcinoma, NOS8140 Adenocarcinoma, NOS8141 Scirrhous adenocarcinoma8153 Gastrinoma, malignant8200 Adenoid cystic carcinoma8210 Adenocarcinoma in adenomatous polyp8211 Tubular adenocarcinoma8240 Carcinoid tumor, NOS8246 Neuroendocrine carcinoma, NOS8249 Atypical carcinoid tumor8260 Papillary adenocarcinoma, NOS8263 Adenocarcinoma in tubulovillous adenoma8290 Oxyphilic adenocarcinoma8310 Clear cell adenocarcinoma, NOS8430 Mucoepidermoid carcinoma8440 Cystadenocarcinoma, NOS8461 Serous surface papillary carcinoma8470 Mucinous cystadenocarcinoma, NOS8480 Mucinous adenocarcinoma8490 Signet ring cell carcinoma
OTHER & UNSPEC.2
39323
217
0.23.60.30.20.3
20.1
8000 Neoplasm, malignant8001 Tumor cells, malignant8002 Malignant tumor, small cell type8003 Malignant tumor, giant cell type8004 Malignant tumor, spindle cell type8010 Carcinoma, NOS
200
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
11286
43122181
113153217362
1,093
0.10.10.20.70.64.00.10.20.20.10.70.11.00.30.10.50.30.20.10.60.30.50.2
100.0
8852 Myxoid liposarcoma8854 Pleomorphic liposarcoma8858 Dedifferentiated liposarcoma8890 Leiomyosarcoma, NOS8900 Rhabdomyosarcoma, NOS8936 Gastrointestinal stromal sarcoma8940 Mixed tumor, malignant, NOS8963 Malignant rhabdoid tumor8980 Carcinosarcoma, NOS8981 Carcinosarcoma, embryonal9064 Germinoma9071 Yolk sac tumor9080 Teratoma, malignant, NOS9085 Mixed germ cell tumor9100 Choriocarcinoma, NOS9170 Lymphangiosarcoma9364 Peripheral neuroectodermal tumor9370 Chordoma, NOS9372 Dedifferentiated chordoma9500 Neuroblastoma, NOS9760 Immunoproliferative disease, NOS9761 Waldenstrom macroglobulinemia9762 Heavy chain disease, NOS
201
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
APPENDIX 100: CANCER NOTIFICATION FORM
202
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
Please Notify a) All case of cancers (i.e. carcinomas, sarcomas, leukaemias and all other malignant tumours) diagnosed or treated in your hospital, clinic or practice. b) Confirmed cases of cancer as well as cases of ‘probable cancer’ in which the diagnosis is based only on clinical finding (i.e. without histological, radiological or other methods of confirmation). c) All cases diagnosed in Malaysia regardless of citizenships or place of domicile of the patient. d) Cancer cases referred to your hospital/clinic/practice which may have already been notified by the previous attending doctor. e) Follow up cases; please use the same form (Fill in name, I/C number, source of information and any other information that is different from the original previous notification form). You may choose to notify only once.
PROCEDURE 1. Patient Identification No. - For Malaysian patient with new I/C No. fill up all the 12 digits and the old I/C No. if available - For patient with only old I/C No. fill up his/her I/C No. in the Identification No. boxes. - Children below 12 years without NRIC, insert patient’s I/C No. with additional M or F in the appropriate boxes indicating mother or father NRIC was used (e.g. A 1234567M) - Passport No. Police/ Arm Forces Identification Card Number to be used for foreigners/ police/ arms personnel. (please indicate) Name – Full name in block letters as in NRIC/ passport Usual Resident Address: Address where the patient usually resides at least for 6 months [Note: The address NRIC may not be the same] Date of birth: Insert date of birth of patient into boxes. [If not available insert year of birth] Sex, Ethnic Group, Citizenship : Tick appropriate box
2. Source of Information (refers to Hospital/ Clinic the notifying doctor is working in)
3. Diagnosis (If insufficient space, write the information on a piece of paper and attach as appendix)
Diagnosis (Site for topography): This refers to the diagnosis at the time of notification Please write in words with as much detail as possible.
Pathological Diagnosis (Morphology): Please write in words with as much detail as possible
4. Date of Diagnosis: Insert date of diagnosis made (Date that can be verified from records) and follow IARC definition*
5. Basis of diagnosis: Tick appropriate box(es) 6. Stage of Disease at the time of diagnosis: Fill in and tick appropriate box(es) 7. Type of treatment: Tick appropriate box(es) and fill in date of first treatment 8. Present status: Tick the appropriate box and fill in relevant details. 9. Date of notification: Insert the date into the appropriate box
APPENDIX 101: EXPLANATORY NOTES FOR COMPLETING CANCER NOTIFICATION FORM
*Definition of Incidence Date 1. Date of first histological or cytological confirmation a) Date when the specimen was taken (biopsy or operation) b) Date of receipt by the pathologist c) Date of the pathology report. 2. Date of admission to the hospital because of this malignancy. 3. Date of first consultation at the outpatient clinic (only). 4. Date of diagnosis, other than 1, 2 or 3. 5. Date of death, if no information than that the patient has died because of a malignancy. 6. Date of death, if the malignancy is discovered at autopsy.
203
MALAYSIAN NATIONAL CANCER REGISTRY REPORT2007-2011
National Cancer Institute, Ministry of HealthNo. 4, Jalan P7, Presint 7, 62250 Putrajaya
Tel : (603) 8892 5555 Fax : (603) 8892 5625
Recommended